<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:dcterms="http://purl.org/dc/terms/"
     xmlns:media="http://search.yahoo.com/mrss/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:cf="https://www.futureplc.com/rss/content-flags"
>
    <channel>
                    <atom:link href="https://www.livescience.com/feeds/tag/health" rel="self" type="application/rss+xml" />
                            <title><![CDATA[ Latest from Live Science in Health ]]></title>
                <link>https://www.livescience.com/health</link>
        <description><![CDATA[ All the latest health content from the Live Science team ]]></description>
                                    <lastBuildDate>Sat, 21 Nov 2026 12:00:00 +0000</lastBuildDate>
                            <language>en</language>
                                <item>
                                                            <title><![CDATA[ Scientists put 78,000 letters of human DNA into a mouse — and unraveled how a rare disease worked ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Scientists have unraveled the workings of a rare disease by putting a large chunk of human DNA into a lab mouse.</p><p>The incurable disorder, called <a href="https://medlineplus.gov/genetics/condition/x-linked-dystonia-parkinsonism/" target="_blank"><u>X-linked dystonia-parkinsonism</u></a> (XDP), mostly affects men of Filipino descent and leads to early death. The new mouse studies revealed previously unknown aspects of the disease's biology that could point to new avenues for treatment.</p><p>The condition has long been thought of as a disease of neurons, as it triggers neuron death in a part of the brain that's key to controlling movement. But the new findings highlight an unsung role of neurons' support cells, called glial cells. </p><p>"This had never been described in this disease before," study co-author <a href="https://med.nyu.edu/faculty/shane-a-liddelow" target="_blank"><u>Shane Liddelow</u></a>, an associate professor in the Institute for Translational Neuroscience at the NYU Grossman School of Medicine, said of the new findings. "It really sort of upended this idea of the disease" as primarily affecting neurons.</p><p>The two studies, published Thursday (Nov. 19) in the journal Cell, not only shed new light on this rare disease but also showcase a powerful technique for mimicking human conditions in laboratory animals. Known as "SwAP-In," it enables researchers to rewrite large portions of an organism's genetic code by inserting big chunks of synthetic DNA. In this case, the approach was used to insert a human gene into lab mice.</p><p>"It is kind of a generic method that can be used to make extensively humanized mice," said study co-author <a href="https://med.nyu.edu/faculty/jef-d-boeke" target="_blank"><u>Jef Boeke</u></a>, director of the Institute for Systems Genetics at the NYU Grossman School of Medicine and a <a href="https://www.science.org/doi/10.1126/science.aaf4557?referrer=https%3A%2F%2Fwww.google.com%2F" target="_blank"><u>lead developer of the SwAP-In technique</u></a>. </p><p>Liddelow anticipates that this new method for humanizing mice, or <a href="https://www.livescience.com/health/immune-system/scientists-breed-most-human-like-mice-yet"><u>tweaking their biology</u></a> to more closely match that of humans, will prove useful for studying a wide range of diseases, from common conditions like Alzheimer's to "<a href="https://my.clevelandclinic.org/health/diseases/rare-and-orphan-diseases" target="_blank"><u>orphan" diseases</u></a> like XDP, which are rare, underresearched and lacking effective treatments.</p><h2 id="a-challenging-disease-to-study">A challenging disease to study</h2><p>XDP is a neurodegenerative condition that particularly impacts the striatum, part of the brain that's crucial for movement. The disease causes symptoms such as slowed movements, tremors, muscle stiffness and involuntary muscle contractions. </p><p>On average, <a href="https://www.orpha.net/en/disease/detail/53351" target="_blank"><u>symptoms emerge</u></a> around age 39 and patients live for 13 to 16 years after their symptoms appear. In late stages of the disease, problems with breathing and swallowing can lead to deadly complications such as malnutrition, aspiration pneumonia and respiratory failure. Historically, XDP has also <a href="https://sunshinecarefoundation.org/understand-xdp/" target="_blank"><u>carried a lot of social stigma</u></a>, which has contributed to high rates of <a href="https://www.herdin.ph/index.php/partner/journal?view=research&amp;cid=48558" target="_blank"><u>depression and suicide among those with the condition</u></a>.</p><p>"Patients get sort of shunned and hidden away," Liddelow said. That, among other factors, made XDP difficult to study. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2560px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="NzvNPo3rsxjDJ9owN7c5De" name="GettyImages-1021833512-inheritance" alt="A cartoon showing how certain genes are inherited." src="https://cdn.mos.cms.futurecdn.net/NzvNPo3rsxjDJ9owN7c5De-1920-80.jpg" mos="" align="middle" fullscreen="" width="2560" height="2560" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">XDP shows an X-linked recessive inheritance pattern (depicted above). </span><span class="credit" itemprop="copyrightHolder">(Image credit: ttsz via Getty Images)</span></figcaption></figure><p>Although XDP isn't fully understood, its underlying genetic cause is known. It stems from a mutation in <a href="https://medlineplus.gov/genetics/gene/taf1/" target="_blank"><u>TAF1</u></a>, a gene on the X chromosome that helps translate DNA sequences into new proteins. Because males carry only one X chromosome — and thus have no backup copy of the gene — the condition affects far more males than females. </p><p>The mutation first appeared in a person on Panay, an island in the Philippines. Due to a phenomenon called the "<a href="https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/founder-mutation" target="_blank"><u>founder effect</u></a>," it has risen in prevalence among people of Filipino ancestry but is not seen in other demographics, Boeke explained. <a href="https://www.tandfonline.com/doi/full/10.3109/00207454.2010.526728" target="_blank"><u>Studies suggest</u></a> there are about 5.7 cases per 100,000 people in the Philippines.</p><p>XDP's rarity and associated stigma have made the condition difficult to study, but there's another layer of complexity: The mutation in TAF1 was originally caused by a "jumping gene" ‪—‬ a bit of DNA that changed its position within the genome. In this instance, the DNA happened to jump into the middle of TAF1 and disrupted its function, Boeke said. </p><p>But the jumping gene in question is found only in primates. Ideally, if you wanted to study the disease in lab mice, you'd have to insert that jumping gene into their DNA — and that's exactly what the researchers did in the <a href="https://www.cell.com/cell/fulltext/S0092-8674(26)00926-8" target="_blank"><u>first of their two new studies</u></a>.</p><h2 id="unraveling-an-orphan-disease">Unraveling an orphan disease</h2><p>Using SwAP-In, the team inserted 78,000 "letters" of human DNA code into mouse embryonic stem cells. This code included part of the human version of the TAF1 gene and the relevant jumping gene that causes XDP. In both lab dishes and living mice, this gene insertion triggered the telltale signs of XDP: low levels of the TAF1 protein, cell death and holes in the brain, especially in the striatum. </p><p>One big difference between mice and humans is that the mouse version of XDP progresses very quickly, with symptoms appearing in just 1.5 months, whereas the human disease takes years to show up. That may be because human bodies have safeguards to help offset the jumping gene's effects — at least for a while — while mice lack this safety net, the study authors theorized.</p><p>That difference in disease progression is actually a "huge advantage" for researchers, Boeke noted. "Because it's so sped up, it's possible to do experiments on therapeutics," he said. For instance, if an experimental drug is successfully fighting the disease, that should be obvious in the mice, whose condition would otherwise progress very quickly.</p><div><blockquote><p>I think that is, one, interesting from a biological standpoint, but two, profoundly important for how you might develop therapies to help these patients.</p><p>Shane Liddelow, an associate professor in the Institute for Translational Neuroscience at the NYU Grossman School of Medicine</p></blockquote></div><p>In the <a href="https://www.cell.com/cell/abstract/S0092-8674(26)01339-5" target="_blank"><u>second of the team's new studies</u></a>, they took a closer look at the new mice with XDP, to see how the disorder affected their brain cells. Through a battery of tests, they realized that glial cells known as oligodendrocytes showed dramatic changes in both their overall numbers and their gene activity. </p><p>These cells would normally make a fatty insulating material called myelin, which wraps around the outgoing wires of neurons to help them send signals. To see how the cells were faring in the XDP mice, study co-author <a href="https://www.liddelowlab.com/priya-prakash" target="_blank"><u>Priya Prakash</u></a>, a postdoctoral scholar in Liddelow's lab, used a blue stain to label the cells within the mouse brain tissue.</p><p>"Where you would normally see this beautiful blue brain, full of lipid, full of myelin, you essentially see a white brain, with none of this lipid there," Liddelow said. This was especially apparent in the striatum and the prefrontal cortex. </p><p>Further experiments revealed that the mutation was preventing oligodendrocytes from fully maturing, and that reduced the amount of myelin made in these parts of the brain. They backed up these findings in brains of people with XDP that had been donated after death. </p><p>The researchers think this extensive loss of insulation may leave neurons vulnerable to dying early, Liddelow said. In short, "this is a neurodegenerative disease that may not first be manifesting in neurons themselves," he emphasized. "I think that is, one, interesting from a biological standpoint, but two, profoundly important for how you might develop therapies to help these patients."</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/silent-x-chromosome-genes-reawaken-in-older-females-perhaps-boosting-brain-power-study-finds">Silent X chromosome genes 'reawaken' in older females, perhaps boosting brain power, study finds</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/scientists-breed-most-human-like-mice-yet">Scientists breed most human-like mice yet</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/gene-on-the-x-chromosome-may-help-explain-high-multiple-sclerosis-rates-in-women">Gene on the X chromosome may help explain high multiple sclerosis rates in women</a></li></ul></p></div></div><p>Together, the studies raise several ideas for treating XDP. One treatment could involve cranking up the activity of the TAF1 gene to boost the levels of its related protein. This idea showed promise in experiments with mouse cells in the team's first paper. The second paper points to oligodendrocytes as potential targets for future therapies, and myelin loss as a potential early sign of the disease that might be useful for diagnosis.</p><p>There's still much more to learn about the biology of XDP and what types of treatments might reverse the drivers of the disease, Liddelow and Boeke emphasized. But now, other scientists have access to a brand-new mouse model that can help them solve the disease's remaining mysteries.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/genetics/scientists-put-78-000-letters-of-human-dna-into-a-mouse-and-unraveled-how-a-rare-disease-worked</link>
                                                                            <description>
                            <![CDATA[ By inserting human genes into lab mice, scientists were able to study the underlying mechanics of a disease that's been notoriously difficult to research. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">YEJMSpV52ZeoGakodkpYn8</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/SDnuChhbcS9ZhohM4CDYKY-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sat, 21 Nov 2026 12:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Genetics]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/SDnuChhbcS9ZhohM4CDYKY-1920-80.jpg">
                                                            <media:credit><![CDATA[Tingting Ji via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A new study unravels a rare condition caused by a genetic mutation on the X chromosome. ]]></media:description>                                                            <media:text><![CDATA[An illustration of a blue 3D rendered chromosome with DNA inside.]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a blue 3D rendered chromosome with DNA inside.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/SDnuChhbcS9ZhohM4CDYKY-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Scientists have unraveled the workings of a rare disease by putting a large chunk of human DNA into a lab mouse.</p><p>The incurable disorder, called <a href="https://medlineplus.gov/genetics/condition/x-linked-dystonia-parkinsonism/" target="_blank"><u>X-linked dystonia-parkinsonism</u></a> (XDP), mostly affects men of Filipino descent and leads to early death. The new mouse studies revealed previously unknown aspects of the disease's biology that could point to new avenues for treatment.</p><p>The condition has long been thought of as a disease of neurons, as it triggers neuron death in a part of the brain that's key to controlling movement. But the new findings highlight an unsung role of neurons' support cells, called glial cells. </p><p>"This had never been described in this disease before," study co-author <a href="https://med.nyu.edu/faculty/shane-a-liddelow" target="_blank"><u>Shane Liddelow</u></a>, an associate professor in the Institute for Translational Neuroscience at the NYU Grossman School of Medicine, said of the new findings. "It really sort of upended this idea of the disease" as primarily affecting neurons.</p><p>The two studies, published Thursday (Nov. 19) in the journal Cell, not only shed new light on this rare disease but also showcase a powerful technique for mimicking human conditions in laboratory animals. Known as "SwAP-In," it enables researchers to rewrite large portions of an organism's genetic code by inserting big chunks of synthetic DNA. In this case, the approach was used to insert a human gene into lab mice.</p><p>"It is kind of a generic method that can be used to make extensively humanized mice," said study co-author <a href="https://med.nyu.edu/faculty/jef-d-boeke" target="_blank"><u>Jef Boeke</u></a>, director of the Institute for Systems Genetics at the NYU Grossman School of Medicine and a <a href="https://www.science.org/doi/10.1126/science.aaf4557?referrer=https%3A%2F%2Fwww.google.com%2F" target="_blank"><u>lead developer of the SwAP-In technique</u></a>. </p><p>Liddelow anticipates that this new method for humanizing mice, or <a href="https://www.livescience.com/health/immune-system/scientists-breed-most-human-like-mice-yet"><u>tweaking their biology</u></a> to more closely match that of humans, will prove useful for studying a wide range of diseases, from common conditions like Alzheimer's to "<a href="https://my.clevelandclinic.org/health/diseases/rare-and-orphan-diseases" target="_blank"><u>orphan" diseases</u></a> like XDP, which are rare, underresearched and lacking effective treatments.</p><h2 id="a-challenging-disease-to-study">A challenging disease to study</h2><p>XDP is a neurodegenerative condition that particularly impacts the striatum, part of the brain that's crucial for movement. The disease causes symptoms such as slowed movements, tremors, muscle stiffness and involuntary muscle contractions. </p><p>On average, <a href="https://www.orpha.net/en/disease/detail/53351" target="_blank"><u>symptoms emerge</u></a> around age 39 and patients live for 13 to 16 years after their symptoms appear. In late stages of the disease, problems with breathing and swallowing can lead to deadly complications such as malnutrition, aspiration pneumonia and respiratory failure. Historically, XDP has also <a href="https://sunshinecarefoundation.org/understand-xdp/" target="_blank"><u>carried a lot of social stigma</u></a>, which has contributed to high rates of <a href="https://www.herdin.ph/index.php/partner/journal?view=research&amp;cid=48558" target="_blank"><u>depression and suicide among those with the condition</u></a>.</p><p>"Patients get sort of shunned and hidden away," Liddelow said. That, among other factors, made XDP difficult to study. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2560px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="NzvNPo3rsxjDJ9owN7c5De" name="GettyImages-1021833512-inheritance" alt="A cartoon showing how certain genes are inherited." src="https://cdn.mos.cms.futurecdn.net/NzvNPo3rsxjDJ9owN7c5De-1920-80.jpg" mos="" align="middle" fullscreen="" width="2560" height="2560" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">XDP shows an X-linked recessive inheritance pattern (depicted above). </span><span class="credit" itemprop="copyrightHolder">(Image credit: ttsz via Getty Images)</span></figcaption></figure><p>Although XDP isn't fully understood, its underlying genetic cause is known. It stems from a mutation in <a href="https://medlineplus.gov/genetics/gene/taf1/" target="_blank"><u>TAF1</u></a>, a gene on the X chromosome that helps translate DNA sequences into new proteins. Because males carry only one X chromosome — and thus have no backup copy of the gene — the condition affects far more males than females. </p><p>The mutation first appeared in a person on Panay, an island in the Philippines. Due to a phenomenon called the "<a href="https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/founder-mutation" target="_blank"><u>founder effect</u></a>," it has risen in prevalence among people of Filipino ancestry but is not seen in other demographics, Boeke explained. <a href="https://www.tandfonline.com/doi/full/10.3109/00207454.2010.526728" target="_blank"><u>Studies suggest</u></a> there are about 5.7 cases per 100,000 people in the Philippines.</p><p>XDP's rarity and associated stigma have made the condition difficult to study, but there's another layer of complexity: The mutation in TAF1 was originally caused by a "jumping gene" ‪—‬ a bit of DNA that changed its position within the genome. In this instance, the DNA happened to jump into the middle of TAF1 and disrupted its function, Boeke said. </p><p>But the jumping gene in question is found only in primates. Ideally, if you wanted to study the disease in lab mice, you'd have to insert that jumping gene into their DNA — and that's exactly what the researchers did in the <a href="https://www.cell.com/cell/fulltext/S0092-8674(26)00926-8" target="_blank"><u>first of their two new studies</u></a>.</p><h2 id="unraveling-an-orphan-disease">Unraveling an orphan disease</h2><p>Using SwAP-In, the team inserted 78,000 "letters" of human DNA code into mouse embryonic stem cells. This code included part of the human version of the TAF1 gene and the relevant jumping gene that causes XDP. In both lab dishes and living mice, this gene insertion triggered the telltale signs of XDP: low levels of the TAF1 protein, cell death and holes in the brain, especially in the striatum. </p><p>One big difference between mice and humans is that the mouse version of XDP progresses very quickly, with symptoms appearing in just 1.5 months, whereas the human disease takes years to show up. That may be because human bodies have safeguards to help offset the jumping gene's effects — at least for a while — while mice lack this safety net, the study authors theorized.</p><p>That difference in disease progression is actually a "huge advantage" for researchers, Boeke noted. "Because it's so sped up, it's possible to do experiments on therapeutics," he said. For instance, if an experimental drug is successfully fighting the disease, that should be obvious in the mice, whose condition would otherwise progress very quickly.</p><div><blockquote><p>I think that is, one, interesting from a biological standpoint, but two, profoundly important for how you might develop therapies to help these patients.</p><p>Shane Liddelow, an associate professor in the Institute for Translational Neuroscience at the NYU Grossman School of Medicine</p></blockquote></div><p>In the <a href="https://www.cell.com/cell/abstract/S0092-8674(26)01339-5" target="_blank"><u>second of the team's new studies</u></a>, they took a closer look at the new mice with XDP, to see how the disorder affected their brain cells. Through a battery of tests, they realized that glial cells known as oligodendrocytes showed dramatic changes in both their overall numbers and their gene activity. </p><p>These cells would normally make a fatty insulating material called myelin, which wraps around the outgoing wires of neurons to help them send signals. To see how the cells were faring in the XDP mice, study co-author <a href="https://www.liddelowlab.com/priya-prakash" target="_blank"><u>Priya Prakash</u></a>, a postdoctoral scholar in Liddelow's lab, used a blue stain to label the cells within the mouse brain tissue.</p><p>"Where you would normally see this beautiful blue brain, full of lipid, full of myelin, you essentially see a white brain, with none of this lipid there," Liddelow said. This was especially apparent in the striatum and the prefrontal cortex. </p><p>Further experiments revealed that the mutation was preventing oligodendrocytes from fully maturing, and that reduced the amount of myelin made in these parts of the brain. They backed up these findings in brains of people with XDP that had been donated after death. </p><p>The researchers think this extensive loss of insulation may leave neurons vulnerable to dying early, Liddelow said. In short, "this is a neurodegenerative disease that may not first be manifesting in neurons themselves," he emphasized. "I think that is, one, interesting from a biological standpoint, but two, profoundly important for how you might develop therapies to help these patients."</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/silent-x-chromosome-genes-reawaken-in-older-females-perhaps-boosting-brain-power-study-finds">Silent X chromosome genes 'reawaken' in older females, perhaps boosting brain power, study finds</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/scientists-breed-most-human-like-mice-yet">Scientists breed most human-like mice yet</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/gene-on-the-x-chromosome-may-help-explain-high-multiple-sclerosis-rates-in-women">Gene on the X chromosome may help explain high multiple sclerosis rates in women</a></li></ul></p></div></div><p>Together, the studies raise several ideas for treating XDP. One treatment could involve cranking up the activity of the TAF1 gene to boost the levels of its related protein. This idea showed promise in experiments with mouse cells in the team's first paper. The second paper points to oligodendrocytes as potential targets for future therapies, and myelin loss as a potential early sign of the disease that might be useful for diagnosis.</p><p>There's still much more to learn about the biology of XDP and what types of treatments might reverse the drivers of the disease, Liddelow and Boeke emphasized. But now, other scientists have access to a brand-new mouse model that can help them solve the disease's remaining mysteries.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Brains of people with PTSD have unique epigenetic marks, study finds ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A study of hundreds of brains has revealed molecular differences in people with post-traumatic stress disorder (PTSD) that are not found in individuals without the condition.</p><p>These molecular marks also differ from those seen in the brains of people with other conditions, like depression, the research found.</p><p>Our environment and experiences influence how our genes work, affecting which genes can be turned on. Rather than changing genes' underlying code, the environment can trigger what are known as <a href="https://www.cdc.gov/genomics-and-health/epigenetics/index.html" target="_blank"><u>epigenetic changes</u></a>, which include certain chemicals that attach to DNA molecules and change their structure. </p><p>One such epigenetic change, called methylation, can work like a "dimmer switch" for genes, or even completely block certain genes from turning on.</p><p>"These epigenetic features of the brain are important for shaping the way the brain functions," study co-author <a href="https://liberalarts.utexas.edu/prc/faculty/fac752" target="_blank"><u>Frances Champagne</u></a>, a psychologist at the University of Texas at Austin, told Live Science. "This can give us some insight into why individuals with PTSD develop PTSD, or how [their brains] are different from a healthy brain."</p><p>In the new study, published Friday (Nov. 20) in the journal <a href="https://doi.org/10.1016/j.celrep.2026.118270" target="_blank"><u>Cell Reports</u></a>, scientists took a close look at DNA methylation in 302 brains that had been donated after death. These included 101 brains from individuals diagnosed with PTSD, 101 from people with major depressive disorder and 100 from people without any diagnosed psychiatric disorders. The researchers also had access to these individuals' medical records. </p><p>The team zoomed in on three brain regions: the prefrontal cortex, the amygdala and the hippocampus. The prefrontal cortex handles cognitive functions like planning and decision-making, the <a href="https://www.livescience.com/amygdala.html"><u>amygdala</u></a> is a major hub for emotional processing, and the <a href="https://www.livescience.com/hippocampus"><u>hippocampus</u></a> is key for memory and learning.  </p><p>"The goal of our study was to look at the epigenetics of the PTSD brain and ask how [it] is different from that of an individual who does not have PTSD," Champagne said, "or who comparatively has another diagnosis, like major depressive disorder." </p><p>Compared to the brains of people without any disorders, the brains of people with PTSD had different patterns of methylation in the prefrontal cortex, in particular. By contrast, in major depressive disorder, the amygdala stood out as a brain region with distinct methylation.</p><p>Additionally, in depression, the observed differences in methylation tended to affect the same set of genes across different regions of the brain. This was not the case in PTSD, which showed more inconsistencies in terms of which specific genes were involved. The methylation patterns in PTSD also appeared to vary depending on other factors, such as patients' sex, ethnicity and age at which they experienced trauma. </p><p>The study's results serve as a valuable resource, said <a href="https://med.emory.edu/departments/medicine/divisions/infectious-diseases/studies-programs/bircwh/scholars/seyma-katrinli.html" target="_blank"><u>Seyma Katrinli</u></a>, an investigator in the <a href="https://www.gradytraumaproject.com/" target="_blank"><u>Grady Trauma Project</u></a>, a large PTSD study, at the Emory University School of Medicine. </p><p>Although the findings can't be used to help diagnose PTSD yet, down the line, this area of research could help scientists correlate changes that are measurable in people's blood to changes in the brain, said Katrinli, who was not involved in the new work. Then, <a href="https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health"><u>blood tests could help guide the diagnosis</u></a> and treatment of PTSD, she suggested.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/traumatic-memories-are-processed-differently-in-ptsd">Traumatic memories are processed differently in PTSD</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how">Psychedelics may rewire the brain to treat PTSD. Scientists are finally beginning to understand how.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/memory/tour-de-force-study-may-explain-why-trauma-can-lead-to-ptsd">'Tour de force' study may explain why trauma can lead to PTSD</a></li></ul></p></div></div><p>That said, the study had limitations. Because the scientists analyzed postmortem brains, they relied on the medical reports rather than assessing the study subjects directly. Additionally, both PTSD and major depressive disorder are associated with substance use, which also causes DNA methylation; this potential confounding factor was not accounted for in the study. .</p><p>Finally, at this point, there is no way to tell what triggered the observed differences in DNA methylation. The scientists can't say if the variations are a consequence of PTSD, a risk factor for PTSD, or a downstream effect of other things that co-occur with PTSD. </p><p>The research sets the stage to "help us ask better questions," Champagne said. Her team is now looking to investigate factors — such as sex, the timing of traumatic experiences, or history of substance use — that may be driving the variation within PTSD. </p><p>"It's a very exciting foray into epigenetic profiling in the brain," she said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz.</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/genetics/brains-of-people-with-ptsd-have-unique-epigenetic-marks-study-finds</link>
                                                                            <description>
                            <![CDATA[ The brains of people with PTSD bear molecular changes that differ from those in people with other conditions, like depression, a new study finds. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">38s7vZv9ZLpdpEnYiVaZvZ</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/u48ZGtMRhUG9JrKTPP8fBH-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 20 Nov 2026 21:50:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Genetics]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Payal Dhar ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/w467DFeqc7TwcULfKgixpM-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Payal Dhar (she/they) is a freelance journalist, writing on science, technology, and society. They cover AI, engineering, materials science, cybersecurity, space, games, online communities, and any shiny new technology that catches their eye. She has written for Science News, Scientific American, Nature, Washington Post, Guardian, Chemical &amp; Engineering News, IEEE Spectrum, and others. They also write science-fiction and fantasty. You can follow her @payaldhar.bluesky.social or read her work at &lt;a href=&quot;http://payaldhar.contently.com/&quot; target=&quot;_blank&quot;&gt;payaldhar.contently.com&lt;/a&gt;.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/u48ZGtMRhUG9JrKTPP8fBH-1920-80.jpg">
                                                            <media:credit><![CDATA[JUAN GAERTNER/SCIENCE PHOTO LIBRARY via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A new study zoomed in on the epigenetics of brain cells in people with PTSD.]]></media:description>                                                            <media:text><![CDATA[A double-helix strand of DNA against a dark background.]]></media:text>
                                <media:title type="plain"><![CDATA[A double-helix strand of DNA against a dark background.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/u48ZGtMRhUG9JrKTPP8fBH-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A study of hundreds of brains has revealed molecular differences in people with post-traumatic stress disorder (PTSD) that are not found in individuals without the condition.</p><p>These molecular marks also differ from those seen in the brains of people with other conditions, like depression, the research found.</p><p>Our environment and experiences influence how our genes work, affecting which genes can be turned on. Rather than changing genes' underlying code, the environment can trigger what are known as <a href="https://www.cdc.gov/genomics-and-health/epigenetics/index.html" target="_blank"><u>epigenetic changes</u></a>, which include certain chemicals that attach to DNA molecules and change their structure. </p><p>One such epigenetic change, called methylation, can work like a "dimmer switch" for genes, or even completely block certain genes from turning on.</p><p>"These epigenetic features of the brain are important for shaping the way the brain functions," study co-author <a href="https://liberalarts.utexas.edu/prc/faculty/fac752" target="_blank"><u>Frances Champagne</u></a>, a psychologist at the University of Texas at Austin, told Live Science. "This can give us some insight into why individuals with PTSD develop PTSD, or how [their brains] are different from a healthy brain."</p><p>In the new study, published Friday (Nov. 20) in the journal <a href="https://doi.org/10.1016/j.celrep.2026.118270" target="_blank"><u>Cell Reports</u></a>, scientists took a close look at DNA methylation in 302 brains that had been donated after death. These included 101 brains from individuals diagnosed with PTSD, 101 from people with major depressive disorder and 100 from people without any diagnosed psychiatric disorders. The researchers also had access to these individuals' medical records. </p><p>The team zoomed in on three brain regions: the prefrontal cortex, the amygdala and the hippocampus. The prefrontal cortex handles cognitive functions like planning and decision-making, the <a href="https://www.livescience.com/amygdala.html"><u>amygdala</u></a> is a major hub for emotional processing, and the <a href="https://www.livescience.com/hippocampus"><u>hippocampus</u></a> is key for memory and learning.  </p><p>"The goal of our study was to look at the epigenetics of the PTSD brain and ask how [it] is different from that of an individual who does not have PTSD," Champagne said, "or who comparatively has another diagnosis, like major depressive disorder." </p><p>Compared to the brains of people without any disorders, the brains of people with PTSD had different patterns of methylation in the prefrontal cortex, in particular. By contrast, in major depressive disorder, the amygdala stood out as a brain region with distinct methylation.</p><p>Additionally, in depression, the observed differences in methylation tended to affect the same set of genes across different regions of the brain. This was not the case in PTSD, which showed more inconsistencies in terms of which specific genes were involved. The methylation patterns in PTSD also appeared to vary depending on other factors, such as patients' sex, ethnicity and age at which they experienced trauma. </p><p>The study's results serve as a valuable resource, said <a href="https://med.emory.edu/departments/medicine/divisions/infectious-diseases/studies-programs/bircwh/scholars/seyma-katrinli.html" target="_blank"><u>Seyma Katrinli</u></a>, an investigator in the <a href="https://www.gradytraumaproject.com/" target="_blank"><u>Grady Trauma Project</u></a>, a large PTSD study, at the Emory University School of Medicine. </p><p>Although the findings can't be used to help diagnose PTSD yet, down the line, this area of research could help scientists correlate changes that are measurable in people's blood to changes in the brain, said Katrinli, who was not involved in the new work. Then, <a href="https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health"><u>blood tests could help guide the diagnosis</u></a> and treatment of PTSD, she suggested.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/traumatic-memories-are-processed-differently-in-ptsd">Traumatic memories are processed differently in PTSD</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how">Psychedelics may rewire the brain to treat PTSD. Scientists are finally beginning to understand how.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/memory/tour-de-force-study-may-explain-why-trauma-can-lead-to-ptsd">'Tour de force' study may explain why trauma can lead to PTSD</a></li></ul></p></div></div><p>That said, the study had limitations. Because the scientists analyzed postmortem brains, they relied on the medical reports rather than assessing the study subjects directly. Additionally, both PTSD and major depressive disorder are associated with substance use, which also causes DNA methylation; this potential confounding factor was not accounted for in the study. .</p><p>Finally, at this point, there is no way to tell what triggered the observed differences in DNA methylation. The scientists can't say if the variations are a consequence of PTSD, a risk factor for PTSD, or a downstream effect of other things that co-occur with PTSD. </p><p>The research sets the stage to "help us ask better questions," Champagne said. Her team is now looking to investigate factors — such as sex, the timing of traumatic experiences, or history of substance use — that may be driving the variation within PTSD. </p><p>"It's a very exciting foray into epigenetic profiling in the brain," she said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz.</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ New study rewrites the role of a major speech hub in the brain ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A new study has rewritten the role of one of the brain's major speech hubs, opening new possibilities for treating people who can't communicate verbally due to brain damage.</p><p>The study, published Thursday (Nov. 19) in the journal <a href="https://www.science.org/doi/10.1126/science.aef8963" target="_blank"><u>Science</u></a>, may help to solve a 150-year-old mystery in neuroscience.</p><p>Nowadays, neuroscientists use cutting-edge tools to tease apart the junctions and wiring of our complex brains. But some basic theories in the field are far from new and rest on past discoveries. One of those theories concerns how the brain produces and comprehends speech. </p><p>In the 1860s, German neuroanatomist Carl Wernicke identified an area of the brain that is critical to speech and usually found in the temporal lobe on the left side of the organ. Damage to Wernicke's area makes it challenging for people to understand what others are saying ‪—‬ a condition known as <a href="https://www.ncbi.nlm.nih.gov/books/NBK441951/" target="_blank"><u>Wernicke's aphasia</u></a>. Therefore, the brain region has been primarily thought of as a decoder that helps us break down the meaning of other people's speech.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1600px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="AbnCBCofAewq5h8bvMSgB" name="Wernicke's_area_-_lateral_view" alt="A cartoon showing a translucent skull with a tan brain and a red area highlighted." src="https://cdn.mos.cms.futurecdn.net/AbnCBCofAewq5h8bvMSgB-1920-80.png" mos="" align="middle" fullscreen="1" width="1600" height="1600" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/AbnCBCofAewq5h8bvMSgB-1920-80.png' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Wernicke's area (red) is found in the left temporal lobe.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Polygon data were generated by Database Center for Life Science(DBCLS)[2]., <a href="https://creativecommons.org/licenses/by-sa/2.1/jp/deed.en">CC BY-SA 2.1 JP</a>, via Wikimedia Commons)</span></figcaption></figure><p>But that isn't the whole story. While people who have Wernicke's aphasia can speak in a normal cadence, the words they use don't match their intention. They might substitute semantically related words, with "shoe" becoming "foot," or they might mix up words that have similar sounds, like "leg" and "peg." This can make their sentences sound like nonsensical word salad and thus undermine patients' ability to communicate. </p><p>These symptoms make it clear that damage to Wernicke's area affects not just speech comprehension but also speech production. But neuroscientists couldn't identify how this function arose in the brain region or which cells contributed to it. </p><p>The question "has remained a mystery for over 150 years now," said study co-author <a href="https://changlab.ucsf.edu/team" target="_blank"><u>Alexander Silva</u></a>, a neuroscientist at the University of California, San Francisco. </p><p>"One hypothesis is [that] it acts kind of like a proofreader. It listens to you speak, and it corrects errors," Silva explained. "But another is that there's actually dedicated activity in this area that generates upcoming speech."</p><p>In their new study, Silva and his colleagues set out to solve the conundrum, using a series of complementary tests that involved recording people's brain activity as they spoke. They had access to powerful tools for understanding brain function, like electrocorticography electrodes, which are implanted onto the brain's surface to measure neural activity. The precision of these tools enabled the team to investigate Wernicke's area at high temporal and spatial resolutions, Silva told Live Science. </p><p>The team recruited 28 participants with epilepsy, who already had electrodes implanted to monitor their seizures. They identified a small group of brain cells within Wernicke's area that fired about a quarter of a second before participants spoke words aloud. The signal seemed to be preparing for the speech production, and it could be separated from linked auditory signals made by cells responding to the resulting sound of the spoken words. </p><p>But this evidence alone couldn't prove that these cells actually caused speech; it could only correlate the signal with speech production. To connect the dots, the scientists mapped the brains of hundreds of people who were undergoing surgery to have temporal-lobe tumors removed and tested how the surgery affected their speech. </p><p>This analysis supported their previous findings; patients were much more likely to have trouble speaking after surgery if the procedure had damaged Wernicke's area, suggesting the area had a role in speech production. </p><div><blockquote><p>We already knew that damage to Wernicke's area can lead to speech production errors, but this publication answers why.</p><p>Adeen Flinker, a neuroscientist at New York University</p></blockquote></div><p>Finally, in 13 people with implanted electrodes and undamaged Wernicke's areas, the researchers tested what happened when they stimulated the brain. When the scientists sent a wave of electricity through the speech-preparation area just before participants opened their mouths to talk, the stimulation caused them to make word errors that resembled Wernicke's aphasia. </p><p>The researchers then moved on to a different question: Could these discoveries about Wernicke's area help people whose speech is affected by brain damage? </p><p>Using more electrode data, the team identified individual brain cells in Wernicke's area that were linked to saying particular words. Then, they looked at two patients with speech paralysis; these individuals were unable to speak after strokes damaged their brainstems and they'd had electrodes implanted in their brains that sent signals to brain-computer speech devices. </p><p>The devices which interpret signals from undamaged areas of the brain to spell out words the patients are trying to say onto a screen. In these patients, the scientists monitored activity from neurons in Wernicke's area with electrodes and were able to decode what the participants were attempting to communicate. </p><p>Silva said these discoveries rewrite the textbook on Wernicke's area. <a href="https://med.nyu.edu/faculty/adeen-flinker" target="_blank"><u>Adeen Flinker</u></a>, a neuroscientist at New York University who was not involved in the study, agreed. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/ultrasound-waves-that-jiggle-deep-brain-structures-may-relieve-delusions-in-schizophrenia-small-trial-hints">Ultrasound waves that jiggle deep brain structures may relieve delusions in schizophrenia, small trial hints</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/neuroscience-findings-often-cant-be-replicated-and-its-a-big-problem-for-what-we-know-about-the-brain">Neuroscience findings often can't be replicated ‪—‬ and it's a big problem for what we know about the brain</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/its-kind-of-the-holy-grail-of-what-is-memory-neuroscientist-steve-ramirez-studies-the-physical-basis-of-memory-in-a-quest-to-manipulate-it">'It's kind of the holy grail of what is memory': Neuroscientist Steve Ramirez studies the physical basis of memory in a quest to manipulate it</a></li></ul></p></div></div><p>"We already knew that damage to Wernicke's area can lead to speech production errors, but this publication answers why," Flinker told Live Science. </p><p>The new findings could lead to <a href="https://www.livescience.com/health/neuroscience/new-brain-implant-can-decode-a-persons-inner-monologue"><u>better brain-computer interfaces</u></a> for treating aphasia, Silva said. Until now, patients who have benefited from these interfaces have mainly had problems with the pathways linking their motor cortex and mouth muscles, he said, such as people with amyotrophic lateral sclerosis (ALS). </p><p>"This is actually a small number of patients relative to the number of patients that have aphasia ‪—‬ so a language disorder from injury to the cortex itself," Silva said. These patients have vocal paralysis but are unable to benefit from BCIs because of this cortical damage, Flinker noted.</p><p>This special spot in Wernicke's area could be a new target for brain-computer interfaces aimed at helping patients with aphasia, Silva continued. "We really think that this is an area that could expand the number of people that could benefit from the technology in the near future," he concluded.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/new-study-rewrites-the-role-of-a-major-speech-hub-in-the-brain</link>
                                                                            <description>
                            <![CDATA[ Wernicke's area was thought to be mostly linked to understanding speech. A landmark new study has something more to say. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">V6ah7uTJ2ficGSZgQSn88i</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/Zv84qaJkrx7RYznQbgsMwV-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 19 Nov 2026 20:24:33 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ RJ Mackenzie ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/8HL7ZNmUgBBqZ5oMPxHuE4-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/Zv84qaJkrx7RYznQbgsMwV-1920-80.jpg">
                                                            <media:credit><![CDATA[kemalbas via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A new neuroscience studies zooms in on Wernicke&amp;#39;s area, a part of the brain best known for helping us understand speech.]]></media:description>                                                            <media:text><![CDATA[A cartoon showing a green head with various colored speech bubbles in it.]]></media:text>
                                <media:title type="plain"><![CDATA[A cartoon showing a green head with various colored speech bubbles in it.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/Zv84qaJkrx7RYznQbgsMwV-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A new study has rewritten the role of one of the brain's major speech hubs, opening new possibilities for treating people who can't communicate verbally due to brain damage.</p><p>The study, published Thursday (Nov. 19) in the journal <a href="https://www.science.org/doi/10.1126/science.aef8963" target="_blank"><u>Science</u></a>, may help to solve a 150-year-old mystery in neuroscience.</p><p>Nowadays, neuroscientists use cutting-edge tools to tease apart the junctions and wiring of our complex brains. But some basic theories in the field are far from new and rest on past discoveries. One of those theories concerns how the brain produces and comprehends speech. </p><p>In the 1860s, German neuroanatomist Carl Wernicke identified an area of the brain that is critical to speech and usually found in the temporal lobe on the left side of the organ. Damage to Wernicke's area makes it challenging for people to understand what others are saying ‪—‬ a condition known as <a href="https://www.ncbi.nlm.nih.gov/books/NBK441951/" target="_blank"><u>Wernicke's aphasia</u></a>. Therefore, the brain region has been primarily thought of as a decoder that helps us break down the meaning of other people's speech.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1600px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="AbnCBCofAewq5h8bvMSgB" name="Wernicke's_area_-_lateral_view" alt="A cartoon showing a translucent skull with a tan brain and a red area highlighted." src="https://cdn.mos.cms.futurecdn.net/AbnCBCofAewq5h8bvMSgB-1920-80.png" mos="" align="middle" fullscreen="1" width="1600" height="1600" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/AbnCBCofAewq5h8bvMSgB-1920-80.png' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Wernicke's area (red) is found in the left temporal lobe.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Polygon data were generated by Database Center for Life Science(DBCLS)[2]., <a href="https://creativecommons.org/licenses/by-sa/2.1/jp/deed.en">CC BY-SA 2.1 JP</a>, via Wikimedia Commons)</span></figcaption></figure><p>But that isn't the whole story. While people who have Wernicke's aphasia can speak in a normal cadence, the words they use don't match their intention. They might substitute semantically related words, with "shoe" becoming "foot," or they might mix up words that have similar sounds, like "leg" and "peg." This can make their sentences sound like nonsensical word salad and thus undermine patients' ability to communicate. </p><p>These symptoms make it clear that damage to Wernicke's area affects not just speech comprehension but also speech production. But neuroscientists couldn't identify how this function arose in the brain region or which cells contributed to it. </p><p>The question "has remained a mystery for over 150 years now," said study co-author <a href="https://changlab.ucsf.edu/team" target="_blank"><u>Alexander Silva</u></a>, a neuroscientist at the University of California, San Francisco. </p><p>"One hypothesis is [that] it acts kind of like a proofreader. It listens to you speak, and it corrects errors," Silva explained. "But another is that there's actually dedicated activity in this area that generates upcoming speech."</p><p>In their new study, Silva and his colleagues set out to solve the conundrum, using a series of complementary tests that involved recording people's brain activity as they spoke. They had access to powerful tools for understanding brain function, like electrocorticography electrodes, which are implanted onto the brain's surface to measure neural activity. The precision of these tools enabled the team to investigate Wernicke's area at high temporal and spatial resolutions, Silva told Live Science. </p><p>The team recruited 28 participants with epilepsy, who already had electrodes implanted to monitor their seizures. They identified a small group of brain cells within Wernicke's area that fired about a quarter of a second before participants spoke words aloud. The signal seemed to be preparing for the speech production, and it could be separated from linked auditory signals made by cells responding to the resulting sound of the spoken words. </p><p>But this evidence alone couldn't prove that these cells actually caused speech; it could only correlate the signal with speech production. To connect the dots, the scientists mapped the brains of hundreds of people who were undergoing surgery to have temporal-lobe tumors removed and tested how the surgery affected their speech. </p><p>This analysis supported their previous findings; patients were much more likely to have trouble speaking after surgery if the procedure had damaged Wernicke's area, suggesting the area had a role in speech production. </p><div><blockquote><p>We already knew that damage to Wernicke's area can lead to speech production errors, but this publication answers why.</p><p>Adeen Flinker, a neuroscientist at New York University</p></blockquote></div><p>Finally, in 13 people with implanted electrodes and undamaged Wernicke's areas, the researchers tested what happened when they stimulated the brain. When the scientists sent a wave of electricity through the speech-preparation area just before participants opened their mouths to talk, the stimulation caused them to make word errors that resembled Wernicke's aphasia. </p><p>The researchers then moved on to a different question: Could these discoveries about Wernicke's area help people whose speech is affected by brain damage? </p><p>Using more electrode data, the team identified individual brain cells in Wernicke's area that were linked to saying particular words. Then, they looked at two patients with speech paralysis; these individuals were unable to speak after strokes damaged their brainstems and they'd had electrodes implanted in their brains that sent signals to brain-computer speech devices. </p><p>The devices which interpret signals from undamaged areas of the brain to spell out words the patients are trying to say onto a screen. In these patients, the scientists monitored activity from neurons in Wernicke's area with electrodes and were able to decode what the participants were attempting to communicate. </p><p>Silva said these discoveries rewrite the textbook on Wernicke's area. <a href="https://med.nyu.edu/faculty/adeen-flinker" target="_blank"><u>Adeen Flinker</u></a>, a neuroscientist at New York University who was not involved in the study, agreed. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/ultrasound-waves-that-jiggle-deep-brain-structures-may-relieve-delusions-in-schizophrenia-small-trial-hints">Ultrasound waves that jiggle deep brain structures may relieve delusions in schizophrenia, small trial hints</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/neuroscience-findings-often-cant-be-replicated-and-its-a-big-problem-for-what-we-know-about-the-brain">Neuroscience findings often can't be replicated ‪—‬ and it's a big problem for what we know about the brain</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/its-kind-of-the-holy-grail-of-what-is-memory-neuroscientist-steve-ramirez-studies-the-physical-basis-of-memory-in-a-quest-to-manipulate-it">'It's kind of the holy grail of what is memory': Neuroscientist Steve Ramirez studies the physical basis of memory in a quest to manipulate it</a></li></ul></p></div></div><p>"We already knew that damage to Wernicke's area can lead to speech production errors, but this publication answers why," Flinker told Live Science. </p><p>The new findings could lead to <a href="https://www.livescience.com/health/neuroscience/new-brain-implant-can-decode-a-persons-inner-monologue"><u>better brain-computer interfaces</u></a> for treating aphasia, Silva said. Until now, patients who have benefited from these interfaces have mainly had problems with the pathways linking their motor cortex and mouth muscles, he said, such as people with amyotrophic lateral sclerosis (ALS). </p><p>"This is actually a small number of patients relative to the number of patients that have aphasia ‪—‬ so a language disorder from injury to the cortex itself," Silva said. These patients have vocal paralysis but are unable to benefit from BCIs because of this cortical damage, Flinker noted.</p><p>This special spot in Wernicke's area could be a new target for brain-computer interfaces aimed at helping patients with aphasia, Silva continued. "We really think that this is an area that could expand the number of people that could benefit from the technology in the near future," he concluded.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ The immune system 'remembers' germs by tweaking its epigenetics, study shows ]]></title>
                                                                                                <dc:content><![CDATA[ <p>The immune system has several ways of remembering threats it's encountered and then mounting stronger defenses in the future. Now, a new study unpacks how cells keep one type of immune memory from fading, and the findings might matter for treating diseases like cancer and Alzheimer's disease.</p><p>The research zoomed in on immune cells' <a href="https://www.livescience.com/health/genetics/scientists-just-rewrote-our-understanding-of-epigenetics"><u>epigenetics</u></a> ‪—‬ the methods that cells use to control genes without changing their underlying DNA codes. This can involve changing how DNA is packaged inside cells, for example. DNA molecules are typically wound around tiny spools inside cells, and their gene activity depends on how tightly or loosely they're wound. Molecules called epigenetic markers can grab hold of the spool to tweak how the DNA is wound and thus activate or silence certain genes. </p><p><a href="https://linkinghub.elsevier.com/retrieve/pii/S1074-7613(20)30452-0" target="_blank"><u>Past research found</u></a> epigenetic changes can prime immune cells against threats. The immune system's first line of defense — innate immune cells — can be switched into an activated state so they're ready to go if they encounter a germ. This form of immune memory, known as "trained immunity," broadly enhances the cells' defenses, enabling them to respond to threats more quickly and powerfully than "untrained" cells would.</p><p>To flip that switch in the cells, a molecule latches onto the spool that DNA is wound around, specifically near genes involved in sparking <a href="https://www.livescience.com/health/immune-system/if-you-dont-have-inflammation-then-youll-die-how-scientists-are-reprogramming-the-bodys-natural-superpower"><u>inflammation</u></a>. That subtle molecular tweak "holds those genes poised for rapid activation," said <a href="https://scholar.google.com/citations?user=Klxiq9sAAAAJ&amp;hl=en" target="_blank"><u>Musa Mhlanga</u></a>, a cell biologist and molecular geneticist at the Radboud Institute for Molecular Life Sciences in the Netherlands who wasn't involved in the new study. </p><p>However, scientists didn't know how that change was maintained over time. </p><p>The immune memory should have been destroyed soon after it was made, given that "the cell has enzymes whose entire job is to strip that mark off," Mhlanga told Live Science in an email. But somehow, the memory stuck. "So the obvious question was never really answered: how does a mark survive weeks or months against machinery actively removing it?" Mhlanga said.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="bQvRq2wytuDMXTfGXicjh9" name="GettyImages-1359392185-macrophages" alt="An illustration of a series of blue spiky balls against a blue background." src="https://cdn.mos.cms.futurecdn.net/bQvRq2wytuDMXTfGXicjh9-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/bQvRq2wytuDMXTfGXicjh9-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The research focused on cells of the innate immune system, including macrophages (pictured), which gobble up germs, dead cells and cellular debris. </span><span class="credit" itemprop="copyrightHolder">(Image credit: ARTUR PLAWGO / SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>The new study, published Oct. 30 in the journal <a href="https://www.science.org/doi/10.1126/sciimmunol.aea5625" target="_blank"><u>Science Immunology</u></a>, may answer that question.</p><p>The research investigated the phenomenon in mouse immune cells and live lab mice, as well as some human cells in lab dishes. Past studies hinted that, when immune cells switch into their "primed" state, their metabolism changes. This, in turn, drives up the production of a molecule called nicotinamide adenine dinucleotide (NAD+), which has long been known to help regulate how DNA gets packaged in cells.</p><p>In this case, though, the molecule took on a surprising role, Mhlanga said. NAD+ usually gets used up when enzymes orchestrate chemical reactions. But when it comes to the enzymes that normally erase immune cells' memory, called KDM5a, that wasn't the case.  </p><p>NAD+ latches onto that epigenetic eraser but doesn't get used up in the process; instead, it shuts down KDM5a, as if it were pushing an "off" button. By restraining its memory eraser, the immune cell remains in a primed and activated state, ready to ignite inflammation when triggered.</p><p>In experiments with mice, the researchers found that reducing or eliminating NAD+ from immune cells prevented them from entering this primed state. In mice with cancer, this hobbled the immune system's ability to attack tumor cells. </p><p>Additionally, in aging mice, the team observed that NAD+ levels dwindle in concert with the innate immune system's ability to respond to threats. The research builds a convincing "molecular bridge" between those two facts, Mhlanga said, raising a hypothesis for <a href="https://www.livescience.com/health/aging/scientists-have-identified-a-protein-signature-in-blood-that-could-predict-healthy-aging"><u>why immunity gets worse with age</u></a>.</p><p>Broadly, the research adds to scientists' understanding of how innate immune cells enter this primed, inflammatory state. This line of research may help scientists understand "why some vaccines protect against diseases they were never designed for," Mhlanga said. </p><p>For example, a tuberculosis vaccine called Bacille Calmette-Guérin (BDG) is thought to mount a broad immune response that may help stave off many conditions, from <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11857995/" target="_blank"><u>viral infections</u></a> to <a href="https://www.livescience.com/health/alzheimers-dementia/could-vaccines-prevent-and-treat-alzheimers-disease"><u>Alzheimer's disease</u></a>. (Some scientists think that Alzheimer's stems from a dysregulated immune response that BCG may help to normalize.)</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/regular-exercise-reshapes-the-immune-system-at-a-cellular-level-study-suggests">Regular exercise reshapes the immune system at a cellular level, study suggests</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/insomnia-and-anxiety-come-with-a-weaker-immune-system-a-new-study-starts-to-unravel-why">Insomnia and anxiety come with a weaker immune system</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/immune-genes-linked-to-bigger-brains-and-longer-lifespans-in-mammals-including-humans">Immune genes linked to bigger brains and longer lifespans in mammals — including humans</a></li></ul></p></div></div><p>While this line of research could have wide-ranging applications, the new study has some limitations. The researchers did a few experiments with human cells and backed up some of their findings in mice with data from human cancer patients. However, "the human data are thin by comparison with the mouse work," Mhlanga noted, so they bear further confirmation. </p><p>In the future, he'd be interested in studies exploring NAD+ in the context of the aging immune system, cancer and Alzheimer's disease. The recent research hints that pushing NAD+ to optimal levels could help counter each of these conditions.</p><p>But especially in cancer, where the disease's biology varies by the tumour type and stage, "it is not a simple 'more NAD+ is better' story," he cautioned, "and I'd resist it being written as one."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/immune-system/the-immune-system-remembers-germs-by-tweaking-its-epigenetics-study-shows</link>
                                                                            <description>
                            <![CDATA[ A new study helps explain how the immune system's first line of defense stays ready to fight off germs and diseases. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">QtuMuRqpbaemfGP6pLXZHh</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/KAqH5BDFbcm3Ze39ESftBP-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 19 Nov 2026 19:15:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Immune System]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/KAqH5BDFbcm3Ze39ESftBP-1920-80.jpg">
                                                            <media:credit><![CDATA[koto_fejan via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Epigenetics describes ways that cells control their genes without changing their DNA. One method is changing how DNA molecules are wound around histones (pictured), which are spool-like proteins.]]></media:description>                                                            <media:text><![CDATA[Two 3D clustered cells against a dark background]]></media:text>
                                <media:title type="plain"><![CDATA[Two 3D clustered cells against a dark background]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/KAqH5BDFbcm3Ze39ESftBP-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>The immune system has several ways of remembering threats it's encountered and then mounting stronger defenses in the future. Now, a new study unpacks how cells keep one type of immune memory from fading, and the findings might matter for treating diseases like cancer and Alzheimer's disease.</p><p>The research zoomed in on immune cells' <a href="https://www.livescience.com/health/genetics/scientists-just-rewrote-our-understanding-of-epigenetics"><u>epigenetics</u></a> ‪—‬ the methods that cells use to control genes without changing their underlying DNA codes. This can involve changing how DNA is packaged inside cells, for example. DNA molecules are typically wound around tiny spools inside cells, and their gene activity depends on how tightly or loosely they're wound. Molecules called epigenetic markers can grab hold of the spool to tweak how the DNA is wound and thus activate or silence certain genes. </p><p><a href="https://linkinghub.elsevier.com/retrieve/pii/S1074-7613(20)30452-0" target="_blank"><u>Past research found</u></a> epigenetic changes can prime immune cells against threats. The immune system's first line of defense — innate immune cells — can be switched into an activated state so they're ready to go if they encounter a germ. This form of immune memory, known as "trained immunity," broadly enhances the cells' defenses, enabling them to respond to threats more quickly and powerfully than "untrained" cells would.</p><p>To flip that switch in the cells, a molecule latches onto the spool that DNA is wound around, specifically near genes involved in sparking <a href="https://www.livescience.com/health/immune-system/if-you-dont-have-inflammation-then-youll-die-how-scientists-are-reprogramming-the-bodys-natural-superpower"><u>inflammation</u></a>. That subtle molecular tweak "holds those genes poised for rapid activation," said <a href="https://scholar.google.com/citations?user=Klxiq9sAAAAJ&amp;hl=en" target="_blank"><u>Musa Mhlanga</u></a>, a cell biologist and molecular geneticist at the Radboud Institute for Molecular Life Sciences in the Netherlands who wasn't involved in the new study. </p><p>However, scientists didn't know how that change was maintained over time. </p><p>The immune memory should have been destroyed soon after it was made, given that "the cell has enzymes whose entire job is to strip that mark off," Mhlanga told Live Science in an email. But somehow, the memory stuck. "So the obvious question was never really answered: how does a mark survive weeks or months against machinery actively removing it?" Mhlanga said.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="bQvRq2wytuDMXTfGXicjh9" name="GettyImages-1359392185-macrophages" alt="An illustration of a series of blue spiky balls against a blue background." src="https://cdn.mos.cms.futurecdn.net/bQvRq2wytuDMXTfGXicjh9-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/bQvRq2wytuDMXTfGXicjh9-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The research focused on cells of the innate immune system, including macrophages (pictured), which gobble up germs, dead cells and cellular debris. </span><span class="credit" itemprop="copyrightHolder">(Image credit: ARTUR PLAWGO / SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>The new study, published Oct. 30 in the journal <a href="https://www.science.org/doi/10.1126/sciimmunol.aea5625" target="_blank"><u>Science Immunology</u></a>, may answer that question.</p><p>The research investigated the phenomenon in mouse immune cells and live lab mice, as well as some human cells in lab dishes. Past studies hinted that, when immune cells switch into their "primed" state, their metabolism changes. This, in turn, drives up the production of a molecule called nicotinamide adenine dinucleotide (NAD+), which has long been known to help regulate how DNA gets packaged in cells.</p><p>In this case, though, the molecule took on a surprising role, Mhlanga said. NAD+ usually gets used up when enzymes orchestrate chemical reactions. But when it comes to the enzymes that normally erase immune cells' memory, called KDM5a, that wasn't the case.  </p><p>NAD+ latches onto that epigenetic eraser but doesn't get used up in the process; instead, it shuts down KDM5a, as if it were pushing an "off" button. By restraining its memory eraser, the immune cell remains in a primed and activated state, ready to ignite inflammation when triggered.</p><p>In experiments with mice, the researchers found that reducing or eliminating NAD+ from immune cells prevented them from entering this primed state. In mice with cancer, this hobbled the immune system's ability to attack tumor cells. </p><p>Additionally, in aging mice, the team observed that NAD+ levels dwindle in concert with the innate immune system's ability to respond to threats. The research builds a convincing "molecular bridge" between those two facts, Mhlanga said, raising a hypothesis for <a href="https://www.livescience.com/health/aging/scientists-have-identified-a-protein-signature-in-blood-that-could-predict-healthy-aging"><u>why immunity gets worse with age</u></a>.</p><p>Broadly, the research adds to scientists' understanding of how innate immune cells enter this primed, inflammatory state. This line of research may help scientists understand "why some vaccines protect against diseases they were never designed for," Mhlanga said. </p><p>For example, a tuberculosis vaccine called Bacille Calmette-Guérin (BDG) is thought to mount a broad immune response that may help stave off many conditions, from <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11857995/" target="_blank"><u>viral infections</u></a> to <a href="https://www.livescience.com/health/alzheimers-dementia/could-vaccines-prevent-and-treat-alzheimers-disease"><u>Alzheimer's disease</u></a>. (Some scientists think that Alzheimer's stems from a dysregulated immune response that BCG may help to normalize.)</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/regular-exercise-reshapes-the-immune-system-at-a-cellular-level-study-suggests">Regular exercise reshapes the immune system at a cellular level, study suggests</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/insomnia-and-anxiety-come-with-a-weaker-immune-system-a-new-study-starts-to-unravel-why">Insomnia and anxiety come with a weaker immune system</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/immune-genes-linked-to-bigger-brains-and-longer-lifespans-in-mammals-including-humans">Immune genes linked to bigger brains and longer lifespans in mammals — including humans</a></li></ul></p></div></div><p>While this line of research could have wide-ranging applications, the new study has some limitations. The researchers did a few experiments with human cells and backed up some of their findings in mice with data from human cancer patients. However, "the human data are thin by comparison with the mouse work," Mhlanga noted, so they bear further confirmation. </p><p>In the future, he'd be interested in studies exploring NAD+ in the context of the aging immune system, cancer and Alzheimer's disease. The recent research hints that pushing NAD+ to optimal levels could help counter each of these conditions.</p><p>But especially in cancer, where the disease's biology varies by the tumour type and stage, "it is not a simple 'more NAD+ is better' story," he cautioned, "and I'd resist it being written as one."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Man's 'silly experiment' at work led to a fatal 'rectal explosion' ]]></title>
                                                                                                <dc:content><![CDATA[ <p><strong>The patient: </strong>A 35-year-old man in the Czech Republic</p><p><strong>The symptoms: </strong>The man was injured while working in a factory. His co-workers learned he'd been hurt after he crawled from the ground floor to the first floor and shouted for help. He had severe abdominal pain and rectal bleeding, and he said he had been injured while conducting "a silly experiment" involving a pressurized air system. However, he did not describe exactly what had happened. </p><p>"He repeatedly stressed that the incident was his own fault," doctors later wrote in <a href="https://link.springer.com/article/10.1007/s00414-020-02344-7" target="_blank"><u>a report of his case</u></a>. </p><p><strong>What happened next: </strong>The man was flown by helicopter to a nearby hospital, but during the flight, he became unresponsive and showed signs of <a href="https://cvrti.utah.edu/what-causes-hemorrhagic-shock-a-comprehensive-guide-to-its-triggers-and-risk-factors/" target="_blank"><u>hemorrhagic shock</u></a> — a type of shock caused by significant blood loss over a short period. <a href="https://www.merckmanuals.com/professional/critical-care-medicine/shock-and-fluid-resuscitation/shock" target="_blank"><u>Shock</u></a>, broadly, is when organs and body tissues don't receive enough oxygen due to decreased blood flow; if untreated, it can lead to organ failure and death.</p><p>Medical attendants in the helicopter worked to revive the man, but he died before he could be admitted to the hospital. Because the fatal injury occurred at the man's workplace, the police ordered a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4925615/" target="_blank"><u>medicolegal autopsy</u></a>, which both identifies the cause of death and collects details for law enforcement agencies, as part of an inquest procedure. </p><p><strong>The autopsy: </strong>The coroner examined the body and noted that the soft tissues of the man's face were swollen and abnormally distended from retained air. The man's anus and genital areas were similarly distended and densely coated with dried blood, with radial tears in the skin surrounding the anus.</p><p>Next, the coroner conducted an internal examination. The man's brain was swollen, and he had air bubbles in his brain and chest cavity. Blood had collected around his diaphragm (the large muscle that helps inflate and deflate the lungs). It had also accumulated in the wall between the heart chambers on the left side, in tubes leading to his lungs, and in the membranes covering his lungs and heart. Reservoirs of blood also pooled in the man's abdominal cavity, in the tube leading to his right kidney, and in his digestive organs. </p><p>The man's heart was "shrunken and empty," according to the report.</p><p>The autopsy also revealed foreign objects stuck between loops of the man's small intestine. These included three pieces of a black rubber pipe stopper and scraps of a plastic bag. His rectum — the final straight portion of the large intestine — had detached violently from his anus. It was surrounded by blood and marked with a laceration that was nearly circular, indicating that an "explosive rectal injury" had triggered hemorrhagic shock and caused the man's death, the coroner concluded.</p><p><strong>Further investigation:</strong> Additional evidence from the factory and rubber fragments in the man's small intestine provided the police with further insight into his injuries; additional clues came from his internet search history, including photos of himself that he'd submitted to an amateur sex website. </p><p>The police concluded that the man had been performing autoerotic anal stimulation while at work, using a rubber inflatable pipe stopper measuring 2 to 3 inches (50 to 70 millimeters) in diameter, and an air gun, a handheld device for directing powerful jets of compressed air.</p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years">A woman carried a 'stone baby' in her abdomen for 3 years</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-mom-experienced-extreme-unhappiness-only-when-she-breastfed">Mom experienced 'extreme unhappiness' only when she breastfed</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-a-man-swallowed-a-bone-then-forgot-about-it-15-years-later-doctors-found-it-in-his-appendix">A man swallowed a bone, and‬ 15 years later, doctors found it in his appendix</a></li></ul></p></div></div><p>They suggested that the man likely attached the expandable pipe stopper to the muzzle of the air gun, which was in turn connected to the factory's air distribution system by a long, high-pressure hose. He then covered the pipe stopper with a plastic bag, inserted it into his rectal cavity, and pressed the air gun's trigger, causing "an unexpected abrupt inflation and explosive bursting of the pipe stopper within his rectum," the doctors wrote in the case report.</p><p><strong>What makes the case unique: </strong>This case is the first recorded example of a person dying from a "rectal explosion during self-gratification," the doctors wrote.<strong> </strong>Piecing together the circumstances leading up to the man's injury was important for the hospital's doctors and law enforcement to understand how the fatality likely occurred, the authors said. </p><p>When performed responsibly and consensually, rectal insertion of foreign bodies typically does not cause significant injury, the authors added. However, "the introduction of some objects into the rectum might have unpredictable and even fatal effects." </p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/mans-silly-experiment-at-work-led-to-a-fatal-rectal-explosion-diagnostic-dilemma</link>
                                                                            <description>
                            <![CDATA[ A factory worker experimented with a pressurized air system while on the job, and it resulted in a fatal injury. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">yjiaNB9AALD2cyfXxXDEwn</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/o38G5CJJigWDhauDvkmvNH-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 18 Nov 2026 11:00:00 +0000</pubDate>                                                                                                                                <updated>Thu, 19 Nov 2026 11:01:10 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Mindy Weisberger ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/AhFB8tWuFKe7LsbCTX5BUE-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Mindy Weisberger is a science journalist and author of the book &quot;Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control,&quot; published by Hopkins Press. She formerly edited for Scholastic and reported for Live Science as a channel editor and senior writer. She has reported on general science, covering climate change, paleontology, biology and space. Mindy studied film at Columbia University; prior to Live Science she produced, wrote and directed media for the American Museum of Natural History in New York City. Her videos about dinosaurs, astrophysics, biodiversity and evolution appear in museums and science centers worldwide, earning awards such as the CINE Golden Eagle and the Communicator Award of Excellence. Her writing has also appeared in Scientific American, The Washington Post, How It Works Magazine and CNN.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/o38G5CJJigWDhauDvkmvNH-1920-80.jpg">
                                                            <media:credit><![CDATA[sutiporn somnam via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A factory worker sustained a fatal injury after misusing a pressurized air system and air gun.]]></media:description>                                                            <media:text><![CDATA[A close up of two hands holding a dial with two meters on it and a series of tubes.]]></media:text>
                                <media:title type="plain"><![CDATA[A close up of two hands holding a dial with two meters on it and a series of tubes.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/o38G5CJJigWDhauDvkmvNH-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><strong>The patient: </strong>A 35-year-old man in the Czech Republic</p><p><strong>The symptoms: </strong>The man was injured while working in a factory. His co-workers learned he'd been hurt after he crawled from the ground floor to the first floor and shouted for help. He had severe abdominal pain and rectal bleeding, and he said he had been injured while conducting "a silly experiment" involving a pressurized air system. However, he did not describe exactly what had happened. </p><p>"He repeatedly stressed that the incident was his own fault," doctors later wrote in <a href="https://link.springer.com/article/10.1007/s00414-020-02344-7" target="_blank"><u>a report of his case</u></a>. </p><p><strong>What happened next: </strong>The man was flown by helicopter to a nearby hospital, but during the flight, he became unresponsive and showed signs of <a href="https://cvrti.utah.edu/what-causes-hemorrhagic-shock-a-comprehensive-guide-to-its-triggers-and-risk-factors/" target="_blank"><u>hemorrhagic shock</u></a> — a type of shock caused by significant blood loss over a short period. <a href="https://www.merckmanuals.com/professional/critical-care-medicine/shock-and-fluid-resuscitation/shock" target="_blank"><u>Shock</u></a>, broadly, is when organs and body tissues don't receive enough oxygen due to decreased blood flow; if untreated, it can lead to organ failure and death.</p><p>Medical attendants in the helicopter worked to revive the man, but he died before he could be admitted to the hospital. Because the fatal injury occurred at the man's workplace, the police ordered a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4925615/" target="_blank"><u>medicolegal autopsy</u></a>, which both identifies the cause of death and collects details for law enforcement agencies, as part of an inquest procedure. </p><p><strong>The autopsy: </strong>The coroner examined the body and noted that the soft tissues of the man's face were swollen and abnormally distended from retained air. The man's anus and genital areas were similarly distended and densely coated with dried blood, with radial tears in the skin surrounding the anus.</p><p>Next, the coroner conducted an internal examination. The man's brain was swollen, and he had air bubbles in his brain and chest cavity. Blood had collected around his diaphragm (the large muscle that helps inflate and deflate the lungs). It had also accumulated in the wall between the heart chambers on the left side, in tubes leading to his lungs, and in the membranes covering his lungs and heart. Reservoirs of blood also pooled in the man's abdominal cavity, in the tube leading to his right kidney, and in his digestive organs. </p><p>The man's heart was "shrunken and empty," according to the report.</p><p>The autopsy also revealed foreign objects stuck between loops of the man's small intestine. These included three pieces of a black rubber pipe stopper and scraps of a plastic bag. His rectum — the final straight portion of the large intestine — had detached violently from his anus. It was surrounded by blood and marked with a laceration that was nearly circular, indicating that an "explosive rectal injury" had triggered hemorrhagic shock and caused the man's death, the coroner concluded.</p><p><strong>Further investigation:</strong> Additional evidence from the factory and rubber fragments in the man's small intestine provided the police with further insight into his injuries; additional clues came from his internet search history, including photos of himself that he'd submitted to an amateur sex website. </p><p>The police concluded that the man had been performing autoerotic anal stimulation while at work, using a rubber inflatable pipe stopper measuring 2 to 3 inches (50 to 70 millimeters) in diameter, and an air gun, a handheld device for directing powerful jets of compressed air.</p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years">A woman carried a 'stone baby' in her abdomen for 3 years</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-mom-experienced-extreme-unhappiness-only-when-she-breastfed">Mom experienced 'extreme unhappiness' only when she breastfed</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-a-man-swallowed-a-bone-then-forgot-about-it-15-years-later-doctors-found-it-in-his-appendix">A man swallowed a bone, and‬ 15 years later, doctors found it in his appendix</a></li></ul></p></div></div><p>They suggested that the man likely attached the expandable pipe stopper to the muzzle of the air gun, which was in turn connected to the factory's air distribution system by a long, high-pressure hose. He then covered the pipe stopper with a plastic bag, inserted it into his rectal cavity, and pressed the air gun's trigger, causing "an unexpected abrupt inflation and explosive bursting of the pipe stopper within his rectum," the doctors wrote in the case report.</p><p><strong>What makes the case unique: </strong>This case is the first recorded example of a person dying from a "rectal explosion during self-gratification," the doctors wrote.<strong> </strong>Piecing together the circumstances leading up to the man's injury was important for the hospital's doctors and law enforcement to understand how the fatality likely occurred, the authors said. </p><p>When performed responsibly and consensually, rectal insertion of foreign bodies typically does not cause significant injury, the authors added. However, "the introduction of some objects into the rectum might have unpredictable and even fatal effects." </p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ For centuries, we drew the pregnant body without a head. Now we need to fill in what we left blank. ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Look closely at the medical illustrations used in textbooks to depict the physiological changes of pregnancy, and you'll notice something strange: The bodies often have no heads. Generations of physicians learned to picture the pregnant patient as a torso — a uterus, a placenta, a growing belly — with everything above the neck left blank.</p><p>That blank space is not an oversight by the illustrator. It is a faithful map of what medicine chose to study. We need to move on and create a complete picture of what happens during and after pregnancy so we can develop measures to prevent maternal deaths. </p><p>For hundreds of years, we have devoted enormous effort to characterizing how pregnancy remodels nearly every organ and system in the body: the cardiovascular changes, the recalibration of the immune system, the metabolic adjustments — most of them orchestrated by hormones the placenta pours into the bloodstream. That knowledge of what is normal is exactly what lets us recognize and treat what is not, from gestational diabetes to preeclampsia. But the brain, one of the most important organs in the human body, was left out altogether.</p><p>It wasn't until 2016 that my colleagues and I published the first study showing that pregnancy profoundly and measurably changes the structure of the <a href="https://www.livescience.com/29365-human-brain.html"><u>human brain</u></a>. That finding, which we described in the journal <a href="https://www.nature.com/articles/nn.4458" target="_blank"><u>Nature Neuroscience</u></a>, became the seed of my lab. In the years since, a remarkable picture has emerged. The brain changes associated with pregnancy and the postpartum phase are more pronounced, or at least occur more rapidly, than those of adolescence — the transformation we usually treat as the epitome of a remodeling brain. </p><p>Today, neuroscientists consider the months of pregnancy and the postpartum period to be one of the most plastic periods for the adult brain. These changes are dynamic; <a href="https://www.livescience.com/health/neuroscience/striking-brain-scans-reveal-how-one-mom-s-brain-changed-during-pregnancy"><u>some regions shrink in volume</u></a> during gestation and grow after birth, while others follow the opposite pattern. They are driven by hormones, tracking with the enormous swings in estrogens and other hormones across pregnancy. And they are long-lasting — some of these structural changes persist for years, and preliminary evidence <a href="https://www.pnas.org/doi/10.1073/pnas.1910666116" target="_blank"><u>suggests they may last decades</u></a>. Or, as folk wisdom has long put it, <em>once a mother, always a mother</em>.</p><div><blockquote><p>For centuries, we drew the pregnant body without a head. We now have the tools to fill in what we left blank. </p></blockquote></div><p>These findings raise a question I'm asked constantly: Are these brain changes behind the phenomenon of "mommy brain," sometimes called "momnesia"? It is an effect many women report, and it deserves a careful accounting of its possible causes — among them sleep deprivation and the enormous mental and metabolic load of gestating and raising a human being. We are still investigating, but the data so far point in a reassuring direction: These brain changes are not associated with worse cognitive functioning. If anything, it's the opposite: We have <a href="https://pubmed.ncbi.nlm.nih.gov/27991897/" target="_blank"><u>evidence</u></a> that the women whose brains changed the most were the ones who reported greater well-being and, in turn, <a href="https://www.nature.com/articles/s41467-025-55830-" target="_blank"><u>an easier time bonding with their newborns</u></a>.</p><p>But not every change is benign. The same plasticity that helps a mother adapt can also carry risk. In one of <a href="https://www.science.org/doi/10.1126/sciadv.adt5619?referrer=https%3A%2F%2Fwww.google.com%2F" target="_blank"><u>our most recent studies</u></a>, published in the journal Science Advances in 2025, we found that certain brain changes were associated with a greater rise in depressive symptoms during the postpartum period. And here is the other side of the coin: A highly plastic brain is also a vulnerable one. </p><p>During pregnancy and the postpartum period, that same capacity for change makes the brain more susceptible to disturbances. The window that should lead to learning and bonding, for some women, opens onto suffering instead — especially when society fails to support them, when it doesn't recognize this period as a stage in which women need protection and support from their families and institutions.</p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1151px;"><p class="vanilla-image-block" style="padding-top:177.93%;"><img id="jS7MRCFREfuxZoiNsMRmMj" name="Cristina" alt="brain scan with a baby's arm to the left side" src="https://cdn.mos.cms.futurecdn.net/jS7MRCFREfuxZoiNsMRmMj-1920-80.jpg" mos="" align="left" fullscreen="" width="1151" height="2048" attribution="" endorsement="" class="pull-leftinline" /></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">The brain changes during pregnancy and the postpartum period are more pronounced and rapid than those that take place during adolescence.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Cristina Ballesteros)</span></figcaption></figure><p>The epidemiological data are as alarming as the personal stories behind them. Roughly <a href="https://pubmed.ncbi.nlm.nih.gov/33176244/" target="_blank"><u>1 in 5 women</u></a> will experience perinatal depression. In developed countries, suicide linked to peripartum mental disorders is one of the leading causes of maternal death. Let me say that again, because it bears repeating: Suicide linked to peripartum mental disorders is one of the leading causes of maternal death. And what happens to a mother's mental health does not stay with her — it ripples out to the well-being of her baby, her family and society as a whole. Advancing maternal mental health  is urgent, and the first step is to generate the high-quality data that will let us truly understand the brain transformation that accompanies pregnancy and the postpartum period — to describe what happens to mothers on the basis of science, not personal opinion, inherited prejudice or incomplete medical models.</p><p>It is a serious problem, but the solution is straightforward ‪—‬ especially now, in the age of <a href="https://www.livescience.com/technology/artificial-intelligence"><u>artificial intelligence</u></a>. The tools of modern data science are extraordinarily powerful, but they are hungry ‪—‬ they need large, high-quality, deeply characterized datasets to learn from and make predictions. In maternal brain health, those datasets do not yet exist. We have blood biobanks from pregnancy, neuroimaging from postpartum parents, questionnaires on bonding, records on breastfeeding — but they sit in separate silos, captured at different moments, never integrated. No resource follows the same women from before conception, through pregnancy, and years past birth, linking biofluids, neuroimaging, neuropsychological assessments, and the social conditions of their lives.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/i-almost-died-from-flu-my-life-didnt-go-back-to-normal-after-opinion">I almost died from flu. My life didn't go back to normal after.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/everything-we-did-started-coming-back-to-the-mitochondria-how-replacing-cells-powerhouses-could-revolutionize-transplant-surgery-and-treat-kids-with-devastating-diseases">When a battery dies, you replace it — how jumpstarting cells with fresh mitochondria could revolutionize medicine</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health">Psychiatry's bible, the DSM, is getting upgraded to include biological markers. A psychiatrist explains what that means for mental health.</a></li></ul></p></div></div><p>Building that resource should be a priority for anyone who cares about women's health. It is the kind of infrastructure that transformed other fields. Databases like the <a href="https://adni.loni.usc.edu/" target="_blank"><u>Alzheimer's Disease Neuroimaging Initiative</u></a> for Alzheimer's disease and the<em> </em><a href="https://abcdstudy.org/" target="_blank"><u>Adolescent Brain Cognitive Development</u></a> study for adolescence turned scattered observations into predictive science. Motherhood deserves the same — not a footnote appended to the study of something else. It deserves its own chapter — its own public, longitudinal, well-characterized database, spanning from molecules to societies.</p><p>For the past nine years, my lab's efforts have focused on laying the groundwork for such a database, and we now have hundreds of participants assessed before pregnancy, during pregnancy, and in the postpartum period. But hundreds is not enough. To do this science properly, we need to scale from hundreds of women to thousands and to ensure, as much as possible, adequate geographic and social representation. My role within initiatives like <a href="https://enigma.ini.usc.edu/ongoing/enigma-neuroendocrinology/" target="_blank"><u>ENIGMA-Neuroendocrinology</u></a> and the <a href="https://wbhi.ucsb.edu/" target="_blank"><u>Ann S. Bowers Women's Brain Health Initiative</u></a> is to coordinate with other outstanding researchers to reach that goal with the highest quality and the greatest urgency we can manage.</p><p>None of this requires a scientific miracle. It requires a decision to treat the maternal brain as something worth studying with the same rigor and the same resources we devote to every other domain of biomedicine. For centuries, we drew the pregnant body without a head. We now have the tools to fill in what we left blank. What we need is the collective will, and the sustained funding, to finish the picture.</p><p><em>If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. There is also an online chat at 988lifeline.org.</em></p><p><u></u><a href="https://www.livescience.com/opinion"><u>Opinion</u></a><em> on Live Science gives you insight on the most important issues in science that affect you and the world around you today, written by experts and leading scientists in their field.</em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>        <div class="featured_product_block featured_block_horizontal" data-id="0241718e-e1b5-11f1-915c-c5370c8d1bda">            <a href="https://www.amazon.com/dp/0262054787/" data-model-name="A Mother's Brain: the New Science of the Neuro-Maternal Revolution" data-model-brand="" ><div class='product-image-widthsetter'><p class='vanilla-image-block' data-bordeaux-image-check="" style='padding-top:150%';><img style="width: 100%" class="featured_image" src="https://cdn.mos.cms.futurecdn.net/vrGC2WXUbwsbDK86DCMS6H.jpg" alt="A Mother's Brain: the New Science of the Neuro-Maternal Revolution" /></p></div></a>            <div class="featured_product_details_wrapper">                <div class="featured_product_title_wrapper">                                        <div class='featured__brand'>MIT Press</div>                                        <div class="featured__title">A Mother's Brain: the New Science of the Neuro-Maternal Revolution</div>                                    </div>                <div class="subtitle__description">                                                            <p><p>Eighty-five percent of women experience pregnancy at some point in their lives. It enables the very existence of our species. Yet this first step in the process of nurturing the next generation has had little serious, rigorous study — until now. </p><p>Susana Carmona's <em>A Mother’s Brain </em>is a landmark in ending sexual bias in women's health. Among her many initiatives, she is building a unique longitudinal database tracking how mothers’ brains change from preconception to several years after childbirth.</p></p>                </div>                            </div>        </div> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/for-centuries-we-drew-the-pregnant-body-without-a-head-now-we-need-to-fill-in-what-we-left-blank-how-motherhood-affects-the-brain-opinion</link>
                                                                            <description>
                            <![CDATA[ We need to understand how motherhood changes the brain, says neuroscientist <b>Susana Carmona</b>. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">svEbZ9z4jPwB8CZXpVt2R</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/4qb5hPBbbXbxvxF6R8DcNS-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 18 Nov 2026 10:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 18 Nov 2026 11:51:34 +0000</updated>
                                                                                                                                            <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Susana Carmona ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/grFP9e7VfsrGhitdGknmcG-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/4qb5hPBbbXbxvxF6R8DcNS-1920-80.jpg">
                                                            <media:credit><![CDATA[Golden_SUN/Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Peripartum mental disorders are a leading cause of maternal deaths, yet there is little dedicated research to understand how pregnancy alters the brain. ]]></media:description>                                                            <media:text><![CDATA[drawing of a pregnant woman with a brain for a thought bubble]]></media:text>
                                <media:title type="plain"><![CDATA[drawing of a pregnant woman with a brain for a thought bubble]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/4qb5hPBbbXbxvxF6R8DcNS-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Look closely at the medical illustrations used in textbooks to depict the physiological changes of pregnancy, and you'll notice something strange: The bodies often have no heads. Generations of physicians learned to picture the pregnant patient as a torso — a uterus, a placenta, a growing belly — with everything above the neck left blank.</p><p>That blank space is not an oversight by the illustrator. It is a faithful map of what medicine chose to study. We need to move on and create a complete picture of what happens during and after pregnancy so we can develop measures to prevent maternal deaths. </p><p>For hundreds of years, we have devoted enormous effort to characterizing how pregnancy remodels nearly every organ and system in the body: the cardiovascular changes, the recalibration of the immune system, the metabolic adjustments — most of them orchestrated by hormones the placenta pours into the bloodstream. That knowledge of what is normal is exactly what lets us recognize and treat what is not, from gestational diabetes to preeclampsia. But the brain, one of the most important organs in the human body, was left out altogether.</p><p>It wasn't until 2016 that my colleagues and I published the first study showing that pregnancy profoundly and measurably changes the structure of the <a href="https://www.livescience.com/29365-human-brain.html"><u>human brain</u></a>. That finding, which we described in the journal <a href="https://www.nature.com/articles/nn.4458" target="_blank"><u>Nature Neuroscience</u></a>, became the seed of my lab. In the years since, a remarkable picture has emerged. The brain changes associated with pregnancy and the postpartum phase are more pronounced, or at least occur more rapidly, than those of adolescence — the transformation we usually treat as the epitome of a remodeling brain. </p><p>Today, neuroscientists consider the months of pregnancy and the postpartum period to be one of the most plastic periods for the adult brain. These changes are dynamic; <a href="https://www.livescience.com/health/neuroscience/striking-brain-scans-reveal-how-one-mom-s-brain-changed-during-pregnancy"><u>some regions shrink in volume</u></a> during gestation and grow after birth, while others follow the opposite pattern. They are driven by hormones, tracking with the enormous swings in estrogens and other hormones across pregnancy. And they are long-lasting — some of these structural changes persist for years, and preliminary evidence <a href="https://www.pnas.org/doi/10.1073/pnas.1910666116" target="_blank"><u>suggests they may last decades</u></a>. Or, as folk wisdom has long put it, <em>once a mother, always a mother</em>.</p><div><blockquote><p>For centuries, we drew the pregnant body without a head. We now have the tools to fill in what we left blank. </p></blockquote></div><p>These findings raise a question I'm asked constantly: Are these brain changes behind the phenomenon of "mommy brain," sometimes called "momnesia"? It is an effect many women report, and it deserves a careful accounting of its possible causes — among them sleep deprivation and the enormous mental and metabolic load of gestating and raising a human being. We are still investigating, but the data so far point in a reassuring direction: These brain changes are not associated with worse cognitive functioning. If anything, it's the opposite: We have <a href="https://pubmed.ncbi.nlm.nih.gov/27991897/" target="_blank"><u>evidence</u></a> that the women whose brains changed the most were the ones who reported greater well-being and, in turn, <a href="https://www.nature.com/articles/s41467-025-55830-" target="_blank"><u>an easier time bonding with their newborns</u></a>.</p><p>But not every change is benign. The same plasticity that helps a mother adapt can also carry risk. In one of <a href="https://www.science.org/doi/10.1126/sciadv.adt5619?referrer=https%3A%2F%2Fwww.google.com%2F" target="_blank"><u>our most recent studies</u></a>, published in the journal Science Advances in 2025, we found that certain brain changes were associated with a greater rise in depressive symptoms during the postpartum period. And here is the other side of the coin: A highly plastic brain is also a vulnerable one. </p><p>During pregnancy and the postpartum period, that same capacity for change makes the brain more susceptible to disturbances. The window that should lead to learning and bonding, for some women, opens onto suffering instead — especially when society fails to support them, when it doesn't recognize this period as a stage in which women need protection and support from their families and institutions.</p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1151px;"><p class="vanilla-image-block" style="padding-top:177.93%;"><img id="jS7MRCFREfuxZoiNsMRmMj" name="Cristina" alt="brain scan with a baby's arm to the left side" src="https://cdn.mos.cms.futurecdn.net/jS7MRCFREfuxZoiNsMRmMj-1920-80.jpg" mos="" align="left" fullscreen="" width="1151" height="2048" attribution="" endorsement="" class="pull-leftinline" /></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">The brain changes during pregnancy and the postpartum period are more pronounced and rapid than those that take place during adolescence.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Cristina Ballesteros)</span></figcaption></figure><p>The epidemiological data are as alarming as the personal stories behind them. Roughly <a href="https://pubmed.ncbi.nlm.nih.gov/33176244/" target="_blank"><u>1 in 5 women</u></a> will experience perinatal depression. In developed countries, suicide linked to peripartum mental disorders is one of the leading causes of maternal death. Let me say that again, because it bears repeating: Suicide linked to peripartum mental disorders is one of the leading causes of maternal death. And what happens to a mother's mental health does not stay with her — it ripples out to the well-being of her baby, her family and society as a whole. Advancing maternal mental health  is urgent, and the first step is to generate the high-quality data that will let us truly understand the brain transformation that accompanies pregnancy and the postpartum period — to describe what happens to mothers on the basis of science, not personal opinion, inherited prejudice or incomplete medical models.</p><p>It is a serious problem, but the solution is straightforward ‪—‬ especially now, in the age of <a href="https://www.livescience.com/technology/artificial-intelligence"><u>artificial intelligence</u></a>. The tools of modern data science are extraordinarily powerful, but they are hungry ‪—‬ they need large, high-quality, deeply characterized datasets to learn from and make predictions. In maternal brain health, those datasets do not yet exist. We have blood biobanks from pregnancy, neuroimaging from postpartum parents, questionnaires on bonding, records on breastfeeding — but they sit in separate silos, captured at different moments, never integrated. No resource follows the same women from before conception, through pregnancy, and years past birth, linking biofluids, neuroimaging, neuropsychological assessments, and the social conditions of their lives.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/i-almost-died-from-flu-my-life-didnt-go-back-to-normal-after-opinion">I almost died from flu. My life didn't go back to normal after.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/everything-we-did-started-coming-back-to-the-mitochondria-how-replacing-cells-powerhouses-could-revolutionize-transplant-surgery-and-treat-kids-with-devastating-diseases">When a battery dies, you replace it — how jumpstarting cells with fresh mitochondria could revolutionize medicine</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health">Psychiatry's bible, the DSM, is getting upgraded to include biological markers. A psychiatrist explains what that means for mental health.</a></li></ul></p></div></div><p>Building that resource should be a priority for anyone who cares about women's health. It is the kind of infrastructure that transformed other fields. Databases like the <a href="https://adni.loni.usc.edu/" target="_blank"><u>Alzheimer's Disease Neuroimaging Initiative</u></a> for Alzheimer's disease and the<em> </em><a href="https://abcdstudy.org/" target="_blank"><u>Adolescent Brain Cognitive Development</u></a> study for adolescence turned scattered observations into predictive science. Motherhood deserves the same — not a footnote appended to the study of something else. It deserves its own chapter — its own public, longitudinal, well-characterized database, spanning from molecules to societies.</p><p>For the past nine years, my lab's efforts have focused on laying the groundwork for such a database, and we now have hundreds of participants assessed before pregnancy, during pregnancy, and in the postpartum period. But hundreds is not enough. To do this science properly, we need to scale from hundreds of women to thousands and to ensure, as much as possible, adequate geographic and social representation. My role within initiatives like <a href="https://enigma.ini.usc.edu/ongoing/enigma-neuroendocrinology/" target="_blank"><u>ENIGMA-Neuroendocrinology</u></a> and the <a href="https://wbhi.ucsb.edu/" target="_blank"><u>Ann S. Bowers Women's Brain Health Initiative</u></a> is to coordinate with other outstanding researchers to reach that goal with the highest quality and the greatest urgency we can manage.</p><p>None of this requires a scientific miracle. It requires a decision to treat the maternal brain as something worth studying with the same rigor and the same resources we devote to every other domain of biomedicine. For centuries, we drew the pregnant body without a head. We now have the tools to fill in what we left blank. What we need is the collective will, and the sustained funding, to finish the picture.</p><p><em>If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. There is also an online chat at 988lifeline.org.</em></p><p><u></u><a href="https://www.livescience.com/opinion"><u>Opinion</u></a><em> on Live Science gives you insight on the most important issues in science that affect you and the world around you today, written by experts and leading scientists in their field.</em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>        <div class="featured_product_block featured_block_horizontal" data-id="0241718e-e1b5-11f1-915c-c5370c8d1bda">            <a href="https://www.amazon.com/dp/0262054787/" data-model-name="A Mother's Brain: the New Science of the Neuro-Maternal Revolution" data-model-brand="" ><div class='product-image-widthsetter'><p class='vanilla-image-block' data-bordeaux-image-check="" style='padding-top:150%';><img style="width: 100%" class="featured_image" src="https://cdn.mos.cms.futurecdn.net/vrGC2WXUbwsbDK86DCMS6H.jpg" alt="A Mother's Brain: the New Science of the Neuro-Maternal Revolution" /></p></div></a>            <div class="featured_product_details_wrapper">                <div class="featured_product_title_wrapper">                                        <div class='featured__brand'>MIT Press</div>                                        <div class="featured__title">A Mother's Brain: the New Science of the Neuro-Maternal Revolution</div>                                    </div>                <div class="subtitle__description">                                                            <p><p>Eighty-five percent of women experience pregnancy at some point in their lives. It enables the very existence of our species. Yet this first step in the process of nurturing the next generation has had little serious, rigorous study — until now. </p><p>Susana Carmona's <em>A Mother’s Brain </em>is a landmark in ending sexual bias in women's health. Among her many initiatives, she is building a unique longitudinal database tracking how mothers’ brains change from preconception to several years after childbirth.</p></p>                </div>                            </div>        </div>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Tiny robots can tumble through blood vessels to help dissolve blood clots, early test shows ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Microrobots controlled by magnets can sweep drugs towards hard-to-reach blood clots in the body, boosting the efficacy of these life-saving treatments, early tests in animals suggest. </p><p>In tests with pigs, the microbots helped to dissolve clots around 10 times faster than medication alone. The research team is now working on further safety testing to ready the technology for eventual human trials. </p><p>"The whole construct is inspired by nature," said lead researcher<a href="https://hest.ethz.ch/en/studies/health-sciences-and-technology/master-hst/tutors/tutors-a-z/simone-schuerle-finke.html" target="_blank"> <u>Simone Schürle</u></a>, professor of medical microsystems at ETH Zürich. "There are these tiny bacteria that have little magnetic backbones which they use to navigate with the Earth's magnetic field, and we were really struck by the physics and the properties of them when exposed to rotating magnetic fields," Schürle told Live Science.</p><p>ETH Zürich <a href="https://ethz.ch/en/news-and-events/eth-news/news/2026/11/dissolving-blood-clots-with-flow-generating-microbots.html" target="_blank"><u>announced the research in a statement</u></a> on Nov. 9. It has not been described in a peer-reviewed study yet.</p><h2 id="tiny-robots-tumbling-through-blood-vessels">Tiny robots tumbling through blood vessels</h2><p>Left untreated, blood clots can cause life-threatening damage. These blockages can restrict the flow of blood to the body's key tissues, triggering serious cardiovascular events, such as <a href="https://www.livescience.com/health/heart-circulation/what-happens-during-a-heart-attack"><u>heart attacks</u></a> or strokes, which starve cells of oxygen. </p><p>Doctors can either remove clots manually with tools or deliver clot-dissolving drugs, called thrombolytics, close to the site of the blockage. However, getting these medications through the final few millimeters of their journey is often the hardest part. </p><p>"When a pipe becomes blocked in a branched pipe system, the fluid encounters greater resistance and instead flows through alternative routes where it can pass more easily," Schürle explained. "So when you then try to bring in drugs to dissolve the clot, they won't flow into this area because it's occluded [blocked off]."</p><p>This is where microbots can help. The bots are tiny particles whose movements can be controlled by external magnets, which send them rotating and tumbling through blood vessels. These bots can redirect the interrupted blood flow and thus carry essential drugs straight to their target, Schürle and her team say. </p><p>Each bullet-shaped microbot contains a magnetic backbone of iron oxide nanoparticles, which is surrounded by a protective sheath of hydrogel polymer. When exposed to a rotating magnetic field, the microbots essentially start to somersault through the blood vessel, creating little vortices that help carry the drugs along with them. </p><p>Crucially, the bots' rigid backbone ensures that they spin predictably, while the gel body prevents the particles from sticking together and forming a clump.</p><figure role="gallery"><figure><img src="https://cdn.mos.cms.futurecdn.net/hVtyA6vjDCUbvTNdPX8txF-1920-80.jpg" alt="a diagram shows the microbots being introduced to a blood vessel" /><figcaption><small role="credit">ETH News</small></figcaption></figure><figure><img src="https://cdn.mos.cms.futurecdn.net/wrzTJF9KU3UWmUderHXZ2G-1920-80.jpg" alt="diagram shows a close up of the robots helping dissolve a blood clot" /><figcaption><small role="credit">ETH News</small></figcaption></figure></figure><p>The team first tested the microbots in a silicon model of a blood vessel that contained clots of pigs' blood. Aided by the rotating microparticles, a thrombolytic drug dissolved the blockages around 10 times faster than medication alone did. That's a potentially life-saving difference, the researchers said. </p><p>They then repeated the experiment in live pigs, placing clots in vessels in each of the animals' kidneys. "When we introduced our micro-robots with a conventional, state-of-the-art drug, we could reperfuse [restore blood flow to] a much larger area than if only the drug was there," Schürle said. "The next step is doing safety studies over a longer time and in larger animals."</p><p>Earlier safety studies in mice showed that both the iron oxide and the gel sheath polymer safely break down in the body within a few weeks. However, the team will now need to demonstrate that the device is safe in larger mammals before it can be trialed in human patients; their latest test in pigs did not look at how the device broke down or how the pigs fared after the clots were dissolved. </p><p>Ultimately, the researchers hope that the bots could be injected into the body alongside the thrombolytic medicine. Once inside, they'd be controlled by targeted electromagnets, making the technique easy to integrate into existing clinical procedures for treating clots.</p><div  class="fancy-box"><div class="fancy_box-title">Related Stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/heart-circulation/what-causes-blood-clots">What causes blood clots?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diabetes/slaying-zombie-cells-in-blood-vessels-could-be-key-to-treating-diabetes-early-study-finds">Slaying 'zombie cells' in blood vessels could be key to treating diabetes, early study finds</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/heart-circulation/mini-arteries-on-a-chip-could-help-predict-a-persons-risk-of-stroke">Mini 'arteries-on-a-chip' could help predict a person's risk of stroke</a></li></ul></p></div></div><p>The team's research is still undergoing peer review, but Schürle has applied for a patent for the microbots' production, which uses a droplet-based microfluidics technique to form each individual particle. </p><p>"It's a very cheap, high throughput method to produce the micro-robots," she said. "It's about improving the [clot-dissolving] procedure where it is lacking and helping the drugs travel the last millimeters to be really effective."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/heart-circulation/tiny-robots-can-tumble-through-blood-vessels-to-help-dissolve-blood-clots-early-test-shows</link>
                                                                            <description>
                            <![CDATA[ In recent animal tests, tiny robots released into the bloodstream showed promise for treating blood clots. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">5WoQny6Fzvntnk6YtiVkad</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/rT6n9K4bQpHFm3oCTkjrY3-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 16 Nov 2026 16:00:00 +0000</pubDate>                                                                                                                                <updated>Tue, 17 Nov 2026 12:23:13 +0000</updated>
                                                                                                                                            <category><![CDATA[Heart & Circulation]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Victoria Atkinson ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/myPb7j2m9WcKXy9W9CXaxZ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/rT6n9K4bQpHFm3oCTkjrY3-1920-80.jpg">
                                                            <media:credit><![CDATA[ETH News]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The tiny robots are sent somersaulting through blood vessels by magnetic fields. ]]></media:description>                                                            <media:text><![CDATA[a diagram of tiny, oblong robots tumbling through a blood vessel]]></media:text>
                                <media:title type="plain"><![CDATA[a diagram of tiny, oblong robots tumbling through a blood vessel]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/rT6n9K4bQpHFm3oCTkjrY3-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Microrobots controlled by magnets can sweep drugs towards hard-to-reach blood clots in the body, boosting the efficacy of these life-saving treatments, early tests in animals suggest. </p><p>In tests with pigs, the microbots helped to dissolve clots around 10 times faster than medication alone. The research team is now working on further safety testing to ready the technology for eventual human trials. </p><p>"The whole construct is inspired by nature," said lead researcher<a href="https://hest.ethz.ch/en/studies/health-sciences-and-technology/master-hst/tutors/tutors-a-z/simone-schuerle-finke.html" target="_blank"> <u>Simone Schürle</u></a>, professor of medical microsystems at ETH Zürich. "There are these tiny bacteria that have little magnetic backbones which they use to navigate with the Earth's magnetic field, and we were really struck by the physics and the properties of them when exposed to rotating magnetic fields," Schürle told Live Science.</p><p>ETH Zürich <a href="https://ethz.ch/en/news-and-events/eth-news/news/2026/11/dissolving-blood-clots-with-flow-generating-microbots.html" target="_blank"><u>announced the research in a statement</u></a> on Nov. 9. It has not been described in a peer-reviewed study yet.</p><h2 id="tiny-robots-tumbling-through-blood-vessels">Tiny robots tumbling through blood vessels</h2><p>Left untreated, blood clots can cause life-threatening damage. These blockages can restrict the flow of blood to the body's key tissues, triggering serious cardiovascular events, such as <a href="https://www.livescience.com/health/heart-circulation/what-happens-during-a-heart-attack"><u>heart attacks</u></a> or strokes, which starve cells of oxygen. </p><p>Doctors can either remove clots manually with tools or deliver clot-dissolving drugs, called thrombolytics, close to the site of the blockage. However, getting these medications through the final few millimeters of their journey is often the hardest part. </p><p>"When a pipe becomes blocked in a branched pipe system, the fluid encounters greater resistance and instead flows through alternative routes where it can pass more easily," Schürle explained. "So when you then try to bring in drugs to dissolve the clot, they won't flow into this area because it's occluded [blocked off]."</p><p>This is where microbots can help. The bots are tiny particles whose movements can be controlled by external magnets, which send them rotating and tumbling through blood vessels. These bots can redirect the interrupted blood flow and thus carry essential drugs straight to their target, Schürle and her team say. </p><p>Each bullet-shaped microbot contains a magnetic backbone of iron oxide nanoparticles, which is surrounded by a protective sheath of hydrogel polymer. When exposed to a rotating magnetic field, the microbots essentially start to somersault through the blood vessel, creating little vortices that help carry the drugs along with them. </p><p>Crucially, the bots' rigid backbone ensures that they spin predictably, while the gel body prevents the particles from sticking together and forming a clump.</p><figure role="gallery"><figure><img src="https://cdn.mos.cms.futurecdn.net/hVtyA6vjDCUbvTNdPX8txF-1920-80.jpg" alt="a diagram shows the microbots being introduced to a blood vessel" /><figcaption><small role="credit">ETH News</small></figcaption></figure><figure><img src="https://cdn.mos.cms.futurecdn.net/wrzTJF9KU3UWmUderHXZ2G-1920-80.jpg" alt="diagram shows a close up of the robots helping dissolve a blood clot" /><figcaption><small role="credit">ETH News</small></figcaption></figure></figure><p>The team first tested the microbots in a silicon model of a blood vessel that contained clots of pigs' blood. Aided by the rotating microparticles, a thrombolytic drug dissolved the blockages around 10 times faster than medication alone did. That's a potentially life-saving difference, the researchers said. </p><p>They then repeated the experiment in live pigs, placing clots in vessels in each of the animals' kidneys. "When we introduced our micro-robots with a conventional, state-of-the-art drug, we could reperfuse [restore blood flow to] a much larger area than if only the drug was there," Schürle said. "The next step is doing safety studies over a longer time and in larger animals."</p><p>Earlier safety studies in mice showed that both the iron oxide and the gel sheath polymer safely break down in the body within a few weeks. However, the team will now need to demonstrate that the device is safe in larger mammals before it can be trialed in human patients; their latest test in pigs did not look at how the device broke down or how the pigs fared after the clots were dissolved. </p><p>Ultimately, the researchers hope that the bots could be injected into the body alongside the thrombolytic medicine. Once inside, they'd be controlled by targeted electromagnets, making the technique easy to integrate into existing clinical procedures for treating clots.</p><div  class="fancy-box"><div class="fancy_box-title">Related Stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/heart-circulation/what-causes-blood-clots">What causes blood clots?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diabetes/slaying-zombie-cells-in-blood-vessels-could-be-key-to-treating-diabetes-early-study-finds">Slaying 'zombie cells' in blood vessels could be key to treating diabetes, early study finds</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/heart-circulation/mini-arteries-on-a-chip-could-help-predict-a-persons-risk-of-stroke">Mini 'arteries-on-a-chip' could help predict a person's risk of stroke</a></li></ul></p></div></div><p>The team's research is still undergoing peer review, but Schürle has applied for a patent for the microbots' production, which uses a droplet-based microfluidics technique to form each individual particle. </p><p>"It's a very cheap, high throughput method to produce the micro-robots," she said. "It's about improving the [clot-dissolving] procedure where it is lacking and helping the drugs travel the last millimeters to be really effective."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'Links with the British royal family would eventually prove crucial': How DNA solved the 70-year mystery of what happened to the executed members of the last Russian imperial family ]]></title>
                                                                                                <dc:content><![CDATA[ <p>In 1917, the Russian Revolution was in full swing. Tsar Nicholas II had abdicated, and he and his family were exiled to a remote Siberian town. There were plans to get the family to the U.K., but King George V (Nicholas' first cousin) and the British government withdrew their offer of asylum over concerns of the ramifications. </p><p>After the Russian Provisional Government was overthrown by the more extreme Bolsheviks in October 1917, Nicholas, his wife, their children and several members of the family's staff were moved to Ipatiev House in Yekaterinburg, where, in July 1918, they were executed. Their bodies were hidden and remained lost to time ‪for nearly a century —‬ until modern technology, with some help from the British royal family, unraveled the fascinating story of their disappearance. </p><p>In this excerpt from "<a href="https://www.simonandschuster.com/books/The-Secrets-of-Our-DNA/Turi-King/9798897102402" target="_blank"><u>The Secrets of Our DNA: How Genetics Has Changed the World</u></a>" (Pegasus Books, 2026), author <a href="https://researchportal.bath.ac.uk/en/persons/turi-king/" target="_blank"><u>Turi King</u></a>, director of the Center for Evolution at the University of Bath, looks back at the incredible story of how DNA was used to solve a major mystery of modern history: What happened to the last members of the House of Romanov?</p><p>I was sitting in a lecture theatre at Cambridge University in 1994 when one of my lecturers, <a href="https://www.mn.uio.no/ibv/english/people/aca/erikaha/" target="_blank"><u>Erika Hagelberg</u></a>, spoke about a <a href="https://www.nature.com/articles/ng0294-130" target="_blank"><u>new study</u></a> she had just been involved in. It was the first major case to combine both mitochondrial DNA and DNA fingerprinting to identify human remains: those of the Russian imperial family. </p><p>But first I need to take you back to Russia in 1917 and the abdication of the tsar following the Russian Revolution. </p><p>The Russian royal family, the Romanovs, had been the reigning imperial dynasty since 1617, and three centuries later, Tsar Nicholas II was on the throne. Nicholas was the cousin of George V, king of the United Kingdom, their mothers being sisters, and had married George's cousin Princess Alix (Alexandra) of Hesse, who was apparently Queen Victoria's favourite grandchild. Nicholas and Alix had five children, four daughters (Olga, Tatiana, Maria and Anastasia) and a son, Alexei. </p><p>The tsar and his wife were not well liked by the Russian population and political unrest culminated in the revolution of 1917, when Nicholas was forced to abdicate. The family were kept under house arrest and in 1918 they were moved to Ipatiev House in Yekaterinburg with the royal physician, Dr Botkin, and three of their staff. On the night of 16 July, the family, their doctor and staff were herded into the cellar together and executed. Their bodies were then taken to a secret location and placed in a hastily dug communal grave, doused in sulphuric acid in an attempt to disfigure them and hinder identification, and then covered over, the location of the grave being lost for more than 70 years. </p><figure class="van-image-figure  extended-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="5XfWyT2c2Qn7SMorU4KV9k" name="GettyImages-919806534-Ipatiev House" alt="A black and white photo showing a large white marble structure." src="https://cdn.mos.cms.futurecdn.net/5XfWyT2c2Qn7SMorU4KV9k-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="extended expandable" /><a href='https://cdn.mos.cms.futurecdn.net/5XfWyT2c2Qn7SMorU4KV9k-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" extended-layout"><span class="caption-text">The Ipatiev House in Yekaterinburg, 1919. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Heritage Images via Getty Images)</span></figcaption></figure><p>Ironically, the new Russian government had wanted to get the Romanovs out of Russia due to the risk of their becoming a rallying point, but a plan to grant asylum to the Romanovs in the U.K. because of their links with the British royal family fell through, owing to a reluctance on the part of George V to grant it. Yet those links with the British royal family would eventually prove crucial in their identification. </p><p>Fast-forward to 1991, when several skeletons were found in a shallow grave some 20 miles from Yekaterinburg. Many of the bones were badly damaged but it was possible to determine, based on examination of the skeletal remains, that there were nine individuals — two short of the 11 killed that night. The faces of the skulls were badly damaged in all of the skeletons, all of them showing evidence of violence either in the form of bullet holes or bayonet wounds or both. Before the genetic study, Russian forensic scientists had used numerous techniques alongside historical data to tentatively identify the remains as some of the members of the Russian royal family, their doctor and servants. </p><p>These included examining the bones, to determine approximate age and sex, and some of the teeth, the expensive dental work, incorporating gold, platinum and porcelain, indicating that certain remains must belong to members of an aristocratic family. The team worked out that the two missing individuals would have been two of the children, one of the daughters (while it was hard to determine which one it would be, given how close in age they were, it was thought that it was either Maria or Anastasia) and the son, Prince Alexei. </p><p>The Russian chief forensic medical examiner then contacted a team in the U.K., which included Erika, to see if genetic evidence could be used to confirm the identification. The U.K. team used the amelogenin genetic sex test, now part of standard forensic DNA testing, which confirmed the sex of the skeletons (four male and five female bodies), while an early form of DNA profiling showed that there was a family group here — two parents and three children — and four unrelated individuals. So far, so good. </p><p>Next, they needed to prove that this was the Russian royal family, and they did this using mitochondrial DNA analysis. As you'll remember, mitochondrial DNA is passed down by a mother to all her children, male and female, but only daughters can pass it on — so if female-line family members of Tsar Nicholas and Tsarina Alexandra could be found and would agree to give a DNA test, their mitochondrial DNA should match that of their royal ancestors. It just so happened that the late Prince Philip, husband of the late Queen Elizabeth, was related to the tsarina through the female line: she was his great-aunt, his maternal grandmother being the sister of the tsarina. He kindly gave a DNA sample. </p><p>The testing that they did was standard for the time in that they looked at two regions known as hypervariable regions 1 and 2 (HVR1 and HVR2). You'll remember that mitochondrial DNA has 37 rather crucial genes on it where any "typo" that occurs as the DNA is being copied could have serious consequences if the mutation is deleterious. By contrast, in those parts of the mitochondrial genome that don't code for anything, such as these two hypervariable regions, mutations can occur more freely without necessarily causing issues, meaning that these regions contain much more genetic variation. These are the sections of mitochondrial DNA that scientists began analysing for identification purposes. While it's not as precise as DNA profiling because many thousands of people will all have the same mitochondrial DNA type, it can be very helpful in a case such as this. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="7Wa7fumCk4og68qRfkep4d" name="GettyImages-52115851-prince philip" alt="A man with white hair wearing a gray blazer looks to the right of the camera." src="https://cdn.mos.cms.futurecdn.net/7Wa7fumCk4og68qRfkep4d-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/7Wa7fumCk4og68qRfkep4d-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Prince Philip's DNA was eventually used to confirm the identities of the lost Romanov family.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Tim Graham via Getty Images)</span></figcaption></figure><p>When the team sequenced these two regions, Prince Philip's mitochondrial DNA was found to match that of the putative remains of the tsarina and her daughters. Next they found two living female-line relatives of the tsar, descended from his maternal grandmother: a great-great-niece, Princess Xenia Cheremeteff Sfiris, and a first cousin twice removed, James Carnegie, 3rd Duke of Fife. The mitochondrial DNA from these two matched each other perfectly, and they, in turn, matched that of the tsar, except at one base where there was both a match and a mismatch. </p><p>This is because the tsar had what's known as a heteroplasmy at this position: some of the mitochondrial DNA sequences showed a T and others showed a C, his maternal relatives showing a T. Heteroplasmy is known to take place primarily through mutations occurring when the DNA is copied to make new cells in a person's lifetime, but it can be inherited from a maternal ancestor with heteroplasmy. Extremely rarely, it can come from paternal mitochondrial DNA making it into the cell. So the fact that heteroplasmy existed in the DNA sample didn't negate the match, and the probability that these were the Romanovs was still between 70 to 1 through to 840,000 to 1 in favour. But, it did sow some seeds of doubt. Incidentally, we now know that heteroplasmy is fairly common, with potentially over half of the human population having at least one heteroplasmy, albeit at a low percentage in terms of their mitochondrial DNA carrying it. </p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/vikings/it-gives-us-a-glimpse-of-a-different-kind-of-viking-life-archaeologist-neil-price-on-the-sea-kings-sorcerers-and-sami-who-lived-during-the-viking-age">'It gives us a glimpse of a different kind of Viking life': Archaeologist Neil Price on the sea-kings, sorcerers and Sámi who lived during the Viking Age</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/everything-we-did-started-coming-back-to-the-mitochondria-how-replacing-cells-powerhouses-could-revolutionize-transplant-surgery-and-treat-kids-with-devastating-diseases?M_BT=506772722552367">When a battery dies, you replace it — how jumpstarting cells with fresh mitochondria could revolutionize medicine</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/author-lise-barneoud-on-the-bizarre-and-provoking-world-of-microchimerism-when-cells-from-one-person-live-in-another-genetically-distinct-individual">Author Lise Barnéoud on the bizarre and provoking world of microchimerism — when cells from one person live in another, genetically distinct individual</a></li></ul></p></div></div><p>So, to be doubly sure, in 1996 the remains of the tsar's brother, Georgij, who had died in 1899, were exhumed and he was found to have exactly the same mitochondrial heteroplasmy. Given the very low chance of two people having this particular heteroplasmy if they weren't related, this pointed to the mitochondrial DNA data the researchers obtained being 130,000,000 times more likely if these were the Romanovs than if they were an unrelated family. </p><p>The case was solved in terms of identifying the tsar, tsarina and three of their daughters, but the mystery still remained as to what had happened to the two other children. In the scientific paper reporting the results, the authors conjectured that possibly the two children had been buried separately, or that they could have survived the massacre. Incidentally, there was a woman living in the U.S. who claimed to be Anastasia, saying she had managed to escape being executed, and so the fact that two of the children were missing from the Romanov family group only fuelled the idea that maybe she truly was the missing princess. </p><p>Then, in 2007, a group of amateur archaeologists, digging a mere 70 metres away from the previously discovered mass grave, came across more human remains. Skeletal evidence showed that they were the remains of two bodies, a young woman aged 15-19 and a probable male aged 12-15. DNA analysis was brought to bear and again showed that the two individuals were siblings and related to the Romanovs already identified. As an extra DNA test, Y-chromosome testing was carried out, the Y chromosome being passed from father to son, to confirm that the Y chromosome of the newly found male skeleton was indeed male and that it matched the Y chromosome of the tsar. This also then matched male-line relatives — a second cousin once removed of the tsar (third cousin of Alexei) through Tsar Nicholas I. The missing Romanov children had been found. </p><p><em>Adapted from</em><a href="https://www.simonandschuster.com/books/The-Secrets-of-Our-DNA/Turi-King/9798897102402"><em> </em><u><em>The Secrets of Our DNA: How Genetics Has Changed the World</em></u></a><em> by Turi King. Published by Pegasus Books. Copyright © 2026. All rights reserved. </em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>        <div class="featured_product_block featured_block_horizontal" data-id="41b29654-d797-11f1-8c47-1525df0b2f0f">            <a href="https://www.amazon.com/exec/obidos/ASIN/B0GPNMTN58" data-model-name="The Secrets of Our DNA: How Genetics Has Changed the World" data-model-brand="" ><div class='product-image-widthsetter'><p class='vanilla-image-block' data-bordeaux-image-check="" style='padding-top:150%';><img style="width: 100%" class="featured_image" src="https://cdn.mos.cms.futurecdn.net/NUTorxg3BFeJjrqt5LGUt5.jpg" alt="An image of a book titled "The Secrets of our DNA: How Genetics Has Changed the World"" /></p></div></a>            <div class="featured_product_details_wrapper">                <div class="featured_product_title_wrapper">                                        <div class='featured__brand'>Pegasus Books</div>                                        <div class="featured__title">The Secrets of Our DNA: How Genetics Has Changed the World</div>                                    </div>                <div class="subtitle__description">                                                            <p><p>From an award-winning expert on DNA, discover the myth-busting book that opens a dazzling window into the world of modern genetics.</p><p>Fascinating, compassionate, and entirely captivating, The Secrets of Our DNA is the essential book that explains how genetics has changed and transformed the world around us.</p></p>                </div>                            </div>        </div> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/genetics/links-with-the-british-royal-family-would-eventually-prove-crucial-how-dna-solved-the-70-year-mystery-of-what-happened-to-the-executed-members-of-the-last-russian-imperial-family</link>
                                                                            <description>
                            <![CDATA[ In this excerpt from "The Secrets of our DNA," geneticist Turi King examines how DNA was used to reveal the ultimate fate of the last members of the House of Romanov. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">G64cuKMN5LsJZPmqRtsShD</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/eQJMmcSsNS3pe8Ek3VLP6J-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sat, 14 Nov 2026 09:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Genetics]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Turi King ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/u75J7hLSHxpk2Uk9ck2ft5-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                        <dc:contributor><![CDATA[ Hannah Osborne ]]></dc:contributor>
                                                                    <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/eQJMmcSsNS3pe8Ek3VLP6J-1920-80.jpg">
                                                            <media:credit><![CDATA[ Heritage Images via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The entire Romanov family was executed in 1918 following the Russian Revolution. ]]></media:description>                                                            <media:text><![CDATA[A black and white photo of a family sitting together.]]></media:text>
                                <media:title type="plain"><![CDATA[A black and white photo of a family sitting together.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/eQJMmcSsNS3pe8Ek3VLP6J-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>In 1917, the Russian Revolution was in full swing. Tsar Nicholas II had abdicated, and he and his family were exiled to a remote Siberian town. There were plans to get the family to the U.K., but King George V (Nicholas' first cousin) and the British government withdrew their offer of asylum over concerns of the ramifications. </p><p>After the Russian Provisional Government was overthrown by the more extreme Bolsheviks in October 1917, Nicholas, his wife, their children and several members of the family's staff were moved to Ipatiev House in Yekaterinburg, where, in July 1918, they were executed. Their bodies were hidden and remained lost to time ‪for nearly a century —‬ until modern technology, with some help from the British royal family, unraveled the fascinating story of their disappearance. </p><p>In this excerpt from "<a href="https://www.simonandschuster.com/books/The-Secrets-of-Our-DNA/Turi-King/9798897102402" target="_blank"><u>The Secrets of Our DNA: How Genetics Has Changed the World</u></a>" (Pegasus Books, 2026), author <a href="https://researchportal.bath.ac.uk/en/persons/turi-king/" target="_blank"><u>Turi King</u></a>, director of the Center for Evolution at the University of Bath, looks back at the incredible story of how DNA was used to solve a major mystery of modern history: What happened to the last members of the House of Romanov?</p><p>I was sitting in a lecture theatre at Cambridge University in 1994 when one of my lecturers, <a href="https://www.mn.uio.no/ibv/english/people/aca/erikaha/" target="_blank"><u>Erika Hagelberg</u></a>, spoke about a <a href="https://www.nature.com/articles/ng0294-130" target="_blank"><u>new study</u></a> she had just been involved in. It was the first major case to combine both mitochondrial DNA and DNA fingerprinting to identify human remains: those of the Russian imperial family. </p><p>But first I need to take you back to Russia in 1917 and the abdication of the tsar following the Russian Revolution. </p><p>The Russian royal family, the Romanovs, had been the reigning imperial dynasty since 1617, and three centuries later, Tsar Nicholas II was on the throne. Nicholas was the cousin of George V, king of the United Kingdom, their mothers being sisters, and had married George's cousin Princess Alix (Alexandra) of Hesse, who was apparently Queen Victoria's favourite grandchild. Nicholas and Alix had five children, four daughters (Olga, Tatiana, Maria and Anastasia) and a son, Alexei. </p><p>The tsar and his wife were not well liked by the Russian population and political unrest culminated in the revolution of 1917, when Nicholas was forced to abdicate. The family were kept under house arrest and in 1918 they were moved to Ipatiev House in Yekaterinburg with the royal physician, Dr Botkin, and three of their staff. On the night of 16 July, the family, their doctor and staff were herded into the cellar together and executed. Their bodies were then taken to a secret location and placed in a hastily dug communal grave, doused in sulphuric acid in an attempt to disfigure them and hinder identification, and then covered over, the location of the grave being lost for more than 70 years. </p><figure class="van-image-figure  extended-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="5XfWyT2c2Qn7SMorU4KV9k" name="GettyImages-919806534-Ipatiev House" alt="A black and white photo showing a large white marble structure." src="https://cdn.mos.cms.futurecdn.net/5XfWyT2c2Qn7SMorU4KV9k-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="extended expandable" /><a href='https://cdn.mos.cms.futurecdn.net/5XfWyT2c2Qn7SMorU4KV9k-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" extended-layout"><span class="caption-text">The Ipatiev House in Yekaterinburg, 1919. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Heritage Images via Getty Images)</span></figcaption></figure><p>Ironically, the new Russian government had wanted to get the Romanovs out of Russia due to the risk of their becoming a rallying point, but a plan to grant asylum to the Romanovs in the U.K. because of their links with the British royal family fell through, owing to a reluctance on the part of George V to grant it. Yet those links with the British royal family would eventually prove crucial in their identification. </p><p>Fast-forward to 1991, when several skeletons were found in a shallow grave some 20 miles from Yekaterinburg. Many of the bones were badly damaged but it was possible to determine, based on examination of the skeletal remains, that there were nine individuals — two short of the 11 killed that night. The faces of the skulls were badly damaged in all of the skeletons, all of them showing evidence of violence either in the form of bullet holes or bayonet wounds or both. Before the genetic study, Russian forensic scientists had used numerous techniques alongside historical data to tentatively identify the remains as some of the members of the Russian royal family, their doctor and servants. </p><p>These included examining the bones, to determine approximate age and sex, and some of the teeth, the expensive dental work, incorporating gold, platinum and porcelain, indicating that certain remains must belong to members of an aristocratic family. The team worked out that the two missing individuals would have been two of the children, one of the daughters (while it was hard to determine which one it would be, given how close in age they were, it was thought that it was either Maria or Anastasia) and the son, Prince Alexei. </p><p>The Russian chief forensic medical examiner then contacted a team in the U.K., which included Erika, to see if genetic evidence could be used to confirm the identification. The U.K. team used the amelogenin genetic sex test, now part of standard forensic DNA testing, which confirmed the sex of the skeletons (four male and five female bodies), while an early form of DNA profiling showed that there was a family group here — two parents and three children — and four unrelated individuals. So far, so good. </p><p>Next, they needed to prove that this was the Russian royal family, and they did this using mitochondrial DNA analysis. As you'll remember, mitochondrial DNA is passed down by a mother to all her children, male and female, but only daughters can pass it on — so if female-line family members of Tsar Nicholas and Tsarina Alexandra could be found and would agree to give a DNA test, their mitochondrial DNA should match that of their royal ancestors. It just so happened that the late Prince Philip, husband of the late Queen Elizabeth, was related to the tsarina through the female line: she was his great-aunt, his maternal grandmother being the sister of the tsarina. He kindly gave a DNA sample. </p><p>The testing that they did was standard for the time in that they looked at two regions known as hypervariable regions 1 and 2 (HVR1 and HVR2). You'll remember that mitochondrial DNA has 37 rather crucial genes on it where any "typo" that occurs as the DNA is being copied could have serious consequences if the mutation is deleterious. By contrast, in those parts of the mitochondrial genome that don't code for anything, such as these two hypervariable regions, mutations can occur more freely without necessarily causing issues, meaning that these regions contain much more genetic variation. These are the sections of mitochondrial DNA that scientists began analysing for identification purposes. While it's not as precise as DNA profiling because many thousands of people will all have the same mitochondrial DNA type, it can be very helpful in a case such as this. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="7Wa7fumCk4og68qRfkep4d" name="GettyImages-52115851-prince philip" alt="A man with white hair wearing a gray blazer looks to the right of the camera." src="https://cdn.mos.cms.futurecdn.net/7Wa7fumCk4og68qRfkep4d-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/7Wa7fumCk4og68qRfkep4d-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Prince Philip's DNA was eventually used to confirm the identities of the lost Romanov family.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Tim Graham via Getty Images)</span></figcaption></figure><p>When the team sequenced these two regions, Prince Philip's mitochondrial DNA was found to match that of the putative remains of the tsarina and her daughters. Next they found two living female-line relatives of the tsar, descended from his maternal grandmother: a great-great-niece, Princess Xenia Cheremeteff Sfiris, and a first cousin twice removed, James Carnegie, 3rd Duke of Fife. The mitochondrial DNA from these two matched each other perfectly, and they, in turn, matched that of the tsar, except at one base where there was both a match and a mismatch. </p><p>This is because the tsar had what's known as a heteroplasmy at this position: some of the mitochondrial DNA sequences showed a T and others showed a C, his maternal relatives showing a T. Heteroplasmy is known to take place primarily through mutations occurring when the DNA is copied to make new cells in a person's lifetime, but it can be inherited from a maternal ancestor with heteroplasmy. Extremely rarely, it can come from paternal mitochondrial DNA making it into the cell. So the fact that heteroplasmy existed in the DNA sample didn't negate the match, and the probability that these were the Romanovs was still between 70 to 1 through to 840,000 to 1 in favour. But, it did sow some seeds of doubt. Incidentally, we now know that heteroplasmy is fairly common, with potentially over half of the human population having at least one heteroplasmy, albeit at a low percentage in terms of their mitochondrial DNA carrying it. </p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/vikings/it-gives-us-a-glimpse-of-a-different-kind-of-viking-life-archaeologist-neil-price-on-the-sea-kings-sorcerers-and-sami-who-lived-during-the-viking-age">'It gives us a glimpse of a different kind of Viking life': Archaeologist Neil Price on the sea-kings, sorcerers and Sámi who lived during the Viking Age</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/everything-we-did-started-coming-back-to-the-mitochondria-how-replacing-cells-powerhouses-could-revolutionize-transplant-surgery-and-treat-kids-with-devastating-diseases?M_BT=506772722552367">When a battery dies, you replace it — how jumpstarting cells with fresh mitochondria could revolutionize medicine</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/author-lise-barneoud-on-the-bizarre-and-provoking-world-of-microchimerism-when-cells-from-one-person-live-in-another-genetically-distinct-individual">Author Lise Barnéoud on the bizarre and provoking world of microchimerism — when cells from one person live in another, genetically distinct individual</a></li></ul></p></div></div><p>So, to be doubly sure, in 1996 the remains of the tsar's brother, Georgij, who had died in 1899, were exhumed and he was found to have exactly the same mitochondrial heteroplasmy. Given the very low chance of two people having this particular heteroplasmy if they weren't related, this pointed to the mitochondrial DNA data the researchers obtained being 130,000,000 times more likely if these were the Romanovs than if they were an unrelated family. </p><p>The case was solved in terms of identifying the tsar, tsarina and three of their daughters, but the mystery still remained as to what had happened to the two other children. In the scientific paper reporting the results, the authors conjectured that possibly the two children had been buried separately, or that they could have survived the massacre. Incidentally, there was a woman living in the U.S. who claimed to be Anastasia, saying she had managed to escape being executed, and so the fact that two of the children were missing from the Romanov family group only fuelled the idea that maybe she truly was the missing princess. </p><p>Then, in 2007, a group of amateur archaeologists, digging a mere 70 metres away from the previously discovered mass grave, came across more human remains. Skeletal evidence showed that they were the remains of two bodies, a young woman aged 15-19 and a probable male aged 12-15. DNA analysis was brought to bear and again showed that the two individuals were siblings and related to the Romanovs already identified. As an extra DNA test, Y-chromosome testing was carried out, the Y chromosome being passed from father to son, to confirm that the Y chromosome of the newly found male skeleton was indeed male and that it matched the Y chromosome of the tsar. This also then matched male-line relatives — a second cousin once removed of the tsar (third cousin of Alexei) through Tsar Nicholas I. The missing Romanov children had been found. </p><p><em>Adapted from</em><a href="https://www.simonandschuster.com/books/The-Secrets-of-Our-DNA/Turi-King/9798897102402"><em> </em><u><em>The Secrets of Our DNA: How Genetics Has Changed the World</em></u></a><em> by Turi King. Published by Pegasus Books. Copyright © 2026. All rights reserved. </em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>        <div class="featured_product_block featured_block_horizontal" data-id="41b29654-d797-11f1-8c47-1525df0b2f0f">            <a href="https://www.amazon.com/exec/obidos/ASIN/B0GPNMTN58" data-model-name="The Secrets of Our DNA: How Genetics Has Changed the World" data-model-brand="" ><div class='product-image-widthsetter'><p class='vanilla-image-block' data-bordeaux-image-check="" style='padding-top:150%';><img style="width: 100%" class="featured_image" src="https://cdn.mos.cms.futurecdn.net/NUTorxg3BFeJjrqt5LGUt5.jpg" alt="An image of a book titled "The Secrets of our DNA: How Genetics Has Changed the World"" /></p></div></a>            <div class="featured_product_details_wrapper">                <div class="featured_product_title_wrapper">                                        <div class='featured__brand'>Pegasus Books</div>                                        <div class="featured__title">The Secrets of Our DNA: How Genetics Has Changed the World</div>                                    </div>                <div class="subtitle__description">                                                            <p><p>From an award-winning expert on DNA, discover the myth-busting book that opens a dazzling window into the world of modern genetics.</p><p>Fascinating, compassionate, and entirely captivating, The Secrets of Our DNA is the essential book that explains how genetics has changed and transformed the world around us.</p></p>                </div>                            </div>        </div>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Measles is back in the United States, WHO authorities say ]]></title>
                                                                                                <dc:content><![CDATA[ <p><em>Editor's note: The </em><a href="https://www.cnbc.com/2026/11/17/us-measles-elimination-status.html" target="_blank"><u><em>Pan American Health Organization (PAHO) officially announced</em></u></a><em> its decision to revoke the United States' measles elimination status on Nov. 17, 2026. The week prior, the Wall Street Journal reported that the PAHO had reached that decision. </em></p><p>Measles is officially back in the United States after the disease had been eliminated from the country for more than 25 years.</p><p>The U.S. officially eliminated measles in 2000, meaning that at that time, the country had gone over a year without continuous domestic spread of the disease. Travelers would occasionally bring measles into the country, <a href="https://www.livescience.com/65606-measles-cases-reach-record-high.html"><u>sometimes sparking significant local outbreaks</u></a>, but these didn't tip enough dominoes to lead to ongoing domestic transmission. </p><p>That status has now changed, <a href="https://www.wsj.com/health/u-s-loses-measles-elimination-status-as-historic-resurgence-sickens-thousands-b95e8780" target="_blank">t<u>he Wall Street Journal reported</u></a> Friday (Nov. 13). The Pan American Health Organization (PAHO), which is the regional office of the World Health Organization for the Americas, has reevaluated the United States' measles elimination status and determined that it should be revoked. With this decision, the U.S. joins several other nations that have seen a local return of measles, including <a href="https://www.livescience.com/health/viruses-infections-disease/the-uk-has-lost-its-measles-elimination-status-again"><u>the U.K.</u></a> and <a href="https://www.livescience.com/health/viruses-infections-disease/canada-has-lost-its-measles-elimination-status-heres-what-that-means"><u>Canada</u></a>.</p><p>The decision follows a series of major measles outbreaks that kicked off in January 2025. <a href="https://www.cdc.gov/measles/data-research/index.html"><u>Nearly 2,300 cases</u></a> were reported nationwide in 2025, and so far in 2026, almost <a href="https://www.cdc.gov/measles/data-research/" target="_blank"><u>5,412 confirmed cases</u></a> have been confirmed, although both tallies are likely undercounts.</p><p>"When January 2025 picked up, I felt like this might be the point of no return," <a href="https://research.childrenshospital.org/researchers/maimuna-majumder"><u>Maimuna Majumder</u></a>, a distinguished scholar in the Computational Health Informatics Program at Boston Children's Hospital, <a href="https://www.livescience.com/health/viruses-infections-disease/this-might-be-the-point-of-no-return-experts-on-the-current-measles-outbreak-and-where-we-go-from-here"><u>previously told Live Science</u></a>. "I do want to just stress that measles elimination has always been a tenuous prospect, and it is, by design, tenuous," she added.</p><p>It takes work to keep an eliminated disease from resurging. The effort rests largely on keeping vaccination rates above a critical threshold — because the measles virus spreads so easily, at least <a href="https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00063-3/fulltext"><u>95% of the population</u></a> needs immunity via either vaccination or past infection to prevent large outbreaks from occurring and fueling uncontrolled spread. National measles vaccination rates <a href="https://www.cdc.gov/schoolvaxview/data/index.html"><u>have been falling</u></a> in recent years, with <a href="https://www.kff.org/other-health/state-indicator/vaccination-coverage-rates-among-kindergartners/?currentTimeframe=0&amp;sortModel=%7B%22colId%22:%22MMR%22,%22sort%22:%22desc%22%7D"><u>just 10 states</u></a> reporting rates above the immunity threshold among kindergarteners for 2025-2026. </p><p><a href="https://www.kff.org/other-health/measles-elimination-status-what-it-is-and-how-the-u-s-could-lose-it/"><u>Experts point to</u></a> several factors to explain the trend, including declining funds and staff for public health efforts and wavering public trust in vaccines and scientific expertise. The <a href="https://www.livescience.com/health/viruses-infections-disease/us-is-on-track-to-lose-its-measles-elimination-status-in-months-rfk-needs-to-go-opinion"><u>appointment of vaccine skeptic Robert F. Kennedy Jr.</u></a> as health secretary and the <a href="https://www.livescience.com/health/i-dont-know-if-cdc-will-survive-to-be-quite-frank-former-cdc-officials-describe-the-disintegration-of-the-agency-under-rfk"><u>loss of long-standing federal health leadership</u></a> further fueled the trend, they say, as vaccine guidance has been <a href="https://www.livescience.com/health/medicine-drugs/cdc-committee-votes-to-change-measles-vaccine-guidance-for-young-children"><u>changed in ways that likely sow confusion</u></a> and the federal rhetoric around vaccines now frames their safety and effectiveness as open questions when they are actually well-established. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:700px;"><p class="vanilla-image-block" style="padding-top:66.14%;"><img id="DZYGn3sGxGLpoWcGqB5xmZ" name="17980_lores-measles baby" alt="A close up of a baby with red bumps on its face." src="https://cdn.mos.cms.futurecdn.net/DZYGn3sGxGLpoWcGqB5xmZ-1920-80.jpg" mos="" align="middle" fullscreen="1" width="700" height="463" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/DZYGn3sGxGLpoWcGqB5xmZ-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Measles infections can have serious consequences, including long-term disability and death. </span><span class="credit" itemprop="copyrightHolder">(Image credit: CDC/ Rebecca Martin, PhD)</span></figcaption></figure><p>The nation's <a href="https://www.livescience.com/health/viruses-infections-disease/2-people-die-of-measles-in-pennsylvania-as-vaccination-rates-drop-across-the-nation"><u>first measles-related deaths this year</u></a> were reported in Pennsylvania in August, and <a href="https://www.cidrap.umn.edu/measles/pennsylvania-reports-another-measles-related-death-2nd-jefferson-county"><u>five more have followed</u></a>, according to state health officials. (Some of these deaths have not been confirmed <a href="https://www.reuters.com/world/kennedy-asked-remove-pennsylvania-measles-death-cdc-tally-sources-say-2026-09-03/"><u>by the federal government</u></a>.) A death reported in <a href="https://www.cidrap.umn.edu/measles/baby-wisconsin-has-died-measles-3rd-such-us-death-week"><u>Wisconsin</u></a> and another in <a href="https://www.nytimes.com/2026/11/02/nyregion/measles-death-child-new-york-lewis-county.html"><u>New York</u></a> have brought the current total to eight, <a href="https://publications.aap.org/redbook/resources/15187/Red-Book-Online-Outbreaks-Measles?autologincheck=redirected"><u>per states' counts</u></a>. </p><p>In the U.S., about <a href="https://www.nfid.org/infectious-disease/measles/"><u>1 to 3 out of every 1,000</u></a> measles cases results in death. Pennsylvania has recorded <a href="https://www.pa.gov/agencies/health/diseases-conditions/infectious-disease/measles"><u>just over 1,500 cases</u></a>, so its number of reported deaths is higher than expected, hinting that the state's true case rate has not been fully captured in the data.</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/measles-resurgence-in-the-us-is-a-grim-sign-of-whats-coming">Measles' resurgence in the US is a grim sign of what's coming</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/are-you-protected-against-measles-do-you-need-a-booster-shot-everything-you-need-to-know-about-immunity">Are you protected against measles? Do you need a booster shot? Everything you need to know about immunity</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/measles-wipes-immune-memory.html">Measles wipes your immune system's 'memory,' so it can't fight other infections</a></li></ul></p></div></div><p>In survivors, <a href="https://www.livescience.com/health/viruses-infections-disease/measles-has-long-term-health-consequences-for-kids-vaccines-can-prevent-all-of-them"><u>measles can cause long-term health problems</u></a>, including brain damage and immune amnesia, in which the immune cells tasked with remembering past infections have their "memories" wiped.</p><p>The PAHO's meeting to reevaluate the United States' status was <a href="https://www.cnn.com/2026/03/02/health/us-measles-elimination-status-paho-meeting-delay"><u>originally scheduled for April</u></a> but was pushed to November. </p><p>To regain its measles elimination status, the U.S. must go 12 months without continuous spread of the virus. </p><p>Disclaimer: This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/viruses-infections-disease/measles-is-back-in-the-united-states-who-authorities-say</link>
                                                                            <description>
                            <![CDATA[ The Pan American Health Organization has determined that the U.S. has lost its measles elimination status, meaning domestic spread of the virus is now significant and sustained. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">DhgM2rZri4D3FKjT2h9FYB</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/tvbFcaZYVLYtaubbR8GgQV-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sat, 14 Nov 2026 04:07:49 +0000</pubDate>                                                                                                                                <updated>Tue, 17 Nov 2026 16:26:56 +0000</updated>
                                                                                                                                            <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/tvbFcaZYVLYtaubbR8GgQV-1920-80.jpg">
                                                            <media:credit><![CDATA[koto_feja via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Public health campaigns stymied measles spread in the U.S. for years, but now, the virus is once again endemic to the country.]]></media:description>                                                            <media:text><![CDATA[An illustration of a series of spiky virus cells in a bloodstream.]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a series of spiky virus cells in a bloodstream.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/tvbFcaZYVLYtaubbR8GgQV-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><em>Editor's note: The </em><a href="https://www.cnbc.com/2026/11/17/us-measles-elimination-status.html" target="_blank"><u><em>Pan American Health Organization (PAHO) officially announced</em></u></a><em> its decision to revoke the United States' measles elimination status on Nov. 17, 2026. The week prior, the Wall Street Journal reported that the PAHO had reached that decision. </em></p><p>Measles is officially back in the United States after the disease had been eliminated from the country for more than 25 years.</p><p>The U.S. officially eliminated measles in 2000, meaning that at that time, the country had gone over a year without continuous domestic spread of the disease. Travelers would occasionally bring measles into the country, <a href="https://www.livescience.com/65606-measles-cases-reach-record-high.html"><u>sometimes sparking significant local outbreaks</u></a>, but these didn't tip enough dominoes to lead to ongoing domestic transmission. </p><p>That status has now changed, <a href="https://www.wsj.com/health/u-s-loses-measles-elimination-status-as-historic-resurgence-sickens-thousands-b95e8780" target="_blank">t<u>he Wall Street Journal reported</u></a> Friday (Nov. 13). The Pan American Health Organization (PAHO), which is the regional office of the World Health Organization for the Americas, has reevaluated the United States' measles elimination status and determined that it should be revoked. With this decision, the U.S. joins several other nations that have seen a local return of measles, including <a href="https://www.livescience.com/health/viruses-infections-disease/the-uk-has-lost-its-measles-elimination-status-again"><u>the U.K.</u></a> and <a href="https://www.livescience.com/health/viruses-infections-disease/canada-has-lost-its-measles-elimination-status-heres-what-that-means"><u>Canada</u></a>.</p><p>The decision follows a series of major measles outbreaks that kicked off in January 2025. <a href="https://www.cdc.gov/measles/data-research/index.html"><u>Nearly 2,300 cases</u></a> were reported nationwide in 2025, and so far in 2026, almost <a href="https://www.cdc.gov/measles/data-research/" target="_blank"><u>5,412 confirmed cases</u></a> have been confirmed, although both tallies are likely undercounts.</p><p>"When January 2025 picked up, I felt like this might be the point of no return," <a href="https://research.childrenshospital.org/researchers/maimuna-majumder"><u>Maimuna Majumder</u></a>, a distinguished scholar in the Computational Health Informatics Program at Boston Children's Hospital, <a href="https://www.livescience.com/health/viruses-infections-disease/this-might-be-the-point-of-no-return-experts-on-the-current-measles-outbreak-and-where-we-go-from-here"><u>previously told Live Science</u></a>. "I do want to just stress that measles elimination has always been a tenuous prospect, and it is, by design, tenuous," she added.</p><p>It takes work to keep an eliminated disease from resurging. The effort rests largely on keeping vaccination rates above a critical threshold — because the measles virus spreads so easily, at least <a href="https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00063-3/fulltext"><u>95% of the population</u></a> needs immunity via either vaccination or past infection to prevent large outbreaks from occurring and fueling uncontrolled spread. National measles vaccination rates <a href="https://www.cdc.gov/schoolvaxview/data/index.html"><u>have been falling</u></a> in recent years, with <a href="https://www.kff.org/other-health/state-indicator/vaccination-coverage-rates-among-kindergartners/?currentTimeframe=0&amp;sortModel=%7B%22colId%22:%22MMR%22,%22sort%22:%22desc%22%7D"><u>just 10 states</u></a> reporting rates above the immunity threshold among kindergarteners for 2025-2026. </p><p><a href="https://www.kff.org/other-health/measles-elimination-status-what-it-is-and-how-the-u-s-could-lose-it/"><u>Experts point to</u></a> several factors to explain the trend, including declining funds and staff for public health efforts and wavering public trust in vaccines and scientific expertise. The <a href="https://www.livescience.com/health/viruses-infections-disease/us-is-on-track-to-lose-its-measles-elimination-status-in-months-rfk-needs-to-go-opinion"><u>appointment of vaccine skeptic Robert F. Kennedy Jr.</u></a> as health secretary and the <a href="https://www.livescience.com/health/i-dont-know-if-cdc-will-survive-to-be-quite-frank-former-cdc-officials-describe-the-disintegration-of-the-agency-under-rfk"><u>loss of long-standing federal health leadership</u></a> further fueled the trend, they say, as vaccine guidance has been <a href="https://www.livescience.com/health/medicine-drugs/cdc-committee-votes-to-change-measles-vaccine-guidance-for-young-children"><u>changed in ways that likely sow confusion</u></a> and the federal rhetoric around vaccines now frames their safety and effectiveness as open questions when they are actually well-established. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:700px;"><p class="vanilla-image-block" style="padding-top:66.14%;"><img id="DZYGn3sGxGLpoWcGqB5xmZ" name="17980_lores-measles baby" alt="A close up of a baby with red bumps on its face." src="https://cdn.mos.cms.futurecdn.net/DZYGn3sGxGLpoWcGqB5xmZ-1920-80.jpg" mos="" align="middle" fullscreen="1" width="700" height="463" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/DZYGn3sGxGLpoWcGqB5xmZ-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Measles infections can have serious consequences, including long-term disability and death. </span><span class="credit" itemprop="copyrightHolder">(Image credit: CDC/ Rebecca Martin, PhD)</span></figcaption></figure><p>The nation's <a href="https://www.livescience.com/health/viruses-infections-disease/2-people-die-of-measles-in-pennsylvania-as-vaccination-rates-drop-across-the-nation"><u>first measles-related deaths this year</u></a> were reported in Pennsylvania in August, and <a href="https://www.cidrap.umn.edu/measles/pennsylvania-reports-another-measles-related-death-2nd-jefferson-county"><u>five more have followed</u></a>, according to state health officials. (Some of these deaths have not been confirmed <a href="https://www.reuters.com/world/kennedy-asked-remove-pennsylvania-measles-death-cdc-tally-sources-say-2026-09-03/"><u>by the federal government</u></a>.) A death reported in <a href="https://www.cidrap.umn.edu/measles/baby-wisconsin-has-died-measles-3rd-such-us-death-week"><u>Wisconsin</u></a> and another in <a href="https://www.nytimes.com/2026/11/02/nyregion/measles-death-child-new-york-lewis-county.html"><u>New York</u></a> have brought the current total to eight, <a href="https://publications.aap.org/redbook/resources/15187/Red-Book-Online-Outbreaks-Measles?autologincheck=redirected"><u>per states' counts</u></a>. </p><p>In the U.S., about <a href="https://www.nfid.org/infectious-disease/measles/"><u>1 to 3 out of every 1,000</u></a> measles cases results in death. Pennsylvania has recorded <a href="https://www.pa.gov/agencies/health/diseases-conditions/infectious-disease/measles"><u>just over 1,500 cases</u></a>, so its number of reported deaths is higher than expected, hinting that the state's true case rate has not been fully captured in the data.</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/measles-resurgence-in-the-us-is-a-grim-sign-of-whats-coming">Measles' resurgence in the US is a grim sign of what's coming</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/are-you-protected-against-measles-do-you-need-a-booster-shot-everything-you-need-to-know-about-immunity">Are you protected against measles? Do you need a booster shot? Everything you need to know about immunity</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/measles-wipes-immune-memory.html">Measles wipes your immune system's 'memory,' so it can't fight other infections</a></li></ul></p></div></div><p>In survivors, <a href="https://www.livescience.com/health/viruses-infections-disease/measles-has-long-term-health-consequences-for-kids-vaccines-can-prevent-all-of-them"><u>measles can cause long-term health problems</u></a>, including brain damage and immune amnesia, in which the immune cells tasked with remembering past infections have their "memories" wiped.</p><p>The PAHO's meeting to reevaluate the United States' status was <a href="https://www.cnn.com/2026/03/02/health/us-measles-elimination-status-paho-meeting-delay"><u>originally scheduled for April</u></a> but was pushed to November. </p><p>To regain its measles elimination status, the U.S. must go 12 months without continuous spread of the virus. </p><p>Disclaimer: This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'Like writing and directing your own movie': Live Science readers share whether they'd learn to lucid dream if they could ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Lucid dreaming describes when you realize you're in a dream as it's unfolding. Sometimes, people can control the content of their dreams from this state of awareness. </p><p>Recently, researchers claimed that they <a href="https://www.livescience.com/health/neuroscience/neuroscientists-reveal-method-to-train-people-to-have-lucid-dreams-and-it-involves-virtual-reality-and-mediation"><u>found a way to "train" people to lucid dream</u></a> by having them meditate and complete virtual-reality-augmented exercises while they were awake. Following the release of that study, Live Science asked its readers <a href="https://www.livescience.com/health/sleep/would-you-learn-to-lucid-dream-if-you-could"><u>whether they would learn to lucid dream</u></a> if they could.</p><p>Over 300 readers weighed in, with 77% saying "Yes, I'd want to try to control my dreams." Additionally, 17% of respondents said "No, I already lucid dream enough without training," 3% said "No, I don't see the point," and the final 3% said they weren't sure.</p><p>In the comments, one reader shared that they'd once experimented with <a href="https://www.livescience.com/little-known-sleep-stage-may-be-creative-sweet-spot"><u>hypnagogic napping</u></a>, a technique famously used by Thomas Edison and Salvador Dalí in which the famous luminaries would wake themselves up just as they were drifting to sleep. Edison claimed that this helped him access a creative sweet spot at the edge of sleep and wakefulness.</p><p>"When I was experimenting with the hypnagogic state (using the Edison method) I started having spontaneous lucid dreams," the reader wrote. "I can confidently say, that there were some of the most profound experiences of my life, so the answer is definitely yes."</p><p>Another reader reported having lucid dreams "about once or twice a year," adding that they typically wake up shortly after realizing it's a dream. "My most recent one was of my recently deceased wife. I became very sad when I realized she wasn't supposed to be there," the reader wrote. "I hugged her and told her I don't want to be without her. She replied that I could live a long life if I took care of myself (This was a very typical response from her...lol). I feel very blessed to have had that dream."</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/can-you-dream-during-non-rem-sleep">Can you dream during non-REM sleep?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/do-blind-people-see-images-in-their-dreams">Do blind people 'see' images in their dreams?</a> </li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/62703-why-we-forget-dreams-quickly.html">Why can't we remember our dreams?</a></li></ul></p></div></div><p>Other readers <a href="https://www.facebook.com/share/p/1Gycz5kLE4/?mibextid=wwXIfr" target="_blank"><u>chimed in on Facebook</u></a>. "Already have it [lucid dreaming], but if I didn't I would certainly practice to do so," one wrote. "Hell yes," another said, in response to the idea of training themselves to lucid dream.</p><p>Other readers noted that they already lucid dream quite often or that they can consistently control their dreams, with one even saying that all of their dreams are lucid. Another said, "Some nights I interrupt it [my dream] like Monty Python — 'Too silly!' and start over." </p><p>But while one person compared lucid dreaming to "writing and directing your own movie," another noted that "lucid dreams can be boring, repetitive, annoying." So while many people would practice lucid dreaming if they could, not everyone sees the appeal.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/sleep/like-writing-and-directing-your-own-movie-live-science-readers-share-whether-theyd-learn-to-lucid-dream-if-they-could</link>
                                                                            <description>
                            <![CDATA[ Over 300 Live Science readers responded to a recent poll about whether they'd train themselves to lucid dream if they could. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">6NWCa3FM8av7ZHMk2VfpLG</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/BNuic6cbfEJUAPEA4EPLj7-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 12 Nov 2026 21:18:14 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Sleep]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/BNuic6cbfEJUAPEA4EPLj7-1920-80.jpg">
                                                            <media:credit><![CDATA[Maria Korneeva via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Would you learn to lucid dream if you could? Here&amp;#39;s what other Live Science readers had to say.]]></media:description>                                                            <media:text><![CDATA[photo of a woman sleeping with swirling dots and streaks of light around her]]></media:text>
                                <media:title type="plain"><![CDATA[photo of a woman sleeping with swirling dots and streaks of light around her]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/BNuic6cbfEJUAPEA4EPLj7-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Lucid dreaming describes when you realize you're in a dream as it's unfolding. Sometimes, people can control the content of their dreams from this state of awareness. </p><p>Recently, researchers claimed that they <a href="https://www.livescience.com/health/neuroscience/neuroscientists-reveal-method-to-train-people-to-have-lucid-dreams-and-it-involves-virtual-reality-and-mediation"><u>found a way to "train" people to lucid dream</u></a> by having them meditate and complete virtual-reality-augmented exercises while they were awake. Following the release of that study, Live Science asked its readers <a href="https://www.livescience.com/health/sleep/would-you-learn-to-lucid-dream-if-you-could"><u>whether they would learn to lucid dream</u></a> if they could.</p><p>Over 300 readers weighed in, with 77% saying "Yes, I'd want to try to control my dreams." Additionally, 17% of respondents said "No, I already lucid dream enough without training," 3% said "No, I don't see the point," and the final 3% said they weren't sure.</p><p>In the comments, one reader shared that they'd once experimented with <a href="https://www.livescience.com/little-known-sleep-stage-may-be-creative-sweet-spot"><u>hypnagogic napping</u></a>, a technique famously used by Thomas Edison and Salvador Dalí in which the famous luminaries would wake themselves up just as they were drifting to sleep. Edison claimed that this helped him access a creative sweet spot at the edge of sleep and wakefulness.</p><p>"When I was experimenting with the hypnagogic state (using the Edison method) I started having spontaneous lucid dreams," the reader wrote. "I can confidently say, that there were some of the most profound experiences of my life, so the answer is definitely yes."</p><p>Another reader reported having lucid dreams "about once or twice a year," adding that they typically wake up shortly after realizing it's a dream. "My most recent one was of my recently deceased wife. I became very sad when I realized she wasn't supposed to be there," the reader wrote. "I hugged her and told her I don't want to be without her. She replied that I could live a long life if I took care of myself (This was a very typical response from her...lol). I feel very blessed to have had that dream."</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/can-you-dream-during-non-rem-sleep">Can you dream during non-REM sleep?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/do-blind-people-see-images-in-their-dreams">Do blind people 'see' images in their dreams?</a> </li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/62703-why-we-forget-dreams-quickly.html">Why can't we remember our dreams?</a></li></ul></p></div></div><p>Other readers <a href="https://www.facebook.com/share/p/1Gycz5kLE4/?mibextid=wwXIfr" target="_blank"><u>chimed in on Facebook</u></a>. "Already have it [lucid dreaming], but if I didn't I would certainly practice to do so," one wrote. "Hell yes," another said, in response to the idea of training themselves to lucid dream.</p><p>Other readers noted that they already lucid dream quite often or that they can consistently control their dreams, with one even saying that all of their dreams are lucid. Another said, "Some nights I interrupt it [my dream] like Monty Python — 'Too silly!' and start over." </p><p>But while one person compared lucid dreaming to "writing and directing your own movie," another noted that "lucid dreams can be boring, repetitive, annoying." So while many people would practice lucid dreaming if they could, not everyone sees the appeal.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A widely used antibiotic for acne and infections is linked to risk of pregnancy loss, new study finds ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Taking doxycycline, a commonly prescribed antibiotic, during the first trimester of pregnancy may increase the risk of pregnancy loss, a new study suggests.</p><p>The antibiotic is broad-spectrum, meaning it targets a wide range of bacteria. It's <a href="https://www.drugs.com/doxycycline.html" target="_blank"><u>often used to treat</u></a> acne, respiratory infections and sexually transmitted infections, such as chlamydia and syphilis. Doctors generally avoid prescribing the drug during the second and third trimesters because it belongs to a <a href="https://pmc.ncbi.nlm.nih.gov/articles/pmid/35248788/" target="_blank"><u>class of antibiotics</u></a> that can bind to calcium in developing bones. <a href="https://onlinelibrary.wiley.com/doi/10.1111/ahe.70030" target="_blank"><u>Animal studies</u></a> suggest that this may disrupt fetal bone development.</p><p>However, evidence on doxycycline's safety during early pregnancy has been mixed and limited. The new study, published Tuesday (Nov. 10) in the journal <a href="https://www.acpjournals.org/doi/10.7326/ANNALS-26-01647" target="_blank"><u>Annals of Internal Medicine</u></a>, provides clearer evidence of a link between doxycycline use in the first trimester and pregnancy loss.</p><p>"I would advise physicians to carefully consider the benefit-risk balance when prescribing doxycycline to women who are pregnant or planning a pregnancy," study first author <a href="https://pharmacy.ufl.edu/profile/winterstein-almut/" target="_blank"><u>Almut Winterstein</u></a>, a pharmacist and drug-safety researcher at the University of Florida, told Live Science in an email.</p><h2 id="a-higher-risk-than-other-antibiotics">A higher risk than other antibiotics</h2><p>Using information from two U.S. insurance databases, the researchers analyzed 224,870 pregnancies in people ages 12 to 55. More than 218,230 of these patients were treated for respiratory tract infections, and over 6,630 were treated for acne, between conception and the end of the first trimester. About 4,385 of the women filled a prescription for doxycycline during that time frame, while the others received an alternative antibiotic.</p><p>Among women with respiratory infections, those prescribed doxycycline had a 40% to 54% higher risk of pregnancy loss, compared with those prescribed amoxicillin, another broad-spectrum antibiotic in a different class. The exact level of risk varied between the two databases. </p><p>The researchers also compared the doxycycline users against women prescribed macrolides, the class of antibiotics that includes azithromycin (or "Z-Pak"). Again, the doxycycline users saw a higher risk — 39% and 36% higher, respectively.</p><p>Among the patients treated for acne, doxycycline users had a 49% higher risk of pregnancy loss in one database than those given the antibiotic clindamycin. In the second database, though, the difference wasn't statistically significant. Winterstein said that may be because there were fewer patients included in that analysis.</p><p>Overall, doxycycline was associated with seven to 11 additional pregnancy losses per 100 pregnancies, compared with the other antibiotic options assessed, the researchers reported.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2560px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="5ZCv383rdbmMJ6ynoK4AMT" name="GettyImages-2266670090" alt="woman looking at result of pregnancy test while standing in a bathroom" src="https://cdn.mos.cms.futurecdn.net/5ZCv383rdbmMJ6ynoK4AMT-1920-80.jpg" mos="" align="middle" fullscreen="" width="2560" height="1440" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The researchers examined the risk associated with taking various antibiotics in the first 12 weeks of pregnancy. </span><span class="credit" itemprop="copyrightHolder">(Image credit: MementoJpeg via Getty Images)</span></figcaption></figure><h2 id="what-drives-the-risk">What drives the risk?</h2><p>It is not yet clear how the drug might contribute to pregnancy loss. Because the study was observational, it cannot prove that the antibiotic itself caused those losses, which included miscarriages and stillbirths. (Miscarriage is pregnancy loss before 20 weeks of pregnancy, whereas stillbirth refers to pregnancy loss after the 20th week.)</p><p>Animal studies hint that doxycycline could interfere with early placental development, potentially making it harder for the placenta to support a growing pregnancy, <a href="https://www.flinders.edu.au/people/luke.grzeskowiak" target="_blank"><u>Luke Grzeskowiak</u></a>, an associate professor and clinical pharmacist at Flinders University in Australia who was not involved in the study, said in an email. </p><p>The study authors also noted in their report that the drug may have direct effects on the developing embryo. But these explanations remain hypothetical; the researchers have not established that either mechanism occurs in humans.</p><p>"Pregnancy loss affects around one in four pregnancies and can happen for many reasons," Grzeskowiak noted. Although doxycycline exposure may add to that risk, taking the antibiotic does not necessarily mean pregnancy loss will occur. The available data suggests that it is just one risk factor among many.</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/could-an-antibiotic-taken-after-unprotected-sex-prevent-stis-what-to-know-about-doxy-pep">Could an antibiotic taken after unprotected sex prevent STIs? What to know about doxy-PEP.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/they-didnt-question-it-why-doctors-prescribe-too-many-antibiotics">'They didn't question it': Why doctors prescribe too many antibiotics</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/valproic-acid-birth-defects-study">Mini-brains show how common drug freezes cell division in the womb, causing birth defects</a></li></ul></p></div></div><p>Because doxycycline may be prescribed before a pregnancy is recognized, doctors should consider the possibility of pregnancy when prescribing this drug to women of reproductive age, particularly those who are sexually active, Grzeskowiak suggested. That does not mean doctors should avoid prescribing the antibiotic to these women, he emphasized; rather, clinicians should consider pregnancy plans and medical history when choosing a treatment. </p><p>In some cases, doxycycline may still be the best option for a severe infection, Winterstein told Live Science,<em> </em>and that infection could itself put a pregnancy at risk. But for less-serious infections, safer alternatives may be available, she said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/reproductive-health/a-widely-used-antibiotic-for-acne-and-infections-is-linked-to-risk-of-pregnancy-loss-new-study-finds</link>
                                                                            <description>
                            <![CDATA[ A common antibiotic may be linked to a higher risk of miscarriage and stillbirth when used early in pregnancy, a new study suggests. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">WwFo2sBSk7BgWHKbNhUcKh</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/J5Q7CnfkbChnY57XdSRC99-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 12 Nov 2026 19:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Reproductive Health]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Isha Ishtiaq ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/wXThBYHTfbXiYY2GhijqFf-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/J5Q7CnfkbChnY57XdSRC99-1920-80.jpg">
                                                            <media:credit><![CDATA[iStock / Getty Images Plus]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The antibiotic doxycycline is commonly prescribed for a range of infections, as well as for acne.]]></media:description>                                                            <media:text><![CDATA[light blue, oblong pills in sealed packages]]></media:text>
                                <media:title type="plain"><![CDATA[light blue, oblong pills in sealed packages]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/J5Q7CnfkbChnY57XdSRC99-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Taking doxycycline, a commonly prescribed antibiotic, during the first trimester of pregnancy may increase the risk of pregnancy loss, a new study suggests.</p><p>The antibiotic is broad-spectrum, meaning it targets a wide range of bacteria. It's <a href="https://www.drugs.com/doxycycline.html" target="_blank"><u>often used to treat</u></a> acne, respiratory infections and sexually transmitted infections, such as chlamydia and syphilis. Doctors generally avoid prescribing the drug during the second and third trimesters because it belongs to a <a href="https://pmc.ncbi.nlm.nih.gov/articles/pmid/35248788/" target="_blank"><u>class of antibiotics</u></a> that can bind to calcium in developing bones. <a href="https://onlinelibrary.wiley.com/doi/10.1111/ahe.70030" target="_blank"><u>Animal studies</u></a> suggest that this may disrupt fetal bone development.</p><p>However, evidence on doxycycline's safety during early pregnancy has been mixed and limited. The new study, published Tuesday (Nov. 10) in the journal <a href="https://www.acpjournals.org/doi/10.7326/ANNALS-26-01647" target="_blank"><u>Annals of Internal Medicine</u></a>, provides clearer evidence of a link between doxycycline use in the first trimester and pregnancy loss.</p><p>"I would advise physicians to carefully consider the benefit-risk balance when prescribing doxycycline to women who are pregnant or planning a pregnancy," study first author <a href="https://pharmacy.ufl.edu/profile/winterstein-almut/" target="_blank"><u>Almut Winterstein</u></a>, a pharmacist and drug-safety researcher at the University of Florida, told Live Science in an email.</p><h2 id="a-higher-risk-than-other-antibiotics">A higher risk than other antibiotics</h2><p>Using information from two U.S. insurance databases, the researchers analyzed 224,870 pregnancies in people ages 12 to 55. More than 218,230 of these patients were treated for respiratory tract infections, and over 6,630 were treated for acne, between conception and the end of the first trimester. About 4,385 of the women filled a prescription for doxycycline during that time frame, while the others received an alternative antibiotic.</p><p>Among women with respiratory infections, those prescribed doxycycline had a 40% to 54% higher risk of pregnancy loss, compared with those prescribed amoxicillin, another broad-spectrum antibiotic in a different class. The exact level of risk varied between the two databases. </p><p>The researchers also compared the doxycycline users against women prescribed macrolides, the class of antibiotics that includes azithromycin (or "Z-Pak"). Again, the doxycycline users saw a higher risk — 39% and 36% higher, respectively.</p><p>Among the patients treated for acne, doxycycline users had a 49% higher risk of pregnancy loss in one database than those given the antibiotic clindamycin. In the second database, though, the difference wasn't statistically significant. Winterstein said that may be because there were fewer patients included in that analysis.</p><p>Overall, doxycycline was associated with seven to 11 additional pregnancy losses per 100 pregnancies, compared with the other antibiotic options assessed, the researchers reported.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2560px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="5ZCv383rdbmMJ6ynoK4AMT" name="GettyImages-2266670090" alt="woman looking at result of pregnancy test while standing in a bathroom" src="https://cdn.mos.cms.futurecdn.net/5ZCv383rdbmMJ6ynoK4AMT-1920-80.jpg" mos="" align="middle" fullscreen="" width="2560" height="1440" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The researchers examined the risk associated with taking various antibiotics in the first 12 weeks of pregnancy. </span><span class="credit" itemprop="copyrightHolder">(Image credit: MementoJpeg via Getty Images)</span></figcaption></figure><h2 id="what-drives-the-risk">What drives the risk?</h2><p>It is not yet clear how the drug might contribute to pregnancy loss. Because the study was observational, it cannot prove that the antibiotic itself caused those losses, which included miscarriages and stillbirths. (Miscarriage is pregnancy loss before 20 weeks of pregnancy, whereas stillbirth refers to pregnancy loss after the 20th week.)</p><p>Animal studies hint that doxycycline could interfere with early placental development, potentially making it harder for the placenta to support a growing pregnancy, <a href="https://www.flinders.edu.au/people/luke.grzeskowiak" target="_blank"><u>Luke Grzeskowiak</u></a>, an associate professor and clinical pharmacist at Flinders University in Australia who was not involved in the study, said in an email. </p><p>The study authors also noted in their report that the drug may have direct effects on the developing embryo. But these explanations remain hypothetical; the researchers have not established that either mechanism occurs in humans.</p><p>"Pregnancy loss affects around one in four pregnancies and can happen for many reasons," Grzeskowiak noted. Although doxycycline exposure may add to that risk, taking the antibiotic does not necessarily mean pregnancy loss will occur. The available data suggests that it is just one risk factor among many.</p><div  class="fancy-box"><div class="fancy_box-title">RELATED STORIES</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/could-an-antibiotic-taken-after-unprotected-sex-prevent-stis-what-to-know-about-doxy-pep">Could an antibiotic taken after unprotected sex prevent STIs? What to know about doxy-PEP.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/they-didnt-question-it-why-doctors-prescribe-too-many-antibiotics">'They didn't question it': Why doctors prescribe too many antibiotics</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/valproic-acid-birth-defects-study">Mini-brains show how common drug freezes cell division in the womb, causing birth defects</a></li></ul></p></div></div><p>Because doxycycline may be prescribed before a pregnancy is recognized, doctors should consider the possibility of pregnancy when prescribing this drug to women of reproductive age, particularly those who are sexually active, Grzeskowiak suggested. That does not mean doctors should avoid prescribing the antibiotic to these women, he emphasized; rather, clinicians should consider pregnancy plans and medical history when choosing a treatment. </p><p>In some cases, doxycycline may still be the best option for a severe infection, Winterstein told Live Science,<em> </em>and that infection could itself put a pregnancy at risk. But for less-serious infections, safer alternatives may be available, she said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ When a battery dies, you replace it — how jumpstarting cells with fresh mitochondria could revolutionize medicine ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A newborn baby's heart is roughly the size of a walnut — which makes open-heart surgery challenging. </p><p>Each year, about 10,000 babies in the United States are <a href="https://www.cdc.gov/heart-defects/data/index.html" target="_blank"><u>born with critical heart defects</u></a> that may require surgery to fix, often fairly soon after birth. In these infants, the two major arteries of the heart could have <a href="https://www.hopkinsmedicine.org/all-childrens-hospital/services/heart-institute/heart-conditions-we-treat/d-transposition-of-the-great-arteries" target="_blank"><u>swapped positions</u></a> or the left side of the heart may be <a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/hypoplastic-left-heart-syndrome-hlhs-in-children" target="_blank"><u>far too small to pump properly</u></a>. </p><p>Even if their surgeries go well, these babies face perilous recoveries. A complication can arise when blood flows back into the repaired heart, triggering what's known as an ischemia-reperfusion injury. This can stun the organ, triggering extensive damage that requires doctors to place the baby on a <a href="https://www.mayoclinic.org/tests-procedures/ecmo/about/pac-20484615" target="_blank"><u>life-support machine</u></a> that pumps and infuses oxygen into blood to sub in for the hampered heart and lungs. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6712998/" target="_blank"><u>Only about 40%</u></a> of newborns make it off the machine, because often, their tiny hearts don't recover.</p><p>Doctors and scientists at Boston Children's Hospital have been working to improve those odds using a creative idea: replacing the fuel source in damaged heart cells to help them bounce back from injury. That fuel source is mitochondria, the "batteries" found in most cells in the body. In this case, the mitochondria are isolated from an abdominal muscle and then injected directly into the heart.</p><p>As of April, 17 babies have undergone this procedure, and <a href="https://www.jtcvs.org/article/S0022-5223(17)30258-1/pdf" target="_blank"><u>80% made it off ECMO</u></a>. It's too soon to say if the treatment improves overall survival rates, but the early data hints that it might. A <a href="https://clinicaltrials.gov/study/NCT02851758" target="_blank"><u>clinical trial is currently underway</u></a>.</p><figure class="van-image-figure pull-right inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1199px;"><p class="vanilla-image-block" style="padding-top:83.74%;"><img id="oo5QXf9KTL5MCjfyagQUfN" name="McCully and Emani" alt="Two men stand next to each other, the one on the left wearing a dark suit and red tie and the one on the right wearing a white lab coat." src="https://cdn.mos.cms.futurecdn.net/oo5QXf9KTL5MCjfyagQUfN-1920-80.jpg" mos="" align="right" fullscreen="1" width="1199" height="1004" attribution="" endorsement="" class="pull-rightinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/oo5QXf9KTL5MCjfyagQUfN-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-right inline-layout"><span class="caption-text">James McCully (left) and his colleague Dr. Sitaram Emani of Boston Children's Hospital have developed a technique to transplant mitochondria into the hearts of children recovering from surgery.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of Boston Children's Hospital)</span></figcaption></figure><p>"The first one or two for me were pretty nerve-wracking," said <a href="https://research.childrenshospital.org/researchers/james-mccully" target="_blank"><u>James McCully</u></a>, a research associate at Boston Children's Hospital and associate professor of surgery at Harvard Medical School whose pioneering work paved the way for these procedures. His team isolates and purifies the mitochondria that a surgical team then transplants into patients. </p><p>"But you know, the heart comes back — you can actually almost see it coming back" in real time, he told Live Science. A heart deprived of energy looks pallid, while a freshly rejuvenated heart blushes a healthy pink.</p><p>Baby heart infusions are just one example of the promise of "mitochondrial transplantation." Following McCully's lead, other scientists have started investigating whether infusions of mitochondria could revitalize donated organs destined for transplantation, help stroke patients recover, and treat kids with devastating diseases. This work is still highly experimental, and its route to regulatory approval remains unclear.</p><p>But at its core is a straightforward idea: When a battery dies, you replace it.</p><h2 id="relic-of-our-evolutionary-past">Relic of our evolutionary past</h2><p>The human body contains <a href="https://www.livescience.com/health/anatomy/how-many-cells-are-in-the-human-body-new-study-provides-an-answer"><u>tens of trillions of cells</u></a>, most of which contain hundreds to thousands of mitochondria. Following some back-of-the-envelope math, that means the total potential energy in each person "is the equivalent of a lightning bolt," <a href="https://www.chop.edu/doctors/wallace-douglas-c" target="_blank"><u>Douglas Wallace</u></a>, director of the Center for Mitochondrial and Epigenomic Medicine at Children's Hospital of Philadelphia, told attendees last year at a <a href="https://umdf.org/event/frontiers-in-mitochondrial-medicine/" target="_blank"><u>symposium on mitochondrial medicine</u></a>.</p><p>Mitochondria, in a word, are powerful. They produce most of the chemical energy used by complex cells by churning out a molecule called <a href="https://www.genome.gov/genetics-glossary/Mitochondria" target="_blank"><u>adenosine triphosphate</u></a> (ATP). The idea of transferring these fuel factories from one cell to another as a medical treatment emerged less than two decades ago — but cells have been doing such swaps on their own for eons.</p><figure class="van-image-figure  full-width-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' ><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="SZSSGKoKAPqqKnRJzF8M9M" name="GettyImages-2282045539-mitochondria" alt="An illustration of a brown, kidney-shaped organelle in a tunnel." src="https://cdn.mos.cms.futurecdn.net/SZSSGKoKAPqqKnRJzF8M9M-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="full-width expandable" /><a href='https://cdn.mos.cms.futurecdn.net/SZSSGKoKAPqqKnRJzF8M9M-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" full-width-layout"><span class="caption-text">A leading theory posits that mitochondria evolved from simple microbes. And today, they still retain distinctly microbial features. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Behnoush Hajan/Science Photo Library via Getty Images)</span></figcaption></figure><p><a href="https://pathology.wustl.edu/people/jonathan-r-brestoff-md-phd/" target="_blank"><u>Dr. Jon Brestoff</u></a>, an associate professor of pathology and immunology and director of the Immunometabolism Initiative at the Washington University School of Medicine in St. Louis, describes this ability to move from cell to cell as a <a href="https://www.nature.com/articles/s42255-024-01200-x" target="_blank"><u>relic of mitochondria's bacterial past</u></a>. "It is hypothesized that mitochondria transfer has likely been retained throughout evolution of <a href="https://www.livescience.com/65922-prokaryotic-vs-eukaryotic-cells.html"><u>eukaryotic</u></a> life," the huge domain of life that includes all plants, fungi, protists and animals, Brestoff told Live Science.</p><p>Mitochondria are the powerhouses of <a href="https://www.cell.com/current-biology/fulltext/S0960-9822%2816%2930263-9" target="_blank"><u>nearly all</u></a> complex cells on Earth, and there are a <a href="https://www.nature.com/scitable/topicpage/the-origin-of-mitochondria-14232356/" target="_blank"><u>few theories</u></a> as to how they adopted that ubiquitous role. A leading idea posits that, some 1.5 billion to 2 billion years ago, one simple cell engulfed another. The bacterial cell that got swallowed carried a circular loop of DNA inside its membrane, and that captured cell <a href="https://www.livescience.com/health/relatives-of-the-1st-mitochondria-may-be-living-in-geothermal-hot-springs-today"><u>later became what we now know as the mitochondrion</u></a>. The new organelle enabled cells to take advantage of the abundance of oxygen on our planet by converting it into usable fuel.</p><p>Mitochondria retained bacteria-like features, such as having their own DNA and membranes. But in 2006, researchers reported that <a href="https://www.pnas.org/doi/10.1073/pnas.0510511103" target="_blank"><u>mitochondria can also exit their "host"</u></a> and survive the journey into a totally different cell — a phenomenon known as mitochondrial transfer. </p><p>"That was a complete revolution in thinking," said <a href="https://feinstein.northwell.edu/institutes-researchers/our-researchers/lance-b-becker-md-faha" target="_blank"><u>Dr. Lance Becker</u></a>, professor and Chair of the Department of Emergency Medicine at Northwell Health and the Feinstein Institutes for Medical Research. "With that notion that mitochondria might be mobile, that they might cross boundaries, that they might go from one cell to another cell, came the possibility that maybe that was something we could use to help people."</p><p>The 2006 study showed that cells that had been depleted of their own mitochondrial DNA could obtain healthy mitochondria from neighboring cells. After receiving other cells' powerhouses, the once-depleted cells were able to conduct energetically costly processes, such as cell division. </p><p>This research provided the <a href="https://www.nature.com/articles/s41586-023-06537-z?fromPaywallRec=false#Sec15" target="_blank"><u>first evidence</u></a> that one cell can "donate" metabolic properties to its neighbor by sending over a fresh batch of mitochondria. Scientists once thought cells had to make all of their own mitochondria, but now, "I think cells have the ability to 'put their hand up' when they need mitochondria," Becker told Live Science.</p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:500px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="mJcdAGczwewjeGB58QbbSh" name="brestoff headshot" alt="A man with blond hair and a beard wearing a beige long sleeve and dark round glasses smiles at the camera." src="https://cdn.mos.cms.futurecdn.net/mJcdAGczwewjeGB58QbbSh-1920-80.jpg" mos="" align="left" fullscreen="1" width="500" height="500" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/mJcdAGczwewjeGB58QbbSh-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">Jon Brestoff is studying the use of mitochondrial transplantation for genetic diseases that impair the function of these cellular powerhouses. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of Jon Brestoff)</span></figcaption></figure><p>Because those first experiments were done in lab dishes, initially, "it was unclear whether or not it was really biologically meaningful or relevant," Brestoff said. But within the past five to six years, improved tools and techniques have enabled scientists to watch mitochondrial transfer unfold within living organisms, he noted. It's been shown that <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8527836/" target="_blank"><u>cells of the same type</u></a> can exchange mitochondria, as can <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11623344/" target="_blank"><u>cells of different types</u></a>.</p><p>As scientists' fundamental understanding of mitochondrial transfer grew, the notion of doing the same thing therapeutically gained more traction.</p><p>"That procedure," Brestoff said, "is rooted in the biology of mitochondria transfer." </p><h2 id="quot-the-heart-came-back-quot">"The heart came back"</h2><p>Just two years after the landmark 2006 paper, <a href="https://journals.physiology.org/doi/full/10.1152/ajpheart.00567.2008" target="_blank"><u>McCully's research group</u></a> released data that hinted at the medicinal potential of mitochondrial transplantation.</p><p>Since then, these complementary lines of research — the foundational biology and the preclinical investigation — have continued in parallel. McCully's preclinical work helped to inspire other labs to explore the use of mitochondrial transplantation for a range of medical applications, including organ transplants and treatments for stroke and genetic disease. </p><p>McCully is "the pioneer — the guru of the field," said <a href="https://school.wakehealth.edu/faculty/o/giuseppe-orlando" target="_blank"><u>Dr. Giuseppe Orlando</u></a>, a professor of surgery and regenerative medicine at Wake Forest University School of Medicine who is exploring mitochondrial transplantation as a way to maintain the integrity of transplant organs. </p><p>McCully's road to mitochondrial transplantation started in the 1980s. As a molecular biologist, he wanted to uncover mechanisms that protect the heart from damage, particularly when the organ's oxygen supply is compromised — such as during ischemia, or low blood flow. With an eye on older adults, he wanted to spare patients' heart tissue from the damage and cell death that can occur before and during heart surgery.  </p><div><blockquote><p>It changed color, went back to a pink hue, and just kept on going.</p><p>James McCully, a research associate at Boston Children's Hospital </p></blockquote></div><p>McCully and his collaborators initially "didn't care about the mitochondria one iota," he said. They were more focused on the nucleus, the control center that houses most of a cell's DNA, and its influence on cellular pathways that might boost the heart's resilience to ischemia. But "what we found was that everything we did started coming back to the mitochondria," he said.</p><p>They found that ischemia triggers damage and dysfunction in mitochondria that persists even after the heart's oxygen supply is restored; this <a href="https://www.mdpi.com/2076-3921/8/10/454" target="_blank"><u>dysfunction ultimately kills cells</u></a>. The damaged mitochondria swell up, leak their innards, and set off a chain reaction that causes a cell to self-destruct. </p><p>McCully and colleagues observed that biological pathways that seemed to reduce this cell death often centered on the mitochondria. "We were looking around at either pathways upstream of the mitochondria or downstream of the mitochondria," he said. </p><p>So, logically, they started looking directly at mitochondria, studying what the organelle looks like before, during and after ischemia. One day, while isolating mitochondria from a laboratory pig, the animal developed fibrillation, meaning its heart began beating very quickly, with an uncoordinated and rapid rhythm. The team tried to reset the heart's rhythm with electric shocks and medications, to no avail. But McCully had an idea.  </p><p>"At that point in time, the heart's kind of [got a] gray pallor, and it looks dead," he said. "And I said, 'Go upstairs; grab some of those mitochondria that we've isolated from the non-ischemic type. Just bring them down.'" They'd previously gathered some healthy mitochondria from the same pig, in hopes of generating a "before-and-after" picture of ischemia. Instead, McCully suspended those healthy mitochondria in a solution and then injected them directly into the pig's fibrillating heart.</p><p>"And the heart came back — started beating normally. It changed color, went back to a pink hue, and just kept on going," he said.</p><figure role="gallery"><figure><img src="https://cdn.mos.cms.futurecdn.net/S6jzkQAJMeoap25Wn65yJF-1920-80.jpg" alt="A blurry picture with the word "Warning" on it" /><figcaption><small role="credit">Live Science</small></figcaption></figure><figure><img src="https://cdn.mos.cms.futurecdn.net/6YUHPJhfF5SuvHJ6stgkmK-1920-80.jpg" alt="A close up of a surgery happening on someone's muscle" /><figcaption><small role="credit">Emani, S.M., et al. (2017) The Journal of Thoracic and Cardiovascular Surgery.</small></figcaption></figure><figure><img src="https://cdn.mos.cms.futurecdn.net/rLmtjXzc6FbuZWJDBjF9dP-1920-80.jpg" alt="A close up of a heart surgery where the heart is being injected with a syringe." /><figcaption><small role="credit">Emani, S.M., et al. (2017) The Journal of Thoracic and Cardiovascular Surgery.</small></figcaption></figure></figure><p>That serendipitous experiment led to a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2637784/" target="_blank"><u>formal test of the technique in rabbit hearts</u></a>, the results of which were published in 2008. In the study, they introduced healthy mitochondria to the rabbits' hearts during ischemia, just before reperfusion — when blood is reintroduced into the oxygen-starved tissue. They found that the mitochondria improved the organs' recovery and reduced tissue death. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10757322/" target="_blank"><u>Further research in animals</u></a> suggested that mitochondria that originated from one type of tissue, like liver tissue or skeletal muscle, could be introduced to other tissue types, such as cardiac muscle. </p><p>After seeing McCully's results in various animal experiments, including more with pigs, <a href="https://www.childrenshospital.org/providers/pedro-j-del-nido" target="_blank"><u>Dr. Pedro del Nido</u></a>, chair of cardiac surgery at Boston Children's and a professor of child surgery at Harvard Medical School, approached him about testing the technique in human patients — namely, in babies on a life-support machine known as ECMO. </p><p>"He saw it in the animals; he saw what was going on," McCully said. "And he deemed it as being a possible intervention to save these kids." </p><p>They sought permission from the Food and Drug Administration (FDA) to test the procedure and cleared the required regulatory hurdles. The process was made slightly easier because the mitochondria were coming from the patients' own bodies, not from a donor, McCully noted. Once given the go-ahead, they set forth with the help of <a href="https://www.childrenshospital.org/providers/sitaram-emani" target="_blank"><u>Dr. Sitaram Emani</u></a>, a heart surgeon at Boston Children's. The first procedure <a href="https://www.griffincatalyst.org/priorities/science-and-medicine/saving-lives-through-a-daring-medical-breakthrough/" target="_blank"><u>took place in 2014</u></a>.</p><p>During each procedure, Emani and the surgical team collect a small sample of skeletal muscle from the patient, and McCully then isolates whole mitochondria from the tissue and prepares them in a syringe. He refined the isolation technique so the time from collecting the muscle sample to injecting mitochondria is only 30 minutes. Lately, the team has been developing a technique they can perform in the operating room, rather than in a lab, which could cut the time to 20 minutes. Emani uses various tests, including echocardiography, to see which areas of the heart tissue move the least, and injects mitochondria straight into those areas.</p><p>"It's great to be able to see something you've done and worked on for so many years actually provide a benefit," McCully said.</p><h2 id="transplants-for-transplant-organs">Transplants for transplant organs</h2><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:692px;"><p class="vanilla-image-block" style="padding-top:130.06%;"><img id="VkxDokkaQzMaTdjf5pwhbe" name="orlando headshot.JPG" alt="A bald man with glasses wearing a white lab coat smiles at the camera." src="https://cdn.mos.cms.futurecdn.net/VkxDokkaQzMaTdjf5pwhbe-1920-80.jpg" mos="" align="left" fullscreen="1" width="692" height="900" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/VkxDokkaQzMaTdjf5pwhbe-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">Dr. Giuseppe Orlando thinks that mitochondrial transplantation could serve as a potential method for fortifying donated organs that are intended for transplant patients. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of Dr. Giuseppe Orlando)</span></figcaption></figure><p>While McCully is trying to protect infant hearts, other scientists want to do the same for other organs — including those destined for transplant surgeries.</p><p>To Orlando, mitochondria represent a potential way to make donated kidneys work better. "In transplant medicine, one of the major issues is making sure that the organs that are procured are well stored and kept viable until implantation," said Orlando, who is also president of the <a href="https://tts.org/ctrms-about/ctrms-presidents-message" target="_blank"><u>Cell Transplant and Regenerative Medicine Society</u></a>.</p><p>Maintaining an organ's viability means preserving mitochondrial function as much as possible, but the transplantation process is tough on the organelles. "That energy plant is damaged. So it's pretty obvious that you should start thinking about a way to replace the damaged mitochondria," Orlando said.</p><p>Donated organs suffer some damage when they're unplugged from the donors' bloodstream, in part because this cuts off mitochondria's crucial oxygen supply. And then, paradoxically, the donor organs also get damaged when they're plugged into the recipient's bloodstream. That's because the fast flow of blood triggers the production of <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reactive-oxygen-species#:~:text=A%20build%20up%20of%20reactive,Also%20called%20oxygen%20radical." target="_blank"><u>free radicals</u></a> — unstable molecules that damage tissues. </p><p>While healthy organs normally produce some free radicals, reperfusion unleashes a flood. "It's more than the organ can bear and sustain," Orlando explained. This damage contributes to a phenomenon called delayed graft function, in which a transplanted kidney doesn't work right away so the patient ends up needing dialysis in the first week after surgery.</p><p>"You want to make sure that the kidney wakes up faster," Orlando said. That's where mitochondria come in.</p><p>Orlando was introduced to the idea of mitochondrial transplantation around 2019 through a collaboration with <a href="https://www.researchgate.net/profile/Benedetta-Bussolati" target="_blank"><u>Dr. Benedetta Bussolati</u></a>, a nephrologist and full professor of laboratory medicine at the University of Turin in Italy. Her lab had been studying mitochondrial transplantation in isolated kidney cells in lab experiments, and they reached out to Orlando about extending that work to lab animals.  </p><p>In pigs, the researchers ran experiments in which the animals' kidneys were collected and stored in the same way human kidneys commonly would be prior to being transplanted. One set of kidneys received a placebo treatment, while another got an infusion of mitochondria from the donor pigs' muscle tissue. Upon being reperfused, the <a href="https://journals.lww.com/annalsofsurgery/fulltext/2023/12000/mitochondria_transplantation_mitigates_damage_in.55.aspx" target="_blank"><u>treated kidneys produced fewer free radicals</u></a> and accrued less damage than the untreated kidneys did, the team reported in 2023.</p><p>They backed up this finding by analyzing <a href="https://www.livescience.com/what-is-RNA.html"><u>RNA</u></a>, a molecule that reflects which genes are active in cells. Compared with the untreated kidneys, the treated kidneys showed greater activity in genes involved in mitochondrial metabolism and lower activity in genes involved in repairing injuries.</p><figure class="van-image-figure  full-width-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' ><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="ukrzgEDy3NpEreCnz65ViB" name="GettyImages-669232658-surgery" alt="A close up of a series of white-gloved hands doing surgery on a patient in a dark room." src="https://cdn.mos.cms.futurecdn.net/ukrzgEDy3NpEreCnz65ViB-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="full-width expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ukrzgEDy3NpEreCnz65ViB-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" full-width-layout"><span class="caption-text">Orlando thinks that mitochondrial transplantations could help organs "wake up" faster after being transferred from an organ donor to a recipient.   </span><span class="credit" itemprop="copyrightHolder">(Image credit: PIERRE-PHILIPPE MARCOU via Getty Images)</span></figcaption></figure><p>Some groups are exploring mitochondrial transplantation in other donor organs, like the lungs — specifically, lungs treated with "<a href="https://www.livescience.com/how-long-can-donated-organs-last-before-transplant.html"><u>ex vivo perfusion</u></a>" (EVP), an emerging approach that helps retain the viability of transplant organs. Rather than placing a donor organ in a cooler of ice, as is generally standard, EVP flushes an organ with nutrient- and oxygen-rich fluid, helping to maintain its function until the transplant surgery. In lab experiments <a href="https://www.jhltonline.org/article/S1053-2498(24)01938-7/fulltext" target="_blank"><u>with pig</u></a> and <a href="https://www.jhltonline.org/article/S1053-2498(23)00002-5/pdf" target="_blank"><u>human lungs</u></a>, scientists found that introducing fresh mitochondria during EVP further improved the organs' function while reducing inflammation and free radicals.   </p><p>Across different organ transplants, Orlando sees mitochondria as a potential means to improve patient outcomes and expand the pool of available organs. There are scenarios in which would-be organ donors die unexpectedly of cardiac arrest and <a href="https://journals.lww.com/transplantjournal/fulltext/2020/08000/uncontrolled_donation_after_circulatory_death__a.12.aspx" target="_blank"><u>their organs are damaged</u></a> in the process; mitochondrial transplants may help make such organs fit for patients, <a href="https://wms-site.com/press-media/1163-study-shows-mitochondrial-transplantation-effective-in-reversing-damage-to-kidneys-and-kidney-cells" target="_blank"><u>Orlando has said</u></a>.</p><p>In the near term, Orlando and his colleagues are continuing to study the basic science of mitochondrial transplantation for this clinical purpose; they've also been cleared to run a clinical trial with donor kidneys but need more funds to proceed. </p><p>Looking to the more distant future, he and other experts in the field envision a world where transplant organs can be bioengineered and stored in banks, ready and waiting for the patients who need them, Orlando said. If that vision materializes, he suggested, mitochondrial transplants might be useful for preparing banked organs for transplantation "by giving them kind of an energy boost."</p><h2 id="reaching-the-brain">Reaching the brain</h2><p>If infusions of fresh mitochondria could help the heart, kidney and lungs, what about the brain? That's the question <a href="https://neurosurgery.uw.edu/bio/melanie-walker-md" target="_blank"><u>Dr. Melanie Walker</u></a> and colleagues at the University of Washington School of Medicine (UW Medicine) want to answer. </p><p>Walker, a clinical professor of neurological surgery, treats patients who have had ischemic strokes, which are caused by blood clots blocking blood flow to the brain. The immediate aim of post-stroke treatment is to clear out the blocked "pipe" and restore circulation to the brain as quickly as possible, she said. But no matter how quickly this is done, some brain cells are damaged. And once the blood clot is removed, the brain may then suffer a reperfusion injury.</p><p>Standard treatments can dissolve the clot but don't protect the brain, Walker said. "What about all those cells that are maybe not quite dead — they're on the verge of maybe dying? What can we do to support those guys?" she asked.</p><p>The UW Medicine team had heard about McCully's work in Boston and wondered if something similar could be applied in stroke patients. But while heart surgery exposes the tissue in need of new mitochondria, accessing the brain is trickier. "You don't do a craniotomy to give an IV medicine," Walker told Live Science.</p><p>But Walker realized that a harmful downstream effect of stroke might provide an opportunity for treatment. Immediately after a stroke, the brain's protective shield — known as the blood-brain barrier — becomes <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10832427/" target="_blank"><u>more permeable than usual</u></a>, allowing more substances to pass from the bloodstream into brain tissue. That might open a door for mitochondrial transplantation.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="HwaCbboMt4do4UF4DWVh8W" name="GettyImages-930111308-surgery" alt="A surgeon in blue scrubs and gloved hands inserts a wire into a tube." src="https://cdn.mos.cms.futurecdn.net/HwaCbboMt4do4UF4DWVh8W-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/HwaCbboMt4do4UF4DWVh8W-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">One method of treating ischemic strokes is to physically remove the clot using a procedure called a thrombectomy, which a surgeon is preparing for in the photo above. Dr. Melanie Walker and colleagues tried combining this approach with mitochondrial transplantation.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: BSIP via Getty Images)</span></figcaption></figure><p><a href="https://www.ahajournals.org/doi/10.1161/SVIN.122.000644" target="_blank"><u>A 2023 mouse study spearheaded by University of Virginia researchers</u></a> and co-authored by Walker backed this idea, finding that mitochondria entered the brain after stroke and integrated into brain cells. These mitochondria had been gathered from muscle tissue, as in McCully's studies, and introduced to the brain via an artery. The treatment increased ATP production while reducing cell death caused by the stroke, compared with untreated mice's brains.</p><p>This work paved the way to the <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11615905/" target="_blank"><u>first trial using mitochondrial transplant in the human brain</u></a>. The small safety trial included adult patients who'd had ischemic strokes and underwent thrombectomies ‪—‬ surgeries to remove the clots from their blood vessels. Four received mitochondrial transplants during their procedures and 12 did not. Mitochondria were injected near the site of each patient's stroke, into the closest branch of one of the brain's major arteries.</p><p>No negative side effects were tied to the transplants, hinting that the procedure is safe in humans. "But the next question is, how do we understand if it helps? And those are harder trials to design," Walker said. That's partly because the transplants are tacked onto the clot-removal procedure, so it's difficult to separate their effects from those of the clot removal itself, she noted.</p><p>Future trials will also need to explore exactly where the transplanted mitochondria end up in the human brain, how well they function once inside brain cells, and how the dose and timing of the transplant affect patients' outcomes, the trial runners wrote in their report. For the moment, Walker said her team is focused on exploring the safety aspects of the approach and have no further trials planned at this time. </p><h2 id="mitochondrial-diseases-and-what-39-s-next">Mitochondrial diseases — and what's next</h2><p>Beyond heart defects, transplant organs and stroke, researchers are looking to mitochondrial transplantation as a solution for genetic conditions that harm mitochondria directly. Brestoff and colleagues are investigating the therapy's potential for treating <a href="https://medlineplus.gov/genetics/condition/leigh-syndrome/#causes" target="_blank"><u>Leigh syndrome</u></a>, a rare neurological condition caused by genetic mutations that disrupt the fuel-producing machinery in mitochondria.</p><p>"Those kids have a terrible prognosis," Brestoff said. <a href="https://www.seattlechildrens.org/research/featured-research/huff-leigh-syndrome/" target="_blank"><u>Most children with the most common form</u></a> of the syndrome, whose symptoms show up by age 2, die by age 3. There is no cure for the syndrome, and treatments to relieve its symptoms <a href="https://www.curemito.org/after-diagnosis/" target="_blank"><u>are limited</u></a>. So if it works, mitochondrial transplantation could fill a big gap. </p><p>So far, the approach shows promise in lab mice with a severe form of Leigh syndrome, improving the rodents' function and extending their median lifespan by 19% to 24%, <a href="https://www.nature.com/articles/s42255-024-01125-5" target="_blank"><u>the researchers demonstrated in 2024</u></a>. They're now studying the approach in cells derived from patients with the disease.</p><div><blockquote><p>I can get the mitochondria from you and put them into me, me into you — doesn't really matter.</p><p>James McCully, a research associate at Boston Children's Hospital</p></blockquote></div><p>Some companies, such as Israel-headquartered Minovia Therapeutics, are already running clinical trials with patients with other types of mitochondrial disease. Minovia is running one with <a href="https://www.globenewswire.com/news-release/2025/06/30/3107471/0/en/minovia-therapeutics-announces-fda-fast-track-and-rare-pediatric-disease-designations-for-mnv-201-in-pearson-syndrome.html" target="_blank"><u>children with Pearson syndrome</u></a>, in which missing mitochondrial DNA <a href="https://medlineplus.gov/genetics/condition/pearson-syndrome/" target="_blank"><u>hinders the function of bone marrow</u></a>, which normally makes blood and immune cells.</p><p>While patients with a heart or brain problem may be able to pluck mitochondria from healthy muscles, people with mitochondrial disease don't necessarily have healthy mitochondria to spare. Especially for these patients, getting mitochondria from other people ‪—‬ known as heterologous transplantation ‪—‬ likely makes the most sense. What's more, for transplantation to be used widely for any purpose, there would need to be an "off-the-shelf" mitochondrial product available, Brestoff said.</p><p>Such a product could eliminate the step in Boston Children's heart procedure where mitochondria have to be isolated from a patient while they're waiting, open on an operating table. "Getting them from the recipient can sometimes be problematic, because the recipients are sick. All the organs, all the tissue is quite distressed," McCully noted. A standardized and safety-tested mitochondrial product would therefore be a boon for the field.</p><p>Brestoff is on the scientific advisory board of <a href="https://www.luca-science.com/" target="_blank"><u>LUCA Science</u></a> and a consultant for <a href="https://www.cellergy-bio.com/" target="_blank"><u>Cellergy Therapeutics</u></a>, two companies that are developing mitochondria as therapeutic agents. These companies exemplify the effort to come up with ready-made products that could someday bring the therapy to more patients.</p><p>A shift to heterologous transplantation does raise concerns about immune reactions. "You have some variations in the proteins that are present in your mitochondria that I don't have," Brestoff noted. "So it is possible that our immune systems recognize heterologous mitochondria as non-self." </p><p>But McCully doesn't expect immune reactions to be a big problem, based on his research in animals. "I can get the mitochondria from you and put them into me, me into you — doesn't really matter," he said. Early <a href="https://www.science.org/doi/10.1126/scitranslmed.abo3724" target="_blank"><u>trial results from Minovia</u></a> and others suggest heterologous transplantations come with minimal side effects, at least at doses tested so far.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/neanderthals/neanderthals-and-our-ancestors-mated-repeatedly-what-were-these-relationships-like">Neanderthal DNA still survives in our human family tree. What were our ancient relatives' relationships like?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/adversity-shaped-our-evolution-as-a-species-people-raised-in-it-may-have-underrecognized-strengths-because-of-it">Adversity shaped our evolution as a species. People raised in it may have underrecognized strengths because of it.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how">Psychedelics may rewire the brain to treat PTSD. Scientists are finally beginning to understand how.</a></li></ul></p></div></div><p>Another roadblock is that the FDA has not approved any organelles as therapies yet, so the standards and regulatory framework for the field are still being established, Brestoff said.</p><p>Despite that hurdle, the field has advanced significantly since its start as a niche, theoretical interest and then a highly experimental procedure for the sickest newborns. Scientists are now exploring the treatment as a solution to many common conditions, from <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13232979/" target="_blank"><u>rheumatoid arthritis</u></a> to <a href="https://www.livescience.com/health/neuroscience/mitochondrial-transfer-into-nerves-could-relieve-chronic-pain-early-study-hints"><u>chronic pain</u></a>.</p><p>Becker compared the state of the field to the early days of organ transplantation.</p><p>"It just turned out that it was revolutionary, when all of a sudden you could just give a person a kidney transplant," he said. "I think it's going to be kind of similar with mitochondria." </p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/viruses-infections-disease/everything-we-did-started-coming-back-to-the-mitochondria-how-replacing-cells-powerhouses-could-revolutionize-transplant-surgery-and-treat-kids-with-devastating-diseases</link>
                                                                            <description>
                            <![CDATA[ Mitochondria can become compromised in a number of medical conditions. What if they could be replaced like batteries? ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">fucYetFkYTmeia2CszcnS3</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/YTAe7uWKb4HN2z7BihKh7C-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 12 Nov 2026 17:00:00 +0000</pubDate>                                                                                                                                <updated>Thu, 19 Nov 2026 14:49:58 +0000</updated>
                                                                                                                                            <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/YTAe7uWKb4HN2z7BihKh7C-1920-80.jpg">
                                                            <media:credit><![CDATA[Christian Gralingen for Live Science]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Mitochondrial transplantation is based on a simple premise: When a battery dies, you replace it.]]></media:description>                                                            <media:text><![CDATA[A cartoon of a pink mitochondria with various organs and batteries and dials connected to it by lines.]]></media:text>
                                <media:title type="plain"><![CDATA[A cartoon of a pink mitochondria with various organs and batteries and dials connected to it by lines.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/YTAe7uWKb4HN2z7BihKh7C-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A newborn baby's heart is roughly the size of a walnut — which makes open-heart surgery challenging. </p><p>Each year, about 10,000 babies in the United States are <a href="https://www.cdc.gov/heart-defects/data/index.html" target="_blank"><u>born with critical heart defects</u></a> that may require surgery to fix, often fairly soon after birth. In these infants, the two major arteries of the heart could have <a href="https://www.hopkinsmedicine.org/all-childrens-hospital/services/heart-institute/heart-conditions-we-treat/d-transposition-of-the-great-arteries" target="_blank"><u>swapped positions</u></a> or the left side of the heart may be <a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/hypoplastic-left-heart-syndrome-hlhs-in-children" target="_blank"><u>far too small to pump properly</u></a>. </p><p>Even if their surgeries go well, these babies face perilous recoveries. A complication can arise when blood flows back into the repaired heart, triggering what's known as an ischemia-reperfusion injury. This can stun the organ, triggering extensive damage that requires doctors to place the baby on a <a href="https://www.mayoclinic.org/tests-procedures/ecmo/about/pac-20484615" target="_blank"><u>life-support machine</u></a> that pumps and infuses oxygen into blood to sub in for the hampered heart and lungs. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6712998/" target="_blank"><u>Only about 40%</u></a> of newborns make it off the machine, because often, their tiny hearts don't recover.</p><p>Doctors and scientists at Boston Children's Hospital have been working to improve those odds using a creative idea: replacing the fuel source in damaged heart cells to help them bounce back from injury. That fuel source is mitochondria, the "batteries" found in most cells in the body. In this case, the mitochondria are isolated from an abdominal muscle and then injected directly into the heart.</p><p>As of April, 17 babies have undergone this procedure, and <a href="https://www.jtcvs.org/article/S0022-5223(17)30258-1/pdf" target="_blank"><u>80% made it off ECMO</u></a>. It's too soon to say if the treatment improves overall survival rates, but the early data hints that it might. A <a href="https://clinicaltrials.gov/study/NCT02851758" target="_blank"><u>clinical trial is currently underway</u></a>.</p><figure class="van-image-figure pull-right inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1199px;"><p class="vanilla-image-block" style="padding-top:83.74%;"><img id="oo5QXf9KTL5MCjfyagQUfN" name="McCully and Emani" alt="Two men stand next to each other, the one on the left wearing a dark suit and red tie and the one on the right wearing a white lab coat." src="https://cdn.mos.cms.futurecdn.net/oo5QXf9KTL5MCjfyagQUfN-1920-80.jpg" mos="" align="right" fullscreen="1" width="1199" height="1004" attribution="" endorsement="" class="pull-rightinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/oo5QXf9KTL5MCjfyagQUfN-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-right inline-layout"><span class="caption-text">James McCully (left) and his colleague Dr. Sitaram Emani of Boston Children's Hospital have developed a technique to transplant mitochondria into the hearts of children recovering from surgery.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of Boston Children's Hospital)</span></figcaption></figure><p>"The first one or two for me were pretty nerve-wracking," said <a href="https://research.childrenshospital.org/researchers/james-mccully" target="_blank"><u>James McCully</u></a>, a research associate at Boston Children's Hospital and associate professor of surgery at Harvard Medical School whose pioneering work paved the way for these procedures. His team isolates and purifies the mitochondria that a surgical team then transplants into patients. </p><p>"But you know, the heart comes back — you can actually almost see it coming back" in real time, he told Live Science. A heart deprived of energy looks pallid, while a freshly rejuvenated heart blushes a healthy pink.</p><p>Baby heart infusions are just one example of the promise of "mitochondrial transplantation." Following McCully's lead, other scientists have started investigating whether infusions of mitochondria could revitalize donated organs destined for transplantation, help stroke patients recover, and treat kids with devastating diseases. This work is still highly experimental, and its route to regulatory approval remains unclear.</p><p>But at its core is a straightforward idea: When a battery dies, you replace it.</p><h2 id="relic-of-our-evolutionary-past">Relic of our evolutionary past</h2><p>The human body contains <a href="https://www.livescience.com/health/anatomy/how-many-cells-are-in-the-human-body-new-study-provides-an-answer"><u>tens of trillions of cells</u></a>, most of which contain hundreds to thousands of mitochondria. Following some back-of-the-envelope math, that means the total potential energy in each person "is the equivalent of a lightning bolt," <a href="https://www.chop.edu/doctors/wallace-douglas-c" target="_blank"><u>Douglas Wallace</u></a>, director of the Center for Mitochondrial and Epigenomic Medicine at Children's Hospital of Philadelphia, told attendees last year at a <a href="https://umdf.org/event/frontiers-in-mitochondrial-medicine/" target="_blank"><u>symposium on mitochondrial medicine</u></a>.</p><p>Mitochondria, in a word, are powerful. They produce most of the chemical energy used by complex cells by churning out a molecule called <a href="https://www.genome.gov/genetics-glossary/Mitochondria" target="_blank"><u>adenosine triphosphate</u></a> (ATP). The idea of transferring these fuel factories from one cell to another as a medical treatment emerged less than two decades ago — but cells have been doing such swaps on their own for eons.</p><figure class="van-image-figure  full-width-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' ><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="SZSSGKoKAPqqKnRJzF8M9M" name="GettyImages-2282045539-mitochondria" alt="An illustration of a brown, kidney-shaped organelle in a tunnel." src="https://cdn.mos.cms.futurecdn.net/SZSSGKoKAPqqKnRJzF8M9M-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="full-width expandable" /><a href='https://cdn.mos.cms.futurecdn.net/SZSSGKoKAPqqKnRJzF8M9M-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" full-width-layout"><span class="caption-text">A leading theory posits that mitochondria evolved from simple microbes. And today, they still retain distinctly microbial features. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Behnoush Hajan/Science Photo Library via Getty Images)</span></figcaption></figure><p><a href="https://pathology.wustl.edu/people/jonathan-r-brestoff-md-phd/" target="_blank"><u>Dr. Jon Brestoff</u></a>, an associate professor of pathology and immunology and director of the Immunometabolism Initiative at the Washington University School of Medicine in St. Louis, describes this ability to move from cell to cell as a <a href="https://www.nature.com/articles/s42255-024-01200-x" target="_blank"><u>relic of mitochondria's bacterial past</u></a>. "It is hypothesized that mitochondria transfer has likely been retained throughout evolution of <a href="https://www.livescience.com/65922-prokaryotic-vs-eukaryotic-cells.html"><u>eukaryotic</u></a> life," the huge domain of life that includes all plants, fungi, protists and animals, Brestoff told Live Science.</p><p>Mitochondria are the powerhouses of <a href="https://www.cell.com/current-biology/fulltext/S0960-9822%2816%2930263-9" target="_blank"><u>nearly all</u></a> complex cells on Earth, and there are a <a href="https://www.nature.com/scitable/topicpage/the-origin-of-mitochondria-14232356/" target="_blank"><u>few theories</u></a> as to how they adopted that ubiquitous role. A leading idea posits that, some 1.5 billion to 2 billion years ago, one simple cell engulfed another. The bacterial cell that got swallowed carried a circular loop of DNA inside its membrane, and that captured cell <a href="https://www.livescience.com/health/relatives-of-the-1st-mitochondria-may-be-living-in-geothermal-hot-springs-today"><u>later became what we now know as the mitochondrion</u></a>. The new organelle enabled cells to take advantage of the abundance of oxygen on our planet by converting it into usable fuel.</p><p>Mitochondria retained bacteria-like features, such as having their own DNA and membranes. But in 2006, researchers reported that <a href="https://www.pnas.org/doi/10.1073/pnas.0510511103" target="_blank"><u>mitochondria can also exit their "host"</u></a> and survive the journey into a totally different cell — a phenomenon known as mitochondrial transfer. </p><p>"That was a complete revolution in thinking," said <a href="https://feinstein.northwell.edu/institutes-researchers/our-researchers/lance-b-becker-md-faha" target="_blank"><u>Dr. Lance Becker</u></a>, professor and Chair of the Department of Emergency Medicine at Northwell Health and the Feinstein Institutes for Medical Research. "With that notion that mitochondria might be mobile, that they might cross boundaries, that they might go from one cell to another cell, came the possibility that maybe that was something we could use to help people."</p><p>The 2006 study showed that cells that had been depleted of their own mitochondrial DNA could obtain healthy mitochondria from neighboring cells. After receiving other cells' powerhouses, the once-depleted cells were able to conduct energetically costly processes, such as cell division. </p><p>This research provided the <a href="https://www.nature.com/articles/s41586-023-06537-z?fromPaywallRec=false#Sec15" target="_blank"><u>first evidence</u></a> that one cell can "donate" metabolic properties to its neighbor by sending over a fresh batch of mitochondria. Scientists once thought cells had to make all of their own mitochondria, but now, "I think cells have the ability to 'put their hand up' when they need mitochondria," Becker told Live Science.</p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:500px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="mJcdAGczwewjeGB58QbbSh" name="brestoff headshot" alt="A man with blond hair and a beard wearing a beige long sleeve and dark round glasses smiles at the camera." src="https://cdn.mos.cms.futurecdn.net/mJcdAGczwewjeGB58QbbSh-1920-80.jpg" mos="" align="left" fullscreen="1" width="500" height="500" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/mJcdAGczwewjeGB58QbbSh-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">Jon Brestoff is studying the use of mitochondrial transplantation for genetic diseases that impair the function of these cellular powerhouses. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of Jon Brestoff)</span></figcaption></figure><p>Because those first experiments were done in lab dishes, initially, "it was unclear whether or not it was really biologically meaningful or relevant," Brestoff said. But within the past five to six years, improved tools and techniques have enabled scientists to watch mitochondrial transfer unfold within living organisms, he noted. It's been shown that <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8527836/" target="_blank"><u>cells of the same type</u></a> can exchange mitochondria, as can <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11623344/" target="_blank"><u>cells of different types</u></a>.</p><p>As scientists' fundamental understanding of mitochondrial transfer grew, the notion of doing the same thing therapeutically gained more traction.</p><p>"That procedure," Brestoff said, "is rooted in the biology of mitochondria transfer." </p><h2 id="quot-the-heart-came-back-quot">"The heart came back"</h2><p>Just two years after the landmark 2006 paper, <a href="https://journals.physiology.org/doi/full/10.1152/ajpheart.00567.2008" target="_blank"><u>McCully's research group</u></a> released data that hinted at the medicinal potential of mitochondrial transplantation.</p><p>Since then, these complementary lines of research — the foundational biology and the preclinical investigation — have continued in parallel. McCully's preclinical work helped to inspire other labs to explore the use of mitochondrial transplantation for a range of medical applications, including organ transplants and treatments for stroke and genetic disease. </p><p>McCully is "the pioneer — the guru of the field," said <a href="https://school.wakehealth.edu/faculty/o/giuseppe-orlando" target="_blank"><u>Dr. Giuseppe Orlando</u></a>, a professor of surgery and regenerative medicine at Wake Forest University School of Medicine who is exploring mitochondrial transplantation as a way to maintain the integrity of transplant organs. </p><p>McCully's road to mitochondrial transplantation started in the 1980s. As a molecular biologist, he wanted to uncover mechanisms that protect the heart from damage, particularly when the organ's oxygen supply is compromised — such as during ischemia, or low blood flow. With an eye on older adults, he wanted to spare patients' heart tissue from the damage and cell death that can occur before and during heart surgery.  </p><div><blockquote><p>It changed color, went back to a pink hue, and just kept on going.</p><p>James McCully, a research associate at Boston Children's Hospital </p></blockquote></div><p>McCully and his collaborators initially "didn't care about the mitochondria one iota," he said. They were more focused on the nucleus, the control center that houses most of a cell's DNA, and its influence on cellular pathways that might boost the heart's resilience to ischemia. But "what we found was that everything we did started coming back to the mitochondria," he said.</p><p>They found that ischemia triggers damage and dysfunction in mitochondria that persists even after the heart's oxygen supply is restored; this <a href="https://www.mdpi.com/2076-3921/8/10/454" target="_blank"><u>dysfunction ultimately kills cells</u></a>. The damaged mitochondria swell up, leak their innards, and set off a chain reaction that causes a cell to self-destruct. </p><p>McCully and colleagues observed that biological pathways that seemed to reduce this cell death often centered on the mitochondria. "We were looking around at either pathways upstream of the mitochondria or downstream of the mitochondria," he said. </p><p>So, logically, they started looking directly at mitochondria, studying what the organelle looks like before, during and after ischemia. One day, while isolating mitochondria from a laboratory pig, the animal developed fibrillation, meaning its heart began beating very quickly, with an uncoordinated and rapid rhythm. The team tried to reset the heart's rhythm with electric shocks and medications, to no avail. But McCully had an idea.  </p><p>"At that point in time, the heart's kind of [got a] gray pallor, and it looks dead," he said. "And I said, 'Go upstairs; grab some of those mitochondria that we've isolated from the non-ischemic type. Just bring them down.'" They'd previously gathered some healthy mitochondria from the same pig, in hopes of generating a "before-and-after" picture of ischemia. Instead, McCully suspended those healthy mitochondria in a solution and then injected them directly into the pig's fibrillating heart.</p><p>"And the heart came back — started beating normally. It changed color, went back to a pink hue, and just kept on going," he said.</p><figure role="gallery"><figure><img src="https://cdn.mos.cms.futurecdn.net/S6jzkQAJMeoap25Wn65yJF-1920-80.jpg" alt="A blurry picture with the word "Warning" on it" /><figcaption><small role="credit">Live Science</small></figcaption></figure><figure><img src="https://cdn.mos.cms.futurecdn.net/6YUHPJhfF5SuvHJ6stgkmK-1920-80.jpg" alt="A close up of a surgery happening on someone's muscle" /><figcaption><small role="credit">Emani, S.M., et al. (2017) The Journal of Thoracic and Cardiovascular Surgery.</small></figcaption></figure><figure><img src="https://cdn.mos.cms.futurecdn.net/rLmtjXzc6FbuZWJDBjF9dP-1920-80.jpg" alt="A close up of a heart surgery where the heart is being injected with a syringe." /><figcaption><small role="credit">Emani, S.M., et al. (2017) The Journal of Thoracic and Cardiovascular Surgery.</small></figcaption></figure></figure><p>That serendipitous experiment led to a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2637784/" target="_blank"><u>formal test of the technique in rabbit hearts</u></a>, the results of which were published in 2008. In the study, they introduced healthy mitochondria to the rabbits' hearts during ischemia, just before reperfusion — when blood is reintroduced into the oxygen-starved tissue. They found that the mitochondria improved the organs' recovery and reduced tissue death. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10757322/" target="_blank"><u>Further research in animals</u></a> suggested that mitochondria that originated from one type of tissue, like liver tissue or skeletal muscle, could be introduced to other tissue types, such as cardiac muscle. </p><p>After seeing McCully's results in various animal experiments, including more with pigs, <a href="https://www.childrenshospital.org/providers/pedro-j-del-nido" target="_blank"><u>Dr. Pedro del Nido</u></a>, chair of cardiac surgery at Boston Children's and a professor of child surgery at Harvard Medical School, approached him about testing the technique in human patients — namely, in babies on a life-support machine known as ECMO. </p><p>"He saw it in the animals; he saw what was going on," McCully said. "And he deemed it as being a possible intervention to save these kids." </p><p>They sought permission from the Food and Drug Administration (FDA) to test the procedure and cleared the required regulatory hurdles. The process was made slightly easier because the mitochondria were coming from the patients' own bodies, not from a donor, McCully noted. Once given the go-ahead, they set forth with the help of <a href="https://www.childrenshospital.org/providers/sitaram-emani" target="_blank"><u>Dr. Sitaram Emani</u></a>, a heart surgeon at Boston Children's. The first procedure <a href="https://www.griffincatalyst.org/priorities/science-and-medicine/saving-lives-through-a-daring-medical-breakthrough/" target="_blank"><u>took place in 2014</u></a>.</p><p>During each procedure, Emani and the surgical team collect a small sample of skeletal muscle from the patient, and McCully then isolates whole mitochondria from the tissue and prepares them in a syringe. He refined the isolation technique so the time from collecting the muscle sample to injecting mitochondria is only 30 minutes. Lately, the team has been developing a technique they can perform in the operating room, rather than in a lab, which could cut the time to 20 minutes. Emani uses various tests, including echocardiography, to see which areas of the heart tissue move the least, and injects mitochondria straight into those areas.</p><p>"It's great to be able to see something you've done and worked on for so many years actually provide a benefit," McCully said.</p><h2 id="transplants-for-transplant-organs">Transplants for transplant organs</h2><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:692px;"><p class="vanilla-image-block" style="padding-top:130.06%;"><img id="VkxDokkaQzMaTdjf5pwhbe" name="orlando headshot.JPG" alt="A bald man with glasses wearing a white lab coat smiles at the camera." src="https://cdn.mos.cms.futurecdn.net/VkxDokkaQzMaTdjf5pwhbe-1920-80.jpg" mos="" align="left" fullscreen="1" width="692" height="900" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/VkxDokkaQzMaTdjf5pwhbe-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">Dr. Giuseppe Orlando thinks that mitochondrial transplantation could serve as a potential method for fortifying donated organs that are intended for transplant patients. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of Dr. Giuseppe Orlando)</span></figcaption></figure><p>While McCully is trying to protect infant hearts, other scientists want to do the same for other organs — including those destined for transplant surgeries.</p><p>To Orlando, mitochondria represent a potential way to make donated kidneys work better. "In transplant medicine, one of the major issues is making sure that the organs that are procured are well stored and kept viable until implantation," said Orlando, who is also president of the <a href="https://tts.org/ctrms-about/ctrms-presidents-message" target="_blank"><u>Cell Transplant and Regenerative Medicine Society</u></a>.</p><p>Maintaining an organ's viability means preserving mitochondrial function as much as possible, but the transplantation process is tough on the organelles. "That energy plant is damaged. So it's pretty obvious that you should start thinking about a way to replace the damaged mitochondria," Orlando said.</p><p>Donated organs suffer some damage when they're unplugged from the donors' bloodstream, in part because this cuts off mitochondria's crucial oxygen supply. And then, paradoxically, the donor organs also get damaged when they're plugged into the recipient's bloodstream. That's because the fast flow of blood triggers the production of <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reactive-oxygen-species#:~:text=A%20build%20up%20of%20reactive,Also%20called%20oxygen%20radical." target="_blank"><u>free radicals</u></a> — unstable molecules that damage tissues. </p><p>While healthy organs normally produce some free radicals, reperfusion unleashes a flood. "It's more than the organ can bear and sustain," Orlando explained. This damage contributes to a phenomenon called delayed graft function, in which a transplanted kidney doesn't work right away so the patient ends up needing dialysis in the first week after surgery.</p><p>"You want to make sure that the kidney wakes up faster," Orlando said. That's where mitochondria come in.</p><p>Orlando was introduced to the idea of mitochondrial transplantation around 2019 through a collaboration with <a href="https://www.researchgate.net/profile/Benedetta-Bussolati" target="_blank"><u>Dr. Benedetta Bussolati</u></a>, a nephrologist and full professor of laboratory medicine at the University of Turin in Italy. Her lab had been studying mitochondrial transplantation in isolated kidney cells in lab experiments, and they reached out to Orlando about extending that work to lab animals.  </p><p>In pigs, the researchers ran experiments in which the animals' kidneys were collected and stored in the same way human kidneys commonly would be prior to being transplanted. One set of kidneys received a placebo treatment, while another got an infusion of mitochondria from the donor pigs' muscle tissue. Upon being reperfused, the <a href="https://journals.lww.com/annalsofsurgery/fulltext/2023/12000/mitochondria_transplantation_mitigates_damage_in.55.aspx" target="_blank"><u>treated kidneys produced fewer free radicals</u></a> and accrued less damage than the untreated kidneys did, the team reported in 2023.</p><p>They backed up this finding by analyzing <a href="https://www.livescience.com/what-is-RNA.html"><u>RNA</u></a>, a molecule that reflects which genes are active in cells. Compared with the untreated kidneys, the treated kidneys showed greater activity in genes involved in mitochondrial metabolism and lower activity in genes involved in repairing injuries.</p><figure class="van-image-figure  full-width-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' ><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="ukrzgEDy3NpEreCnz65ViB" name="GettyImages-669232658-surgery" alt="A close up of a series of white-gloved hands doing surgery on a patient in a dark room." src="https://cdn.mos.cms.futurecdn.net/ukrzgEDy3NpEreCnz65ViB-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="full-width expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ukrzgEDy3NpEreCnz65ViB-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" full-width-layout"><span class="caption-text">Orlando thinks that mitochondrial transplantations could help organs "wake up" faster after being transferred from an organ donor to a recipient.   </span><span class="credit" itemprop="copyrightHolder">(Image credit: PIERRE-PHILIPPE MARCOU via Getty Images)</span></figcaption></figure><p>Some groups are exploring mitochondrial transplantation in other donor organs, like the lungs — specifically, lungs treated with "<a href="https://www.livescience.com/how-long-can-donated-organs-last-before-transplant.html"><u>ex vivo perfusion</u></a>" (EVP), an emerging approach that helps retain the viability of transplant organs. Rather than placing a donor organ in a cooler of ice, as is generally standard, EVP flushes an organ with nutrient- and oxygen-rich fluid, helping to maintain its function until the transplant surgery. In lab experiments <a href="https://www.jhltonline.org/article/S1053-2498(24)01938-7/fulltext" target="_blank"><u>with pig</u></a> and <a href="https://www.jhltonline.org/article/S1053-2498(23)00002-5/pdf" target="_blank"><u>human lungs</u></a>, scientists found that introducing fresh mitochondria during EVP further improved the organs' function while reducing inflammation and free radicals.   </p><p>Across different organ transplants, Orlando sees mitochondria as a potential means to improve patient outcomes and expand the pool of available organs. There are scenarios in which would-be organ donors die unexpectedly of cardiac arrest and <a href="https://journals.lww.com/transplantjournal/fulltext/2020/08000/uncontrolled_donation_after_circulatory_death__a.12.aspx" target="_blank"><u>their organs are damaged</u></a> in the process; mitochondrial transplants may help make such organs fit for patients, <a href="https://wms-site.com/press-media/1163-study-shows-mitochondrial-transplantation-effective-in-reversing-damage-to-kidneys-and-kidney-cells" target="_blank"><u>Orlando has said</u></a>.</p><p>In the near term, Orlando and his colleagues are continuing to study the basic science of mitochondrial transplantation for this clinical purpose; they've also been cleared to run a clinical trial with donor kidneys but need more funds to proceed. </p><p>Looking to the more distant future, he and other experts in the field envision a world where transplant organs can be bioengineered and stored in banks, ready and waiting for the patients who need them, Orlando said. If that vision materializes, he suggested, mitochondrial transplants might be useful for preparing banked organs for transplantation "by giving them kind of an energy boost."</p><h2 id="reaching-the-brain">Reaching the brain</h2><p>If infusions of fresh mitochondria could help the heart, kidney and lungs, what about the brain? That's the question <a href="https://neurosurgery.uw.edu/bio/melanie-walker-md" target="_blank"><u>Dr. Melanie Walker</u></a> and colleagues at the University of Washington School of Medicine (UW Medicine) want to answer. </p><p>Walker, a clinical professor of neurological surgery, treats patients who have had ischemic strokes, which are caused by blood clots blocking blood flow to the brain. The immediate aim of post-stroke treatment is to clear out the blocked "pipe" and restore circulation to the brain as quickly as possible, she said. But no matter how quickly this is done, some brain cells are damaged. And once the blood clot is removed, the brain may then suffer a reperfusion injury.</p><p>Standard treatments can dissolve the clot but don't protect the brain, Walker said. "What about all those cells that are maybe not quite dead — they're on the verge of maybe dying? What can we do to support those guys?" she asked.</p><p>The UW Medicine team had heard about McCully's work in Boston and wondered if something similar could be applied in stroke patients. But while heart surgery exposes the tissue in need of new mitochondria, accessing the brain is trickier. "You don't do a craniotomy to give an IV medicine," Walker told Live Science.</p><p>But Walker realized that a harmful downstream effect of stroke might provide an opportunity for treatment. Immediately after a stroke, the brain's protective shield — known as the blood-brain barrier — becomes <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10832427/" target="_blank"><u>more permeable than usual</u></a>, allowing more substances to pass from the bloodstream into brain tissue. That might open a door for mitochondrial transplantation.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="HwaCbboMt4do4UF4DWVh8W" name="GettyImages-930111308-surgery" alt="A surgeon in blue scrubs and gloved hands inserts a wire into a tube." src="https://cdn.mos.cms.futurecdn.net/HwaCbboMt4do4UF4DWVh8W-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/HwaCbboMt4do4UF4DWVh8W-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">One method of treating ischemic strokes is to physically remove the clot using a procedure called a thrombectomy, which a surgeon is preparing for in the photo above. Dr. Melanie Walker and colleagues tried combining this approach with mitochondrial transplantation.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: BSIP via Getty Images)</span></figcaption></figure><p><a href="https://www.ahajournals.org/doi/10.1161/SVIN.122.000644" target="_blank"><u>A 2023 mouse study spearheaded by University of Virginia researchers</u></a> and co-authored by Walker backed this idea, finding that mitochondria entered the brain after stroke and integrated into brain cells. These mitochondria had been gathered from muscle tissue, as in McCully's studies, and introduced to the brain via an artery. The treatment increased ATP production while reducing cell death caused by the stroke, compared with untreated mice's brains.</p><p>This work paved the way to the <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11615905/" target="_blank"><u>first trial using mitochondrial transplant in the human brain</u></a>. The small safety trial included adult patients who'd had ischemic strokes and underwent thrombectomies ‪—‬ surgeries to remove the clots from their blood vessels. Four received mitochondrial transplants during their procedures and 12 did not. Mitochondria were injected near the site of each patient's stroke, into the closest branch of one of the brain's major arteries.</p><p>No negative side effects were tied to the transplants, hinting that the procedure is safe in humans. "But the next question is, how do we understand if it helps? And those are harder trials to design," Walker said. That's partly because the transplants are tacked onto the clot-removal procedure, so it's difficult to separate their effects from those of the clot removal itself, she noted.</p><p>Future trials will also need to explore exactly where the transplanted mitochondria end up in the human brain, how well they function once inside brain cells, and how the dose and timing of the transplant affect patients' outcomes, the trial runners wrote in their report. For the moment, Walker said her team is focused on exploring the safety aspects of the approach and have no further trials planned at this time. </p><h2 id="mitochondrial-diseases-and-what-39-s-next">Mitochondrial diseases — and what's next</h2><p>Beyond heart defects, transplant organs and stroke, researchers are looking to mitochondrial transplantation as a solution for genetic conditions that harm mitochondria directly. Brestoff and colleagues are investigating the therapy's potential for treating <a href="https://medlineplus.gov/genetics/condition/leigh-syndrome/#causes" target="_blank"><u>Leigh syndrome</u></a>, a rare neurological condition caused by genetic mutations that disrupt the fuel-producing machinery in mitochondria.</p><p>"Those kids have a terrible prognosis," Brestoff said. <a href="https://www.seattlechildrens.org/research/featured-research/huff-leigh-syndrome/" target="_blank"><u>Most children with the most common form</u></a> of the syndrome, whose symptoms show up by age 2, die by age 3. There is no cure for the syndrome, and treatments to relieve its symptoms <a href="https://www.curemito.org/after-diagnosis/" target="_blank"><u>are limited</u></a>. So if it works, mitochondrial transplantation could fill a big gap. </p><p>So far, the approach shows promise in lab mice with a severe form of Leigh syndrome, improving the rodents' function and extending their median lifespan by 19% to 24%, <a href="https://www.nature.com/articles/s42255-024-01125-5" target="_blank"><u>the researchers demonstrated in 2024</u></a>. They're now studying the approach in cells derived from patients with the disease.</p><div><blockquote><p>I can get the mitochondria from you and put them into me, me into you — doesn't really matter.</p><p>James McCully, a research associate at Boston Children's Hospital</p></blockquote></div><p>Some companies, such as Israel-headquartered Minovia Therapeutics, are already running clinical trials with patients with other types of mitochondrial disease. Minovia is running one with <a href="https://www.globenewswire.com/news-release/2025/06/30/3107471/0/en/minovia-therapeutics-announces-fda-fast-track-and-rare-pediatric-disease-designations-for-mnv-201-in-pearson-syndrome.html" target="_blank"><u>children with Pearson syndrome</u></a>, in which missing mitochondrial DNA <a href="https://medlineplus.gov/genetics/condition/pearson-syndrome/" target="_blank"><u>hinders the function of bone marrow</u></a>, which normally makes blood and immune cells.</p><p>While patients with a heart or brain problem may be able to pluck mitochondria from healthy muscles, people with mitochondrial disease don't necessarily have healthy mitochondria to spare. Especially for these patients, getting mitochondria from other people ‪—‬ known as heterologous transplantation ‪—‬ likely makes the most sense. What's more, for transplantation to be used widely for any purpose, there would need to be an "off-the-shelf" mitochondrial product available, Brestoff said.</p><p>Such a product could eliminate the step in Boston Children's heart procedure where mitochondria have to be isolated from a patient while they're waiting, open on an operating table. "Getting them from the recipient can sometimes be problematic, because the recipients are sick. All the organs, all the tissue is quite distressed," McCully noted. A standardized and safety-tested mitochondrial product would therefore be a boon for the field.</p><p>Brestoff is on the scientific advisory board of <a href="https://www.luca-science.com/" target="_blank"><u>LUCA Science</u></a> and a consultant for <a href="https://www.cellergy-bio.com/" target="_blank"><u>Cellergy Therapeutics</u></a>, two companies that are developing mitochondria as therapeutic agents. These companies exemplify the effort to come up with ready-made products that could someday bring the therapy to more patients.</p><p>A shift to heterologous transplantation does raise concerns about immune reactions. "You have some variations in the proteins that are present in your mitochondria that I don't have," Brestoff noted. "So it is possible that our immune systems recognize heterologous mitochondria as non-self." </p><p>But McCully doesn't expect immune reactions to be a big problem, based on his research in animals. "I can get the mitochondria from you and put them into me, me into you — doesn't really matter," he said. Early <a href="https://www.science.org/doi/10.1126/scitranslmed.abo3724" target="_blank"><u>trial results from Minovia</u></a> and others suggest heterologous transplantations come with minimal side effects, at least at doses tested so far.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/neanderthals/neanderthals-and-our-ancestors-mated-repeatedly-what-were-these-relationships-like">Neanderthal DNA still survives in our human family tree. What were our ancient relatives' relationships like?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/adversity-shaped-our-evolution-as-a-species-people-raised-in-it-may-have-underrecognized-strengths-because-of-it">Adversity shaped our evolution as a species. People raised in it may have underrecognized strengths because of it.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how">Psychedelics may rewire the brain to treat PTSD. Scientists are finally beginning to understand how.</a></li></ul></p></div></div><p>Another roadblock is that the FDA has not approved any organelles as therapies yet, so the standards and regulatory framework for the field are still being established, Brestoff said.</p><p>Despite that hurdle, the field has advanced significantly since its start as a niche, theoretical interest and then a highly experimental procedure for the sickest newborns. Scientists are now exploring the treatment as a solution to many common conditions, from <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13232979/" target="_blank"><u>rheumatoid arthritis</u></a> to <a href="https://www.livescience.com/health/neuroscience/mitochondrial-transfer-into-nerves-could-relieve-chronic-pain-early-study-hints"><u>chronic pain</u></a>.</p><p>Becker compared the state of the field to the early days of organ transplantation.</p><p>"It just turned out that it was revolutionary, when all of a sudden you could just give a person a kidney transplant," he said. "I think it's going to be kind of similar with mitochondria." </p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ More people could count as obese under newly proposed definition — here's what you need to know ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Obesity is linked to a range of health problems ‪—‬ including heart disease, diabetes and early death ‪—‬ but it can be hard to know who is most at risk for these outcomes. Doctors and researchers often use body mass index (<a href="https://www.livescience.com/bmi-health-weight"><u>BMI</u></a>) as a convenient tool to assess patients, but this metric does not account for individual differences in body composition, <a href="https://www.livescience.com/health/obesity/bmi-alone-is-an-imperfect-measure-of-fat-leading-medical-association-says"><u>scientists have long argued</u></a>.</p><p>"BMI misses a lot of information," <a href="https://www.kcl.ac.uk/people/francesco-rubino" target="_blank"><u>Dr. Francesco Rubino</u></a>, a professor of bariatric and metabolic surgery at King's College London, told Live Science. </p><p>Rubino recently chaired a team of 56 experts that was assembled to <a href="https://doi.org/10.1016/S2213-8587(23)00058-X" target="_blank"><u>better define obesity</u></a> and develop new diagnostic criteria for the condition. First proposed in January 2025, their <a href="https://doi.org/10.1016/S2213-8587(24)00316-4" target="_blank"><u>new framework</u></a> includes more body measurements beyond BMI and distinguishes between "preclinical" and "clinical" obesity.</p><p>Now, a new study published Wednesday (Nov. 11) in the journal <a href="https://doi.org/10.1038/s41586-026-11237-5" target="_blank"><u>Nature</u></a> confirms that these new criteria could detect obesity with greater precision than BMI alone. In other words, with the new approach, more people would be accurately diagnosed with obesity and fewer people would be misdiagnosed than are with BMI alone.</p><p>Live Science spoke with Rubino and other experts to break down the new findings and learn what they mean for patients.</p><h2 id="what-are-the-limitations-of-bmi">What are the limitations of BMI?</h2><p>At the simplest level, obesity is excess body fat. There are <a href="https://obesitymedicine.org/blog/what-is-the-gold-standard-for-determining-body-fat/" target="_blank"><u>special scans</u></a> and exams that <a href="https://www.livescience.com/health/bmi-should-be-replaced-experts-argue-heres-what-the-alternative-could-be" target="_blank"><u>send weak electrical signals</u></a> through the body to measure a person's body fat percentage directly, but criteria based on body measurements are more accessible across clinical settings.</p><p>BMI is the most common of these measurements, as it simply involves dividing a person's weight by their height squared. However, it does not account for individual differences in lean muscle mass or bone density. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="hWBESdMKZkaZGhzF2H6NpY" name="GettyImages-2271528463-scale" alt="A close up of a vertical scale with a doctor's hand shifting weights on it." src="https://cdn.mos.cms.futurecdn.net/hWBESdMKZkaZGhzF2H6NpY-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/hWBESdMKZkaZGhzF2H6NpY-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">BMI doesn't capture nuances and variation between patients, experts argue, and it limits what doctors can say about a given person's health risk. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Marco Ortiz via Getty Images)</span></figcaption></figure><p>Additionally, the different BMI categories — such as "overweight" and "obese" — don't carry the same risks for all patients. Certain racial and ethnic groups tend to experience health consequences, such as higher mortality rates, <a href="https://doi.org/10.1007/s10654-012-9695-5" target="_blank"><u>at different BMI levels than others do</u></a>.</p><h2 id="what-metrics-does-the-new-obesity-definition-use">What metrics does the new obesity definition use?</h2><p>For a given patient being assessed for obesity, the proposed guidelines would suggest using at least one additional body measurement alongside BMI and having their doctor review their medical history for other signs of bodily or organ dysfunction.</p><p>The proposed body measurements are less influenced by a person's muscle mass or bone structure than BMI is. They include waist circumference, waist-to-hip ratio and waist-to-height ratio. Notably, because different ethnicities are associated with different fat distribution patterns in the body, the latest Nature study incorporated different <a href="https://doi.org/10.3390/nu16223838" target="_blank"><u>waist circumference cutoffs based that varied by ethnicity</u></a>.</p><p>In addition to these body measurements, the proposed criteria look at 18 conditions and signs of bodily or organ dysfunction that are related to obesity, such as cardiovascular diseases, joint pain and sleep apnea. (All 18 factors can <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/table/T2/" target="_blank"><u>be found detailed in this chart</u></a>.) </p><h2 id="what-is-the-difference-between-preclinical-and-clinical-obesity">What is the difference between preclinical and clinical obesity?</h2><p>Rubino and his colleagues — which together made up what's known as a <a href="https://www.thelancet.com/commissions-do" target="_blank"><u>Lancet Commission</u></a> — defined "clinical obesity" as a disease state involving at least one of 18 forms of bodily dysfunction caused by excess fat tissue. Preclinical obesity, by contrast, is when a person is at risk of this disease state and may need interventions to avoid obesity-related dysfunction. </p><p>That means that two people with the same BMI, waist circumference and waist-to-height ratio may be classified differently, depending on whether they have other conditions. In the new study, between 77% and 91% of individuals with preclinical obesity did not progress to clinical obesity within 10 years, depending on the cohort analyzed.</p><p>This distinction can be complicated, though, as the diagnostic metrics for each form of dysfunction contain their own ambiguities. </p><p>"There needs to be more consensus on what's actually defining clinical obesity," said <a href="https://ifh.rutgers.edu/profile/aayush-visaria-md/" target="_blank"><u>Dr. Aayush Visaria</u></a>, an internal medicine instructor at Rutgers Robert Wood Johnson Medical School in New Jersey. Visaira was not involved in writing the new criteria but authored an <a href="https://doi.org/10.1001/jamanetworkopen.2026.27738" target="_blank"><u>analysis of the proposed measures</u></a>. </p><p>The Lancet Commission argues that the categories of preclinical and clinical obesity could help doctors identify the people with the greatest need for treatment. The researchers tracked health outcomes using electronic health records from China, the United Kingdom, the United States and Spain, and they determined that their clinical obesity classification was better at flagging people's risk of death than BMI alone. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="wgD75SnunfBfq7mQELGMkL" name="GettyImages-2273515587-GLP" alt="A close up of a woman holding a GLP-1 injector" src="https://cdn.mos.cms.futurecdn.net/wgD75SnunfBfq7mQELGMkL-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/wgD75SnunfBfq7mQELGMkL-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Changing the diagnostic criteria for obesity could, in turn, change who is recommended to receive weight-control medications.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Galina Zhigalova via Getty Images)</span></figcaption></figure><p>They found no clear association between BMI and mortality risk, but clinical obesity was linked to a 69% greater risk of all-cause mortality, compared to no obesity.</p><h2 id="would-the-new-criteria-affect-the-overall-prevalence-of-obesity">Would the new criteria affect the overall prevalence of obesity?</h2><p>The Lancet Commission's approach could drive a small net uptick in individuals diagnosed with obesity, according to the new study. </p><p>Under the current framework, "we are definitely missing some people who actually need obesity treatment but just did not meet the BMI criteria," said <a href="https://biologicalsciences.uchicago.edu/faculty/jennifer-hwang-do-ms" target="_blank"><u>Dr. Jennifer Hwang</u></a>, an instructor of medicine at the University of Chicago who has published <a href="https://doi.org/10.1002/oby.70144" target="_blank"><u>her own analysis of the new </u></a><a href="https://doi.org/10.1002/oby.70144" target="_blank"><u>criteria</u></a>.</p><p>With the BMI-only approach, people with BMIs of 30 or higher are categorized as obese. With the new definition, some people with BMIs under 30 would be newly categorized as clinically obese, while a smaller group of people with high BMIs would suddenly not count as clinically obese, the Nature study predicted. </p><p>For instance, the former group might include people who have "overweight" BMIs but also have obesity-related dysfunction, while the latter group might include people with "obese" BMIs but without any dysfunction. </p><p>Overall, the new criteria would increase obesity prevalence by about 3.3% to 7.4%, the team predicted. The percentage varied depending on the group analyzed.</p><h2 id="what-would-it-take-to-implement-this-new-definition">What would it take to implement this new definition?</h2><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/colorectal-cancer-cases-in-kids-have-risen-sixfold-over-past-2-decades-researchers-are-racing-to-understand-why">Colorectal cancer cases in kids have risen sixfold over past 2 decades ‪—‬ researchers are racing to understand why</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/christina-applegate-misdiagnosis-why-can-ms-be-difficult-to-diagnose">Christina Applegate misdiagnosis: Why can MS be difficult to diagnose?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/zombified-cells-may-drive-aging-and-scientists-are-devising-new-ways-to-get-rid-of-them">'Zombie cells' may drive aging, and scientists are devising new ways to get rid of them</a></li></ul></p></div></div><p>More research is needed to prove that the Lancet Commission's criteria would improve patient care and be practical to use in a clinical setting, Hwang said. She noted potential challenges in implementing both new aspects of the new framework. While the body measurements sound simple enough to use, clinicians would need training to perform them accurately.</p><p>Providers also may struggle with the new distinction between preclinical and clinical obesity. <a href="https://doi.org/10.1002/oby.70070" target="_blank"><u>A 2025 analysis of the Lancet Commission framework</u></a> noted that some patients who qualify for obesity medications under the Food and Drug Administration's guidelines may be recharacterized as having preclinical obesity and no longer receive a prescription.</p><p>Rubino and the rest of the Lancet Commission plan to continue validating their framework to see how it could best support personalized obesity treatment. For instance, they want to determine which forms of organ dysfunction are of greatest concern and develop a way of scoring each patient's level of risk.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/more-people-could-count-as-obese-under-newly-proposed-definition-heres-what-you-need-to-know</link>
                                                                            <description>
                            <![CDATA[ A new study supports a more nuanced approach to obesity diagnosis. Here's what to know. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">b2RKe5pxgcHg6VBR5PGCJT</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/Yt5Rr4PnkaRHxH8KTe2qL4-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 11 Nov 2026 16:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 11 Nov 2026 20:07:01 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Lauren Schneider ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/5pJMPoJukHhyjB7CuxEXh4-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/Yt5Rr4PnkaRHxH8KTe2qL4-1920-80.jpg">
                                                            <media:credit><![CDATA[ isayildiz via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Waist circumference is one new measure included in the proposed criteria for diagnosing obesity.]]></media:description>                                                            <media:text><![CDATA[A person measures another person&#039;s waist with a yellow measuring tape]]></media:text>
                                <media:title type="plain"><![CDATA[A person measures another person&#039;s waist with a yellow measuring tape]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/Yt5Rr4PnkaRHxH8KTe2qL4-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Obesity is linked to a range of health problems ‪—‬ including heart disease, diabetes and early death ‪—‬ but it can be hard to know who is most at risk for these outcomes. Doctors and researchers often use body mass index (<a href="https://www.livescience.com/bmi-health-weight"><u>BMI</u></a>) as a convenient tool to assess patients, but this metric does not account for individual differences in body composition, <a href="https://www.livescience.com/health/obesity/bmi-alone-is-an-imperfect-measure-of-fat-leading-medical-association-says"><u>scientists have long argued</u></a>.</p><p>"BMI misses a lot of information," <a href="https://www.kcl.ac.uk/people/francesco-rubino" target="_blank"><u>Dr. Francesco Rubino</u></a>, a professor of bariatric and metabolic surgery at King's College London, told Live Science. </p><p>Rubino recently chaired a team of 56 experts that was assembled to <a href="https://doi.org/10.1016/S2213-8587(23)00058-X" target="_blank"><u>better define obesity</u></a> and develop new diagnostic criteria for the condition. First proposed in January 2025, their <a href="https://doi.org/10.1016/S2213-8587(24)00316-4" target="_blank"><u>new framework</u></a> includes more body measurements beyond BMI and distinguishes between "preclinical" and "clinical" obesity.</p><p>Now, a new study published Wednesday (Nov. 11) in the journal <a href="https://doi.org/10.1038/s41586-026-11237-5" target="_blank"><u>Nature</u></a> confirms that these new criteria could detect obesity with greater precision than BMI alone. In other words, with the new approach, more people would be accurately diagnosed with obesity and fewer people would be misdiagnosed than are with BMI alone.</p><p>Live Science spoke with Rubino and other experts to break down the new findings and learn what they mean for patients.</p><h2 id="what-are-the-limitations-of-bmi">What are the limitations of BMI?</h2><p>At the simplest level, obesity is excess body fat. There are <a href="https://obesitymedicine.org/blog/what-is-the-gold-standard-for-determining-body-fat/" target="_blank"><u>special scans</u></a> and exams that <a href="https://www.livescience.com/health/bmi-should-be-replaced-experts-argue-heres-what-the-alternative-could-be" target="_blank"><u>send weak electrical signals</u></a> through the body to measure a person's body fat percentage directly, but criteria based on body measurements are more accessible across clinical settings.</p><p>BMI is the most common of these measurements, as it simply involves dividing a person's weight by their height squared. However, it does not account for individual differences in lean muscle mass or bone density. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="hWBESdMKZkaZGhzF2H6NpY" name="GettyImages-2271528463-scale" alt="A close up of a vertical scale with a doctor's hand shifting weights on it." src="https://cdn.mos.cms.futurecdn.net/hWBESdMKZkaZGhzF2H6NpY-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/hWBESdMKZkaZGhzF2H6NpY-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">BMI doesn't capture nuances and variation between patients, experts argue, and it limits what doctors can say about a given person's health risk. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Marco Ortiz via Getty Images)</span></figcaption></figure><p>Additionally, the different BMI categories — such as "overweight" and "obese" — don't carry the same risks for all patients. Certain racial and ethnic groups tend to experience health consequences, such as higher mortality rates, <a href="https://doi.org/10.1007/s10654-012-9695-5" target="_blank"><u>at different BMI levels than others do</u></a>.</p><h2 id="what-metrics-does-the-new-obesity-definition-use">What metrics does the new obesity definition use?</h2><p>For a given patient being assessed for obesity, the proposed guidelines would suggest using at least one additional body measurement alongside BMI and having their doctor review their medical history for other signs of bodily or organ dysfunction.</p><p>The proposed body measurements are less influenced by a person's muscle mass or bone structure than BMI is. They include waist circumference, waist-to-hip ratio and waist-to-height ratio. Notably, because different ethnicities are associated with different fat distribution patterns in the body, the latest Nature study incorporated different <a href="https://doi.org/10.3390/nu16223838" target="_blank"><u>waist circumference cutoffs based that varied by ethnicity</u></a>.</p><p>In addition to these body measurements, the proposed criteria look at 18 conditions and signs of bodily or organ dysfunction that are related to obesity, such as cardiovascular diseases, joint pain and sleep apnea. (All 18 factors can <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/table/T2/" target="_blank"><u>be found detailed in this chart</u></a>.) </p><h2 id="what-is-the-difference-between-preclinical-and-clinical-obesity">What is the difference between preclinical and clinical obesity?</h2><p>Rubino and his colleagues — which together made up what's known as a <a href="https://www.thelancet.com/commissions-do" target="_blank"><u>Lancet Commission</u></a> — defined "clinical obesity" as a disease state involving at least one of 18 forms of bodily dysfunction caused by excess fat tissue. Preclinical obesity, by contrast, is when a person is at risk of this disease state and may need interventions to avoid obesity-related dysfunction. </p><p>That means that two people with the same BMI, waist circumference and waist-to-height ratio may be classified differently, depending on whether they have other conditions. In the new study, between 77% and 91% of individuals with preclinical obesity did not progress to clinical obesity within 10 years, depending on the cohort analyzed.</p><p>This distinction can be complicated, though, as the diagnostic metrics for each form of dysfunction contain their own ambiguities. </p><p>"There needs to be more consensus on what's actually defining clinical obesity," said <a href="https://ifh.rutgers.edu/profile/aayush-visaria-md/" target="_blank"><u>Dr. Aayush Visaria</u></a>, an internal medicine instructor at Rutgers Robert Wood Johnson Medical School in New Jersey. Visaira was not involved in writing the new criteria but authored an <a href="https://doi.org/10.1001/jamanetworkopen.2026.27738" target="_blank"><u>analysis of the proposed measures</u></a>. </p><p>The Lancet Commission argues that the categories of preclinical and clinical obesity could help doctors identify the people with the greatest need for treatment. The researchers tracked health outcomes using electronic health records from China, the United Kingdom, the United States and Spain, and they determined that their clinical obesity classification was better at flagging people's risk of death than BMI alone. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="wgD75SnunfBfq7mQELGMkL" name="GettyImages-2273515587-GLP" alt="A close up of a woman holding a GLP-1 injector" src="https://cdn.mos.cms.futurecdn.net/wgD75SnunfBfq7mQELGMkL-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/wgD75SnunfBfq7mQELGMkL-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Changing the diagnostic criteria for obesity could, in turn, change who is recommended to receive weight-control medications.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Galina Zhigalova via Getty Images)</span></figcaption></figure><p>They found no clear association between BMI and mortality risk, but clinical obesity was linked to a 69% greater risk of all-cause mortality, compared to no obesity.</p><h2 id="would-the-new-criteria-affect-the-overall-prevalence-of-obesity">Would the new criteria affect the overall prevalence of obesity?</h2><p>The Lancet Commission's approach could drive a small net uptick in individuals diagnosed with obesity, according to the new study. </p><p>Under the current framework, "we are definitely missing some people who actually need obesity treatment but just did not meet the BMI criteria," said <a href="https://biologicalsciences.uchicago.edu/faculty/jennifer-hwang-do-ms" target="_blank"><u>Dr. Jennifer Hwang</u></a>, an instructor of medicine at the University of Chicago who has published <a href="https://doi.org/10.1002/oby.70144" target="_blank"><u>her own analysis of the new </u></a><a href="https://doi.org/10.1002/oby.70144" target="_blank"><u>criteria</u></a>.</p><p>With the BMI-only approach, people with BMIs of 30 or higher are categorized as obese. With the new definition, some people with BMIs under 30 would be newly categorized as clinically obese, while a smaller group of people with high BMIs would suddenly not count as clinically obese, the Nature study predicted. </p><p>For instance, the former group might include people who have "overweight" BMIs but also have obesity-related dysfunction, while the latter group might include people with "obese" BMIs but without any dysfunction. </p><p>Overall, the new criteria would increase obesity prevalence by about 3.3% to 7.4%, the team predicted. The percentage varied depending on the group analyzed.</p><h2 id="what-would-it-take-to-implement-this-new-definition">What would it take to implement this new definition?</h2><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/colorectal-cancer-cases-in-kids-have-risen-sixfold-over-past-2-decades-researchers-are-racing-to-understand-why">Colorectal cancer cases in kids have risen sixfold over past 2 decades ‪—‬ researchers are racing to understand why</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/christina-applegate-misdiagnosis-why-can-ms-be-difficult-to-diagnose">Christina Applegate misdiagnosis: Why can MS be difficult to diagnose?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/zombified-cells-may-drive-aging-and-scientists-are-devising-new-ways-to-get-rid-of-them">'Zombie cells' may drive aging, and scientists are devising new ways to get rid of them</a></li></ul></p></div></div><p>More research is needed to prove that the Lancet Commission's criteria would improve patient care and be practical to use in a clinical setting, Hwang said. She noted potential challenges in implementing both new aspects of the new framework. While the body measurements sound simple enough to use, clinicians would need training to perform them accurately.</p><p>Providers also may struggle with the new distinction between preclinical and clinical obesity. <a href="https://doi.org/10.1002/oby.70070" target="_blank"><u>A 2025 analysis of the Lancet Commission framework</u></a> noted that some patients who qualify for obesity medications under the Food and Drug Administration's guidelines may be recharacterized as having preclinical obesity and no longer receive a prescription.</p><p>Rubino and the rest of the Lancet Commission plan to continue validating their framework to see how it could best support personalized obesity treatment. For instance, they want to determine which forms of organ dysfunction are of greatest concern and develop a way of scoring each patient's level of risk.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A man swallowed a bone, and‬ 15 years later, doctors found it in his appendix ]]></title>
                                                                                                <dc:content><![CDATA[ <p><strong>The patient: </strong>A 45-year-old man in<strong> </strong>Italy</p><p><strong>The symptoms: </strong>The man went to the emergency room because he had a sharp pain in his lower-right abdomen. </p><p><strong>What happened next:</strong> When doctors examined the man, the type of pain and the location of his discomfort suggested that he might have <a href="https://www.livescience.com/appendicitis-causes-symptoms-and-treatment"><u>appendicitis</u></a>, or inflammation of the appendix. </p><p>Appendicitis can be dangerous because it can cause the appendix to burst and release bacteria from the bowels into the abdominal cavity, thereby infecting the cavity's lining. This infection, called <a href="https://my.clevelandclinic.org/health/diseases/17831-peritonitis" target="_blank"><u>peritonitis</u></a>, can spread to the bloodstream and cause the life-threatening condition <a href="https://www.mayoclinic.org/diseases-conditions/sepsis/symptoms-causes/syc-20351214" target="_blank"><u>sepsis</u></a>, which kicks the immune system into overdrive.</p><p>Even though the patient had acute pain in his lower-right abdomen, he did not show signs of <a href="https://my.clevelandclinic.org/health/diseases/17831-peritonitis" target="_blank"><u>peritonitis</u></a>, such as fever, nausea, symptoms of dehydration and an elevated heart rate, according to a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3692956/" target="_blank"><u>report of his case</u></a>. His doctors then performed abdominal ultrasound scans and found that the man's abdominal organs, including the appendix, appeared normal, with no signs of inflammation.</p><p>The report's authors did not include details about the man's treatment after this examination. But eight months later, he was still in pain and returned to the hospital for further evaluation, they noted.</p><p><strong>The diagnosis: </strong>This time, when medical personnel questioned the man, he recalled that approximately 15 years earlier, he had accidentally swallowed a piece of a long bone containing edible marrow. The report does not mention if the man sought treatment immediately after swallowing this bone.</p><p>At this second visit, doctors performed an abdominal X-ray and found a round object near the upper right of the man's pelvis. It measured about an inch (2.5 centimeters) long and a little over an inch (3 cm) wide. </p><p>According to a subsequent CT scan, the object contained bone tissue and was near the appendix. When the doctors looked inside the patient's abdomen with a laparoscope — a long, flexible tool with a camera at one end — they saw that the appendix was enlarged. </p><p><strong>The treatment: </strong>Surgeons performed a <a href="https://my.clevelandclinic.org/health/procedures/21922-appendectomy" target="_blank"><u>laparoscopic appendectomy</u></a>, which uses small incisions in the abdomen to insert instruments for removing the appendix. Inside the appendix was a hardened mass of fecal matter, called a fecaloma, which surrounded a long bone. </p><p>The organ's muscular walls had been stretched out by the mass, but there were no signs of inflammation. No complications developed after the surgery, and the patient was discharged two days later. The report does not describe any follow-up visits or treatments.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="CNzLAwx82yBgmWEj35AqQg" name="GettyImages-1386003172-appendix" alt="An illustration of the human gut in blue with the appendix in orange." src="https://cdn.mos.cms.futurecdn.net/CNzLAwx82yBgmWEj35AqQg-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/CNzLAwx82yBgmWEj35AqQg-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The appendix (orange) is a small, thin pouch of tissue attached to the colon. </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p><strong>What makes the case unique: </strong>It's relatively uncommon for people to accidentally swallow something indigestible and then require a medical visit for it.<strong> </strong>In the United States annually, <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/lary.70477" target="_blank"><u>about 120,000 people</u></a> — roughly 90% of whom are children — are treated for ingesting foreign objects, and most of the objects are swallowed accidentally. Most commonly, the adults requiring treatment have ingested jewelry, while children are more likely to swallow <a href="https://publications.aap.org/pediatrics/article-abstract/143/5/e20181988/77066/Foreign-Body-Ingestions-of-Young-Children-Treated?redirectedFrom=fulltext" target="_blank"><u>coins, toys and batteries</u></a>. </p><p>Typically, small, swallowed items pass harmlessly through the intestines <a href="https://www.health.harvard.edu/digestive-health/swallowed-object-a-to-z" target="_blank"><u>within 48 hours</u></a>; less than 1% require surgical intervention. Some objects, however, need immediate attention. For example, sharp items can tear the esophagus or puncture digestive organs. Batteries are hazardous if swallowed, as they contain corrosive acid that can leak into the gut. And small magnets are a big risk, especially if <a href="https://www.cpsc.gov/s3fs-public/5221.pdf" target="_blank"><u>two or more are involved</u></a>, since they may stick together through intestinal walls, which can tear holes in tissues or cause blockages and contortions in the intestines.   </p><p>Swallowed foreign bodies rarely affect the appendix. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6663284/" target="_blank"><u>Whether they enter the organ</u></a> depends on the size of the opening into the appendix where it connects to the colon (which can vary between individuals), the dimensions of the ingested object, and the appendix's position in the body at the time. These objects cause approximately 0.005% cases of appendicitis, according to the man's case report. <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1651-2227.2008.00794.x" target="_blank"><u>Such items recovered by surgeons</u></a> through appendectomies include pieces of coal, nails, bits of enamel and glass, shells, dental crowns and bullets.</p><p>When a foreign body migrates to the appendix, it typically generates appendicitis within a few months, at most. However, this is not always the case. <a href="https://pubmed.ncbi.nlm.nih.gov/12856854/" target="_blank"><u>One report described</u></a> a man who had eaten pigeons as a child and discovered more than 30 years later that he had 27 lead shot pellets in his appendix. Despite containing these pellets from the birds' flesh, his appendix was not inflamed. </p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-mom-experienced-extreme-unhappiness-only-when-she-breastfed">Mom experienced 'extreme unhappiness' only when she breastfed</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-a-fighter-pilot-had-unexplained-headaches-for-over-a-year-the-cause-was-hiding-in-plain-sight">A fighter pilot had unexplained headaches for over a year. The cause was hiding in plain sight.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years">A woman carried a 'stone baby' in her abdomen for 3 years </a></li></ul></p></div></div><p>"It is therefore possible, although rare, that a foreign body in the appendix even after many years (in our case, 15 years) does not lead to an authentic appendicitis either histologically or clinically," the authors of the marrowbone case report wrote. </p><p>They added that their patient was the first record in the scientific literature of a sizable bone lingering inside an appendix for more than a decade without causing significant inflammation. His pain was likely caused by physical shifting of the hard mass. His experience presented "a unique clinical picture," the doctors wrote. </p><p>"This case could offer a possible diagnostic and therapeutic option for appropriately treating patients with foreign bodies within the appendix," they said.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/diagnostic-dilemma-a-man-swallowed-a-bone-then-forgot-about-it-15-years-later-doctors-found-it-in-his-appendix</link>
                                                                            <description>
                            <![CDATA[ A man's appendix had to be removed, but not for dangerous inflammation, as you might expect. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">BSc3iJg7o8LToXfg88iB35</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/HvRVLssXmGZLQwb8tHCiUe-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 11 Nov 2026 11:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Mindy Weisberger ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/AhFB8tWuFKe7LsbCTX5BUE-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Mindy Weisberger is a science journalist and author of the book &quot;Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control,&quot; published by Hopkins Press. She formerly edited for Scholastic and reported for Live Science as a channel editor and senior writer. She has reported on general science, covering climate change, paleontology, biology and space. Mindy studied film at Columbia University; prior to Live Science she produced, wrote and directed media for the American Museum of Natural History in New York City. Her videos about dinosaurs, astrophysics, biodiversity and evolution appear in museums and science centers worldwide, earning awards such as the CINE Golden Eagle and the Communicator Award of Excellence. Her writing has also appeared in Scientific American, The Washington Post, How It Works Magazine and CNN.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/HvRVLssXmGZLQwb8tHCiUe-1920-80.jpg">
                                                            <media:credit><![CDATA[ urbazon via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A man sought medical care for pain in his lower-right abdomen, a symptom that can sometimes point to appendicitis. ]]></media:description>                                                            <media:text><![CDATA[A person with an ultrasound machine stands over a laying down man]]></media:text>
                                <media:title type="plain"><![CDATA[A person with an ultrasound machine stands over a laying down man]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/HvRVLssXmGZLQwb8tHCiUe-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><strong>The patient: </strong>A 45-year-old man in<strong> </strong>Italy</p><p><strong>The symptoms: </strong>The man went to the emergency room because he had a sharp pain in his lower-right abdomen. </p><p><strong>What happened next:</strong> When doctors examined the man, the type of pain and the location of his discomfort suggested that he might have <a href="https://www.livescience.com/appendicitis-causes-symptoms-and-treatment"><u>appendicitis</u></a>, or inflammation of the appendix. </p><p>Appendicitis can be dangerous because it can cause the appendix to burst and release bacteria from the bowels into the abdominal cavity, thereby infecting the cavity's lining. This infection, called <a href="https://my.clevelandclinic.org/health/diseases/17831-peritonitis" target="_blank"><u>peritonitis</u></a>, can spread to the bloodstream and cause the life-threatening condition <a href="https://www.mayoclinic.org/diseases-conditions/sepsis/symptoms-causes/syc-20351214" target="_blank"><u>sepsis</u></a>, which kicks the immune system into overdrive.</p><p>Even though the patient had acute pain in his lower-right abdomen, he did not show signs of <a href="https://my.clevelandclinic.org/health/diseases/17831-peritonitis" target="_blank"><u>peritonitis</u></a>, such as fever, nausea, symptoms of dehydration and an elevated heart rate, according to a <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3692956/" target="_blank"><u>report of his case</u></a>. His doctors then performed abdominal ultrasound scans and found that the man's abdominal organs, including the appendix, appeared normal, with no signs of inflammation.</p><p>The report's authors did not include details about the man's treatment after this examination. But eight months later, he was still in pain and returned to the hospital for further evaluation, they noted.</p><p><strong>The diagnosis: </strong>This time, when medical personnel questioned the man, he recalled that approximately 15 years earlier, he had accidentally swallowed a piece of a long bone containing edible marrow. The report does not mention if the man sought treatment immediately after swallowing this bone.</p><p>At this second visit, doctors performed an abdominal X-ray and found a round object near the upper right of the man's pelvis. It measured about an inch (2.5 centimeters) long and a little over an inch (3 cm) wide. </p><p>According to a subsequent CT scan, the object contained bone tissue and was near the appendix. When the doctors looked inside the patient's abdomen with a laparoscope — a long, flexible tool with a camera at one end — they saw that the appendix was enlarged. </p><p><strong>The treatment: </strong>Surgeons performed a <a href="https://my.clevelandclinic.org/health/procedures/21922-appendectomy" target="_blank"><u>laparoscopic appendectomy</u></a>, which uses small incisions in the abdomen to insert instruments for removing the appendix. Inside the appendix was a hardened mass of fecal matter, called a fecaloma, which surrounded a long bone. </p><p>The organ's muscular walls had been stretched out by the mass, but there were no signs of inflammation. No complications developed after the surgery, and the patient was discharged two days later. The report does not describe any follow-up visits or treatments.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="CNzLAwx82yBgmWEj35AqQg" name="GettyImages-1386003172-appendix" alt="An illustration of the human gut in blue with the appendix in orange." src="https://cdn.mos.cms.futurecdn.net/CNzLAwx82yBgmWEj35AqQg-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/CNzLAwx82yBgmWEj35AqQg-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The appendix (orange) is a small, thin pouch of tissue attached to the colon. </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p><strong>What makes the case unique: </strong>It's relatively uncommon for people to accidentally swallow something indigestible and then require a medical visit for it.<strong> </strong>In the United States annually, <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/lary.70477" target="_blank"><u>about 120,000 people</u></a> — roughly 90% of whom are children — are treated for ingesting foreign objects, and most of the objects are swallowed accidentally. Most commonly, the adults requiring treatment have ingested jewelry, while children are more likely to swallow <a href="https://publications.aap.org/pediatrics/article-abstract/143/5/e20181988/77066/Foreign-Body-Ingestions-of-Young-Children-Treated?redirectedFrom=fulltext" target="_blank"><u>coins, toys and batteries</u></a>. </p><p>Typically, small, swallowed items pass harmlessly through the intestines <a href="https://www.health.harvard.edu/digestive-health/swallowed-object-a-to-z" target="_blank"><u>within 48 hours</u></a>; less than 1% require surgical intervention. Some objects, however, need immediate attention. For example, sharp items can tear the esophagus or puncture digestive organs. Batteries are hazardous if swallowed, as they contain corrosive acid that can leak into the gut. And small magnets are a big risk, especially if <a href="https://www.cpsc.gov/s3fs-public/5221.pdf" target="_blank"><u>two or more are involved</u></a>, since they may stick together through intestinal walls, which can tear holes in tissues or cause blockages and contortions in the intestines.   </p><p>Swallowed foreign bodies rarely affect the appendix. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6663284/" target="_blank"><u>Whether they enter the organ</u></a> depends on the size of the opening into the appendix where it connects to the colon (which can vary between individuals), the dimensions of the ingested object, and the appendix's position in the body at the time. These objects cause approximately 0.005% cases of appendicitis, according to the man's case report. <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1651-2227.2008.00794.x" target="_blank"><u>Such items recovered by surgeons</u></a> through appendectomies include pieces of coal, nails, bits of enamel and glass, shells, dental crowns and bullets.</p><p>When a foreign body migrates to the appendix, it typically generates appendicitis within a few months, at most. However, this is not always the case. <a href="https://pubmed.ncbi.nlm.nih.gov/12856854/" target="_blank"><u>One report described</u></a> a man who had eaten pigeons as a child and discovered more than 30 years later that he had 27 lead shot pellets in his appendix. Despite containing these pellets from the birds' flesh, his appendix was not inflamed. </p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-mom-experienced-extreme-unhappiness-only-when-she-breastfed">Mom experienced 'extreme unhappiness' only when she breastfed</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-a-fighter-pilot-had-unexplained-headaches-for-over-a-year-the-cause-was-hiding-in-plain-sight">A fighter pilot had unexplained headaches for over a year. The cause was hiding in plain sight.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years">A woman carried a 'stone baby' in her abdomen for 3 years </a></li></ul></p></div></div><p>"It is therefore possible, although rare, that a foreign body in the appendix even after many years (in our case, 15 years) does not lead to an authentic appendicitis either histologically or clinically," the authors of the marrowbone case report wrote. </p><p>They added that their patient was the first record in the scientific literature of a sizable bone lingering inside an appendix for more than a decade without causing significant inflammation. His pain was likely caused by physical shifting of the hard mass. His experience presented "a unique clinical picture," the doctors wrote. </p><p>"This case could offer a possible diagnostic and therapeutic option for appropriately treating patients with foreign bodies within the appendix," they said.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Would you learn to lucid dream if you could? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>During dreams, bizarre scenes you encounter can seem as tangible as reality; you feel as though you're really flying through the sky or being chased through a jungle of bright-purple trees. But in special cases, people realize they're in the midst of a dream as it's unfolding. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/do-your-dreams-change-as-you-age">Do your dreams change as you age?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/why-are-recurring-dreams-usually-nightmares">Why are recurring dreams usually nightmares?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/do-people-dream-in-color-or-black-and-white">Do people dream in color or black and white?</a></li></ul></p></div></div><p>Called lucid dreaming, this phenomenon occurs when we suddenly regain <a href="https://www.brainfacts.org/thinking-sensing-and-behaving/sleep/2025/the-fascinating-neuroscience-of-lucid-dreaming-072325" target="_blank"><u>our capacity for metacognition</u></a>, or thinking about our own thoughts, in the middle of a dream. Lucid dreamers can sometimes even control the content or trajectory of their dreams. Now, researchers claim that they've <a href="https://www.livescience.com/health/neuroscience/neuroscientists-reveal-method-to-train-people-to-have-lucid-dreams-and-it-involves-virtual-reality-and-mediation"><u>found a way to "train" people to lucid dream</u></a> by having them meditate and complete virtual-reality-augmented exercises while they're awake.</p><p>In a study involving a few dozen participants, the scientists found that repeating this training twice a week for a month significantly increased how often participants experienced lucid dreaming. They say the approach could have practical applications as an intervention for <a href="https://www.livescience.com/turn-off-nightmares.html"><u>people with nightmares</u></a>, anxiety or post-traumatic stress disorder — but those applications are theoretical, for now.</p><p>If you could learn how to lucid dream, would you? Let us know in the poll below, and add your thoughts in the comments. </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-OdnxZe"></div>                            </div>                            <script src="https://kwizly.com/embed/OdnxZe.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/sleep/would-you-learn-to-lucid-dream-if-you-could</link>
                                                                            <description>
                            <![CDATA[ Neuroscientists say people can be "trained" to recognize when they're dreaming — in other words, lucid dreaming may be an acquirable skill. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">wL2BBE28BxkvMchKnvS7qY</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/M8bWT96d827uhLnMgo2my3-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sun, 08 Nov 2026 17:00:00 +0000</pubDate>                                                                                                                                <updated>Tue, 10 Nov 2026 20:16:28 +0000</updated>
                                                                                                                                            <category><![CDATA[Sleep]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/M8bWT96d827uhLnMgo2my3-1920-80.jpg">
                                                            <media:credit><![CDATA[Klaus Vedfelt via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Do you ever lucid dream? And if you don&amp;#39;t, would you want to?]]></media:description>                                                            <media:text><![CDATA[A woman with long dark hair floats in her white pajamas in the sky.]]></media:text>
                                <media:title type="plain"><![CDATA[A woman with long dark hair floats in her white pajamas in the sky.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/M8bWT96d827uhLnMgo2my3-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>During dreams, bizarre scenes you encounter can seem as tangible as reality; you feel as though you're really flying through the sky or being chased through a jungle of bright-purple trees. But in special cases, people realize they're in the midst of a dream as it's unfolding. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/do-your-dreams-change-as-you-age">Do your dreams change as you age?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/why-are-recurring-dreams-usually-nightmares">Why are recurring dreams usually nightmares?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/dreams/do-people-dream-in-color-or-black-and-white">Do people dream in color or black and white?</a></li></ul></p></div></div><p>Called lucid dreaming, this phenomenon occurs when we suddenly regain <a href="https://www.brainfacts.org/thinking-sensing-and-behaving/sleep/2025/the-fascinating-neuroscience-of-lucid-dreaming-072325" target="_blank"><u>our capacity for metacognition</u></a>, or thinking about our own thoughts, in the middle of a dream. Lucid dreamers can sometimes even control the content or trajectory of their dreams. Now, researchers claim that they've <a href="https://www.livescience.com/health/neuroscience/neuroscientists-reveal-method-to-train-people-to-have-lucid-dreams-and-it-involves-virtual-reality-and-mediation"><u>found a way to "train" people to lucid dream</u></a> by having them meditate and complete virtual-reality-augmented exercises while they're awake.</p><p>In a study involving a few dozen participants, the scientists found that repeating this training twice a week for a month significantly increased how often participants experienced lucid dreaming. They say the approach could have practical applications as an intervention for <a href="https://www.livescience.com/turn-off-nightmares.html"><u>people with nightmares</u></a>, anxiety or post-traumatic stress disorder — but those applications are theoretical, for now.</p><p>If you could learn how to lucid dream, would you? Let us know in the poll below, and add your thoughts in the comments. </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-OdnxZe"></div>                            </div>                            <script src="https://kwizly.com/embed/OdnxZe.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Women often get cold more easily than men — a mouse study offers hints why ]]></title>
                                                                                                <dc:content><![CDATA[ <p>It's a common observation that women often prefer warmer temperatures and feel cold more easily than men do, and the same trend appears among females of other species. Now, a study offers new clues as to what drives this preference — and testosterone may play a part. </p><p>Skin carries sensors to detect heat and cold that influence each organism's decision to stay in or move out of an environment. The new study, published Oct. 28 in the <a href="https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP288076" target="_blank"><u>Journal of Physiology</u></a>, found that these sensors activate at higher temperatures in female mice, which appears to shift their preferred temperature roughly 7 degrees Fahrenheit (4 degrees Celsius) higher than that of male mice. Testosterone seems to influence this difference in activation. </p><p>"You could say it's just a cute observation of no particular importance," said study co-author <a href="https://www.kcl.ac.uk/people/peter-mcnaughton" target="_blank"><u>Peter McNaughton</u></a>, a pharmacologist at King's College London who studies pain, thermal sensation and thermoregulation. "[But] it's got practical ramifications," in that it might be important in designing buildings and spaces that accommodate people, he told Live Science.  </p><h2 id="a-distinct-temperature-preference">A distinct temperature preference</h2><p>Proteins in the skin's nerve endings activate in response to warmth or cold. "You can look at them like little electrical generators in the nerve endings," said <a href="https://profiles.hopkinsmedicine.org/provider/michael-caterina/2777003" target="_blank"><u>Dr. Michael Caterina</u></a>, a neuroscientist at Johns Hopkins University who was not involved in the research. </p><p>When activated, these proteins allow charged ions to enter sensory nerve cells, which, in turn, transmit electrical signals to the brain. The circuits a given nerve cell connects to determines our perception of heat or cold, Caterina told Live Science. </p><p>Beyond humans, it is known that many female animals, <a href="https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP288076" target="_blank"><u>including mice</u></a> <a href="https://onlinelibrary.wiley.com/doi/10.1111/geb.13393" target="_blank"><u>and birds</u></a>, prefer slightly warmer temperatures than their male counterparts do. So the researchers set up an experiment to investigate these differences.</p><p>They put 30 male and 27 female mice on two adjacent plates of different temperatures — one at 91.4 degrees Fahrenheit (33 degrees Celsius) and another that varied between lower and  higher temperatures. A camera tracked the mice's movements and calculated how much time they spent on each plate. </p><p>Both male and female mice spent more time at the 91.4 F plate when the second plate was cooler. However, when put next to a plate measuring 100.4 F (38 C), female mice spent significantly more time on the warmer plate than male mice did. The average preferred surface temperature was approximately 89.6 F (32 C) for male mice and 96.8 F (36 C) for female mice.</p><p>"Since the top of the cage was completely open, there was no question of the air temperature affecting the mice," McNaughton said, so the preference was driven solely by the sensors in their skin. The researchers also measured the internal and skin temperatures of the mice and confirmed that there were no significant differences between the sexes on those fronts.</p><h2 id="the-role-of-testosterone">The role of testosterone </h2><p>The scientists explored what would happen if they genetically deleted the warmth-detector protein. In male mice, this reduced their avoidance of the warmer plate, suggesting this protein normally sends a signal that discourages them from staying on warmer surfaces. The mice's preferred temperature also rose to about 95 F (35 C), closer to that of females.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="XjTDgwwuK8UqMNZgDkw8YK" name="GettyImages-2262059903-testosterone" alt="A 3D model of the molecule testosterone." src="https://cdn.mos.cms.futurecdn.net/XjTDgwwuK8UqMNZgDkw8YK-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/XjTDgwwuK8UqMNZgDkw8YK-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The study suggests that testosterone somehow tweaks the function of heat-sensing nerves in the skin.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Alllex via Getty Images)</span></figcaption></figure><p>In female mice, deleting or blocking the protein did not have any significant effect. </p><p>The team then tried eliminating or blocking the coolness-detecting protein, finding that males and females didn't avoid the cool plates as strongly as they did before. Female mice also spent less time on the warmer plates, but males' preference for the warmer plates didn't change.</p><p>"Females are a little bit more responsive to activation of the cold receptor," Caterina said, "and a little bit less responsive to activation of the warmer receptor." That's despite the temperature-sensing neurons in both sets of mice working identically, the team found.</p><p>The researchers suspected that sex hormones might help to explain this difference.</p><p>They gave a group of male mice a drug that blocks the production of testosterone. Weeks after the treatment, these mice spent more time on the 38 C plate than males with normal testosterone. Meanwhile, female mice given testosterone lost their preference for warmer temperatures. </p><p>Interestingly, giving male mice female hormones, including forms of estrogen and progesterone, did not affect their temperature preferences. And blocking the hormones in female mice also had no effect. These hormones are known to <a href="https://pubmed.ncbi.nlm.nih.gov/28488202/" target="_blank"><u>influence other aspects of temperature regulation</u></a> in the body, though, such as heat dissipation through the skin; but in this case, they didn't seem to affect animals' perception of temperature.</p><p>"So it really seems as though testosterone is the most important determinant," McNaughton said. But these changes were only partial; testosterone did not completely reverse the differences between the sexes. "So there is something else going on that we weren't able to identify," he added.</p><p>The exact mechanism for how testosterone impacts the sensor proteins is not clear. Because the effect happened over weeks, researchers suggested that it did not directly affect the temperature-sensing proteins. It might instead act indirectly by influencing the activity of genes, but further studies would be needed to confirm this idea.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/do-women-get-cold-more-easily-than-men">Do women get cold more easily than men?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/can-humans-sense-wetness">Can humans sense wetness?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/warm-and-cool-temperatures-travel-on-completely-different-paths-to-the-brain-study-finds">Warm and cool temperatures travel on completely different paths to the brain, study finds</a></li></ul></p></div></div><p>Although the researchers did not conduct any tests in humans, McNaughton noted that the same sensor proteins are present in people and that <a href="https://pubmed.ncbi.nlm.nih.gov/30196892/" target="_blank"><u>studies with humans suggest that they behave in a similar way</u></a>.</p><p>This research provides "valuable information" for understanding how the proteins responsible for sensing temperature work, Caterina said. Understanding these mechanisms could be useful for studying conditions like <a href="https://my.clevelandclinic.org/health/diseases/15833-neuropathic-pain" target="_blank"><u>neuropathic pain</u></a>, in which people's sensitivity to heat and cold is enhanced.</p><p>"What kinds of signals create our daily experiences around temperature is by itself very important," he told Live Science. "It's a big part of understanding ourselves as living beings." </p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/women-often-get-cold-more-easily-than-men-a-mouse-study-offers-hints-why</link>
                                                                            <description>
                            <![CDATA[ A new study points to testosterone and proteins in the skin as reasons why males and females experience temperatures differently. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">ubbXdxGeDFskxHuxtcfdva</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/UZL3xtpq3rajthBGiMWw87-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sat, 07 Nov 2026 16:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Zunnash Khan ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/wrV7sdVdmyubSn8MbHtvvc-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/UZL3xtpq3rajthBGiMWw87-1920-80.jpg">
                                                            <media:credit><![CDATA[imv via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Males and females of various animal species show different preference for temperatures in their environments.]]></media:description>                                                            <media:text><![CDATA[Three brown rats hide amidst some wood pieces.]]></media:text>
                                <media:title type="plain"><![CDATA[Three brown rats hide amidst some wood pieces.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/UZL3xtpq3rajthBGiMWw87-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>It's a common observation that women often prefer warmer temperatures and feel cold more easily than men do, and the same trend appears among females of other species. Now, a study offers new clues as to what drives this preference — and testosterone may play a part. </p><p>Skin carries sensors to detect heat and cold that influence each organism's decision to stay in or move out of an environment. The new study, published Oct. 28 in the <a href="https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP288076" target="_blank"><u>Journal of Physiology</u></a>, found that these sensors activate at higher temperatures in female mice, which appears to shift their preferred temperature roughly 7 degrees Fahrenheit (4 degrees Celsius) higher than that of male mice. Testosterone seems to influence this difference in activation. </p><p>"You could say it's just a cute observation of no particular importance," said study co-author <a href="https://www.kcl.ac.uk/people/peter-mcnaughton" target="_blank"><u>Peter McNaughton</u></a>, a pharmacologist at King's College London who studies pain, thermal sensation and thermoregulation. "[But] it's got practical ramifications," in that it might be important in designing buildings and spaces that accommodate people, he told Live Science.  </p><h2 id="a-distinct-temperature-preference">A distinct temperature preference</h2><p>Proteins in the skin's nerve endings activate in response to warmth or cold. "You can look at them like little electrical generators in the nerve endings," said <a href="https://profiles.hopkinsmedicine.org/provider/michael-caterina/2777003" target="_blank"><u>Dr. Michael Caterina</u></a>, a neuroscientist at Johns Hopkins University who was not involved in the research. </p><p>When activated, these proteins allow charged ions to enter sensory nerve cells, which, in turn, transmit electrical signals to the brain. The circuits a given nerve cell connects to determines our perception of heat or cold, Caterina told Live Science. </p><p>Beyond humans, it is known that many female animals, <a href="https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP288076" target="_blank"><u>including mice</u></a> <a href="https://onlinelibrary.wiley.com/doi/10.1111/geb.13393" target="_blank"><u>and birds</u></a>, prefer slightly warmer temperatures than their male counterparts do. So the researchers set up an experiment to investigate these differences.</p><p>They put 30 male and 27 female mice on two adjacent plates of different temperatures — one at 91.4 degrees Fahrenheit (33 degrees Celsius) and another that varied between lower and  higher temperatures. A camera tracked the mice's movements and calculated how much time they spent on each plate. </p><p>Both male and female mice spent more time at the 91.4 F plate when the second plate was cooler. However, when put next to a plate measuring 100.4 F (38 C), female mice spent significantly more time on the warmer plate than male mice did. The average preferred surface temperature was approximately 89.6 F (32 C) for male mice and 96.8 F (36 C) for female mice.</p><p>"Since the top of the cage was completely open, there was no question of the air temperature affecting the mice," McNaughton said, so the preference was driven solely by the sensors in their skin. The researchers also measured the internal and skin temperatures of the mice and confirmed that there were no significant differences between the sexes on those fronts.</p><h2 id="the-role-of-testosterone">The role of testosterone </h2><p>The scientists explored what would happen if they genetically deleted the warmth-detector protein. In male mice, this reduced their avoidance of the warmer plate, suggesting this protein normally sends a signal that discourages them from staying on warmer surfaces. The mice's preferred temperature also rose to about 95 F (35 C), closer to that of females.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="XjTDgwwuK8UqMNZgDkw8YK" name="GettyImages-2262059903-testosterone" alt="A 3D model of the molecule testosterone." src="https://cdn.mos.cms.futurecdn.net/XjTDgwwuK8UqMNZgDkw8YK-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/XjTDgwwuK8UqMNZgDkw8YK-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The study suggests that testosterone somehow tweaks the function of heat-sensing nerves in the skin.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Alllex via Getty Images)</span></figcaption></figure><p>In female mice, deleting or blocking the protein did not have any significant effect. </p><p>The team then tried eliminating or blocking the coolness-detecting protein, finding that males and females didn't avoid the cool plates as strongly as they did before. Female mice also spent less time on the warmer plates, but males' preference for the warmer plates didn't change.</p><p>"Females are a little bit more responsive to activation of the cold receptor," Caterina said, "and a little bit less responsive to activation of the warmer receptor." That's despite the temperature-sensing neurons in both sets of mice working identically, the team found.</p><p>The researchers suspected that sex hormones might help to explain this difference.</p><p>They gave a group of male mice a drug that blocks the production of testosterone. Weeks after the treatment, these mice spent more time on the 38 C plate than males with normal testosterone. Meanwhile, female mice given testosterone lost their preference for warmer temperatures. </p><p>Interestingly, giving male mice female hormones, including forms of estrogen and progesterone, did not affect their temperature preferences. And blocking the hormones in female mice also had no effect. These hormones are known to <a href="https://pubmed.ncbi.nlm.nih.gov/28488202/" target="_blank"><u>influence other aspects of temperature regulation</u></a> in the body, though, such as heat dissipation through the skin; but in this case, they didn't seem to affect animals' perception of temperature.</p><p>"So it really seems as though testosterone is the most important determinant," McNaughton said. But these changes were only partial; testosterone did not completely reverse the differences between the sexes. "So there is something else going on that we weren't able to identify," he added.</p><p>The exact mechanism for how testosterone impacts the sensor proteins is not clear. Because the effect happened over weeks, researchers suggested that it did not directly affect the temperature-sensing proteins. It might instead act indirectly by influencing the activity of genes, but further studies would be needed to confirm this idea.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/do-women-get-cold-more-easily-than-men">Do women get cold more easily than men?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/can-humans-sense-wetness">Can humans sense wetness?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/warm-and-cool-temperatures-travel-on-completely-different-paths-to-the-brain-study-finds">Warm and cool temperatures travel on completely different paths to the brain, study finds</a></li></ul></p></div></div><p>Although the researchers did not conduct any tests in humans, McNaughton noted that the same sensor proteins are present in people and that <a href="https://pubmed.ncbi.nlm.nih.gov/30196892/" target="_blank"><u>studies with humans suggest that they behave in a similar way</u></a>.</p><p>This research provides "valuable information" for understanding how the proteins responsible for sensing temperature work, Caterina said. Understanding these mechanisms could be useful for studying conditions like <a href="https://my.clevelandclinic.org/health/diseases/15833-neuropathic-pain" target="_blank"><u>neuropathic pain</u></a>, in which people's sensitivity to heat and cold is enhanced.</p><p>"What kinds of signals create our daily experiences around temperature is by itself very important," he told Live Science. "It's a big part of understanding ourselves as living beings." </p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ I almost died from flu. My life didn't go back to normal after. ]]></title>
                                                                                                <dc:content><![CDATA[ <p>In February 2011, Madi Allen, a healthy 12-year-old in Central Illinois, who loved playing sports, almost died from the flu. The influenza B virus resulted in her developing necrotizing pneumonia, where the infection triggers inflammation that destroys the tissue of the lungs, methicillin-resistant <em>Staphylococcus aureus</em> (MRSA), and her kidneys shut down. She was put on life support and dialysis, and was intubated for five weeks. She spent another two months in hospital and a decade recovering from the damage caused. </p><p>Allen, now 28, shared her experience with Live Science.  </p><p>I was 12 years old when it all started. I was just a normal seventh grader, I played soccer and basketball. I didn't really have any health issues beforehand — just sports-induced asthma. </p><p>That weekend, I started to feel a little sick, but nothing too bad. My mom kept giving me over-the-counter medicine and it would work for a bit, then once it wore off, it would get really bad. I'd planned to go to one of my friend's birthday parties then spend the night with my best friend. I went to the party, but I texted my mom saying I should come home because I really wasn't feeling well, which was not usual for me at all. That night I asked my mom to sleep with me because I just felt terrible. </p><p>That was Saturday. By Sunday night, the only position that I could get comfortable in was my mom holding me like a baby. My mom just held me all weekend. My whole body just hurt and I started feeling like I couldn't breathe properly. That got way worse Monday morning. </p><p>We were waiting for my pediatrician to open up and my mom suggested taking a shower, saying, "Maybe that will help you feel a bit better before we go to the doctor." She had to help me take a shower because I was so weak, I couldn't stand by myself. She stepped away for a second just to grab a towel and said that when she came back, my lips were turning gray and my eyes were starting to look sunken in. She knew that something was not right so she called my dad, who was at the grocery store, and told him to just leave everything, that we need to get to the hospital. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1600px;"><p class="vanilla-image-block" style="padding-top:75.00%;"><img id="ytWcBezoayVo8N7Cc3us2j" name="IMG_4475" alt="A close up of a woman in a hospital bed breathing from a tube" src="https://cdn.mos.cms.futurecdn.net/ytWcBezoayVo8N7Cc3us2j-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1600" height="1200" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ytWcBezoayVo8N7Cc3us2j-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Allen was put on life support and had to be intubated for five weeks after getting sick with flu.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Madi Allen)</span></figcaption></figure><p>Our local hospital is just a small rural hospital — everybody gets transferred out. They diagnosed me with double pneumonia and then sent me to a different hospital 30 minutes away that specialized more in kids. </p><p>My dad rode with me in the ambulance while my mom went home and grabbed a few things — she thought we'd just be there for a few days. By the time we got to the second hospital, I was in respiratory distress. They wanted to intubate me straight away but were waiting until my mom got there so she could talk to me — my dad did the best he could, but my dad didn't know how to calm me down. </p><p>I don't think the doctors even told me that they were putting me to sleep. My mom had to be the one to tell me. I remember being very scared. They put this mask on my face for the BiPAP [bilevel positive airway pressure machine, which delivers pressurized air to a patient] and I felt like that was suffocating me. It didn't feel like it was helping at all, which, I guess, at that point, it wasn't. They were just trying everything they could. I was begging them to take it off of me, crying and just saying, "one minute, just take it off for one minute." </p><p>Finally my mom tried to calm me down and she's like, "They're gonna have to put you to sleep now." I remember her telling me, "You're just gonna go to sleep for like a couple of hours and then you're gonna wake up and you're gonna feel a lot better."</p><p>My mom had to leave the room while they were doing that. As she was walking out the door, the last thing I said was "Mom" and then I put my hands in a heart shape. That was the last thing I did and the last time my mom heard my voice for five weeks. </p><p>After I was intubated, things got worse. I had to be put on life support so needed to be moved to a bigger hospital in St. Louis, Missouri. The flight team came to evaluate me and they later told me they didn't think they were ever going to get me to Saint Louis. They thought I wasn't going to make the trip. But they said my mom was begging them to help me, everyone in my family was begging them, so they did everything they could to get me on the helicopter. They worked on me for several hours — every time they tried to move me something would go wrong — but eventually they got me there. </p><p>The doctors had to call my parents to get permission to do surgery and put me on life support. My mom said that every time she heard my dad's phone ring, she thought they were calling to tell them that I didn't make it. They were told twice that it was more than likely I was going to pass than make it. They were trying to prepare my parents that I wasn't going to make it. </p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:416px;"><p class="vanilla-image-block" style="padding-top:131.25%;"><img id="ueTCGCwFid2UtWPQN7HXzZ" name="IMG_4477" alt="A close up of a girl with freckles and brown hair" src="https://cdn.mos.cms.futurecdn.net/ueTCGCwFid2UtWPQN7HXzZ-1920-80.jpg" mos="" align="left" fullscreen="1" width="416" height="546" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ueTCGCwFid2UtWPQN7HXzZ-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">After getting out of hospital, it took years for Allen to recover, eventually having part of her lung removed that had been badly damaged by the virus.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Madi Allen)</span></figcaption></figure><p>I woke up five weeks later, and it was very confusing. Everybody was told if I asked what day it was, just to tell me the day of the week. When someone accidentally told me the date, I started crying because my aunt was supposed to be getting married a few weeks later and I was worried about being at her wedding. My mom wasn't there, so my dad had to calm me down and then he told me the wedding had been pushed to October so I could be there. </p><p>The second thing I was worried about was that I was supposed to take a test on the Constitution and that I'd missed it. I ended up taking it in the hospital. I was there for 93 days. I got out the very last week of school, so I got to go in on the last day of school and surprise my classmates and my teachers. </p><p>That summer, I didn't really do anything besides go to doctor's appointments. I was doing physical therapy, occupational therapy and speech therapy — literally all my time was spent at the hospital in therapy. I'd missed three months of school, but I got to start eighth grade with all my friends, and I ended up playing basketball again. But the next several years was a lot of hard work of trying to get back to my normal. </p><p>It probably took the rest of junior high and high school to get back to how I would have been before. It was a very long process and during that time I got sick a lot, so I ended up back in the hospital several times. And it was hard going through that as a teenager — I felt like everybody else is living their normal life, and I felt like I missed out on a lot. Looking back now, I still feel like I did miss out a lot. But I think we made the best of the circumstances.</p><p>During COVID, when I was 22, I kept getting sick, and the doctors finally told me that part of my lung was so damaged from the flu it was causing infections, so they gave me an option of getting part of my lung removed. It was a major surgery, but I did it and that was probably the best decision I ever made, because it's been five years and I have not been in the hospital once. </p><p>I moved to Florida about three years ago, and I started working as a medical assistant in a pulmonary clinic. This semester I got accepted into respiratory therapy school, so for the next two years, I'm going to be in school for respiratory therapy. It's kind of a full circle moment, to come back into the medical field, because there was a point in my life where everybody was asking me, "Oh, do you want to be a doctor? Do you want to be a nurse?" And I'm like, "Absolutely not." I was still so sick that I was there all the time. I never wanted to be there. </p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health">'Now you actually have a blood test': Psychiatry's bible, the DSM, is getting upgraded to include biological markers. A psychiatrist explains what that means for mental health.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/trumps-childhood-vaccine-order-will-threaten-childrens-safety-even-if-it-doesnt-directly-change-policy">Trump's childhood vaccine order will threaten children's safety, even if it doesn't directly change policy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/infectious-diseases-will-seed-new-ground-as-the-planet-warms-heres-where-theyll-spread">Infectious diseases will seed new ground as the planet warms — here's where they'll spread</a></li></ul></p></div></div><p>I went to college and I got a degree in criminal justice, but I never really knew what I wanted to do. I ended up getting a job at our local hospital — that first hospital that I went to. Every time they put me in the ER I just loved being there. That job made me realize that this is what I wanted to do.</p><p>When people hear my story, they don't realize that if I don't tell the end — after the hospital until now — they don't realize that my life didn't go back to normal after. It's taken 10 years. And it's hard. Some of the other family members that we've gotten to know through Families Fighting Flu, it's difficult listening to their stories. Sometimes I feel like I have this survivor's guilt. Their stories sound exactly like mine — but their kids didn't make it. </p><p>Before I got sick I got the flu shot every year, but that year we just got busy and it got put on the back burner. Since getting sick I have always made it a priority to get the flu shot every year. I know it is not a guarantee that I will never get the flu again — but hopefully it will reduce the chances of it ever getting that bad again. </p><p><em>With thanks to </em><a href="https://familiesfightingflu.org/" target="_blank"><em>Families Fighting Flu</em></a><em>, a non-profit organization that promotes flu vaccination and raises awareness of the severity of the infectious disease through families that have been affected.</em></p><p><u></u><a href="https://www.livescience.com/opinion"><u>Opinion</u></a><em> on Live Science gives you insight on the most important issues in science that affect you and the world around you today, written by experts and leading scientists in their field.</em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/flu/i-almost-died-from-flu-my-life-didnt-go-back-to-normal-after-opinion</link>
                                                                            <description>
                            <![CDATA[ <b>Madi Allen</b> was 12 years old when she almost died from flu. Now 28, she shared her story with Live Science. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">QV2k52N8f2FX2wRmuoR7Pn</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/dks7EkpsPFJY5VeHuQQbBK-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sat, 07 Nov 2026 11:00:00 +0000</pubDate>                                                                                                                                <updated>Mon, 16 Nov 2026 14:43:41 +0000</updated>
                                                                                                                                            <category><![CDATA[Flu]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                    <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                                                                <author><![CDATA[ hannah.osborne@futurenet.com (Hannah Osborne) ]]></author>                    <dc:creator><![CDATA[ Hannah Osborne ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/PRdNayA6u3CRaWy5ULdNAg-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Hannah Osborne is the planet Earth and animals editor at Live Science. Prior to Live Science, she worked for several years at Newsweek as the science editor. Before this she was science editor at International Business Times U.K. Hannah holds a master&#039;s in journalism from Goldsmith&#039;s, University of London.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/dks7EkpsPFJY5VeHuQQbBK-1920-80.jpg">
                                                            <media:credit><![CDATA[Madi Allen]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[After almost dying from flu aged 12, Allen graduated and is now training to be a respiratory therapist. ]]></media:description>                                                            <media:text><![CDATA[A blond woman holds up a soccer jersey while wearing a black graduation cap]]></media:text>
                                <media:title type="plain"><![CDATA[A blond woman holds up a soccer jersey while wearing a black graduation cap]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/dks7EkpsPFJY5VeHuQQbBK-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>In February 2011, Madi Allen, a healthy 12-year-old in Central Illinois, who loved playing sports, almost died from the flu. The influenza B virus resulted in her developing necrotizing pneumonia, where the infection triggers inflammation that destroys the tissue of the lungs, methicillin-resistant <em>Staphylococcus aureus</em> (MRSA), and her kidneys shut down. She was put on life support and dialysis, and was intubated for five weeks. She spent another two months in hospital and a decade recovering from the damage caused. </p><p>Allen, now 28, shared her experience with Live Science.  </p><p>I was 12 years old when it all started. I was just a normal seventh grader, I played soccer and basketball. I didn't really have any health issues beforehand — just sports-induced asthma. </p><p>That weekend, I started to feel a little sick, but nothing too bad. My mom kept giving me over-the-counter medicine and it would work for a bit, then once it wore off, it would get really bad. I'd planned to go to one of my friend's birthday parties then spend the night with my best friend. I went to the party, but I texted my mom saying I should come home because I really wasn't feeling well, which was not usual for me at all. That night I asked my mom to sleep with me because I just felt terrible. </p><p>That was Saturday. By Sunday night, the only position that I could get comfortable in was my mom holding me like a baby. My mom just held me all weekend. My whole body just hurt and I started feeling like I couldn't breathe properly. That got way worse Monday morning. </p><p>We were waiting for my pediatrician to open up and my mom suggested taking a shower, saying, "Maybe that will help you feel a bit better before we go to the doctor." She had to help me take a shower because I was so weak, I couldn't stand by myself. She stepped away for a second just to grab a towel and said that when she came back, my lips were turning gray and my eyes were starting to look sunken in. She knew that something was not right so she called my dad, who was at the grocery store, and told him to just leave everything, that we need to get to the hospital. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1600px;"><p class="vanilla-image-block" style="padding-top:75.00%;"><img id="ytWcBezoayVo8N7Cc3us2j" name="IMG_4475" alt="A close up of a woman in a hospital bed breathing from a tube" src="https://cdn.mos.cms.futurecdn.net/ytWcBezoayVo8N7Cc3us2j-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1600" height="1200" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ytWcBezoayVo8N7Cc3us2j-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Allen was put on life support and had to be intubated for five weeks after getting sick with flu.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Madi Allen)</span></figcaption></figure><p>Our local hospital is just a small rural hospital — everybody gets transferred out. They diagnosed me with double pneumonia and then sent me to a different hospital 30 minutes away that specialized more in kids. </p><p>My dad rode with me in the ambulance while my mom went home and grabbed a few things — she thought we'd just be there for a few days. By the time we got to the second hospital, I was in respiratory distress. They wanted to intubate me straight away but were waiting until my mom got there so she could talk to me — my dad did the best he could, but my dad didn't know how to calm me down. </p><p>I don't think the doctors even told me that they were putting me to sleep. My mom had to be the one to tell me. I remember being very scared. They put this mask on my face for the BiPAP [bilevel positive airway pressure machine, which delivers pressurized air to a patient] and I felt like that was suffocating me. It didn't feel like it was helping at all, which, I guess, at that point, it wasn't. They were just trying everything they could. I was begging them to take it off of me, crying and just saying, "one minute, just take it off for one minute." </p><p>Finally my mom tried to calm me down and she's like, "They're gonna have to put you to sleep now." I remember her telling me, "You're just gonna go to sleep for like a couple of hours and then you're gonna wake up and you're gonna feel a lot better."</p><p>My mom had to leave the room while they were doing that. As she was walking out the door, the last thing I said was "Mom" and then I put my hands in a heart shape. That was the last thing I did and the last time my mom heard my voice for five weeks. </p><p>After I was intubated, things got worse. I had to be put on life support so needed to be moved to a bigger hospital in St. Louis, Missouri. The flight team came to evaluate me and they later told me they didn't think they were ever going to get me to Saint Louis. They thought I wasn't going to make the trip. But they said my mom was begging them to help me, everyone in my family was begging them, so they did everything they could to get me on the helicopter. They worked on me for several hours — every time they tried to move me something would go wrong — but eventually they got me there. </p><p>The doctors had to call my parents to get permission to do surgery and put me on life support. My mom said that every time she heard my dad's phone ring, she thought they were calling to tell them that I didn't make it. They were told twice that it was more than likely I was going to pass than make it. They were trying to prepare my parents that I wasn't going to make it. </p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:416px;"><p class="vanilla-image-block" style="padding-top:131.25%;"><img id="ueTCGCwFid2UtWPQN7HXzZ" name="IMG_4477" alt="A close up of a girl with freckles and brown hair" src="https://cdn.mos.cms.futurecdn.net/ueTCGCwFid2UtWPQN7HXzZ-1920-80.jpg" mos="" align="left" fullscreen="1" width="416" height="546" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ueTCGCwFid2UtWPQN7HXzZ-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">After getting out of hospital, it took years for Allen to recover, eventually having part of her lung removed that had been badly damaged by the virus.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Madi Allen)</span></figcaption></figure><p>I woke up five weeks later, and it was very confusing. Everybody was told if I asked what day it was, just to tell me the day of the week. When someone accidentally told me the date, I started crying because my aunt was supposed to be getting married a few weeks later and I was worried about being at her wedding. My mom wasn't there, so my dad had to calm me down and then he told me the wedding had been pushed to October so I could be there. </p><p>The second thing I was worried about was that I was supposed to take a test on the Constitution and that I'd missed it. I ended up taking it in the hospital. I was there for 93 days. I got out the very last week of school, so I got to go in on the last day of school and surprise my classmates and my teachers. </p><p>That summer, I didn't really do anything besides go to doctor's appointments. I was doing physical therapy, occupational therapy and speech therapy — literally all my time was spent at the hospital in therapy. I'd missed three months of school, but I got to start eighth grade with all my friends, and I ended up playing basketball again. But the next several years was a lot of hard work of trying to get back to my normal. </p><p>It probably took the rest of junior high and high school to get back to how I would have been before. It was a very long process and during that time I got sick a lot, so I ended up back in the hospital several times. And it was hard going through that as a teenager — I felt like everybody else is living their normal life, and I felt like I missed out on a lot. Looking back now, I still feel like I did miss out a lot. But I think we made the best of the circumstances.</p><p>During COVID, when I was 22, I kept getting sick, and the doctors finally told me that part of my lung was so damaged from the flu it was causing infections, so they gave me an option of getting part of my lung removed. It was a major surgery, but I did it and that was probably the best decision I ever made, because it's been five years and I have not been in the hospital once. </p><p>I moved to Florida about three years ago, and I started working as a medical assistant in a pulmonary clinic. This semester I got accepted into respiratory therapy school, so for the next two years, I'm going to be in school for respiratory therapy. It's kind of a full circle moment, to come back into the medical field, because there was a point in my life where everybody was asking me, "Oh, do you want to be a doctor? Do you want to be a nurse?" And I'm like, "Absolutely not." I was still so sick that I was there all the time. I never wanted to be there. </p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health">'Now you actually have a blood test': Psychiatry's bible, the DSM, is getting upgraded to include biological markers. A psychiatrist explains what that means for mental health.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/trumps-childhood-vaccine-order-will-threaten-childrens-safety-even-if-it-doesnt-directly-change-policy">Trump's childhood vaccine order will threaten children's safety, even if it doesn't directly change policy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/infectious-diseases-will-seed-new-ground-as-the-planet-warms-heres-where-theyll-spread">Infectious diseases will seed new ground as the planet warms — here's where they'll spread</a></li></ul></p></div></div><p>I went to college and I got a degree in criminal justice, but I never really knew what I wanted to do. I ended up getting a job at our local hospital — that first hospital that I went to. Every time they put me in the ER I just loved being there. That job made me realize that this is what I wanted to do.</p><p>When people hear my story, they don't realize that if I don't tell the end — after the hospital until now — they don't realize that my life didn't go back to normal after. It's taken 10 years. And it's hard. Some of the other family members that we've gotten to know through Families Fighting Flu, it's difficult listening to their stories. Sometimes I feel like I have this survivor's guilt. Their stories sound exactly like mine — but their kids didn't make it. </p><p>Before I got sick I got the flu shot every year, but that year we just got busy and it got put on the back burner. Since getting sick I have always made it a priority to get the flu shot every year. I know it is not a guarantee that I will never get the flu again — but hopefully it will reduce the chances of it ever getting that bad again. </p><p><em>With thanks to </em><a href="https://familiesfightingflu.org/" target="_blank"><em>Families Fighting Flu</em></a><em>, a non-profit organization that promotes flu vaccination and raises awareness of the severity of the infectious disease through families that have been affected.</em></p><p><u></u><a href="https://www.livescience.com/opinion"><u>Opinion</u></a><em> on Live Science gives you insight on the most important issues in science that affect you and the world around you today, written by experts and leading scientists in their field.</em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'Life is too brief to leave this planet': Live Science readers share whether they'd go to Mars, despite health risks ]]></title>
                                                                                                <dc:content><![CDATA[ <p>For centuries, <a href="https://www.livescience.com/34033-mars-myths-misconceptions-quiz.html"><u>Mars</u></a> has been seen as a potential place for future human settlements. But long-duration space travel comes with <a href="https://www.livescience.com/health/ways-the-body-changes-in-space"><u>serious risks to astronauts' health</u></a>, including those resulting from  cosmic radiation and <a href="https://www.livescience.com/astronauts-bone-loss-space"><u>the effects of microgravity</u></a>. </p><p><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0357485&amp;utm_campaign=2026-pr&amp;utm_source=pr&amp;utm_medium=eurekalert&amp;utm_content=title-release" target="_blank"><u>A new study</u></a> found that rats that were exposed to radiation similar to what astronauts might encounter during a Mars mission <a href="https://www.livescience.com/space/space-exploration/cosmic-rays-could-scar-the-heart-raising-risks-for-mars-bound-astronauts-rat-study-hints"><u>developed more scar tissue around their hearts' small blood vessels</u></a> compared with a control group. Although the findings haven't been validated in humans, the results contribute to <a href="https://www.livescience.com/health/reproductive-health/spaceflight-may-harm-the-reproductive-system-of-astronauts-kids-and-grandkids-early-mouse-study-suggests"><u>growing concerns about the potential effects</u></a> of long-haul space missions on astronauts' health. </p><p>Given these new findings, Live Science asked its readers <a href="https://www.livescience.com/space/mars/would-you-risk-your-health-to-visit-mars"><u>whether they'd travel to the Red Planet</u></a>, despite these potential health risks. Over 240 readers weighed in, with 65% picking "No, I don't think the risks are worth it." </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xk9ZNW"></div>                            </div>                            <script src="https://kwizly.com/embed/Xk9ZNW.js" async=""></script><p>Interestingly enough, the comments reflect a slightly different trend. One reader wrote, "Any pioneers who travel to Mars will be facing the prospect of death and never coming back. Even if they make it back, there are any number of health issues that could come up. These risks have not stopped people from exploring throughout human history. The bigger question is who to send?" </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/chinese-lander-reveals-giant-cavity-of-radiation-between-earth-and-the-moon-and-it-could-change-how-lunar-exploration-is-done">Chinese lander reveals giant 'cavity' of radiation between Earth and the moon — and it could change how lunar exploration is done</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/everything-we-know-about-space-travel-is-going-to-change-within-a-decade-the-fusion-breakthrough-that-could-unlock-a-path-to-the-stars">'Everything we know about space travel is going to change within a decade': The fusion breakthrough that could unlock a path to the stars</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/scientists-finally-know-why-astronauts-struggle-to-poop-in-space-and-reveal-a-hidden-risk-of-long-haul-spaceflight">Scientists finally know why astronauts struggle to poop in space — and reveal a hidden risk of long-haul spaceflight</a></li></ul></p></div></div><p>Other commenters echoed this sentiment, with another reader posting, "Explorers in the past have always been exposed to unusual risks; without the risk takers we would still believe <a href="https://www.livescience.com/what-if-flat-earth.html"><u>the world is flat</u></a>." </p><p>Beyond the feelings that Mars will be explored anyway, despite the health risks, other commenters highlighted the cost of these missions, with one reader stating, "Sending flesh water balloons to Mars is ridiculous. For the cost of one human on Mars, we could literally probe the entire solar system and map/sample/rove every planet and every major Moon." </p><p>Others highlighted the mental and emotional cost of a trip to Mars. "As a devoted sci-fi fan for decades, I always wished I could go into space," another reader noted. "Now that I am 77 years old, I realize I would miss the outdoors. The wind and trees, the birdsong and sweet grass under my feet would be a devastating loss. Let the brave explorers go instead. Life is too brief to leave this planet for the uncertainty and dangers of space travel." </p><p>Do you agree with these readers? Let us know your thoughts in the comments!</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/space/mars/life-is-too-brief-to-leave-this-planet-live-science-readers-share-whether-theyd-go-to-mars-despite-health-risks</link>
                                                                            <description>
                            <![CDATA[ Live Science readers respond to a recent poll about whether they'd visit the Red Planet even with potential health risks. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">AGrr9D6CUb6G2TG9wxo8be</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/p4Yy8v7ayVqUckxypoFv3A-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 06 Nov 2026 21:46:33 +0000</pubDate>                                                                                                                                <updated>Fri, 06 Nov 2026 23:16:06 +0000</updated>
                                                                                                                                            <category><![CDATA[Mars]]></category>
                                                    <category><![CDATA[Space]]></category>
                                                    <category><![CDATA[Astronomy]]></category>
                                                    <category><![CDATA[Planets]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kenna Hughes-Castleberry ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mgEvZdqXoF3NyR25Gj96va-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/p4Yy8v7ayVqUckxypoFv3A-1920-80.jpg">
                                                            <media:credit><![CDATA[VICTOR HABBICK VISIONS/SCIENCE PHOTO LIBRARY via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Live Science readers share whether they&amp;#39;d visit Mars, even with potential health risks.]]></media:description>                                                            <media:text><![CDATA[An illustration of a cartoon person in a spacesuit on Mars]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a cartoon person in a spacesuit on Mars]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/p4Yy8v7ayVqUckxypoFv3A-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>For centuries, <a href="https://www.livescience.com/34033-mars-myths-misconceptions-quiz.html"><u>Mars</u></a> has been seen as a potential place for future human settlements. But long-duration space travel comes with <a href="https://www.livescience.com/health/ways-the-body-changes-in-space"><u>serious risks to astronauts' health</u></a>, including those resulting from  cosmic radiation and <a href="https://www.livescience.com/astronauts-bone-loss-space"><u>the effects of microgravity</u></a>. </p><p><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0357485&amp;utm_campaign=2026-pr&amp;utm_source=pr&amp;utm_medium=eurekalert&amp;utm_content=title-release" target="_blank"><u>A new study</u></a> found that rats that were exposed to radiation similar to what astronauts might encounter during a Mars mission <a href="https://www.livescience.com/space/space-exploration/cosmic-rays-could-scar-the-heart-raising-risks-for-mars-bound-astronauts-rat-study-hints"><u>developed more scar tissue around their hearts' small blood vessels</u></a> compared with a control group. Although the findings haven't been validated in humans, the results contribute to <a href="https://www.livescience.com/health/reproductive-health/spaceflight-may-harm-the-reproductive-system-of-astronauts-kids-and-grandkids-early-mouse-study-suggests"><u>growing concerns about the potential effects</u></a> of long-haul space missions on astronauts' health. </p><p>Given these new findings, Live Science asked its readers <a href="https://www.livescience.com/space/mars/would-you-risk-your-health-to-visit-mars"><u>whether they'd travel to the Red Planet</u></a>, despite these potential health risks. Over 240 readers weighed in, with 65% picking "No, I don't think the risks are worth it." </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xk9ZNW"></div>                            </div>                            <script src="https://kwizly.com/embed/Xk9ZNW.js" async=""></script><p>Interestingly enough, the comments reflect a slightly different trend. One reader wrote, "Any pioneers who travel to Mars will be facing the prospect of death and never coming back. Even if they make it back, there are any number of health issues that could come up. These risks have not stopped people from exploring throughout human history. The bigger question is who to send?" </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/chinese-lander-reveals-giant-cavity-of-radiation-between-earth-and-the-moon-and-it-could-change-how-lunar-exploration-is-done">Chinese lander reveals giant 'cavity' of radiation between Earth and the moon — and it could change how lunar exploration is done</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/everything-we-know-about-space-travel-is-going-to-change-within-a-decade-the-fusion-breakthrough-that-could-unlock-a-path-to-the-stars">'Everything we know about space travel is going to change within a decade': The fusion breakthrough that could unlock a path to the stars</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/scientists-finally-know-why-astronauts-struggle-to-poop-in-space-and-reveal-a-hidden-risk-of-long-haul-spaceflight">Scientists finally know why astronauts struggle to poop in space — and reveal a hidden risk of long-haul spaceflight</a></li></ul></p></div></div><p>Other commenters echoed this sentiment, with another reader posting, "Explorers in the past have always been exposed to unusual risks; without the risk takers we would still believe <a href="https://www.livescience.com/what-if-flat-earth.html"><u>the world is flat</u></a>." </p><p>Beyond the feelings that Mars will be explored anyway, despite the health risks, other commenters highlighted the cost of these missions, with one reader stating, "Sending flesh water balloons to Mars is ridiculous. For the cost of one human on Mars, we could literally probe the entire solar system and map/sample/rove every planet and every major Moon." </p><p>Others highlighted the mental and emotional cost of a trip to Mars. "As a devoted sci-fi fan for decades, I always wished I could go into space," another reader noted. "Now that I am 77 years old, I realize I would miss the outdoors. The wind and trees, the birdsong and sweet grass under my feet would be a devastating loss. Let the brave explorers go instead. Life is too brief to leave this planet for the uncertainty and dangers of space travel." </p><p>Do you agree with these readers? Let us know your thoughts in the comments!</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 50% of long COVID patients show improvement in 3 years — but the condition tends to linger in those with this subtype ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Symptoms of long COVID ease in half of patients within three years of the infection that kicked off their illness. </p><p>That's the primary conclusion of a new study that tracked over 1,000 patients with long COVID, a chronic condition that can emerge after an infection with the SARS-CoV-2 virus. Among the patients, the chance of improvement varied sharply depending on how the condition affected their bodily systems.</p><p>In the study, published Tuesday (Nov. 3) in the journal <a href="https://www.acpjournals.org/doi/10.7326/ANNALS-25-05275" target="_blank"><u>Annals of Internal</u><u><em> </em></u><u>Medicine</u></a>, roughly 60% of patients whose predominant symptoms were changes to their ability to taste or smell had significantly improved three years after their first positive test. But less than 20% of those with a multisystem presentation had improved in that time frame. </p><p>This latter group had symptoms that affected their cardiac, nervous and gastrointestinal systems, among others. An expert told Live Science that the condition resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which often arises after an infection and similarly impacts a wide range of bodily systems. </p><p>The new study's findings could help direct the structure of future clinical trials of treatments for long COVID, experts said. </p><h2 id="one-disease-many-symptoms">One disease, many symptoms</h2><p>The patients in the study were enrolled in the long-term <a href="https://recovercovid.org/news/recover-adult-study-protocol-available" target="_blank"><u>RECOVER Adult Study</u></a>. Funded by the National Institutes of Health, the project has recruited thousands of adults across the United States who previously tested positive for COVID-19. </p><p>Researchers scored patients based on how they were affected by a range of symptoms, including fatigue, brain fog, shortness of breath and heart palpitations. The study included patients who scored more than 10 points on a 30-point scale — called the 2024 LC Research Index (LCRI) — which attempted to capture these different symptom combinations. </p><p>Nearly 1,020 patients met this requirement and were tracked over time; they had in-person appointments and filled out symptom surveys every three months. Scientists marked patients as "improved" once they recorded LCRI scores of 10 or less at two consecutive visits. They found that 36% of the participants had improved two years after their inciting COVID-19 infection, and that figure rose to 50% after three years. </p><p>LCRIs hit zero for 26% of the participants after three years, meaning all of their symptoms were gone at the time of the survey. </p><p>Reeder said he was careful to avoid describing the participants as "recovered." This decision was influenced by input from the long COVID community to the RECOVER Adult Study, he said. They highlighted that their symptoms can wax and wane, whereas "recovery" implies a permanent resolution. The new study didn't capture, for example, whether individual patients who recorded meaningful improvement later relapsed. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="QFgieVpUJqjLuQoMobnRXS" name="GettyImages-1677819202-covid" alt="An illustration of a spiky spherical virus." src="https://cdn.mos.cms.futurecdn.net/QFgieVpUJqjLuQoMobnRXS-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/QFgieVpUJqjLuQoMobnRXS-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The researchers analyzed which SARS-CoV-2 strain was associated with the most long COVID cases, controlling for patient vaccination status. </span><span class="credit" itemprop="copyrightHolder">(Image credit: koto_feja via Getty Images)</span></figcaption></figure><p>Some patients' journeys were far less straightforward than the top-line data might suggest. Although men and women improved at similar rates, adults under 46 were more likely to improve than older participants were. Patients affected by the <a href="https://www.livescience.com/coronavirus-variants-after-omicron-2022"><u>Omicron variants</u></a> of SARS-CoV-2, which emerged in 2021 and quickly became the dominant strain of the virus, were more likely to improve than those infected with earlier strains. </p><h2 id="me-cfs-and-long-covid">ME/CFS and long COVID</h2><p>Some of the starkest differences in improvement rates were seen between patients with different symptoms. </p><p><a href="https://jamanetwork.com/journals/jama/article-abstract/2828329" target="_blank"><u>In a previous study</u></a>, RECOVER researchers had grouped participants into five subtypes, using an algorithm to connect patients with similar predominant symptoms: </p><ul><li>Loss of smell or taste</li><li>Chronic cough</li><li>Brain fog</li><li>Heart palpitations</li><li>Symptoms affecting multiple bodily systems</li></ul><p>In the new study, patients in the last three groups were less likely to get better within three years. The final group's rate was particularly low, at just 19%. </p><p><a href="https://cfc.charite.de/en/metas/person/person/address_detail/prof_dr_med_carmen_scheibenbogen-1/" target="_blank"><u>Dr. Carmen Scheibenbogen</u></a>, an immunologist at Charité University Medicine Berlin, said these patients' progress resembles that of people with ME/CFS.</p><p>"It looks as if at least a major subgroup is suffering from ME-CFS," Scheibenbogen said, noting that COVID-19 may have triggered their condition. "This is a disease which is triggered by different infections, but in the end, the disease [itself] is very similar," she said.</p><p>Like long COVID, ME/CFS can affect a wide array of bodily systems, and it <a href="https://www.livescience.com/health/viruses-infections-disease/it-took-the-rug-right-out-from-under-my-life-milestone-mecfs-study-begins-to-explain-disease-but-will-it-lead-to-treatments"><u>remains poorly understood despite recent advances in research</u></a>. </p><p>The team's new findings highlight the need for clinical trials to test possible treatments for long COVID. Both Scheibenbogen and study co-author <a href="https://biostatistics.massgeneral.org/faculty/harrison-reeder-phd/" target="_blank"><u>Harrison Reeder</u></a>, a biostatistician at Massachusetts General Hospital, said these subtypes would be important to consider in the design of these potential trials. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/coronavirus/1-in-22-covid-survivors-develop-debilitating-chronic-syndrome">1 in 22 COVID survivors develop debilitating chronic syndrome</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/coronavirus/brain-fog-in-long-covid-may-be-linked-to-blood-clots">Brain fog in long COVID may be linked to blood clots</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/severe-covid-19-may-wake-up-dormant-viruses-and-lead-to-lasting-physical-disability-study-finds">Severe COVID-19 may wake up dormant viruses and lead to lasting physical disability, study finds</a></li></ul></p></div></div><p>The multisystem subgroup, Reeder said, "might be a group where an effective intervention can make a bigger difference than people who stand to potentially have a higher chance of improvement regardless."</p><p>Future work would need to further scientists' understanding of people affected by long COVID at the level of their genes and proteins, both scientists said. </p><p>"There's a lot of work to do in RECOVER and in the world of long COVID research," Harrison said. "There's a lot of opportunity."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/viruses-infections-disease/50-percent-of-long-covid-patients-show-improvement-in-3-years-but-the-condition-tends-to-linger-in-those-with-this-subtype</link>
                                                                            <description>
                            <![CDATA[ About half of people with long COVID see meaningful improvement in their symptoms after three years, a new study found. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">W9RcjM2khmGYJDmZeZXVk8</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/xvqAFjFJch7ucaj2gissWa-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 06 Nov 2026 17:00:00 +0000</pubDate>                                                                                                                                <updated>Fri, 06 Nov 2026 23:12:37 +0000</updated>
                                                                                                                                            <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ RJ Mackenzie ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/8HL7ZNmUgBBqZ5oMPxHuE4-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/xvqAFjFJch7ucaj2gissWa-1920-80.jpg">
                                                            <media:credit><![CDATA[Justin Paget via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Long COVID patients whose condition involves many bodily systems are more likely to still have symptoms three years out.]]></media:description>                                                            <media:text><![CDATA[A woman sits on a bed in a bedroom.]]></media:text>
                                <media:title type="plain"><![CDATA[A woman sits on a bed in a bedroom.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/xvqAFjFJch7ucaj2gissWa-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Symptoms of long COVID ease in half of patients within three years of the infection that kicked off their illness. </p><p>That's the primary conclusion of a new study that tracked over 1,000 patients with long COVID, a chronic condition that can emerge after an infection with the SARS-CoV-2 virus. Among the patients, the chance of improvement varied sharply depending on how the condition affected their bodily systems.</p><p>In the study, published Tuesday (Nov. 3) in the journal <a href="https://www.acpjournals.org/doi/10.7326/ANNALS-25-05275" target="_blank"><u>Annals of Internal</u><u><em> </em></u><u>Medicine</u></a>, roughly 60% of patients whose predominant symptoms were changes to their ability to taste or smell had significantly improved three years after their first positive test. But less than 20% of those with a multisystem presentation had improved in that time frame. </p><p>This latter group had symptoms that affected their cardiac, nervous and gastrointestinal systems, among others. An expert told Live Science that the condition resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which often arises after an infection and similarly impacts a wide range of bodily systems. </p><p>The new study's findings could help direct the structure of future clinical trials of treatments for long COVID, experts said. </p><h2 id="one-disease-many-symptoms">One disease, many symptoms</h2><p>The patients in the study were enrolled in the long-term <a href="https://recovercovid.org/news/recover-adult-study-protocol-available" target="_blank"><u>RECOVER Adult Study</u></a>. Funded by the National Institutes of Health, the project has recruited thousands of adults across the United States who previously tested positive for COVID-19. </p><p>Researchers scored patients based on how they were affected by a range of symptoms, including fatigue, brain fog, shortness of breath and heart palpitations. The study included patients who scored more than 10 points on a 30-point scale — called the 2024 LC Research Index (LCRI) — which attempted to capture these different symptom combinations. </p><p>Nearly 1,020 patients met this requirement and were tracked over time; they had in-person appointments and filled out symptom surveys every three months. Scientists marked patients as "improved" once they recorded LCRI scores of 10 or less at two consecutive visits. They found that 36% of the participants had improved two years after their inciting COVID-19 infection, and that figure rose to 50% after three years. </p><p>LCRIs hit zero for 26% of the participants after three years, meaning all of their symptoms were gone at the time of the survey. </p><p>Reeder said he was careful to avoid describing the participants as "recovered." This decision was influenced by input from the long COVID community to the RECOVER Adult Study, he said. They highlighted that their symptoms can wax and wane, whereas "recovery" implies a permanent resolution. The new study didn't capture, for example, whether individual patients who recorded meaningful improvement later relapsed. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="QFgieVpUJqjLuQoMobnRXS" name="GettyImages-1677819202-covid" alt="An illustration of a spiky spherical virus." src="https://cdn.mos.cms.futurecdn.net/QFgieVpUJqjLuQoMobnRXS-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/QFgieVpUJqjLuQoMobnRXS-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The researchers analyzed which SARS-CoV-2 strain was associated with the most long COVID cases, controlling for patient vaccination status. </span><span class="credit" itemprop="copyrightHolder">(Image credit: koto_feja via Getty Images)</span></figcaption></figure><p>Some patients' journeys were far less straightforward than the top-line data might suggest. Although men and women improved at similar rates, adults under 46 were more likely to improve than older participants were. Patients affected by the <a href="https://www.livescience.com/coronavirus-variants-after-omicron-2022"><u>Omicron variants</u></a> of SARS-CoV-2, which emerged in 2021 and quickly became the dominant strain of the virus, were more likely to improve than those infected with earlier strains. </p><h2 id="me-cfs-and-long-covid">ME/CFS and long COVID</h2><p>Some of the starkest differences in improvement rates were seen between patients with different symptoms. </p><p><a href="https://jamanetwork.com/journals/jama/article-abstract/2828329" target="_blank"><u>In a previous study</u></a>, RECOVER researchers had grouped participants into five subtypes, using an algorithm to connect patients with similar predominant symptoms: </p><ul><li>Loss of smell or taste</li><li>Chronic cough</li><li>Brain fog</li><li>Heart palpitations</li><li>Symptoms affecting multiple bodily systems</li></ul><p>In the new study, patients in the last three groups were less likely to get better within three years. The final group's rate was particularly low, at just 19%. </p><p><a href="https://cfc.charite.de/en/metas/person/person/address_detail/prof_dr_med_carmen_scheibenbogen-1/" target="_blank"><u>Dr. Carmen Scheibenbogen</u></a>, an immunologist at Charité University Medicine Berlin, said these patients' progress resembles that of people with ME/CFS.</p><p>"It looks as if at least a major subgroup is suffering from ME-CFS," Scheibenbogen said, noting that COVID-19 may have triggered their condition. "This is a disease which is triggered by different infections, but in the end, the disease [itself] is very similar," she said.</p><p>Like long COVID, ME/CFS can affect a wide array of bodily systems, and it <a href="https://www.livescience.com/health/viruses-infections-disease/it-took-the-rug-right-out-from-under-my-life-milestone-mecfs-study-begins-to-explain-disease-but-will-it-lead-to-treatments"><u>remains poorly understood despite recent advances in research</u></a>. </p><p>The team's new findings highlight the need for clinical trials to test possible treatments for long COVID. Both Scheibenbogen and study co-author <a href="https://biostatistics.massgeneral.org/faculty/harrison-reeder-phd/" target="_blank"><u>Harrison Reeder</u></a>, a biostatistician at Massachusetts General Hospital, said these subtypes would be important to consider in the design of these potential trials. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/coronavirus/1-in-22-covid-survivors-develop-debilitating-chronic-syndrome">1 in 22 COVID survivors develop debilitating chronic syndrome</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/coronavirus/brain-fog-in-long-covid-may-be-linked-to-blood-clots">Brain fog in long COVID may be linked to blood clots</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/severe-covid-19-may-wake-up-dormant-viruses-and-lead-to-lasting-physical-disability-study-finds">Severe COVID-19 may wake up dormant viruses and lead to lasting physical disability, study finds</a></li></ul></p></div></div><p>The multisystem subgroup, Reeder said, "might be a group where an effective intervention can make a bigger difference than people who stand to potentially have a higher chance of improvement regardless."</p><p>Future work would need to further scientists' understanding of people affected by long COVID at the level of their genes and proteins, both scientists said. </p><p>"There's a lot of work to do in RECOVER and in the world of long COVID research," Harrison said. "There's a lot of opportunity."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ One-third of babies diagnosed with peanut allergy don't actually have one, study hints ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A peanut allergy diagnosis in infancy can mean years of avoiding the food or undergoing treatments to build tolerance. But a recent study suggests that more than one-third of babies thought to have the allergy may stop reacting badly to peanuts within months of that diagnosis.</p><p>In an analysis published in <a href="https://www.jaci-inpractice.org/article/S2213-2198(26)00776-2/abstract" target="_blank"><u>The Journal of Allergy and Clinical Immunology: In Practice</u></a>, researchers conducted supervised "food challenges" with infants diagnosed with a peanut allergy. These challenges involved giving the babies increasing amounts of peanut protein, with the intention of confirming whether they indeed had an allergy. </p><p>The team found that more than 1 in 3 infants who underwent the food challenge tolerated the peanut protein, meaning they didn't experience symptoms of an allergic reaction.</p><p>"This rate is much higher than we thought," study co-author <a href="https://www.mcri.edu.au/researcher-details/tim-brettig" target="_blank"><u>Dr. Timothy Brettig</u></a>, a pediatric allergist at the National Allergy Centre of Excellence in Australia, told Live Science.</p><p>Between April 2024 and October 2025, Brettig and colleagues retroactively reviewed the medical records of 1,275 infants who had been referred to Australian public hospitals after having a reaction to peanuts before their first birthday. These babies had first been assessed by allergy specialists at a median of 10 months of age. </p><p>For their initial diagnosis, the babies had to have a history of an allergic reaction to peanuts and  show evidence of peanut sensitization on an allergy test. These tests included a skin-prick test, in which peanut extract is placed on the skin before it's lightly pricked, to check for a local reaction; and blood tests that detect <a href="https://www.livescience.com/antibodies.html"><u>antibodies</u></a> against peanut proteins.</p><p>"Children under 1 year of age are an interesting group, as their immune system is still in rapid development and existing allergy tests may not reflect their allergic status well," said <a href="https://www.kcl.ac.uk/people/alexandra-santos" target="_blank"><u>Dr. Alexandra Santos</u></a>, a professor of pediatric allergy at King's College London who was not involved in the study. While these tests can hint that a child is <a href="https://www.questdiagnostics.com/patients/blog/articles/clearing-up-the-confusion-around-food-allergy--intolerance--and-sensitivity" target="_blank"><u>sensitized to certain foods</u></a>, they don't necessarily confirm that a baby will have an allergic reaction upon eating said food; the tests can also give false positives.</p><p>Of the 1,275 infants, 778 later underwent a food challenge roughly six months after their first recorded allergic reaction; at that point, their median age was 13 months old. They were given up to seven gradually increasing doses of peanut protein, ranging from 15 to 1,300 milligrams. These doses were given at 15-minute intervals while medical staff monitored the children for signs of an allergic reaction. </p><p>Nearly 35% of the participants — 271 kids — completed the challenge without reacting. </p><p>"This is an excellent article," said <a href="https://profiles.utsouthwestern.edu/profile/108478/drew-bird.html" target="_blank"><u>Dr. Drew Bird</u></a>, a pediatric allergist at the University of Texas Southwestern Medical Center who was not involved in the study. "The take-home message is to strongly consider a supervised oral food challenge when an infant's peanut allergy diagnosis is uncertain."</p><p>Bird emphasized that these challenges should ideally be done before a child starts <a href="https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/the-current-state-of-oral-immunotherapy" target="_blank"><u>oral immunotherapy</u></a>, a treatment in which patients regularly consume carefully measured amounts of the food they are allergic to. The dose is gradually increased under medical supervision, with the goal of helping the patient tolerate greater amounts of the allergen and reducing the risk of reactions from accidental exposure. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="zoULmszvupK4t3NkaTLH8T" name="GettyImages-1368887252-peanuts" alt="A pile of tan peanuts." src="https://cdn.mos.cms.futurecdn.net/zoULmszvupK4t3NkaTLH8T-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/zoULmszvupK4t3NkaTLH8T-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">An incorrect diagnosis can prompt families to unnecessarily avoid exposing their children to peanuts. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Yevgen Romanenko via Getty Images)</span></figcaption></figure><p>The starting dose is often determined through a similar oral food challenge to the one used in this study, though. So in theory, that challenge would help reveal whether the child needs treatment in the first place. </p><p>Bird cautioned that food challenges should be performed by a board-certified allergist-immunologist and an experienced allergy team in a setting equipped to treat anaphylaxis — a severe, potentially life-threatening allergic reaction.</p><p>In this study, 507 infants reacted during the food challenge, and of those, 61 developed anaphylaxis and were treated with epinephrine (the hormone in EpiPens).</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/allergies/what-do-some-allergies-last-a-lifetime-newly-described-immune-cells-to-blame">Could allergies be 'deleted' someday?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-teenagers-hives-turned-out-to-be-caused-by-rare-water-allergy">Teenager's hives turned out to be caused by rare water allergy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/what-causes-allergies">What causes allergies?</a></li></ul></p></div></div><p>"In an ideal world, with infinite resources," Santos said, "all patients except for those with a history of severe reactions would have a food challenge for diagnosis."</p><p>Because that is not the case, the families of infants whose allergy diagnosis is uncertain may be advised to avoid peanut products while they await a formal food challenge, she noted. But in the interim, they may miss an opportunity to help the child develop tolerance and, in turn, increase the risk that their allergy will persist.</p><p>Food challenges should be prioritized for infants whose allergy diagnoses are uncertain, she said. This would include babies who have low levels of peanut-specific antibodies in their blood or who show only small welts on skin-prick tests.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/allergies/one-third-of-babies-diagnosed-with-peanut-allergy-dont-actually-have-one-study-hints</link>
                                                                            <description>
                            <![CDATA[ New findings suggest that "food challenges" can help prevent children from being saddled with unnecessary allergy diagnoses. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">KpTFkmpEayMB5riUkK46Wk</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/NZ6F3QzLMW2qgkHcZXyCmD-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 05 Nov 2026 11:30:00 +0000</pubDate>                                                                                                                                <updated>Thu, 05 Nov 2026 20:07:08 +0000</updated>
                                                                                                                                            <category><![CDATA[Allergies]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Anirban Mukhopadhyay ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/BC3R7bkLDPTT9zjuB89uHi-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/NZ6F3QzLMW2qgkHcZXyCmD-1920-80.jpg">
                                                            <media:credit><![CDATA[Hafiez Razali via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A study finds that, based on medical history and standard allergy tests alone, many babies thought to have peanut allergies may actually be misdiagnosed.]]></media:description>                                                            <media:text><![CDATA[A close up of a young child with peanut butter on their face.]]></media:text>
                                <media:title type="plain"><![CDATA[A close up of a young child with peanut butter on their face.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/NZ6F3QzLMW2qgkHcZXyCmD-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A peanut allergy diagnosis in infancy can mean years of avoiding the food or undergoing treatments to build tolerance. But a recent study suggests that more than one-third of babies thought to have the allergy may stop reacting badly to peanuts within months of that diagnosis.</p><p>In an analysis published in <a href="https://www.jaci-inpractice.org/article/S2213-2198(26)00776-2/abstract" target="_blank"><u>The Journal of Allergy and Clinical Immunology: In Practice</u></a>, researchers conducted supervised "food challenges" with infants diagnosed with a peanut allergy. These challenges involved giving the babies increasing amounts of peanut protein, with the intention of confirming whether they indeed had an allergy. </p><p>The team found that more than 1 in 3 infants who underwent the food challenge tolerated the peanut protein, meaning they didn't experience symptoms of an allergic reaction.</p><p>"This rate is much higher than we thought," study co-author <a href="https://www.mcri.edu.au/researcher-details/tim-brettig" target="_blank"><u>Dr. Timothy Brettig</u></a>, a pediatric allergist at the National Allergy Centre of Excellence in Australia, told Live Science.</p><p>Between April 2024 and October 2025, Brettig and colleagues retroactively reviewed the medical records of 1,275 infants who had been referred to Australian public hospitals after having a reaction to peanuts before their first birthday. These babies had first been assessed by allergy specialists at a median of 10 months of age. </p><p>For their initial diagnosis, the babies had to have a history of an allergic reaction to peanuts and  show evidence of peanut sensitization on an allergy test. These tests included a skin-prick test, in which peanut extract is placed on the skin before it's lightly pricked, to check for a local reaction; and blood tests that detect <a href="https://www.livescience.com/antibodies.html"><u>antibodies</u></a> against peanut proteins.</p><p>"Children under 1 year of age are an interesting group, as their immune system is still in rapid development and existing allergy tests may not reflect their allergic status well," said <a href="https://www.kcl.ac.uk/people/alexandra-santos" target="_blank"><u>Dr. Alexandra Santos</u></a>, a professor of pediatric allergy at King's College London who was not involved in the study. While these tests can hint that a child is <a href="https://www.questdiagnostics.com/patients/blog/articles/clearing-up-the-confusion-around-food-allergy--intolerance--and-sensitivity" target="_blank"><u>sensitized to certain foods</u></a>, they don't necessarily confirm that a baby will have an allergic reaction upon eating said food; the tests can also give false positives.</p><p>Of the 1,275 infants, 778 later underwent a food challenge roughly six months after their first recorded allergic reaction; at that point, their median age was 13 months old. They were given up to seven gradually increasing doses of peanut protein, ranging from 15 to 1,300 milligrams. These doses were given at 15-minute intervals while medical staff monitored the children for signs of an allergic reaction. </p><p>Nearly 35% of the participants — 271 kids — completed the challenge without reacting. </p><p>"This is an excellent article," said <a href="https://profiles.utsouthwestern.edu/profile/108478/drew-bird.html" target="_blank"><u>Dr. Drew Bird</u></a>, a pediatric allergist at the University of Texas Southwestern Medical Center who was not involved in the study. "The take-home message is to strongly consider a supervised oral food challenge when an infant's peanut allergy diagnosis is uncertain."</p><p>Bird emphasized that these challenges should ideally be done before a child starts <a href="https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/the-current-state-of-oral-immunotherapy" target="_blank"><u>oral immunotherapy</u></a>, a treatment in which patients regularly consume carefully measured amounts of the food they are allergic to. The dose is gradually increased under medical supervision, with the goal of helping the patient tolerate greater amounts of the allergen and reducing the risk of reactions from accidental exposure. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="zoULmszvupK4t3NkaTLH8T" name="GettyImages-1368887252-peanuts" alt="A pile of tan peanuts." src="https://cdn.mos.cms.futurecdn.net/zoULmszvupK4t3NkaTLH8T-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/zoULmszvupK4t3NkaTLH8T-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">An incorrect diagnosis can prompt families to unnecessarily avoid exposing their children to peanuts. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Yevgen Romanenko via Getty Images)</span></figcaption></figure><p>The starting dose is often determined through a similar oral food challenge to the one used in this study, though. So in theory, that challenge would help reveal whether the child needs treatment in the first place. </p><p>Bird cautioned that food challenges should be performed by a board-certified allergist-immunologist and an experienced allergy team in a setting equipped to treat anaphylaxis — a severe, potentially life-threatening allergic reaction.</p><p>In this study, 507 infants reacted during the food challenge, and of those, 61 developed anaphylaxis and were treated with epinephrine (the hormone in EpiPens).</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/allergies/what-do-some-allergies-last-a-lifetime-newly-described-immune-cells-to-blame">Could allergies be 'deleted' someday?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-teenagers-hives-turned-out-to-be-caused-by-rare-water-allergy">Teenager's hives turned out to be caused by rare water allergy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/what-causes-allergies">What causes allergies?</a></li></ul></p></div></div><p>"In an ideal world, with infinite resources," Santos said, "all patients except for those with a history of severe reactions would have a food challenge for diagnosis."</p><p>Because that is not the case, the families of infants whose allergy diagnosis is uncertain may be advised to avoid peanut products while they await a formal food challenge, she noted. But in the interim, they may miss an opportunity to help the child develop tolerance and, in turn, increase the risk that their allergy will persist.</p><p>Food challenges should be prioritized for infants whose allergy diagnoses are uncertain, she said. This would include babies who have low levels of peanut-specific antibodies in their blood or who show only small welts on skin-prick tests.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ This self-powered toothbrush makes electricity to kill cavity-causing bacteria ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A toothbrush that generates its own electricity with every stroke could offer a new way to fight the microbes behind cavities and gum disease.</p><p>Conventional toothbrushes rely on physical scrubbing to remove plaque from teeth and gums. But even after a thorough brush, some bacteria remain and begin rebuilding plaque. To solve that problem, researchers have developed a self-powered toothbrush that converts the friction of brushing into an electrical charge. That electricity is intended to zap the <a href="https://www.livescience.com/health/how-does-plaque-cause-cavities"><u>plaque-promoting bacteria</u></a> and keep them from colonizing teeth.</p><p>"It's great to have new approaches that actually enhance the effect of mechanical cleaning," said <a href="https://www.ncl.ac.uk/dental/people/profile/nickjakubovics.html" target="_blank"><u>Nicholas Jakubovics</u></a>, an oral microbiologist at Newcastle University in the U.K. who was not involved in the study. "The idea that the toothbrush surface itself is actively doing something is really interesting."</p><p>The experimental brush has bristles made from polyvinylidene fluoride (PVDF), a plastic that generates electricity when bent; these types of energy-producing materials are called piezoelectric. As the bristles flex during brushing, they produce an electrical charge that then triggers chemical reactions in saliva and water. These reactions release <a href="https://www.livescience.com/what-is-oxidative-stress"><u>reactive oxygen species</u></a> (ROS), which are highly reactive molecules that can damage bacterial cells.</p><p>Even when the bristles are not being used to brush, they carry a faint surface charge that helps prevent bacteria from clinging to the brush head when the toothbrush isn't in use, the team reported Wednesday (Nov. 4) in the journal <a href="http://www.science.org/doi/10.1126/sciadv.aeg5744" target="_blank"><u>Science Advances</u></a>.</p><p>In laboratory tests where the toothbrush was used on isolated germs, its electrified bristles killed more than half of the <em>Streptococcus mutans</em> bacteria present. These microbes contribute to tooth decay. By comparison, nylon bristles killed just 9% of the bacteria. They also reduced levels of <em>Porphyromonas gingivalis</em>, a bacterium linked to gum disease, by up to 78%, while nylon brushes reduced them by less than 8%. </p><p>When the researchers added an antioxidant — a compound that neutralizes ROS — the new toothbrush's antibacterial effect largely disappeared, highlighting that the ROS are likely the key to its effects.</p><p>The team also found that the activity of certain genes in both <em>S. mutans and P. gingivalis</em> fell after exposure to the electrified bristles. These genes are involved in making ATP-binding cassette (ABC) transporters — molecular pumps that help shuttle essential nutrients across bacterial cell membranes. The researchers suspect that disrupting this machinery makes it harder for these microbes to survive and cling to teeth. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="ZPX6AvdrEdtGLWGCqzyyPG" name="GettyImages-1384473652-toothbrush" alt="A close up of a woman's hand rinsing a toothbrush under a sink faucet." src="https://cdn.mos.cms.futurecdn.net/ZPX6AvdrEdtGLWGCqzyyPG-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ZPX6AvdrEdtGLWGCqzyyPG-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The new toothbrush still needs to be tested in further safety trials. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Kathrin Ziegler via Getty Images)</span></figcaption></figure><p>But Jakubovics was not convinced by that part of the team's explanation. "ABC transporters transport all sorts of different things," he said, adding that the findings did not clearly show how changes in these genes affected the bacteria.</p><p>The researchers also tested the new brush against plaque biofilms — hardy communities of bacteria that stick together and cling to tooth surfaces. For the experiment, they grew human dental plaque on cow tooth enamel and found that the brush removed more than 99% of the biofilm, outperforming a regular nylon brush.</p><p>Finally, the team moved to humans, putting the brush to the test in 115 adults with gum inflammation or tooth decay. These study participants were randomly assigned to use either the new toothbrushes or traditional nylon-bristled brushes twice a day for three months. (The study didn't note whether participants noticed a difference in sensation when using the electrified brushes.)</p><p>By the end of the trial, the participants who used the electrified bristles had less plaque, less gum inflammation and less bleeding than the participants who used ordinary brushes. Plaque samples also showed that the people who used electrified brushes had lower levels of bacteria associated with oral disease and higher levels of beneficial bacteria, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11228166/" target="_blank"><u>which have previously been</u></a> reported to suppress harmful oral bacteria and support oral health. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/heart-circulation/gum-disease-treatment-slows-the-thickening-of-arteries-clinical-trial-shows">Gum disease treatment slows the thickening of arteries, clinical trial shows</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/lost-bacteria-found-on-neanderthal-teeth-could-be-used-to-develop-new-antibiotics">'Lost' bacteria found on Neanderthal teeth could be used to develop new antibiotics</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/animals/our-teeth-evolved-from-fish-body-armor-over-460-million-years-scientists-discover">Our teeth evolved from fish 'body armor' over 460 million years, scientists discover</a></li></ul></p></div></div><p>The researchers think that the disease-linked bacteria may have relatively fragile cell membranes, making them more vulnerable to damage from ROS than the beneficial bacteria. That's a theory that requires further study, though, so it's not completely clear how selective the brush is against plaque-causing bacteria.</p><p>In a test of the toothbrush's durability, the PVDF bristles retained their structure and electrical properties over three months of simulated use. Lab-grown mouse cells repeatedly exposed to brush material showed no signs of damage, and brushing on cow tooth enamel did not increase surface roughness. However, these tests cannot establish whether repeated use of these brushes is safe for humans.</p><p>"We would want to make sure that it is safe on the tissues for long-term use," Jakubovics said. He noted that, in lab tests, bacteria are grown directly on the bristles and exposed to their electricity for hours, "whereas in reality, in the mouth, your bristle is only in contact with the tooth or oral tissue for a very short time."  </p><p>The trial with humans provides some insight into how the brush works in real life, but it was relatively small. Larger studies will be needed to find out whether the toothbrush offers a meaningful advantage over conventional brushes. For now, Jakubovics sees the recent study as just a proof of concept; more information and more convincing clinical data are still needed, he emphasized.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/this-self-powered-toothbrush-makes-electricity-to-kill-cavity-causing-bacteria</link>
                                                                            <description>
                            <![CDATA[ Researchers have created a self-charging toothbrush that helps fight the bacteria linked to cavities and gum disease while preventing plaque buildup. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">B6XRdb4ejYoRezbwQASbQi</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/QeSxGMQckn8mGJFshP5GeP-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 04 Nov 2026 19:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Isha Ishtiaq ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/wXThBYHTfbXiYY2GhijqFf-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/QeSxGMQckn8mGJFshP5GeP-1920-80.jpg">
                                                            <media:credit><![CDATA[Ekaterina Demidova via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A new toothbrush generates electricity as you brush to zap plaque-causing bacteria.]]></media:description>                                                            <media:text><![CDATA[A woman with dark hair wearing a gray shirt brushes her teeth in a mirror]]></media:text>
                                <media:title type="plain"><![CDATA[A woman with dark hair wearing a gray shirt brushes her teeth in a mirror]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/QeSxGMQckn8mGJFshP5GeP-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A toothbrush that generates its own electricity with every stroke could offer a new way to fight the microbes behind cavities and gum disease.</p><p>Conventional toothbrushes rely on physical scrubbing to remove plaque from teeth and gums. But even after a thorough brush, some bacteria remain and begin rebuilding plaque. To solve that problem, researchers have developed a self-powered toothbrush that converts the friction of brushing into an electrical charge. That electricity is intended to zap the <a href="https://www.livescience.com/health/how-does-plaque-cause-cavities"><u>plaque-promoting bacteria</u></a> and keep them from colonizing teeth.</p><p>"It's great to have new approaches that actually enhance the effect of mechanical cleaning," said <a href="https://www.ncl.ac.uk/dental/people/profile/nickjakubovics.html" target="_blank"><u>Nicholas Jakubovics</u></a>, an oral microbiologist at Newcastle University in the U.K. who was not involved in the study. "The idea that the toothbrush surface itself is actively doing something is really interesting."</p><p>The experimental brush has bristles made from polyvinylidene fluoride (PVDF), a plastic that generates electricity when bent; these types of energy-producing materials are called piezoelectric. As the bristles flex during brushing, they produce an electrical charge that then triggers chemical reactions in saliva and water. These reactions release <a href="https://www.livescience.com/what-is-oxidative-stress"><u>reactive oxygen species</u></a> (ROS), which are highly reactive molecules that can damage bacterial cells.</p><p>Even when the bristles are not being used to brush, they carry a faint surface charge that helps prevent bacteria from clinging to the brush head when the toothbrush isn't in use, the team reported Wednesday (Nov. 4) in the journal <a href="http://www.science.org/doi/10.1126/sciadv.aeg5744" target="_blank"><u>Science Advances</u></a>.</p><p>In laboratory tests where the toothbrush was used on isolated germs, its electrified bristles killed more than half of the <em>Streptococcus mutans</em> bacteria present. These microbes contribute to tooth decay. By comparison, nylon bristles killed just 9% of the bacteria. They also reduced levels of <em>Porphyromonas gingivalis</em>, a bacterium linked to gum disease, by up to 78%, while nylon brushes reduced them by less than 8%. </p><p>When the researchers added an antioxidant — a compound that neutralizes ROS — the new toothbrush's antibacterial effect largely disappeared, highlighting that the ROS are likely the key to its effects.</p><p>The team also found that the activity of certain genes in both <em>S. mutans and P. gingivalis</em> fell after exposure to the electrified bristles. These genes are involved in making ATP-binding cassette (ABC) transporters — molecular pumps that help shuttle essential nutrients across bacterial cell membranes. The researchers suspect that disrupting this machinery makes it harder for these microbes to survive and cling to teeth. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="ZPX6AvdrEdtGLWGCqzyyPG" name="GettyImages-1384473652-toothbrush" alt="A close up of a woman's hand rinsing a toothbrush under a sink faucet." src="https://cdn.mos.cms.futurecdn.net/ZPX6AvdrEdtGLWGCqzyyPG-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ZPX6AvdrEdtGLWGCqzyyPG-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The new toothbrush still needs to be tested in further safety trials. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Kathrin Ziegler via Getty Images)</span></figcaption></figure><p>But Jakubovics was not convinced by that part of the team's explanation. "ABC transporters transport all sorts of different things," he said, adding that the findings did not clearly show how changes in these genes affected the bacteria.</p><p>The researchers also tested the new brush against plaque biofilms — hardy communities of bacteria that stick together and cling to tooth surfaces. For the experiment, they grew human dental plaque on cow tooth enamel and found that the brush removed more than 99% of the biofilm, outperforming a regular nylon brush.</p><p>Finally, the team moved to humans, putting the brush to the test in 115 adults with gum inflammation or tooth decay. These study participants were randomly assigned to use either the new toothbrushes or traditional nylon-bristled brushes twice a day for three months. (The study didn't note whether participants noticed a difference in sensation when using the electrified brushes.)</p><p>By the end of the trial, the participants who used the electrified bristles had less plaque, less gum inflammation and less bleeding than the participants who used ordinary brushes. Plaque samples also showed that the people who used electrified brushes had lower levels of bacteria associated with oral disease and higher levels of beneficial bacteria, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11228166/" target="_blank"><u>which have previously been</u></a> reported to suppress harmful oral bacteria and support oral health. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/heart-circulation/gum-disease-treatment-slows-the-thickening-of-arteries-clinical-trial-shows">Gum disease treatment slows the thickening of arteries, clinical trial shows</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/lost-bacteria-found-on-neanderthal-teeth-could-be-used-to-develop-new-antibiotics">'Lost' bacteria found on Neanderthal teeth could be used to develop new antibiotics</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/animals/our-teeth-evolved-from-fish-body-armor-over-460-million-years-scientists-discover">Our teeth evolved from fish 'body armor' over 460 million years, scientists discover</a></li></ul></p></div></div><p>The researchers think that the disease-linked bacteria may have relatively fragile cell membranes, making them more vulnerable to damage from ROS than the beneficial bacteria. That's a theory that requires further study, though, so it's not completely clear how selective the brush is against plaque-causing bacteria.</p><p>In a test of the toothbrush's durability, the PVDF bristles retained their structure and electrical properties over three months of simulated use. Lab-grown mouse cells repeatedly exposed to brush material showed no signs of damage, and brushing on cow tooth enamel did not increase surface roughness. However, these tests cannot establish whether repeated use of these brushes is safe for humans.</p><p>"We would want to make sure that it is safe on the tissues for long-term use," Jakubovics said. He noted that, in lab tests, bacteria are grown directly on the bristles and exposed to their electricity for hours, "whereas in reality, in the mouth, your bristle is only in contact with the tooth or oral tissue for a very short time."  </p><p>The trial with humans provides some insight into how the brush works in real life, but it was relatively small. Larger studies will be needed to find out whether the toothbrush offers a meaningful advantage over conventional brushes. For now, Jakubovics sees the recent study as just a proof of concept; more information and more convincing clinical data are still needed, he emphasized.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Mom experienced 'extreme unhappiness' only when she breastfed ]]></title>
                                                                                                <dc:content><![CDATA[ <p><strong>The patient: </strong>A woman in upstate New York</p><p><strong>The symptoms: </strong>About two weeks after her baby's birth, the woman began experiencing intensely negative emotions at every breastfeeding session. These feelings of "extreme unhappiness" would start just before her milk ejection reflex (during which milk moves from the breast ducts to the nipples) and last up to two minutes. </p><p>The feelings would end abruptly when she finished breastfeeding and then appear again the next time she was about to release milk, according to a <a href="https://link.springer.com/article/10.1186/1746-4358-6-6" target="_blank"><u>report of the case</u></a>, which the patient co-authored. The patient was a breastfeeding counselor for the United States Department of Agriculture Women, Infants, and Children (WIC) Program.</p><p>Until the baby was about 18 months old, this phenomenon would happen every time the woman breastfed — about five times per day, on average. Unlike <a href="https://www.mayoclinic.org/diseases-conditions/postpartum-depression/symptoms-causes/syc-20376617" target="_blank"><u>postpartum depression</u></a>,‬ which can cause persistent feelings of despondency, anxiety and mood swings in new parents,‬ the woman felt "helpless, hopeless, [and] worthless" only during her milk release. She reported that she otherwise felt happy and bonded with her new baby. </p><p><strong>What happened next: </strong>When her baby was 7 months old, the woman began meeting with a lactation consultant, who later co-authored the case report. They worked together to track the mother's symptoms over time, noting when negative feelings began and if any intervention made them subside or worsen. </p><p><strong>The diagnosis: </strong>Because the woman's condition did not have a formal name at the time, she began calling it "dysphoric milk ejection reflex," or D-MER.</p><p>The case report authors initially suspected that fluctuations in the woman's <a href="https://www.livescience.com/health/fertility-pregnancy-birth/love-hormone-oxytocin-can-pause-pregnancy-animal-study-finds"><u>oxytocin</u></a> levels might be causing D-MER, since the hormone is released into the bloodstream prior to the milk ejection reflex during breastfeeding. However, external factors that are known to affect oxytocin levels, such as tobacco use, did not always trigger the woman's symptoms.</p><p>Next, they looked at dopamine.<strong> </strong>The chemical messenger's fluctuations during breastfeeding are less studied than those of oxytocin and prolactin, another hormone linked to lactation. However, dopamine levels have otherwise been connected to strong emotional responses. Activities that seemed to ease the patient's D-MER symptoms — such as taking the cold medication pseudoephedrine, smoking cigarettes or binging on chocolate ice cream — are also known to increase dopamine levels. Meanwhile, acute stress, which reduces dopamine, worsened her symptoms.</p><p>The authors hypothesized that an abrupt drop in dopamine prior to milk release might be a trigger for D-MER.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="Jr6QUuQApJgjfneHvRfKWY" name="newborn baby - GettyImages-590951387" alt="A mom is shown smiling at her newborn baby who she is holding against her chest. The baby is looking up at her face. The background is blurred." src="https://cdn.mos.cms.futurecdn.net/Jr6QUuQApJgjfneHvRfKWY-1920-80.jpg" mos="" align="middle" fullscreen="" width="1920" height="1080" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">D-MER differs from postpartum depression in that the feelings of sadness are very specific to lactation.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Image taken by Mayte Torres via Getty Images)</span></figcaption></figure><p><strong>The treatment: </strong>The woman began taking bupropion (better known by the brand name Wellbutrin), an antidepressant that increases the amount of dopamine in the brain. She saw a dramatic reduction in her D-MER symptoms within a day, and five days later, her symptoms were almost entirely gone. </p><p>However, she stopped taking the drug after a few weeks due to unwanted side effects (which aren't described in the report), and the symptoms came back. She then tried an herbal remedy containing roseroot (<em>Rhodiola rosea</em>), a plant <a href="https://www.nccih.nih.gov/health/rhodiola" target="_blank"><u>historically used</u></a> in some places to manage depression. <a href="https://pubmed.ncbi.nlm.nih.gov/27013349/" target="_blank"><u>Some recent studies</u></a> suggest that compounds in <em>R. rosea</em> interact with receptors for chemical messengers in the brain; however, there is little reliable evidence demonstrating its purported therapeutic benefits, <a href="https://www.nccih.nih.gov/health/rhodiola" target="_blank"><u>according to the National Center for Complementary and Integrative Health</u></a>.</p><p>She took <em>R. rosea</em> three to four times per day, reporting that her symptoms became "much milder" but returned if she skipped a day. As her daughter grew older and the woman breastfed less often, the woman stopped taking the supplement. When the child was 3 years old and no longer breastfeeding, the woman's D-MER symptoms went away entirely.</p><p><strong>What makes the case unique: </strong>Prior to this report, published in 2011, D-MER was not widely recognized or documented in the scientific literature, and there was no research into its causes or treatment. </p><p>The patient and co-author of the report created the website <a href="http://d-mer.org" target="_blank"><u>D-MER.org</u></a> in 2007 to share information about the condition more widely. She hoped to raise awareness among medical professionals and to help breastfeeding people who experience this condition by providing resources and support and encouraging them to understand that what they were feeling was a physiological side effect of nursing. Since the site's launch, hundreds of visitors have described having negative feelings while breastfeeding, according to the report.</p><p>Over the past two decades, more case reports describing the condition have been published. In a 2025 paper in the <a href="https://www.sciencedirect.com/science/article/pii/S0301211525001204" target="_blank"><u>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</u></a>, researchers estimated that roughly 14.2% of lactating parents experience D-MER and that 1 in 6 stop breastfeeding as a result. Dopamine is thought to play a part, but the exact cause of D-MER <a href="https://my.clevelandclinic.org/health/diseases/24879-dysphoric-milk-ejection-reflex" target="_blank"><u>has not been definitively established</u></a> in peer-reviewed research yet. </p><p>There is no definitive treatment for D-MER, although some have anecdotally found relief through techniques for stress reduction, such as meditation and breathing exercises, and by seeking support from partners, friends and breastfeeding groups online. </p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur">Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years">A woman carried a 'stone baby' in her abdomen for 3 years</a></li></ul></p></div></div><p>Short-lived negative feelings resembling D-MER have also been reported in people who are not lactating. These anecdotal accounts describe intense, negative feelings brought on by nipple stimulation. One online discussion group referred to this phenomenon as "sad nipple syndrome," according to the authors of the case report.  As with D-MER, dopamine may play a part, but the overall neurochemistry underlying that emotional response is unknown.</p><p>Breastfeeding and parenthood can be an emotional roller coaster even under the best circumstances, the authors noted. In that sense, they explained, people with D-MER have "the same emotional peaks and valleys" as all new parents do. Yet the negative feelings that accompany D-MER are nonetheless different from the normal range of emotions in the parents of newborns, and they can cause extreme distress if they are not correctly identified and addressed as being specific to breastfeeding. </p><p>People with D-MER, the authors concluded, "serve as a reminder to us all that we do not yet have a complete understanding of human lactation."</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/diagnostic-dilemma-mom-experienced-extreme-unhappiness-only-when-she-breastfed</link>
                                                                            <description>
                            <![CDATA[ A new mom experienced intense feelings of sadness whenever she breastfed. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">CUgLBicJbw99NKenjXznTE</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/cPczFQ9WgCJ6Cva2doyMNW-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 04 Nov 2026 11:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 04 Nov 2026 20:19:56 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Mindy Weisberger ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/AhFB8tWuFKe7LsbCTX5BUE-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Mindy Weisberger is a science journalist and author of the book &quot;Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control,&quot; published by Hopkins Press. She formerly edited for Scholastic and reported for Live Science as a channel editor and senior writer. She has reported on general science, covering climate change, paleontology, biology and space. Mindy studied film at Columbia University; prior to Live Science she produced, wrote and directed media for the American Museum of Natural History in New York City. Her videos about dinosaurs, astrophysics, biodiversity and evolution appear in museums and science centers worldwide, earning awards such as the CINE Golden Eagle and the Communicator Award of Excellence. Her writing has also appeared in Scientific American, The Washington Post, How It Works Magazine and CNN.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/cPczFQ9WgCJ6Cva2doyMNW-1920-80.jpg">
                                                            <media:credit><![CDATA[Antonio Hugo Photo via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A mother reported feeling extremely hopeless during breastfeeding sessions.]]></media:description>                                                            <media:text><![CDATA[An infant is pressed against the chest of their mother with a red background behind them.]]></media:text>
                                <media:title type="plain"><![CDATA[An infant is pressed against the chest of their mother with a red background behind them.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/cPczFQ9WgCJ6Cva2doyMNW-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><strong>The patient: </strong>A woman in upstate New York</p><p><strong>The symptoms: </strong>About two weeks after her baby's birth, the woman began experiencing intensely negative emotions at every breastfeeding session. These feelings of "extreme unhappiness" would start just before her milk ejection reflex (during which milk moves from the breast ducts to the nipples) and last up to two minutes. </p><p>The feelings would end abruptly when she finished breastfeeding and then appear again the next time she was about to release milk, according to a <a href="https://link.springer.com/article/10.1186/1746-4358-6-6" target="_blank"><u>report of the case</u></a>, which the patient co-authored. The patient was a breastfeeding counselor for the United States Department of Agriculture Women, Infants, and Children (WIC) Program.</p><p>Until the baby was about 18 months old, this phenomenon would happen every time the woman breastfed — about five times per day, on average. Unlike <a href="https://www.mayoclinic.org/diseases-conditions/postpartum-depression/symptoms-causes/syc-20376617" target="_blank"><u>postpartum depression</u></a>,‬ which can cause persistent feelings of despondency, anxiety and mood swings in new parents,‬ the woman felt "helpless, hopeless, [and] worthless" only during her milk release. She reported that she otherwise felt happy and bonded with her new baby. </p><p><strong>What happened next: </strong>When her baby was 7 months old, the woman began meeting with a lactation consultant, who later co-authored the case report. They worked together to track the mother's symptoms over time, noting when negative feelings began and if any intervention made them subside or worsen. </p><p><strong>The diagnosis: </strong>Because the woman's condition did not have a formal name at the time, she began calling it "dysphoric milk ejection reflex," or D-MER.</p><p>The case report authors initially suspected that fluctuations in the woman's <a href="https://www.livescience.com/health/fertility-pregnancy-birth/love-hormone-oxytocin-can-pause-pregnancy-animal-study-finds"><u>oxytocin</u></a> levels might be causing D-MER, since the hormone is released into the bloodstream prior to the milk ejection reflex during breastfeeding. However, external factors that are known to affect oxytocin levels, such as tobacco use, did not always trigger the woman's symptoms.</p><p>Next, they looked at dopamine.<strong> </strong>The chemical messenger's fluctuations during breastfeeding are less studied than those of oxytocin and prolactin, another hormone linked to lactation. However, dopamine levels have otherwise been connected to strong emotional responses. Activities that seemed to ease the patient's D-MER symptoms — such as taking the cold medication pseudoephedrine, smoking cigarettes or binging on chocolate ice cream — are also known to increase dopamine levels. Meanwhile, acute stress, which reduces dopamine, worsened her symptoms.</p><p>The authors hypothesized that an abrupt drop in dopamine prior to milk release might be a trigger for D-MER.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="Jr6QUuQApJgjfneHvRfKWY" name="newborn baby - GettyImages-590951387" alt="A mom is shown smiling at her newborn baby who she is holding against her chest. The baby is looking up at her face. The background is blurred." src="https://cdn.mos.cms.futurecdn.net/Jr6QUuQApJgjfneHvRfKWY-1920-80.jpg" mos="" align="middle" fullscreen="" width="1920" height="1080" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">D-MER differs from postpartum depression in that the feelings of sadness are very specific to lactation.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Image taken by Mayte Torres via Getty Images)</span></figcaption></figure><p><strong>The treatment: </strong>The woman began taking bupropion (better known by the brand name Wellbutrin), an antidepressant that increases the amount of dopamine in the brain. She saw a dramatic reduction in her D-MER symptoms within a day, and five days later, her symptoms were almost entirely gone. </p><p>However, she stopped taking the drug after a few weeks due to unwanted side effects (which aren't described in the report), and the symptoms came back. She then tried an herbal remedy containing roseroot (<em>Rhodiola rosea</em>), a plant <a href="https://www.nccih.nih.gov/health/rhodiola" target="_blank"><u>historically used</u></a> in some places to manage depression. <a href="https://pubmed.ncbi.nlm.nih.gov/27013349/" target="_blank"><u>Some recent studies</u></a> suggest that compounds in <em>R. rosea</em> interact with receptors for chemical messengers in the brain; however, there is little reliable evidence demonstrating its purported therapeutic benefits, <a href="https://www.nccih.nih.gov/health/rhodiola" target="_blank"><u>according to the National Center for Complementary and Integrative Health</u></a>.</p><p>She took <em>R. rosea</em> three to four times per day, reporting that her symptoms became "much milder" but returned if she skipped a day. As her daughter grew older and the woman breastfed less often, the woman stopped taking the supplement. When the child was 3 years old and no longer breastfeeding, the woman's D-MER symptoms went away entirely.</p><p><strong>What makes the case unique: </strong>Prior to this report, published in 2011, D-MER was not widely recognized or documented in the scientific literature, and there was no research into its causes or treatment. </p><p>The patient and co-author of the report created the website <a href="http://d-mer.org" target="_blank"><u>D-MER.org</u></a> in 2007 to share information about the condition more widely. She hoped to raise awareness among medical professionals and to help breastfeeding people who experience this condition by providing resources and support and encouraging them to understand that what they were feeling was a physiological side effect of nursing. Since the site's launch, hundreds of visitors have described having negative feelings while breastfeeding, according to the report.</p><p>Over the past two decades, more case reports describing the condition have been published. In a 2025 paper in the <a href="https://www.sciencedirect.com/science/article/pii/S0301211525001204" target="_blank"><u>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</u></a>, researchers estimated that roughly 14.2% of lactating parents experience D-MER and that 1 in 6 stop breastfeeding as a result. Dopamine is thought to play a part, but the exact cause of D-MER <a href="https://my.clevelandclinic.org/health/diseases/24879-dysphoric-milk-ejection-reflex" target="_blank"><u>has not been definitively established</u></a> in peer-reviewed research yet. </p><p>There is no definitive treatment for D-MER, although some have anecdotally found relief through techniques for stress reduction, such as meditation and breathing exercises, and by seeking support from partners, friends and breastfeeding groups online. </p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur">Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years">A woman carried a 'stone baby' in her abdomen for 3 years</a></li></ul></p></div></div><p>Short-lived negative feelings resembling D-MER have also been reported in people who are not lactating. These anecdotal accounts describe intense, negative feelings brought on by nipple stimulation. One online discussion group referred to this phenomenon as "sad nipple syndrome," according to the authors of the case report.  As with D-MER, dopamine may play a part, but the overall neurochemistry underlying that emotional response is unknown.</p><p>Breastfeeding and parenthood can be an emotional roller coaster even under the best circumstances, the authors noted. In that sense, they explained, people with D-MER have "the same emotional peaks and valleys" as all new parents do. Yet the negative feelings that accompany D-MER are nonetheless different from the normal range of emotions in the parents of newborns, and they can cause extreme distress if they are not correctly identified and addressed as being specific to breastfeeding. </p><p>People with D-MER, the authors concluded, "serve as a reminder to us all that we do not yet have a complete understanding of human lactation."</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Would you risk your health to visit Mars? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A crewed mission to <a href="https://www.livescience.com/34033-mars-myths-misconceptions-quiz.html"><u>Mars</u></a> could be one of humanity's greatest achievements, but getting there may come with serious health risks. Beyond the challenges of surviving in space for months at a time, astronauts would face prolonged exposure to <a href="http://www.livescience.com/32516-what-are-cosmic-rays.html"><u>cosmic radiation</u></a> ‪—‬ high-energy particles in space that <a href="https://www.livescience.com/physics-mathematics/how-many-cosmic-particles-are-passing-through-your-body-at-any-moment"><u>can penetrate the human body</u></a> and potentially damage vital organs. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/chinese-lander-reveals-giant-cavity-of-radiation-between-earth-and-the-moon-and-it-could-change-how-lunar-exploration-is-done">Chinese lander reveals giant 'cavity' of radiation between Earth and the moon — and it could change how lunar exploration is done</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/everything-we-know-about-space-travel-is-going-to-change-within-a-decade-the-fusion-breakthrough-that-could-unlock-a-path-to-the-stars">'Everything we know about space travel is going to change within a decade': The fusion breakthrough that could unlock a path to the stars</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/scientists-finally-know-why-astronauts-struggle-to-poop-in-space-and-reveal-a-hidden-risk-of-long-haul-spaceflight">Scientists finally know why astronauts struggle to poop in space — and reveal a hidden risk of long-haul spaceflight</a></li></ul></p></div></div><p>A <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0357485&amp;utm_campaign=2026-pr&amp;utm_source=pr&amp;utm_medium=eurekalert&amp;utm_content=title-release" target="_blank"><u>new study</u></a> suggested that cosmic radiation could pose a particular threat to heart health. Researchers found evidence that rats that were exposed to radiation similar to what human astronauts might encounter during a mission to Mars and back <a href="https://www.livescience.com/space/space-exploration/cosmic-rays-could-scar-the-heart-raising-risks-for-mars-bound-astronauts-rat-study-hints"><u>developed more scar tissue around the small vessels in their hearts</u></a> compared with rats that weren't exposed to space radiation. </p><p>Although the findings haven't been confirmed in humans yet, they add to the <a href="https://www.livescience.com/astronauts-bone-loss-space"><u>growing concerns</u></a> about the <a href="https://www.livescience.com/health/reproductive-health/spaceflight-may-harm-the-reproductive-system-of-astronauts-kids-and-grandkids-early-mouse-study-suggests"><u>long-term health effects</u></a> of sending astronauts on long-duration space missions. </p><p>NASA and other space agencies are working on ways to eventually send humans to Mars and beyond. Given these latest findings, would you travel to Mars? Vote in the poll below, and let us know your thoughts in the comments. </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xk9ZNW"></div>                            </div>                            <script src="https://kwizly.com/embed/Xk9ZNW.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/space/mars/would-you-risk-your-health-to-visit-mars</link>
                                                                            <description>
                            <![CDATA[ A recent rat study hinted that cosmic radiation could pose health risks for future Mars explorers. Live Science asks its readers whether they'd take the journey anyway. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Py9m4oaiXTgfEhcwH376AP</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/aAnZqY2GzkaKSNdzdwJxb3-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 03 Nov 2026 21:46:50 +0000</pubDate>                                                                                                                                <updated>Wed, 04 Nov 2026 12:00:06 +0000</updated>
                                                                                                                                            <category><![CDATA[Mars]]></category>
                                                    <category><![CDATA[Space]]></category>
                                                    <category><![CDATA[Astronomy]]></category>
                                                    <category><![CDATA[Planets]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kenna Hughes-Castleberry ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mgEvZdqXoF3NyR25Gj96va-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/aAnZqY2GzkaKSNdzdwJxb3-1920-80.jpg">
                                                            <media:credit><![CDATA[Nisian Hughes via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Live Science asks its readers whether they would want to go to Mars.]]></media:description>                                                            <media:text><![CDATA[An astronaut wearing a spacesuit walks on a reddish surface.]]></media:text>
                                <media:title type="plain"><![CDATA[An astronaut wearing a spacesuit walks on a reddish surface.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/aAnZqY2GzkaKSNdzdwJxb3-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A crewed mission to <a href="https://www.livescience.com/34033-mars-myths-misconceptions-quiz.html"><u>Mars</u></a> could be one of humanity's greatest achievements, but getting there may come with serious health risks. Beyond the challenges of surviving in space for months at a time, astronauts would face prolonged exposure to <a href="http://www.livescience.com/32516-what-are-cosmic-rays.html"><u>cosmic radiation</u></a> ‪—‬ high-energy particles in space that <a href="https://www.livescience.com/physics-mathematics/how-many-cosmic-particles-are-passing-through-your-body-at-any-moment"><u>can penetrate the human body</u></a> and potentially damage vital organs. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/chinese-lander-reveals-giant-cavity-of-radiation-between-earth-and-the-moon-and-it-could-change-how-lunar-exploration-is-done">Chinese lander reveals giant 'cavity' of radiation between Earth and the moon — and it could change how lunar exploration is done</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/everything-we-know-about-space-travel-is-going-to-change-within-a-decade-the-fusion-breakthrough-that-could-unlock-a-path-to-the-stars">'Everything we know about space travel is going to change within a decade': The fusion breakthrough that could unlock a path to the stars</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/space/space-exploration/scientists-finally-know-why-astronauts-struggle-to-poop-in-space-and-reveal-a-hidden-risk-of-long-haul-spaceflight">Scientists finally know why astronauts struggle to poop in space — and reveal a hidden risk of long-haul spaceflight</a></li></ul></p></div></div><p>A <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0357485&amp;utm_campaign=2026-pr&amp;utm_source=pr&amp;utm_medium=eurekalert&amp;utm_content=title-release" target="_blank"><u>new study</u></a> suggested that cosmic radiation could pose a particular threat to heart health. Researchers found evidence that rats that were exposed to radiation similar to what human astronauts might encounter during a mission to Mars and back <a href="https://www.livescience.com/space/space-exploration/cosmic-rays-could-scar-the-heart-raising-risks-for-mars-bound-astronauts-rat-study-hints"><u>developed more scar tissue around the small vessels in their hearts</u></a> compared with rats that weren't exposed to space radiation. </p><p>Although the findings haven't been confirmed in humans yet, they add to the <a href="https://www.livescience.com/astronauts-bone-loss-space"><u>growing concerns</u></a> about the <a href="https://www.livescience.com/health/reproductive-health/spaceflight-may-harm-the-reproductive-system-of-astronauts-kids-and-grandkids-early-mouse-study-suggests"><u>long-term health effects</u></a> of sending astronauts on long-duration space missions. </p><p>NASA and other space agencies are working on ways to eventually send humans to Mars and beyond. Given these latest findings, would you travel to Mars? Vote in the poll below, and let us know your thoughts in the comments. </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xk9ZNW"></div>                            </div>                            <script src="https://kwizly.com/embed/Xk9ZNW.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'Now you actually have a blood test': Psychiatry's bible, the DSM, is getting upgraded to include biological markers. A psychiatrist explains what that means for mental health. ]]></title>
                                                                                                <dc:content><![CDATA[ <p>For decades, psychiatrists and other mental health professionals have used the "Diagnostic and Statistical Manual of Mental Disorders," or <a href="https://www.psychiatry.org/psychiatrists/practice/dsm" target="_blank"><u>DSM</u></a>, to diagnose patients with conditions such as major depression, anorexia and post-traumatic stress disorder (<a href="https://www.livescience.com/health/neuroscience/traumatic-memories-are-processed-differently-in-ptsd"><u>PTSD</u></a>). To reach diagnoses, mental health practitioners identify symptoms via interview, case history, questionnaire, or observation to paint a clinical picture.</p><p>But for the next version of this "psychiatry bible", the DSM-6, scientists are planning to  add other factors into the diagnostic criteria. </p><p><a href="https://www.psych.uic.edu/profile/anand-kumar" target="_blank"><u>Dr. Anand Kumar</u></a>, a psychiatrist who served for two years on the DSM Strategy Committee, says one of the most important potential changes is the introduction of biological factors into the diagnostic framework. While Kumar, the head of the Department of Psychiatry at the University of Illinois Chicago, no longer serves on the committee, he was influential in discussions about how biology could be incorporated into the DSM-6. Some of these biological factors include data from genome-wide association studies of hundreds or thousands of <a href="https://www.livescience.com/health/genetics/genetics-how-do-we-inherit-traits-from-our-ancestors"><u>genes</u></a> that each increase the risk of a mental disorder by a tiny amount. Other biological factors include signs of inflammation or immune-system dysfunction that may show up in blood tests or brain scans. </p><p>Live Science spoke to Kumar about how this update to the DSM could change the way mental disorders are understood and potentially help improve treatment. </p><p><strong>Kenna Hughes-Castleberry: How is the DSM-6 going to be different from the DSM-5?</strong></p><p><strong>Anand Kumar:</strong> Up to this point, the distinctions between the different major groups — who has clinical depression, or what we call major depression; who has an eating disorder; who has PTSD, etc. — have been based exclusively on clinical grounds: You meet certain criteria, and you fall into this category. If you meet some other criteria, you fall into another category.</p><p>An attempt that's being made now, one of the major attempts for the next DSM, is to introduce biological factors into the manual.</p><p>The idea is not new. It's been discussed in the past, but it was difficult to get a consensus on what goes in and what should not go in. That's still going to be tricky, but at least there's a broad acknowledgement that the time is ready to start introducing biology into the DSM.</p><p>It's very likely that, at the end of it, there will be meaningful changes in a positive kind of way. It's not going to make everyone happy. There are going to be gaps, but the idea is to incrementally improve this and make it more modern as we go along.</p><p><strong>KHC: What sort of biological markers have you seen that we can actually correlate with these disorders?</strong></p><p><strong>AK</strong>: What the committee is doing is taking a more nuanced approach. Outside the realm of <a href="https://www.livescience.com/65748-alzheimers-disease.html"><u>Alzheimer's disease</u></a>, which I'll get into in a minute, there are no clear-cut diagnostic biomarkers — meaning no blood tests or brain scans that you can look at and say, "This person has a diagnosis of depression," or "This person has PTSD," or "This person has schizophrenia."</p><p>The committee talked about how, in addition to biological biomarkers, there's a concept of biological factors. What I mean by that is biological pathways and mechanisms that have a role in the development of a particular disorder, but the findings have not crystallized into a laboratory test.</p><p>For example, <a href="https://www.livescience.com/26579-immune-system.html"><u>immunology</u></a> — the study of the body's response to a variety of stresses, including infections and others — has been shown to be impactful in about <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12672047/" target="_blank"><u>30% of cases of major depression</u></a>. Yet there is no single biological laboratory test that is currently available that can be used [to diagnose immune-mediated depression] in clinical practice. So these come under the category of what we call biological factors.</p><p>In the Alzheimer's disease field there are clear-cut biomarkers. There are now <a href="https://www.livescience.com/health/alzheimers-dementia/alzheimers-blood-tests-are-transforming-how-patients-get-diagnosed-heres-what-to-know"><u>blood tests for proteins</u></a> called tau and amyloid that have been approved by the FDA [Food and Drug Administration] as biomarkers for Alzheimer's disease. Meaning, if you have a clinical picture and a mental-status exam consistent with intellectual decline, you must have a positive biomarker test to be categorized as having definitive Alzheimer's disease.</p><p>And that's new. Ten or 15 years back, there were brain scans, and if you did a lumbar puncture, you could find these proteins in the spinal fluid. But those are invasive. Now you actually have a blood test.</p><figure class="van-image-figure  extended-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="Zxkcvj6iz5uwfugh9p5Dif" name="Alzheimers - GettyImages-639549099.jpg" alt="Medical illustration of a neuron, in blue, in the background being surrounded by a plaque of amyloid-beta protein, in yellow with the illustration visualizing how the proteins join together" src="https://cdn.mos.cms.futurecdn.net/Zxkcvj6iz5uwfugh9p5Dif-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="extended expandable" /><a href='https://cdn.mos.cms.futurecdn.net/Zxkcvj6iz5uwfugh9p5Dif-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" extended-layout"><span class="caption-text">A neuron, in blue, is surrounded by a plaque of amyloid-beta protein, in yellow, which causes the symptoms of Alzheimer's disease. Tests can be used to detect biomarkers for Alzheimer's disease. </span><span class="credit" itemprop="copyrightHolder">(Image credit: JUAN GAERTNER/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>But that degree of precision, for lack of a better term, is not available in the other branches of psychiatry. Nonetheless, there are clues that other pathways and mechanisms are involved.</p><p>I mentioned immunology as one. Another big elephant in the room is genetics.</p><p>Most people think of genetics as an abnormal gene or a <a href="https://www.livescience.com/health/genetics/1st-of-its-kind-database-reveals-how-dna-mutations-destabilize-proteins-triggering-genetic-disease"><u>mutation</u></a> — meaning a gene switches or changes and confers increased risk — as one mutation causing one disease. That's how most people in the general public think about mutations: They cause disease.</p><p>But when you get into complex diseases like <a href="https://www.livescience.com/34733-heart-disease-high-cholesterol-heart-surgery.html"><u>heart disease</u></a> and <a href="https://www.livescience.com/43477-diabetes-symptoms-types.html"><u>diabetes</u></a>, there are multiple genes involved. And diseases may or may not be caused by a gene. Abnormal genes may or may not cause the disease, but they increase risk.</p><p>With mental disorders, the situation becomes immensely more complicated. It's not just a few genes here and there. There are hundreds of genes, each increasing the risk for depression, schizophrenia and anxiety disorders by a small amount.</p><p>So while there is no single genetic test that can now be used, large numbers of genes have consistently been shown — and <a href="https://www.nature.com/articles/s41586-025-09820-3" target="_blank"><u>many of the recent studies</u></a> are strong — to be associated with certain disorders. But because there's no single gene or small group of genes, we cannot walk away from the science. Complexity doesn't mean we throw our hands up and say, "Well, it's all too much."</p><p>It may seem overwhelming, but <a href="https://www.sanger.ac.uk/news_item/expanding-understanding-of-link-between-genetics-and-cognitive-ability/" target="_blank"><u>genetic profiles are better understood</u></a> today than they were 20 years ago. So that's something else this committee is thinking about and I think should take into account going forward: to somehow incorporate that into the diagnostic categories.</p><p><strong>KHC: Do you think there's any sort of risk with adding those biological factors into the DSM? </strong></p><p><strong>AK:</strong> I don't think so, because if you think about genetics, it's not going to be introduced as a biological test.</p><p>Most folks know that mental disorders, like other medical disorders, run in families. And genetics is the most plausible explanation for that. What this does, I hope, is introduce a degree of more comprehensive description of these disorders. So when a busy clinician looks at it, it confirms what they already suspected: There's a family history here, and family history means genetics.</p><p>It's complex, many genes are involved, and it produces a better characterization of this. The diagnosis is still going to remain clinical, but this provides a biological context, very much like, say, diabetes or heart disease.</p><p>Genes and environment cause a variety of medical disorders. With heart disease, there's no one gene. When cardiologists develop a risk profile for heart disease, it includes genes, other physiological factors such as <a href="https://www.livescience.com/bmi-health-weight"><u>BMI</u></a>, which is the weight-height ratio, diet and a variety of environmental factors.</p><p>That degree of classification is missing today in mental health and psychiatry. We hope this is a first step in correcting, if you will, those conceptions about what causes these disorders.</p><p><strong>KHC: How would you end up using this in a psychiatrist's office to guide treatment?</strong></p><p><strong>AK:</strong> I can give you one possible example. I'm reaching a bit.</p><p>There's a term commonly used in clinical psychiatry and psychology called <a href="https://my.clevelandclinic.org/health/articles/comorbidities" target="_blank"><u>comorbidity</u></a>. What it means is that people who are diagnosed with depression also have anxiety, or people who are diagnosed with an anxiety disorder also have substance abuse or alcoholism in general.</p><p>That is not coincidental. It's not something that we just somehow find. A lot of these disorders share genes.</p><p>For example, about<a href="https://pubmed.ncbi.nlm.nih.gov/26249302/" target="_blank"><u> 45%, roughly, of patients diagnosed with a major mood disorder</u></a> also have an anxiety disorder. And you flip that around: About 45%, roughly, of patients <a href="https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305" target="_blank"><u>diagnosed with an anxiety disorder</u></a> — it could be generalized anxiety disorder, what we call PTSD, or a <a href="https://www.livescience.com/human-behavior/what-counts-as-a-phobia"><u>phobia</u></a> — also have a mood disorder.</p><figure class="van-image-figure  full-width-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' ><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="ukfnSEFsahRHmbsUM5GRFh" name="depression-neanderthal-GettyImages-1510833199.jpg" alt="A photograph of a woman looking sad and gazing out a window." src="https://cdn.mos.cms.futurecdn.net/ukfnSEFsahRHmbsUM5GRFh-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="full-width expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ukfnSEFsahRHmbsUM5GRFh-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" full-width-layout"><span class="caption-text"> Patients with anxiety may also be diagnosed with a mood disorder.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: MementoJpeg via Getty Images)</span></figcaption></figure><p>I think when clinicians classify them together, not as the same disorder but as sharing a lot of psychological as well as genetic risk, clinicians should be on the lookout for both. A patient with a mood disorder, for example, could either now or at some later point develop an anxiety disorder. Or someone with an anxiety disorder is at risk for substance abuse.</p><p>So treatments need to be tailored a little more broadly. I'm hoping that'll be something clinicians think about when they talk to patients and their families.</p><p><strong>KHC: What do you think is the most unique aspect, from your perspective, of this upcoming DSM-6?</strong></p><p><strong>AK:</strong> My bias is the biology. I say this because a lot of the other things, the cultural factors, etc., are largely appreciated, and they'll be better characterized. Some things like cognitive changes, such as working memory and attention [tests], are not unique to any given disorder.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/adversity-shaped-our-evolution-as-a-species-people-raised-in-it-may-have-underrecognized-strengths-because-of-it">Adversity shaped our evolution as a species. People raised in it may have underrecognized strengths because of it.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/ancient-alien-like-skulls-have-been-found-on-every-continent-but-antarctica-anthropologists-are-starting-to-figure-out-why">Ancient 'alien-like' skulls have been found on every continent but Antarctica. Anthropologists are starting to figure out why.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/could-psilocybin-treat-brain-injuries-neuroscientist-explains-how-psychedelics-could-fill-a-gap-in-head-trauma-care">Could psilocybin treat brain injuries? Neuroscientist explains how psychedelics could fill a gap in head trauma care</a></li></ul></p></div></div><p>Biology will be qualitatively new when introduced into the DSM, and I hope it's done well. I hope that they do it appropriately, and I think they will [do it] correctly.</p><p>It's not going to be perfect, but it's going to be a first step. I think introducing the idea that genetics, immunology and other factors are very important in the causation of mental disorders, and explain some of the phenomena that we previously could not find an explanation for, is — I hate to use the word "leapfrog" — but that's kind of what it is.</p><p>It moves the field conceptually forward, and not as a slow, steady, gradual increase. For the DSM, it would be an important step forward.</p><p><em>This interview has been condensed and edited lightly for clarity.</em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/now-you-actually-have-a-blood-test-psychiatrys-bible-the-dsm-is-getting-upgraded-to-include-biological-markers-a-psychiatrist-explains-what-that-means-for-mental-health</link>
                                                                            <description>
                            <![CDATA[ The next edition of the "Diagnostic and Statistical Manual Of Mental Disorders" will include biological factors like genetics in studying and diagnosing psychiatric conditions, according to psychiatrist <b> Anand Kumar</b>. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">hn3DJC945K7fx629Qa9T4W</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/6geMfLL8DXcA7Hdx6MvxAM-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 02 Nov 2026 11:00:00 +0000</pubDate>                                                                                                                                <updated>Fri, 06 Nov 2026 18:27:23 +0000</updated>
                                                                                                                                            <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kenna Hughes-Castleberry ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mgEvZdqXoF3NyR25Gj96va-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/6geMfLL8DXcA7Hdx6MvxAM-1920-80.jpg">
                                                            <media:credit><![CDATA[Malte Mueller via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Psychiatrists like Kumar are working to use biological markers like genetics to help psychiatrists better understand mental disorders. ]]></media:description>                                                            <media:text><![CDATA[A cartoon of lab coat wearing scientists on scaffolding next to a person&#039;s head showing a cartoon image of their brain.]]></media:text>
                                <media:title type="plain"><![CDATA[A cartoon of lab coat wearing scientists on scaffolding next to a person&#039;s head showing a cartoon image of their brain.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/6geMfLL8DXcA7Hdx6MvxAM-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>For decades, psychiatrists and other mental health professionals have used the "Diagnostic and Statistical Manual of Mental Disorders," or <a href="https://www.psychiatry.org/psychiatrists/practice/dsm" target="_blank"><u>DSM</u></a>, to diagnose patients with conditions such as major depression, anorexia and post-traumatic stress disorder (<a href="https://www.livescience.com/health/neuroscience/traumatic-memories-are-processed-differently-in-ptsd"><u>PTSD</u></a>). To reach diagnoses, mental health practitioners identify symptoms via interview, case history, questionnaire, or observation to paint a clinical picture.</p><p>But for the next version of this "psychiatry bible", the DSM-6, scientists are planning to  add other factors into the diagnostic criteria. </p><p><a href="https://www.psych.uic.edu/profile/anand-kumar" target="_blank"><u>Dr. Anand Kumar</u></a>, a psychiatrist who served for two years on the DSM Strategy Committee, says one of the most important potential changes is the introduction of biological factors into the diagnostic framework. While Kumar, the head of the Department of Psychiatry at the University of Illinois Chicago, no longer serves on the committee, he was influential in discussions about how biology could be incorporated into the DSM-6. Some of these biological factors include data from genome-wide association studies of hundreds or thousands of <a href="https://www.livescience.com/health/genetics/genetics-how-do-we-inherit-traits-from-our-ancestors"><u>genes</u></a> that each increase the risk of a mental disorder by a tiny amount. Other biological factors include signs of inflammation or immune-system dysfunction that may show up in blood tests or brain scans. </p><p>Live Science spoke to Kumar about how this update to the DSM could change the way mental disorders are understood and potentially help improve treatment. </p><p><strong>Kenna Hughes-Castleberry: How is the DSM-6 going to be different from the DSM-5?</strong></p><p><strong>Anand Kumar:</strong> Up to this point, the distinctions between the different major groups — who has clinical depression, or what we call major depression; who has an eating disorder; who has PTSD, etc. — have been based exclusively on clinical grounds: You meet certain criteria, and you fall into this category. If you meet some other criteria, you fall into another category.</p><p>An attempt that's being made now, one of the major attempts for the next DSM, is to introduce biological factors into the manual.</p><p>The idea is not new. It's been discussed in the past, but it was difficult to get a consensus on what goes in and what should not go in. That's still going to be tricky, but at least there's a broad acknowledgement that the time is ready to start introducing biology into the DSM.</p><p>It's very likely that, at the end of it, there will be meaningful changes in a positive kind of way. It's not going to make everyone happy. There are going to be gaps, but the idea is to incrementally improve this and make it more modern as we go along.</p><p><strong>KHC: What sort of biological markers have you seen that we can actually correlate with these disorders?</strong></p><p><strong>AK</strong>: What the committee is doing is taking a more nuanced approach. Outside the realm of <a href="https://www.livescience.com/65748-alzheimers-disease.html"><u>Alzheimer's disease</u></a>, which I'll get into in a minute, there are no clear-cut diagnostic biomarkers — meaning no blood tests or brain scans that you can look at and say, "This person has a diagnosis of depression," or "This person has PTSD," or "This person has schizophrenia."</p><p>The committee talked about how, in addition to biological biomarkers, there's a concept of biological factors. What I mean by that is biological pathways and mechanisms that have a role in the development of a particular disorder, but the findings have not crystallized into a laboratory test.</p><p>For example, <a href="https://www.livescience.com/26579-immune-system.html"><u>immunology</u></a> — the study of the body's response to a variety of stresses, including infections and others — has been shown to be impactful in about <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12672047/" target="_blank"><u>30% of cases of major depression</u></a>. Yet there is no single biological laboratory test that is currently available that can be used [to diagnose immune-mediated depression] in clinical practice. So these come under the category of what we call biological factors.</p><p>In the Alzheimer's disease field there are clear-cut biomarkers. There are now <a href="https://www.livescience.com/health/alzheimers-dementia/alzheimers-blood-tests-are-transforming-how-patients-get-diagnosed-heres-what-to-know"><u>blood tests for proteins</u></a> called tau and amyloid that have been approved by the FDA [Food and Drug Administration] as biomarkers for Alzheimer's disease. Meaning, if you have a clinical picture and a mental-status exam consistent with intellectual decline, you must have a positive biomarker test to be categorized as having definitive Alzheimer's disease.</p><p>And that's new. Ten or 15 years back, there were brain scans, and if you did a lumbar puncture, you could find these proteins in the spinal fluid. But those are invasive. Now you actually have a blood test.</p><figure class="van-image-figure  extended-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="Zxkcvj6iz5uwfugh9p5Dif" name="Alzheimers - GettyImages-639549099.jpg" alt="Medical illustration of a neuron, in blue, in the background being surrounded by a plaque of amyloid-beta protein, in yellow with the illustration visualizing how the proteins join together" src="https://cdn.mos.cms.futurecdn.net/Zxkcvj6iz5uwfugh9p5Dif-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="extended expandable" /><a href='https://cdn.mos.cms.futurecdn.net/Zxkcvj6iz5uwfugh9p5Dif-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" extended-layout"><span class="caption-text">A neuron, in blue, is surrounded by a plaque of amyloid-beta protein, in yellow, which causes the symptoms of Alzheimer's disease. Tests can be used to detect biomarkers for Alzheimer's disease. </span><span class="credit" itemprop="copyrightHolder">(Image credit: JUAN GAERTNER/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>But that degree of precision, for lack of a better term, is not available in the other branches of psychiatry. Nonetheless, there are clues that other pathways and mechanisms are involved.</p><p>I mentioned immunology as one. Another big elephant in the room is genetics.</p><p>Most people think of genetics as an abnormal gene or a <a href="https://www.livescience.com/health/genetics/1st-of-its-kind-database-reveals-how-dna-mutations-destabilize-proteins-triggering-genetic-disease"><u>mutation</u></a> — meaning a gene switches or changes and confers increased risk — as one mutation causing one disease. That's how most people in the general public think about mutations: They cause disease.</p><p>But when you get into complex diseases like <a href="https://www.livescience.com/34733-heart-disease-high-cholesterol-heart-surgery.html"><u>heart disease</u></a> and <a href="https://www.livescience.com/43477-diabetes-symptoms-types.html"><u>diabetes</u></a>, there are multiple genes involved. And diseases may or may not be caused by a gene. Abnormal genes may or may not cause the disease, but they increase risk.</p><p>With mental disorders, the situation becomes immensely more complicated. It's not just a few genes here and there. There are hundreds of genes, each increasing the risk for depression, schizophrenia and anxiety disorders by a small amount.</p><p>So while there is no single genetic test that can now be used, large numbers of genes have consistently been shown — and <a href="https://www.nature.com/articles/s41586-025-09820-3" target="_blank"><u>many of the recent studies</u></a> are strong — to be associated with certain disorders. But because there's no single gene or small group of genes, we cannot walk away from the science. Complexity doesn't mean we throw our hands up and say, "Well, it's all too much."</p><p>It may seem overwhelming, but <a href="https://www.sanger.ac.uk/news_item/expanding-understanding-of-link-between-genetics-and-cognitive-ability/" target="_blank"><u>genetic profiles are better understood</u></a> today than they were 20 years ago. So that's something else this committee is thinking about and I think should take into account going forward: to somehow incorporate that into the diagnostic categories.</p><p><strong>KHC: Do you think there's any sort of risk with adding those biological factors into the DSM? </strong></p><p><strong>AK:</strong> I don't think so, because if you think about genetics, it's not going to be introduced as a biological test.</p><p>Most folks know that mental disorders, like other medical disorders, run in families. And genetics is the most plausible explanation for that. What this does, I hope, is introduce a degree of more comprehensive description of these disorders. So when a busy clinician looks at it, it confirms what they already suspected: There's a family history here, and family history means genetics.</p><p>It's complex, many genes are involved, and it produces a better characterization of this. The diagnosis is still going to remain clinical, but this provides a biological context, very much like, say, diabetes or heart disease.</p><p>Genes and environment cause a variety of medical disorders. With heart disease, there's no one gene. When cardiologists develop a risk profile for heart disease, it includes genes, other physiological factors such as <a href="https://www.livescience.com/bmi-health-weight"><u>BMI</u></a>, which is the weight-height ratio, diet and a variety of environmental factors.</p><p>That degree of classification is missing today in mental health and psychiatry. We hope this is a first step in correcting, if you will, those conceptions about what causes these disorders.</p><p><strong>KHC: How would you end up using this in a psychiatrist's office to guide treatment?</strong></p><p><strong>AK:</strong> I can give you one possible example. I'm reaching a bit.</p><p>There's a term commonly used in clinical psychiatry and psychology called <a href="https://my.clevelandclinic.org/health/articles/comorbidities" target="_blank"><u>comorbidity</u></a>. What it means is that people who are diagnosed with depression also have anxiety, or people who are diagnosed with an anxiety disorder also have substance abuse or alcoholism in general.</p><p>That is not coincidental. It's not something that we just somehow find. A lot of these disorders share genes.</p><p>For example, about<a href="https://pubmed.ncbi.nlm.nih.gov/26249302/" target="_blank"><u> 45%, roughly, of patients diagnosed with a major mood disorder</u></a> also have an anxiety disorder. And you flip that around: About 45%, roughly, of patients <a href="https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030305" target="_blank"><u>diagnosed with an anxiety disorder</u></a> — it could be generalized anxiety disorder, what we call PTSD, or a <a href="https://www.livescience.com/human-behavior/what-counts-as-a-phobia"><u>phobia</u></a> — also have a mood disorder.</p><figure class="van-image-figure  full-width-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' ><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="ukfnSEFsahRHmbsUM5GRFh" name="depression-neanderthal-GettyImages-1510833199.jpg" alt="A photograph of a woman looking sad and gazing out a window." src="https://cdn.mos.cms.futurecdn.net/ukfnSEFsahRHmbsUM5GRFh-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="full-width expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ukfnSEFsahRHmbsUM5GRFh-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" full-width-layout"><span class="caption-text"> Patients with anxiety may also be diagnosed with a mood disorder.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: MementoJpeg via Getty Images)</span></figcaption></figure><p>I think when clinicians classify them together, not as the same disorder but as sharing a lot of psychological as well as genetic risk, clinicians should be on the lookout for both. A patient with a mood disorder, for example, could either now or at some later point develop an anxiety disorder. Or someone with an anxiety disorder is at risk for substance abuse.</p><p>So treatments need to be tailored a little more broadly. I'm hoping that'll be something clinicians think about when they talk to patients and their families.</p><p><strong>KHC: What do you think is the most unique aspect, from your perspective, of this upcoming DSM-6?</strong></p><p><strong>AK:</strong> My bias is the biology. I say this because a lot of the other things, the cultural factors, etc., are largely appreciated, and they'll be better characterized. Some things like cognitive changes, such as working memory and attention [tests], are not unique to any given disorder.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/adversity-shaped-our-evolution-as-a-species-people-raised-in-it-may-have-underrecognized-strengths-because-of-it">Adversity shaped our evolution as a species. People raised in it may have underrecognized strengths because of it.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/ancient-alien-like-skulls-have-been-found-on-every-continent-but-antarctica-anthropologists-are-starting-to-figure-out-why">Ancient 'alien-like' skulls have been found on every continent but Antarctica. Anthropologists are starting to figure out why.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/could-psilocybin-treat-brain-injuries-neuroscientist-explains-how-psychedelics-could-fill-a-gap-in-head-trauma-care">Could psilocybin treat brain injuries? Neuroscientist explains how psychedelics could fill a gap in head trauma care</a></li></ul></p></div></div><p>Biology will be qualitatively new when introduced into the DSM, and I hope it's done well. I hope that they do it appropriately, and I think they will [do it] correctly.</p><p>It's not going to be perfect, but it's going to be a first step. I think introducing the idea that genetics, immunology and other factors are very important in the causation of mental disorders, and explain some of the phenomena that we previously could not find an explanation for, is — I hate to use the word "leapfrog" — but that's kind of what it is.</p><p>It moves the field conceptually forward, and not as a slow, steady, gradual increase. For the DSM, it would be an important step forward.</p><p><em>This interview has been condensed and edited lightly for clarity.</em></p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Neuroscientists reveal method to train people to have lucid dreams — and it involves virtual reality and meditation ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Lucid dreaming — in which the dreamer is aware that they are dreaming and can sometimes influence the dream's trajectory — is a skill that can be honed, a new study finds. And the researchers found that doing this is surprisingly easy, after training participants to do exactly that using virtual reality (VR) twice a week for just one month.</p><p>The study's results could have practical benefits, said <a href="https://danieljacobmorris.com/" target="_blank"><u>Daniel Morris</u></a>, a cognitive neuroscientist at Northwestern University who studies dreams and was not involved with the work. "Lucid dreaming can benefit people with nightmares by allowing them to transform their nightmares into positive dreams and feel greater agency in their dreams," Morris told Live Science in an email.</p><p>Before this study, published Sept. 28 in the journal <a href="https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2026.1924370/full" target="_blank"><u>Frontiers in Psychology</u></a>, neuroscientists tried to induce lucid dreaming with various methods. These included <a href="https://www.mdpi.com/2076-3425/14/5/496" target="_blank"><u>meditation exercises</u></a> and <a href="https://journals.ub.uni-heidelberg.de/index.php/IJoDR/article/view/37498" target="_blank"><u>so-called reality checks</u></a>, in which participants ask themselves while awake whether unusual phenomena they encounter — such as people wearing odd Halloween costumes — are real or if they're dreaming. The idea is that they will ask themselves the same question in their sleep during bizarre dreams. </p><p>However, "for most people, our day-to-day lives may not feel 'dream-like,'" Morris said, explaining why reality checks have had mixed results and don't reliably trigger lucid dreaming.</p><p>Since dream-like scenarios are rare in waking life, the neuroscientists behind the new study used <a href="https://centrostudiubi.it/en/activities/research/luciddreamingvr/" target="_blank"><u>VR simulations of bizarre situations</u></a> to complement reality-check exercises. </p><p>The team, based at the University of Trento in Italy, recruited university students and asked them to meditate and then perform the VR training. The meditation was intended to increase students' awareness of what they were thinking about in a given moment. Each time they encountered bizarre happenings in the VR environment, such as objects or people violating laws of physics or rapid switches from one scene to another, they performed reality checks.</p><p>After the training, participants went home and were asked to keep a dream diary that they wrote in every morning. They also filled out daily questionnaires, citing the number of dreams they recalled and how many they remembered being lucid.</p><p>The participants experienced lucid dreams four times more often than participants did in a second group that did reality checks without performing any meditation or VR training. The study also included another comparison group, in which participants carried out reality checks during realistic rather than dream-like VR simulations; these participants were over eight times less likely to report lucid dreams. This latter comparison ensured that the results were not caused solely by the use of VR, the researchers said.</p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2180px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="eYDZFgrxe46ZEsKTticXzA" name="Figure2_D" alt="A virtual reality view of two hands holding a sword looking at a tree blocking a door." src="https://cdn.mos.cms.futurecdn.net/eYDZFgrxe46ZEsKTticXzA-1920-80.jpg" mos="" align="left" fullscreen="1" width="2180" height="2180" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/eYDZFgrxe46ZEsKTticXzA-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">When participants encountered something strange, like branches covering a door, they actively asked themselves whether it was real. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of the Italian Buddhist Union Research Center, CC BY license)</span></figcaption></figure><p>It was particularly surprising to find that such little training with the dream-like VR simulations was needed to develop lucid dreaming as a skill, said study co-author <a href="https://webapps.unitn.it/du/en/Persona/PER0039682/Curriculum" target="_blank"><u>Nicola De Pisapia</u></a>, a neuroscientist at the University of Trento. His team ran the experiment for only a month because any longer would have been too demanding for the participants, De Pisapia noted. </p><p>Study co-author <a href="https://webapps.unitn.it/du/en/Persona/PER0280526/Pubblicazioni" target="_blank"><u>Andrea Signorelli</u></a>, a doctoral student in De Pisapia's lab, thinks the VR intervention is at the heart of why the approach worked. People often don't realize that they're dreaming because the dreams "fool" your senses and feel realistic in the moment, he explained. </p><p>"Virtual reality is the technology to fool you on stereoscopic vision and auditory information," he said. The term "stereoscopic" refers to techniques that create 3D illusions from 2D images by mimicking how human eyes see. </p><p>"It's basically the most immersive technology that we have at the moment," making it a good intervention for reality check exercises, Signorelli said.</p><p>The team also compared the number of lucid dreams participants reported against their total number of recalled dreams, which revealed an interesting pattern. On average, participants in each group recalled more dreams after starting the experiment than they did beforehand. However, the dream-simulating VR group recalled the fewest dreams overall after entering the experiment, even though they had the highest number of lucid dreams.</p><p>Signorelli speculated that perhaps it takes a lot of energy to have lucid dreams, which could divert resources away from recalling other dreams. Morris argued that, alternatively, participants in the lucid-dream VR group "may have been less motivated to report non-lucid dreams than the control groups." So there may have been some bias in the reporting.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/technology/virtual-reality/ultrasonic-headband-induces-lucid-dreams-using-ai-its-creators-claim-but-an-expert-remains-skeptical">Ultrasonic headband induces lucid dreams using AI, its creators claim — but an expert remains skeptical</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/sleep/scientists-infiltrated-volunteers-dreams-to-boost-their-creative-thinking">Scientists infiltrated volunteers' dreams to boost their creative thinking</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/real-time-communication-while-dreaming.html">Lucid dreamers can hear and answer questions while still asleep, scientists find</a></li></ul></p></div></div><p>The study had some limitations, such as its small sample size of 38 participants. Plus, neither of the two control groups were asked to meditate, so it is impossible to say whether the meditations or the dreamlike VR sessions had more influence over lucid dreaming in the test group. </p><p>The team is now doing a follow-up study in which the meditation part has been removed, Signorelli said, to reveal whether the VR dream scenarios are the critical factor, as suspected.</p><p>Signorelli said that he would like to see lucid-dream training tailored for each individual. For example, the VR simulations could be personalized to simulate a recurrent nightmare that a given person experiences, training them to recognize triggers specific to that dream, he said. </p><p>"Other future research could explore the potential therapeutic benefits of this intervention for people with nightmares, anxiety, or PTSD [post-traumatic stress disorder]," Morris suggested.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>How much do you know about sleep and dreams? Find out with our </strong><a href="https://www.livescience.com/health/sleep/science-of-sleep-quiz-how-much-do-you-know-about-sleep-and-dreams?hasComeFromProof=true"><u><strong>sleep quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-OL6JJe"></div>                            </div>                            <script src="https://kwizly.com/embed/OL6JJe.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/neuroscientists-reveal-method-to-train-people-to-have-lucid-dreams-and-it-involves-virtual-reality-and-mediation</link>
                                                                            <description>
                            <![CDATA[ People who had no recollection of a lucid dream over the past three years developed the skill after one month of performing a novel training regimen twice a week, neuroscientists report. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Xx48ogLf6ZQJqRRtYwiEw7</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/JbTarwH24z4CPsHjZGNwJN-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 30 Oct 2026 17:30:00 +0000</pubDate>                                                                                                                                <updated>Fri, 30 Oct 2026 19:59:31 +0000</updated>
                                                                                                                                            <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kamal Nahas ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/2TwzMZ2d3eigSWAthQ26QW-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/JbTarwH24z4CPsHjZGNwJN-1920-80.jpg">
                                                            <media:credit><![CDATA[Courtesy of the Italian Buddhist Union Research Center, CC BY license]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Researchers used dream-like VR simulations to train people to lucid dream. The simulations contained odd things, like a house in a tree.]]></media:description>                                                            <media:text><![CDATA[A cartoon image of a house in a large tree.]]></media:text>
                                <media:title type="plain"><![CDATA[A cartoon image of a house in a large tree.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/JbTarwH24z4CPsHjZGNwJN-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Lucid dreaming — in which the dreamer is aware that they are dreaming and can sometimes influence the dream's trajectory — is a skill that can be honed, a new study finds. And the researchers found that doing this is surprisingly easy, after training participants to do exactly that using virtual reality (VR) twice a week for just one month.</p><p>The study's results could have practical benefits, said <a href="https://danieljacobmorris.com/" target="_blank"><u>Daniel Morris</u></a>, a cognitive neuroscientist at Northwestern University who studies dreams and was not involved with the work. "Lucid dreaming can benefit people with nightmares by allowing them to transform their nightmares into positive dreams and feel greater agency in their dreams," Morris told Live Science in an email.</p><p>Before this study, published Sept. 28 in the journal <a href="https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2026.1924370/full" target="_blank"><u>Frontiers in Psychology</u></a>, neuroscientists tried to induce lucid dreaming with various methods. These included <a href="https://www.mdpi.com/2076-3425/14/5/496" target="_blank"><u>meditation exercises</u></a> and <a href="https://journals.ub.uni-heidelberg.de/index.php/IJoDR/article/view/37498" target="_blank"><u>so-called reality checks</u></a>, in which participants ask themselves while awake whether unusual phenomena they encounter — such as people wearing odd Halloween costumes — are real or if they're dreaming. The idea is that they will ask themselves the same question in their sleep during bizarre dreams. </p><p>However, "for most people, our day-to-day lives may not feel 'dream-like,'" Morris said, explaining why reality checks have had mixed results and don't reliably trigger lucid dreaming.</p><p>Since dream-like scenarios are rare in waking life, the neuroscientists behind the new study used <a href="https://centrostudiubi.it/en/activities/research/luciddreamingvr/" target="_blank"><u>VR simulations of bizarre situations</u></a> to complement reality-check exercises. </p><p>The team, based at the University of Trento in Italy, recruited university students and asked them to meditate and then perform the VR training. The meditation was intended to increase students' awareness of what they were thinking about in a given moment. Each time they encountered bizarre happenings in the VR environment, such as objects or people violating laws of physics or rapid switches from one scene to another, they performed reality checks.</p><p>After the training, participants went home and were asked to keep a dream diary that they wrote in every morning. They also filled out daily questionnaires, citing the number of dreams they recalled and how many they remembered being lucid.</p><p>The participants experienced lucid dreams four times more often than participants did in a second group that did reality checks without performing any meditation or VR training. The study also included another comparison group, in which participants carried out reality checks during realistic rather than dream-like VR simulations; these participants were over eight times less likely to report lucid dreams. This latter comparison ensured that the results were not caused solely by the use of VR, the researchers said.</p><figure class="van-image-figure pull-left inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2180px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="eYDZFgrxe46ZEsKTticXzA" name="Figure2_D" alt="A virtual reality view of two hands holding a sword looking at a tree blocking a door." src="https://cdn.mos.cms.futurecdn.net/eYDZFgrxe46ZEsKTticXzA-1920-80.jpg" mos="" align="left" fullscreen="1" width="2180" height="2180" attribution="" endorsement="" class="pull-leftinline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/eYDZFgrxe46ZEsKTticXzA-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class="pull-left inline-layout"><span class="caption-text">When participants encountered something strange, like branches covering a door, they actively asked themselves whether it was real. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Courtesy of the Italian Buddhist Union Research Center, CC BY license)</span></figcaption></figure><p>It was particularly surprising to find that such little training with the dream-like VR simulations was needed to develop lucid dreaming as a skill, said study co-author <a href="https://webapps.unitn.it/du/en/Persona/PER0039682/Curriculum" target="_blank"><u>Nicola De Pisapia</u></a>, a neuroscientist at the University of Trento. His team ran the experiment for only a month because any longer would have been too demanding for the participants, De Pisapia noted. </p><p>Study co-author <a href="https://webapps.unitn.it/du/en/Persona/PER0280526/Pubblicazioni" target="_blank"><u>Andrea Signorelli</u></a>, a doctoral student in De Pisapia's lab, thinks the VR intervention is at the heart of why the approach worked. People often don't realize that they're dreaming because the dreams "fool" your senses and feel realistic in the moment, he explained. </p><p>"Virtual reality is the technology to fool you on stereoscopic vision and auditory information," he said. The term "stereoscopic" refers to techniques that create 3D illusions from 2D images by mimicking how human eyes see. </p><p>"It's basically the most immersive technology that we have at the moment," making it a good intervention for reality check exercises, Signorelli said.</p><p>The team also compared the number of lucid dreams participants reported against their total number of recalled dreams, which revealed an interesting pattern. On average, participants in each group recalled more dreams after starting the experiment than they did beforehand. However, the dream-simulating VR group recalled the fewest dreams overall after entering the experiment, even though they had the highest number of lucid dreams.</p><p>Signorelli speculated that perhaps it takes a lot of energy to have lucid dreams, which could divert resources away from recalling other dreams. Morris argued that, alternatively, participants in the lucid-dream VR group "may have been less motivated to report non-lucid dreams than the control groups." So there may have been some bias in the reporting.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/technology/virtual-reality/ultrasonic-headband-induces-lucid-dreams-using-ai-its-creators-claim-but-an-expert-remains-skeptical">Ultrasonic headband induces lucid dreams using AI, its creators claim — but an expert remains skeptical</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/sleep/scientists-infiltrated-volunteers-dreams-to-boost-their-creative-thinking">Scientists infiltrated volunteers' dreams to boost their creative thinking</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/real-time-communication-while-dreaming.html">Lucid dreamers can hear and answer questions while still asleep, scientists find</a></li></ul></p></div></div><p>The study had some limitations, such as its small sample size of 38 participants. Plus, neither of the two control groups were asked to meditate, so it is impossible to say whether the meditations or the dreamlike VR sessions had more influence over lucid dreaming in the test group. </p><p>The team is now doing a follow-up study in which the meditation part has been removed, Signorelli said, to reveal whether the VR dream scenarios are the critical factor, as suspected.</p><p>Signorelli said that he would like to see lucid-dream training tailored for each individual. For example, the VR simulations could be personalized to simulate a recurrent nightmare that a given person experiences, training them to recognize triggers specific to that dream, he said. </p><p>"Other future research could explore the potential therapeutic benefits of this intervention for people with nightmares, anxiety, or PTSD [post-traumatic stress disorder]," Morris suggested.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>How much do you know about sleep and dreams? Find out with our </strong><a href="https://www.livescience.com/health/sleep/science-of-sleep-quiz-how-much-do-you-know-about-sleep-and-dreams?hasComeFromProof=true"><u><strong>sleep quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-OL6JJe"></div>                            </div>                            <script src="https://kwizly.com/embed/OL6JJe.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Nearly 30% of US adults admit to lying about or exaggerating their symptoms to get antibiotics from doctors, survey finds ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Nearly 30% of U.S. adults have lied to doctors in an effort to obtain antibiotics, either by exaggerating their actual symptoms or by fabricating symptoms, the results of a new national survey suggest. Additionally, in a second survey, about one-quarter of children's caregivers reported lying about their kids' symptoms to get antibiotics on their behalf.</p><p>"As clinicians, we know that patients lie to us sometimes," <a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=37195" target="_blank"><u>Dr. Jeffrey Linder</u></a>, a general internist and primary care clinician-investigator at Northwestern Medicine, wrote in a <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.39549?guestAccessKey=593c7f33-9a82-4ea4-a539-23031164ea28" target="_blank"><u>commentary about the survey findings</u></a>. </p><p>However, the results are still important because the inappropriate use of antibiotics can contribute to the mounting problem of <a href="https://www.livescience.com/health/medicine-drugs/its-real-and-its-happening-antibiotic-resistance-in-kids-is-rising-around-the-world-massive-study-finds"><u>antibiotic resistance</u></a>, in which bacteria build up a tolerance to the drugs designed to kill them. Recent data <a href="https://arpsp.cdc.gov/artr" target="_blank"><u>released by the Centers for Disease Control and Prevention</u></a> (CDC) highlight the extent of the problem: In 2023, drug-resistant bacteria and fungi caused about 9.7 million infections in the U.S., up from <a href="https://www.cidrap.umn.edu/candida-auris/cdc-spotlights-deadly-threat-antibiotic-resistance" target="_blank"><u>2.8 million in 2017</u></a>. In turn, the estimated number of deaths caused by drug-resistant germs rose from 35,000 to 50,800 between the two years. </p><p>A major factor driving resistance among bacteria is the misuse of antibiotics — in other words, using antibiotics for ailments like viral infections, which the drugs do not treat. For individual patients, such prescriptions don't cure their illness and can result in an upset stomach or issues with the <a href="https://www.livescience.com/health/scientists-unveil-atlas-of-the-gut-microbiome"><u>gut microbiome</u></a>, the community of microbes in the intestines. Simultaneously, they place extra pressure on bacteria to evolve resistance, granting the germs opportunities to pick up new strategies for thwarting antibiotics.</p><p>Doctors play a big role in ensuring that the antibiotic prescriptions they write are necessary. Part of their decision-making process comes down to what patients say about their symptoms, some of which may be fabricated, the two new surveys suggest.</p><h2 id="motivations-for-lying">Motivations for lying</h2><p>The new surveys were published Friday (Oct. 30) in the journal JAMA Network Open.</p><p><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.39559?guestAccessKey=e5eb1c33-dac9-4391-8dc8-959322ef1289" target="_blank"><u>The first survey</u></a> was completed by nearly 960 adults from across the U.S. in January and February 2026. It asked whether the respondents had ever told a healthcare provider that their symptoms were worse or more long-lasting than they were in order to get antibiotics, as well as whether they'd ever made up symptoms for the same reason. It then inquired about what motivated a given patient to lie — or avoid lying, if they were truthful — as well as posed contextual questions about their demographics, health behaviors and beliefs.</p><p>Overall, about 28% of the respondents reported misrepresenting their symptoms, including 26% who exaggerated their existing symptoms and 17% who fabricated symptoms. They most frequently lied about cold-like symptoms, such as fever, cough and sore throat. About two-thirds of these patients were at least moderately confident that their lie would motivate a clinician to prescribe them antibiotics, and 77% said the strategy worked for them at least once.</p><p>Often, patients' motivations for lying centered around feeling very sick, holding strong beliefs that antibiotics would help them recover quickly and get back to their responsibilities, and wanting control over the treatments prescribed to them. Compared with people who didn't lie, those who lied were also more likely to feel that clinicians didn't take them seriously or more likely to endorse statements suggesting that antibiotic resistance is a hoax.</p><p>"Greater antibiotic knowledge and aversion to taking antibiotics were associated with lower odds of misrepresentation," meaning lying about symptoms, the study authors noted.</p><p>Less than 30% of these patients regretted their lies or taking the antibiotics prescribed to them. Those that did express regret noted experiencing side effects, noticing that the treatment didn't help or feeling that the lying itself was morally wrong.</p><p><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.39564?guestAccessKey=2eb00cff-66ea-45ed-aecf-f824f53bdae4" target="_blank"><u>The second survey was much smaller</u></a>; it included 236 parents and other guardians of children and teens under 18 years old. It posed similar questions but asked whether the caregivers had lied about their children's symptoms and, if so, what motivated them to lie. </p><p>About 27% reported lying about a child's symptoms to get antibiotics, with 87% of these caregivers believing that their lying worked at least once. Their reasons for lying were very similar to those expressed by the respondents in the first survey.</p><p>"These findings suggest that symptom misrepresentation may contribute to antibiotic overuse in pediatric care," the study authors concluded.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="TkH6P2KSxmiEkaFD74p86b" name="16810_lores.jpg" alt="MRSA, an antibiotic-resistant superbug, often infects people receiving care in hospitals." src="https://cdn.mos.cms.futurecdn.net/TkH6P2KSxmiEkaFD74p86b-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/TkH6P2KSxmiEkaFD74p86b-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Ideally, antibiotics should be used only when truly needed, to help relieve the pressure on bacteria to gain resistance. </span><span class="credit" itemprop="copyrightHolder">(Image credit: CDC/ Melissa Dankel)</span></figcaption></figure><p>The surveys reached a diverse group of people, including a range of ages, demographics and locations within the United States; however, the respondents were not necessarily representative of the whole U.S. population, the authors noted. The prevalence of lying should therefore be seen as a tentative measure to be checked in future studies, rather than an unbiased, population-level metric, they wrote. It's also possible that not all the respondents who lied disclosed that they did so or remembered that they had done so.</p><h2 id="doctors-are-still-the-gatekeepers">Doctors are still the gatekeepers</h2><p>Especially in outpatient settings, which account for most antibiotic use among U.S. patients, it can be difficult for doctors to quickly determine whether a patient needs an antibiotic.</p><p>One factor is that there's a lack of fast, surefire diagnostic tests for many bacterial infections. Outpatient appointments are also extremely short, so doctors sometimes worry about overlooking an infection that could then get worse, <a href="https://medicine.utah.edu/faculty/julia-e-szymczak" target="_blank"><u>Julia Szymczak</u></a>, a medical sociologist at the University of Utah School of Medicine, <a href="https://www.livescience.com/health/medicine-drugs/800-seconds-for-a-sick-visit-some-factors-driving-antibiotic-resistance-have-nothing-to-do-with-biology-says-medical-sociologist-julia-szymczak"><u>previously told Live Science</u></a>. Another major factor is that <a href="https://www.livescience.com/health/medicine-drugs/they-didnt-question-it-why-doctors-prescribe-too-many-antibiotics"><u>clinicians can face pressure to prescribe antibiotics</u></a> from their adult patients or from children's caregivers, as the new surveys reflect.</p><p>But in the face of these pressures and patients' occasional lies, Linder argues that it's still up to the clinicians to do the right thing. "While clinicians might interpret patients' symptom maximization and questions as demands for antibiotics, symptoms do not determine the indication, a diagnosis does," he wrote in the commentary.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/japans-bold-experiment-to-curb-antibiotic-misuse-has-been-a-huge-success-could-it-work-in-the-us">Japan's bold experiment to curb antibiotic misuse has been a huge success. Could it work in the US?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/even-when-knowledge-improves-emotional-anxiety-does-not-easily-disappear-pediatrician-dr-masahiko-sakamoto-on-educating-parents-about-childhood-illnesses">'Teach me! Doctor': Meet the pediatrician on a mission to boost parents' knowledge of childhood illnesses</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/what-the-us-could-learn-from-japans-incentive-for-responsible-antibiotic-use">What the US could learn from Japan's incentive for responsible antibiotic use</a></li></ul></p></div></div><p>"It does not track that approximately 80% of respondents who reported misrepresenting their symptoms obtained a prescription," he added, "unless prescribers were being willfully deceived or, more likely, just getting worn down with what they perceive as patient demand, regardless of actual clinical appropriateness."</p><p>When it comes to making decisions about individual patients, Linder argued that doctors don't necessarily need to think about the big picture of antibiotic resistance and how their patient's case fits into that global trend. Rather, providers should simply ask whether a given prescription is more likely to help or hurt that patient, he said.</p><p>"Clinicians' obligation is to act in patients' best interest," he said, "even if patients are hoping we do something different, even if patients do not like it, or even if patients lie about their symptoms."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/medicine-drugs/nearly-30-percent-of-us-adults-admit-to-lying-about-or-exaggerating-their-symptoms-to-get-antibiotics-from-doctors-survey-finds</link>
                                                                            <description>
                            <![CDATA[ In two new surveys, U.S. adults report lying to their doctors and their children's doctors about symptoms in hopes of being prescribed antibiotics. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">xsxDfCse256rACBMoQSwkf</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/7HbiRHLEn5o96CNhuEZ6v6-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 30 Oct 2026 15:00:00 +0000</pubDate>                                                                                                                                <updated>Fri, 30 Oct 2026 19:09:39 +0000</updated>
                                                                                                                                            <category><![CDATA[Medicine & Drugs]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/7HbiRHLEn5o96CNhuEZ6v6-1920-80.jpg">
                                                            <media:credit><![CDATA[PhotoAlto/Milena Boniek via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[New surveys suggest that, when speaking with doctors, some patients will misrepresent the symptoms they&amp;#39;re experiencing in an attempt to get antibiotics.]]></media:description>                                                            <media:text><![CDATA[A man wearing a lab coat and stethoscope stands over a man in a maroon shirt]]></media:text>
                                <media:title type="plain"><![CDATA[A man wearing a lab coat and stethoscope stands over a man in a maroon shirt]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/7HbiRHLEn5o96CNhuEZ6v6-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Nearly 30% of U.S. adults have lied to doctors in an effort to obtain antibiotics, either by exaggerating their actual symptoms or by fabricating symptoms, the results of a new national survey suggest. Additionally, in a second survey, about one-quarter of children's caregivers reported lying about their kids' symptoms to get antibiotics on their behalf.</p><p>"As clinicians, we know that patients lie to us sometimes," <a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=37195" target="_blank"><u>Dr. Jeffrey Linder</u></a>, a general internist and primary care clinician-investigator at Northwestern Medicine, wrote in a <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.39549?guestAccessKey=593c7f33-9a82-4ea4-a539-23031164ea28" target="_blank"><u>commentary about the survey findings</u></a>. </p><p>However, the results are still important because the inappropriate use of antibiotics can contribute to the mounting problem of <a href="https://www.livescience.com/health/medicine-drugs/its-real-and-its-happening-antibiotic-resistance-in-kids-is-rising-around-the-world-massive-study-finds"><u>antibiotic resistance</u></a>, in which bacteria build up a tolerance to the drugs designed to kill them. Recent data <a href="https://arpsp.cdc.gov/artr" target="_blank"><u>released by the Centers for Disease Control and Prevention</u></a> (CDC) highlight the extent of the problem: In 2023, drug-resistant bacteria and fungi caused about 9.7 million infections in the U.S., up from <a href="https://www.cidrap.umn.edu/candida-auris/cdc-spotlights-deadly-threat-antibiotic-resistance" target="_blank"><u>2.8 million in 2017</u></a>. In turn, the estimated number of deaths caused by drug-resistant germs rose from 35,000 to 50,800 between the two years. </p><p>A major factor driving resistance among bacteria is the misuse of antibiotics — in other words, using antibiotics for ailments like viral infections, which the drugs do not treat. For individual patients, such prescriptions don't cure their illness and can result in an upset stomach or issues with the <a href="https://www.livescience.com/health/scientists-unveil-atlas-of-the-gut-microbiome"><u>gut microbiome</u></a>, the community of microbes in the intestines. Simultaneously, they place extra pressure on bacteria to evolve resistance, granting the germs opportunities to pick up new strategies for thwarting antibiotics.</p><p>Doctors play a big role in ensuring that the antibiotic prescriptions they write are necessary. Part of their decision-making process comes down to what patients say about their symptoms, some of which may be fabricated, the two new surveys suggest.</p><h2 id="motivations-for-lying">Motivations for lying</h2><p>The new surveys were published Friday (Oct. 30) in the journal JAMA Network Open.</p><p><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.39559?guestAccessKey=e5eb1c33-dac9-4391-8dc8-959322ef1289" target="_blank"><u>The first survey</u></a> was completed by nearly 960 adults from across the U.S. in January and February 2026. It asked whether the respondents had ever told a healthcare provider that their symptoms were worse or more long-lasting than they were in order to get antibiotics, as well as whether they'd ever made up symptoms for the same reason. It then inquired about what motivated a given patient to lie — or avoid lying, if they were truthful — as well as posed contextual questions about their demographics, health behaviors and beliefs.</p><p>Overall, about 28% of the respondents reported misrepresenting their symptoms, including 26% who exaggerated their existing symptoms and 17% who fabricated symptoms. They most frequently lied about cold-like symptoms, such as fever, cough and sore throat. About two-thirds of these patients were at least moderately confident that their lie would motivate a clinician to prescribe them antibiotics, and 77% said the strategy worked for them at least once.</p><p>Often, patients' motivations for lying centered around feeling very sick, holding strong beliefs that antibiotics would help them recover quickly and get back to their responsibilities, and wanting control over the treatments prescribed to them. Compared with people who didn't lie, those who lied were also more likely to feel that clinicians didn't take them seriously or more likely to endorse statements suggesting that antibiotic resistance is a hoax.</p><p>"Greater antibiotic knowledge and aversion to taking antibiotics were associated with lower odds of misrepresentation," meaning lying about symptoms, the study authors noted.</p><p>Less than 30% of these patients regretted their lies or taking the antibiotics prescribed to them. Those that did express regret noted experiencing side effects, noticing that the treatment didn't help or feeling that the lying itself was morally wrong.</p><p><a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.39564?guestAccessKey=2eb00cff-66ea-45ed-aecf-f824f53bdae4" target="_blank"><u>The second survey was much smaller</u></a>; it included 236 parents and other guardians of children and teens under 18 years old. It posed similar questions but asked whether the caregivers had lied about their children's symptoms and, if so, what motivated them to lie. </p><p>About 27% reported lying about a child's symptoms to get antibiotics, with 87% of these caregivers believing that their lying worked at least once. Their reasons for lying were very similar to those expressed by the respondents in the first survey.</p><p>"These findings suggest that symptom misrepresentation may contribute to antibiotic overuse in pediatric care," the study authors concluded.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="TkH6P2KSxmiEkaFD74p86b" name="16810_lores.jpg" alt="MRSA, an antibiotic-resistant superbug, often infects people receiving care in hospitals." src="https://cdn.mos.cms.futurecdn.net/TkH6P2KSxmiEkaFD74p86b-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/TkH6P2KSxmiEkaFD74p86b-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Ideally, antibiotics should be used only when truly needed, to help relieve the pressure on bacteria to gain resistance. </span><span class="credit" itemprop="copyrightHolder">(Image credit: CDC/ Melissa Dankel)</span></figcaption></figure><p>The surveys reached a diverse group of people, including a range of ages, demographics and locations within the United States; however, the respondents were not necessarily representative of the whole U.S. population, the authors noted. The prevalence of lying should therefore be seen as a tentative measure to be checked in future studies, rather than an unbiased, population-level metric, they wrote. It's also possible that not all the respondents who lied disclosed that they did so or remembered that they had done so.</p><h2 id="doctors-are-still-the-gatekeepers">Doctors are still the gatekeepers</h2><p>Especially in outpatient settings, which account for most antibiotic use among U.S. patients, it can be difficult for doctors to quickly determine whether a patient needs an antibiotic.</p><p>One factor is that there's a lack of fast, surefire diagnostic tests for many bacterial infections. Outpatient appointments are also extremely short, so doctors sometimes worry about overlooking an infection that could then get worse, <a href="https://medicine.utah.edu/faculty/julia-e-szymczak" target="_blank"><u>Julia Szymczak</u></a>, a medical sociologist at the University of Utah School of Medicine, <a href="https://www.livescience.com/health/medicine-drugs/800-seconds-for-a-sick-visit-some-factors-driving-antibiotic-resistance-have-nothing-to-do-with-biology-says-medical-sociologist-julia-szymczak"><u>previously told Live Science</u></a>. Another major factor is that <a href="https://www.livescience.com/health/medicine-drugs/they-didnt-question-it-why-doctors-prescribe-too-many-antibiotics"><u>clinicians can face pressure to prescribe antibiotics</u></a> from their adult patients or from children's caregivers, as the new surveys reflect.</p><p>But in the face of these pressures and patients' occasional lies, Linder argues that it's still up to the clinicians to do the right thing. "While clinicians might interpret patients' symptom maximization and questions as demands for antibiotics, symptoms do not determine the indication, a diagnosis does," he wrote in the commentary.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/japans-bold-experiment-to-curb-antibiotic-misuse-has-been-a-huge-success-could-it-work-in-the-us">Japan's bold experiment to curb antibiotic misuse has been a huge success. Could it work in the US?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/even-when-knowledge-improves-emotional-anxiety-does-not-easily-disappear-pediatrician-dr-masahiko-sakamoto-on-educating-parents-about-childhood-illnesses">'Teach me! Doctor': Meet the pediatrician on a mission to boost parents' knowledge of childhood illnesses</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/what-the-us-could-learn-from-japans-incentive-for-responsible-antibiotic-use">What the US could learn from Japan's incentive for responsible antibiotic use</a></li></ul></p></div></div><p>"It does not track that approximately 80% of respondents who reported misrepresenting their symptoms obtained a prescription," he added, "unless prescribers were being willfully deceived or, more likely, just getting worn down with what they perceive as patient demand, regardless of actual clinical appropriateness."</p><p>When it comes to making decisions about individual patients, Linder argued that doctors don't necessarily need to think about the big picture of antibiotic resistance and how their patient's case fits into that global trend. Rather, providers should simply ask whether a given prescription is more likely to help or hurt that patient, he said.</p><p>"Clinicians' obligation is to act in patients' best interest," he said, "even if patients are hoping we do something different, even if patients do not like it, or even if patients lie about their symptoms."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Study reveals new clues to why colorectal cancer in young people is so deadly ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Colorectal cancer rates have been rising in people under 50 since the mid-1990s. These early-onset cancers tend to be more aggressive and resistant to treatment than cancers in older adults — and now, scientists may be learning why. </p><p>A new study published Thursday (Oct. 29) in the journal <a href="https://doi.org/10.1038/s41591-026-04721-y" target="_blank"><u>Nature Medicine</u></a> compared colorectal tumors from people between 29 and over 90 years old, and it revealed key differences between young and old patients. </p><p>The new findings might, in turn, help scientists uncover new ways to fight colorectal cancer in young people, said study co-author <a href="https://immunologyphd.hms.harvard.edu/people/ana-anderson" target="_blank"><u>Ana Anderson</u></a>, a professor of neurology at Harvard Medical School and a core faculty member of the Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital. </p><p>"I believe that our study is essentially a turning point now in the field," Anderson told Live Science. "Because up until now, we've had more questions than answers."</p><p>Many questions surround early-onset colorectal cancer, as the disease is <a href="https://www.livescience.com/health/cancer/more-young-people-are-getting-colorectal-cancer-heres-what-scientists-think-might-be-happening"><u>rising in people under 50</u></a> even as it falls in older populations. It's now the <a href="https://www.livescience.com/health/cancer/colorectal-cancer-is-now-the-most-common-cause-of-cancer-deaths-in-the-us-for-people-under-50"><u>leading cause of cancer death</u></a> in the U.S. for people under 50, and its numbers are <a href="https://www.livescience.com/health/cancer/colorectal-cancer-cases-in-kids-have-risen-sixfold-over-past-2-decades-researchers-are-racing-to-understand-why"><u>even on the rise among children and adolescents</u></a>.</p><p>Beyond questions about what's driving this uptick in cases, another mystery has been why this disease is so deadly in young people. </p><p>"The clinical data suggests that the disease in the younger patients is more aggressive overall," Anderson said. "The patients, being very healthy otherwise, do not do well with treatment." </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="hfHbxBxMScKsaxgKnH62a3" name="GettyImages-1501122979-patient" alt="A man in a white dotted hospital gown sits in front of an MRI machine" src="https://cdn.mos.cms.futurecdn.net/hfHbxBxMScKsaxgKnH62a3-1920-80.jpg" mos="" align="middle" fullscreen="" width="2000" height="1125" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The reason why colorectal cancer is often aggressive in younger patients hasn't been clear. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Gerardo Huitrón via Getty Images)</span></figcaption></figure><p>To investigate that mystery, Anderson collaborated with <a href="https://www.dana-farber.org/find-a-doctor/kimmie-ng" target="_blank"><u>Dr. Kimmie Ng</u></a>, an oncologist at the Dana-Farber Cancer Institute, and <a href="https://www.broadinstitute.org/bios/ramnik-xavier" target="_blank"><u>Dr. Ramnik Xavier</u></a>, a gastroenterologist at the Broad Institute and Mass General Brigham. They used a method of analyzing <a href="https://www.livescience.com/what-is-RNA.html"><u>RNA</u></a> in cells that allowed them to work with frozen and banked tumor tissue. RNA, a cousin of DNA, reflects the genes that are active in cells. In all, the team analyzed 189 tumors: 54 from patients under 50 and 135 from patients over 50. </p><p>With that many samples, the researchers could look at gradual differences tied to each age group, instead of just comparing tumors between the younger and older groups overall. That enabled them to pinpoint subtle differences, Anderson said. </p><p>For starters, younger people had a higher proportion of connective tissue cells in their tumors than they did of malignant cancer cells. That pattern was flipped in patients of older ages. Having a smaller proportion of malignant cells might sound good, but connective tissue in tumors can secrete compounds that suppress the immune system, Anderson said. That helps protect the tumor from immune cells that might otherwise target its cells for destruction.</p><p>These connective tissue cells can also physically block chemotherapy drugs from getting to the cancerous cells. This could be one reason younger patients' cancers resist treatment, the researchers suggested. </p><p>Based on patterns of gene activity in the tumors, the researchers suspect that younger patients' cancer cells also show distinct activity related to cell-to-cell communication. That may help the cells migrate through the body more easily than cancer cells in older patients do. In other cancers, this kind of gene activity has been linked to more aggressive tumors and a greater chance that the disease will spread, or metastasize, Anderson said. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/11041-10-deadliest-cancers-cure.html">The 10 deadliest cancers, and why there's no cure</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/gut-bacteria-linked-to-colorectal-cancer-in-young-people">Gut bacteria linked to colorectal cancer in young people</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/colon-cancer-risk-in-young-people-linked-to-one-amino-acid">Colon-cancer risk in young people linked to one amino acid, small study finds</a></li></ul></p></div></div><p>The study's results also turned up an intriguing mystery: the presence of lots of long noncoding RNA. These strands of RNA contain more than 200 building blocks, called nucleotides, that don't provide instructions for building proteins. Coding RNA, in contrast, is ferried to protein-building factories in cells to be used as blueprints. </p><p>Scientists don't know what much of this long noncoding RNA does in the body, nor do they understand what it is doing in the tumors specifically. However, they hope to find out. </p><p>Anderson and her team are already working on manipulating the RNA they found inside cancer cells in petri dishes. In time, this line of research could supply another piece of the puzzle, helping scientists understand why colorectal cancer is so aggressive in young people.</p><p>"It's a new avenue for research into this disease that we previously had no idea about," Anderson said. </p><p>This article is for informational purposes only and is not meant to offer medical advice</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/cancer/study-reveals-new-clues-to-why-colorectal-cancer-in-young-people-is-so-deadly</link>
                                                                            <description>
                            <![CDATA[ Colorectal cancer in young people shows genetic and structural differences that may make it more aggressive and treatment-resistant than the cancer tends to be in older people. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">TPfrguaa3mL7FHy5ZjZrhE</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/8A9X96tqvDNiDCYZgJsXpe-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 29 Oct 2026 10:00:00 +0000</pubDate>                                                                                                                                <updated>Fri, 30 Oct 2026 19:09:39 +0000</updated>
                                                                                                                                            <category><![CDATA[Cancer]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                    <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                                                                                    <dc:creator><![CDATA[ Stephanie Pappas ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/syig84DuW9p8R73hBYHxPc-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/8A9X96tqvDNiDCYZgJsXpe-1920-80.jpg">
                                                            <media:credit><![CDATA[ inkoly via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Colorectal cancer is on the rise in people under 50, and scientists think the disease might fundamentally differ in these younger individuals. ]]></media:description>                                                            <media:text><![CDATA[An illustration of the intestinal system with a large spiky red orb on the right side.]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of the intestinal system with a large spiky red orb on the right side.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/8A9X96tqvDNiDCYZgJsXpe-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Colorectal cancer rates have been rising in people under 50 since the mid-1990s. These early-onset cancers tend to be more aggressive and resistant to treatment than cancers in older adults — and now, scientists may be learning why. </p><p>A new study published Thursday (Oct. 29) in the journal <a href="https://doi.org/10.1038/s41591-026-04721-y" target="_blank"><u>Nature Medicine</u></a> compared colorectal tumors from people between 29 and over 90 years old, and it revealed key differences between young and old patients. </p><p>The new findings might, in turn, help scientists uncover new ways to fight colorectal cancer in young people, said study co-author <a href="https://immunologyphd.hms.harvard.edu/people/ana-anderson" target="_blank"><u>Ana Anderson</u></a>, a professor of neurology at Harvard Medical School and a core faculty member of the Gene Lay Institute of Immunology and Inflammation at Brigham and Women's Hospital. </p><p>"I believe that our study is essentially a turning point now in the field," Anderson told Live Science. "Because up until now, we've had more questions than answers."</p><p>Many questions surround early-onset colorectal cancer, as the disease is <a href="https://www.livescience.com/health/cancer/more-young-people-are-getting-colorectal-cancer-heres-what-scientists-think-might-be-happening"><u>rising in people under 50</u></a> even as it falls in older populations. It's now the <a href="https://www.livescience.com/health/cancer/colorectal-cancer-is-now-the-most-common-cause-of-cancer-deaths-in-the-us-for-people-under-50"><u>leading cause of cancer death</u></a> in the U.S. for people under 50, and its numbers are <a href="https://www.livescience.com/health/cancer/colorectal-cancer-cases-in-kids-have-risen-sixfold-over-past-2-decades-researchers-are-racing-to-understand-why"><u>even on the rise among children and adolescents</u></a>.</p><p>Beyond questions about what's driving this uptick in cases, another mystery has been why this disease is so deadly in young people. </p><p>"The clinical data suggests that the disease in the younger patients is more aggressive overall," Anderson said. "The patients, being very healthy otherwise, do not do well with treatment." </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="hfHbxBxMScKsaxgKnH62a3" name="GettyImages-1501122979-patient" alt="A man in a white dotted hospital gown sits in front of an MRI machine" src="https://cdn.mos.cms.futurecdn.net/hfHbxBxMScKsaxgKnH62a3-1920-80.jpg" mos="" align="middle" fullscreen="" width="2000" height="1125" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The reason why colorectal cancer is often aggressive in younger patients hasn't been clear. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Gerardo Huitrón via Getty Images)</span></figcaption></figure><p>To investigate that mystery, Anderson collaborated with <a href="https://www.dana-farber.org/find-a-doctor/kimmie-ng" target="_blank"><u>Dr. Kimmie Ng</u></a>, an oncologist at the Dana-Farber Cancer Institute, and <a href="https://www.broadinstitute.org/bios/ramnik-xavier" target="_blank"><u>Dr. Ramnik Xavier</u></a>, a gastroenterologist at the Broad Institute and Mass General Brigham. They used a method of analyzing <a href="https://www.livescience.com/what-is-RNA.html"><u>RNA</u></a> in cells that allowed them to work with frozen and banked tumor tissue. RNA, a cousin of DNA, reflects the genes that are active in cells. In all, the team analyzed 189 tumors: 54 from patients under 50 and 135 from patients over 50. </p><p>With that many samples, the researchers could look at gradual differences tied to each age group, instead of just comparing tumors between the younger and older groups overall. That enabled them to pinpoint subtle differences, Anderson said. </p><p>For starters, younger people had a higher proportion of connective tissue cells in their tumors than they did of malignant cancer cells. That pattern was flipped in patients of older ages. Having a smaller proportion of malignant cells might sound good, but connective tissue in tumors can secrete compounds that suppress the immune system, Anderson said. That helps protect the tumor from immune cells that might otherwise target its cells for destruction.</p><p>These connective tissue cells can also physically block chemotherapy drugs from getting to the cancerous cells. This could be one reason younger patients' cancers resist treatment, the researchers suggested. </p><p>Based on patterns of gene activity in the tumors, the researchers suspect that younger patients' cancer cells also show distinct activity related to cell-to-cell communication. That may help the cells migrate through the body more easily than cancer cells in older patients do. In other cancers, this kind of gene activity has been linked to more aggressive tumors and a greater chance that the disease will spread, or metastasize, Anderson said. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/11041-10-deadliest-cancers-cure.html">The 10 deadliest cancers, and why there's no cure</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/gut-bacteria-linked-to-colorectal-cancer-in-young-people">Gut bacteria linked to colorectal cancer in young people</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/colon-cancer-risk-in-young-people-linked-to-one-amino-acid">Colon-cancer risk in young people linked to one amino acid, small study finds</a></li></ul></p></div></div><p>The study's results also turned up an intriguing mystery: the presence of lots of long noncoding RNA. These strands of RNA contain more than 200 building blocks, called nucleotides, that don't provide instructions for building proteins. Coding RNA, in contrast, is ferried to protein-building factories in cells to be used as blueprints. </p><p>Scientists don't know what much of this long noncoding RNA does in the body, nor do they understand what it is doing in the tumors specifically. However, they hope to find out. </p><p>Anderson and her team are already working on manipulating the RNA they found inside cancer cells in petri dishes. In time, this line of research could supply another piece of the puzzle, helping scientists understand why colorectal cancer is so aggressive in young people.</p><p>"It's a new avenue for research into this disease that we previously had no idea about," Anderson said. </p><p>This article is for informational purposes only and is not meant to offer medical advice</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ IBD may transform neurons in the gut, triggering pain even when inflammation is under control ]]></title>
                                                                                                <dc:content><![CDATA[ <p>People with inflammatory bowel disease (IBD) experience gut pain that can be severe, and it doesn't always go away when their inflammation is under control and their colonoscopy looks normal. Now, in a new laboratory study, researchers found a previously unknown pain pathway that may explain this phenomenon.  </p><p>The findings, published Oct. 23 in the journal <a href="http://www.science.org/doi/10.1126/sciimmunol.aeb3809?adobe_mc=MCMID%3D20385556198575689170316460632660515144%7CMCORGID%3D242B6472541199F70A4C98A6%2540AdobeOrg%7CTS%3D1792782435" target="_blank"><u>Science Immunology</u></a>, also point to a potential way to block that pain.</p><p>"Inflammation in the gut has always been thought of like a fire: the sensory nerves alarm because of the smoke and the heat, and when the fire is put out the alarm should stop," said study co-author <a href="https://www.researchgate.net/profile/Xu-Heng-2" target="_blank"><u>Dr. Heng Xu</u></a>, a physician at Ninth People's Hospital in Shanghai. Xu and his colleagues set out to try to isolate what could be causing the pain even when there's no visible "fire" or "smoke." </p><p>"What we found is that the tissue itself changes consistency," Xu told Live Science in an email. "It becomes stiff and less elastic, a bit like a scar, and that stiffness alone keeps triggering the alarm even after the fire is out." </p><p>In <a href="https://my.clevelandclinic.org/health/diseases/10351-ulcerative-colitis" target="_blank"><u>ulcerative colitis</u></a>, the most common form of IBD, inflammation causes ulcers in the gut, as well as symptoms like bloody diarrhea and abdominal cramping. Several medications can help quell this inflammation, but that doesn't necessarily eliminate patients' pain. The researchers wondered if immune cells that live in the gut might contribute to that ongoing pain.</p><p>They zoomed in on a protein called Piezo1; in immune cells, it's known to play a role in inflammation, and in neurons, it contributes to pain signals. The team looked at whether this protein's activity changed in the context of colitis.</p><p>"We started with sequencing data that reads cells one at a time, from the gut tissue of patients with ulcerative colitis and from mice with the disease," Xu said. "One cell type stood out: an immune cell that lives permanently in the gut wall, rather than arriving from the bloodstream when there's trouble." The quantity of these cells was higher in colitis than in healthy guts, and the cells carried more Piezo1 than the other cells analyzed.</p><p>"They sit touching the nerve endings," Xu added.</p><p>In several experiments with lab mice with colitis, the team used a probe to press on the gut tissue and measure how hard it was. This showed that, compared with healthy mice, the gut was stiffer in two models of disease: one with visible inflammation and another with almost none. </p><p>They also measured pain levels in both sets of mice. "In mice with almost no visible gut inflammation, the pain was still there, which is why a colonoscopy can look normal while the patient hurts," Xu said.</p><p>They then looked at Piezo1 in both sets of mice. The protein sits in the immune-cell membrane, and when the stiffened tissue around it is pulled or squeezed, it's as if a button were pressed and a channel opens, Xu said. This sets off a chain reaction that leads to pain, Xu said. </p><p>That's because calcium ions rush into the cell via the channel, and that surge sends a protein called NF-kB from the cell's interior fluid into its nucleus — the control center where DNA is stored. There, NF-kB plugs into a gene, ordering the cell to manufacture nerve growth factor (NGF) that then exits the immune cell.</p><p>This NGF, which is known to amplify pain signals in the body, interacts with nearby pain-sensing neurons. These nerve endings grow denser and become hypersensitive, which makes ordinary gut activity painful, the study suggests.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="SZWbShXAyC79w3FzUj7tiA" name="GettyImages-1463546435-pain" alt="A woman wearing a gray sweater and blue jeans clutches her stomach." src="https://cdn.mos.cms.futurecdn.net/SZWbShXAyC79w3FzUj7tiA-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/SZWbShXAyC79w3FzUj7tiA-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">This newly described mechanism could help explain why ulcerative colitis patients can sometimes contend with pain even when their colonoscopies look normal.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Kinga Krzeminska via Getty Images)</span></figcaption></figure><p>The researchers used chemicals as on-off switches for Piezo1 in immune cells, opening the channel with one and closing it with another. As they did this, they tracked calcium signals and NGF production, and both rose and fell in step with the switch. This result suggests that Piezo1 activity is both necessary for this response and, on its own, enough to trigger it in these cells, Xu said. </p><p>Blocking this chain of events abolished the pain hypersensitivity in both sets of mice. The researchers tried completely removing the Piezo1 gene from the gut immune cells and found that this eliminated the pain. Removing the gene also caused no problems in healthy mice, they noted.</p><p>The study was "well controlled," said <a href="https://profiles.icahn.mssm.edu/hongzhen-hu" target="_blank"><u>Hongzhen Hu</u></a>, the scientific director for the Mark Lebwohl Center for Neuroinflammation and Sensation at the Icahn School of Medicine at Mount Sinai, who was not involved in the research. Future research should address the chemical messengers that coordinate inflammation, called cytokines, and determine whether the same chain reaction occurs in human cells, he said in an email.  </p><p>The mouse experiments also may not reflect long-term, chronic disease in patients, given the mice experienced symptoms only transiently, Xu said. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/one-underlying-cause-of-inflammatory-bowel-disease-pinpointed-in-new-study">One underlying cause of inflammatory bowel disease pinpointed in new study</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/ibd-colon-cancer-microbiome-link">DNA-damaging gut bacteria may fuel colon cancer in patients with inflammatory bowel disease</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/chronic-back-pain-may-activate-an-unexpected-brain-network-study-finds">Chronic back pain may activate an unexpected brain network, study finds</a></li></ul></p></div></div><p>Xu and his colleagues are now aiming to develop a drug that can target Piezo1 to switch off gut pain locally without suppressing the entire immune system. This would be a more targeted treatment than current options, such as immunosuppressants or opioids.</p><p>Other scientists have explored using anti-NGF treatments for other chronic pain conditions but not for ulcerative colitis, Xu noted. Fully blocking NGF might have downsides, he said, since NGF also helps to maintain nerves.</p><p>So more work is needed to translate these findings into a treatment. But for now, the work sheds new light on how immune cells can detect a physical change — such as tissue becoming stiff — and convert it to a pain signal. </p><p>"For the pain field, that's a conceptual shift," Xu said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/immune-system/ibd-may-transform-neurons-in-the-gut-triggering-pain-even-when-inflammation-is-under-control</link>
                                                                            <description>
                            <![CDATA[ A new study with data from mice and human tissues suggests that, in ulcerative colitis, immune cells in the gut might make pain-sensing nerves hypersensitive. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">iFQtwEwSwohaua7PqwH9QD</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/LSkyrb9AaJpZSsmxaa7pBJ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 28 Oct 2026 16:05:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Immune System]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Theresa Sullivan Barger ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/haQyM9UzvWg29wrHyLv62F-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Theresa Sullivan Barger is an award-winning freelance journalist who covers health, science, and the environment. Her stories have appeared in The New York Times, The Boston Globe, Los Angeles Times, AARP, CURE, Discover, Family Circle, Health Central, Next Avenue, IEEE Spectrum, Connecticut Magazine, CT Health Investigative Team,&lt;em&gt; &lt;/em&gt;and more. Based in central Connecticut, she is an advanced master gardener who is passionate about gardening for wildlife, especially pollinators and songbirds.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/LSkyrb9AaJpZSsmxaa7pBJ-1920-80.jpg">
                                                            <media:credit><![CDATA[Henrik5000 via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Resident immune cells in the gut communicate with nearby nerve endings, making the nerves hypersensitive in the context of IBD.]]></media:description>                                                            <media:text><![CDATA[An illustration of a series of spiky cells against a purple background]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a series of spiky cells against a purple background]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/LSkyrb9AaJpZSsmxaa7pBJ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>People with inflammatory bowel disease (IBD) experience gut pain that can be severe, and it doesn't always go away when their inflammation is under control and their colonoscopy looks normal. Now, in a new laboratory study, researchers found a previously unknown pain pathway that may explain this phenomenon.  </p><p>The findings, published Oct. 23 in the journal <a href="http://www.science.org/doi/10.1126/sciimmunol.aeb3809?adobe_mc=MCMID%3D20385556198575689170316460632660515144%7CMCORGID%3D242B6472541199F70A4C98A6%2540AdobeOrg%7CTS%3D1792782435" target="_blank"><u>Science Immunology</u></a>, also point to a potential way to block that pain.</p><p>"Inflammation in the gut has always been thought of like a fire: the sensory nerves alarm because of the smoke and the heat, and when the fire is put out the alarm should stop," said study co-author <a href="https://www.researchgate.net/profile/Xu-Heng-2" target="_blank"><u>Dr. Heng Xu</u></a>, a physician at Ninth People's Hospital in Shanghai. Xu and his colleagues set out to try to isolate what could be causing the pain even when there's no visible "fire" or "smoke." </p><p>"What we found is that the tissue itself changes consistency," Xu told Live Science in an email. "It becomes stiff and less elastic, a bit like a scar, and that stiffness alone keeps triggering the alarm even after the fire is out." </p><p>In <a href="https://my.clevelandclinic.org/health/diseases/10351-ulcerative-colitis" target="_blank"><u>ulcerative colitis</u></a>, the most common form of IBD, inflammation causes ulcers in the gut, as well as symptoms like bloody diarrhea and abdominal cramping. Several medications can help quell this inflammation, but that doesn't necessarily eliminate patients' pain. The researchers wondered if immune cells that live in the gut might contribute to that ongoing pain.</p><p>They zoomed in on a protein called Piezo1; in immune cells, it's known to play a role in inflammation, and in neurons, it contributes to pain signals. The team looked at whether this protein's activity changed in the context of colitis.</p><p>"We started with sequencing data that reads cells one at a time, from the gut tissue of patients with ulcerative colitis and from mice with the disease," Xu said. "One cell type stood out: an immune cell that lives permanently in the gut wall, rather than arriving from the bloodstream when there's trouble." The quantity of these cells was higher in colitis than in healthy guts, and the cells carried more Piezo1 than the other cells analyzed.</p><p>"They sit touching the nerve endings," Xu added.</p><p>In several experiments with lab mice with colitis, the team used a probe to press on the gut tissue and measure how hard it was. This showed that, compared with healthy mice, the gut was stiffer in two models of disease: one with visible inflammation and another with almost none. </p><p>They also measured pain levels in both sets of mice. "In mice with almost no visible gut inflammation, the pain was still there, which is why a colonoscopy can look normal while the patient hurts," Xu said.</p><p>They then looked at Piezo1 in both sets of mice. The protein sits in the immune-cell membrane, and when the stiffened tissue around it is pulled or squeezed, it's as if a button were pressed and a channel opens, Xu said. This sets off a chain reaction that leads to pain, Xu said. </p><p>That's because calcium ions rush into the cell via the channel, and that surge sends a protein called NF-kB from the cell's interior fluid into its nucleus — the control center where DNA is stored. There, NF-kB plugs into a gene, ordering the cell to manufacture nerve growth factor (NGF) that then exits the immune cell.</p><p>This NGF, which is known to amplify pain signals in the body, interacts with nearby pain-sensing neurons. These nerve endings grow denser and become hypersensitive, which makes ordinary gut activity painful, the study suggests.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="SZWbShXAyC79w3FzUj7tiA" name="GettyImages-1463546435-pain" alt="A woman wearing a gray sweater and blue jeans clutches her stomach." src="https://cdn.mos.cms.futurecdn.net/SZWbShXAyC79w3FzUj7tiA-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/SZWbShXAyC79w3FzUj7tiA-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">This newly described mechanism could help explain why ulcerative colitis patients can sometimes contend with pain even when their colonoscopies look normal.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Kinga Krzeminska via Getty Images)</span></figcaption></figure><p>The researchers used chemicals as on-off switches for Piezo1 in immune cells, opening the channel with one and closing it with another. As they did this, they tracked calcium signals and NGF production, and both rose and fell in step with the switch. This result suggests that Piezo1 activity is both necessary for this response and, on its own, enough to trigger it in these cells, Xu said. </p><p>Blocking this chain of events abolished the pain hypersensitivity in both sets of mice. The researchers tried completely removing the Piezo1 gene from the gut immune cells and found that this eliminated the pain. Removing the gene also caused no problems in healthy mice, they noted.</p><p>The study was "well controlled," said <a href="https://profiles.icahn.mssm.edu/hongzhen-hu" target="_blank"><u>Hongzhen Hu</u></a>, the scientific director for the Mark Lebwohl Center for Neuroinflammation and Sensation at the Icahn School of Medicine at Mount Sinai, who was not involved in the research. Future research should address the chemical messengers that coordinate inflammation, called cytokines, and determine whether the same chain reaction occurs in human cells, he said in an email.  </p><p>The mouse experiments also may not reflect long-term, chronic disease in patients, given the mice experienced symptoms only transiently, Xu said. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/one-underlying-cause-of-inflammatory-bowel-disease-pinpointed-in-new-study">One underlying cause of inflammatory bowel disease pinpointed in new study</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/ibd-colon-cancer-microbiome-link">DNA-damaging gut bacteria may fuel colon cancer in patients with inflammatory bowel disease</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/chronic-back-pain-may-activate-an-unexpected-brain-network-study-finds">Chronic back pain may activate an unexpected brain network, study finds</a></li></ul></p></div></div><p>Xu and his colleagues are now aiming to develop a drug that can target Piezo1 to switch off gut pain locally without suppressing the entire immune system. This would be a more targeted treatment than current options, such as immunosuppressants or opioids.</p><p>Other scientists have explored using anti-NGF treatments for other chronic pain conditions but not for ulcerative colitis, Xu noted. Fully blocking NGF might have downsides, he said, since NGF also helps to maintain nerves.</p><p>So more work is needed to translate these findings into a treatment. But for now, the work sheds new light on how immune cells can detect a physical change — such as tissue becoming stiff — and convert it to a pain signal. </p><p>"For the pain field, that's a conceptual shift," Xu said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A woman carried a 'stone baby' in her abdomen for 3 years ]]></title>
                                                                                                <dc:content><![CDATA[ <p><strong>The patient: </strong>A 42-year-old woman in Somaliland, Africa<strong> </strong></p><p><strong>The symptoms: </strong>The woman went to the hospital after having three years of chronic, dull pain in her lower abdomen, as well as a growing sense of heaviness in her abdomen that had worsened in recent months. </p><p>When doctors reviewed her medical history, they learned that, three years earlier, she had experienced a number of symptoms that seemed to indicate a pregnancy. She recalled her abdomen growing over time and feeling "fetal movements," her doctors noted in a <a href="https://www.dovepress.com/lithopedion-following-presumed-primary-abdominal-pregnancy-in-a-42-yea-peer-reviewed-fulltext-article-IMCRJ" target="_blank"><u>report of the case</u></a>. Then, the movements stopped, the abdominal growth halted, and the enlargement gradually subsided. She had not sought medical care during or after this apparent pregnancy.</p><p><strong>What happened next: </strong>When doctors physically examined the woman's abdomen, they found a hard, irregular mass that extended to her belly button and barely moved when they touched it. Blood tests showed mild anemia, meaning she had fewer healthy red blood cells than normal. Her white blood cell count and kidney and liver tests were normal, and a pregnancy test was negative.<strong> </strong></p><p>An ultrasound revealed a calcified mass and an empty uterus. Calcification is a buildup of calcium that hardens tissue into a solid mass.</p><p>To get a better look at the mass, which occupied the woman's lower abdomen and pelvis, the doctors ordered an advanced CT scan to create a 3D model. The imaging revealed that the mass contained clearly identifiable fetal skeletal structures, including a skull, a spinal column, ribs, and arm and leg bones. The mass measured roughly 7 by 5 inches (18 by 13 centimeters). </p><p><strong>The diagnosis:</strong> Doctors concluded that the woman had a lithopedion, or "stone baby." The term comes from the Greek words "lithos," meaning stone, and "paidion," meaning child.</p><p>In a typical pregnancy, an egg is fertilized in a fallopian tube — the structure between the ovaries and the womb — and then travels into the uterus, where it implants in the uterine lining. By contrast, <a href="https://www.sciencedirect.com/science/article/pii/S1930043323000523?via%3Dihub" target="_blank"><u>lithopedions most often start</u></a> as abdominal pregnancies,‬ a type of <a href="https://www.acog.org/advocacy/facts-are-important/understanding-ectopic-pregnancy" target="_blank"><u>ectopic pregnancy</u></a> in which the embryo instead implants on the lining of the abdominal cavity. </p><p>There, the embryo shares the space with organs like the stomach, kidneys and appendix. These misplaced pregnancies are <a href="https://www.livescience.com/health/fertility-pregnancy-birth/unprecedented-woman-delivers-full-term-abdominal-pregnancy-while-also-having-22-pound-cyst-removed"><u>almost never</u></a> viable and are highly life-threatening for the mother. Because the placenta attaches directly to delicate abdominal organs and blood vessels, these carry a severe risk of catastrophic internal bleeding. </p><p>If the fetus dies at a developmental stage when it is too large for the mother's body to naturally break down and absorb, her immune system can sometimes treat the retained tissue as a foreign object. To protect the mother from inflammatory complications and infection, the body progressively deposits calcium over the fetal remains, creating a protective casing. In this case, the calcified fetus likely accounted for the woman's chronic abdominal pain and increasing sense of heaviness, her doctors concluded. </p><p><strong>The treatment:</strong> The doctors performed abdominal surgery to completely remove the calcified fetal mass from the woman's pelvis. </p><p>The day after surgery, she developed a mild fever and nausea, but both resolved with treatment. She remained stable and improved during her hospital stay before being discharged in good condition.</p><p>Follow-up visits over the next six months showed she had healed well, with a complete resolution of her abdominal pain. </p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-a-fighter-pilot-had-unexplained-headaches-for-over-a-year-the-cause-was-hiding-in-plain-sight">A fighter pilot had unexplained headaches for over a year. The cause was hiding in plain sight.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur">Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li></ul></p></div></div><p><strong>What makes this case unique:</strong> Only about <a href="https://onlinelibrary.wiley.com/doi/10.1002/bdr2.2410" target="_blank"><u>340 cases of lithopedion</u></a> have been documented in the medical literature over the past 400 years, with the <a href="https://journals.sagepub.com/doi/10.1177/014107689608900105" target="_blank"><u>earliest documented in 1582</u></a>.</p><p>This woman's case stands out because she was 42 years old, while many recent cases have been diagnosed in postmenopausal women. (Women typically experience menopause around 51 to 52 years old.) In these cases, the initial ectopic pregnancy occurred during the woman's childbearing years, but she unknowingly carried the calcified remains for decades before developing symptoms. For example, a 74-year old woman from India <a href="https://www.livescience.com/47513-baby-skeleton-removed.html"><u>carried her "stone baby" for more than three decades</u></a>. By contrast, the woman's recent case was caught after only three years.</p><p>The case also highlights the challenges of maternal healthcare in resource-limited settings such as Somaliland, where a lack of access to routine prenatal care and early pregnancy scans can lead to delayed diagnoses. That said, the successful use of advanced 3D imaging and complete surgical recovery demonstrate that excellent outcomes are possible even in these constrained environments, the doctors noted.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/reproductive-health/diagnostic-dilemma-a-woman-carried-a-stone-baby-in-her-abdomen-for-3-years</link>
                                                                            <description>
                            <![CDATA[ A woman's unexplained abdominal pain led doctors to a diagnosis that has only been documented a few hundred times over the past 400 years. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">u6cZjTSsfAnRknw2AquS6G</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/ZxTYT5tDRekvNphDoER6oA-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 28 Oct 2026 10:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 28 Oct 2026 19:04:59 +0000</updated>
                                                                                                                                            <category><![CDATA[Reproductive Health]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Anirban Mukhopadhyay ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/BC3R7bkLDPTT9zjuB89uHi-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/ZxTYT5tDRekvNphDoER6oA-1920-80.jpg">
                                                            <media:credit><![CDATA[FG Trade via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A woman in her 40s learned she had a calcified mass in her abdomen that had formed after an ectopic pregnancy. ]]></media:description>                                                            <media:text><![CDATA[A close up of a woman wearing a yellow sweater clutching her stomach. ]]></media:text>
                                <media:title type="plain"><![CDATA[A close up of a woman wearing a yellow sweater clutching her stomach. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/ZxTYT5tDRekvNphDoER6oA-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><strong>The patient: </strong>A 42-year-old woman in Somaliland, Africa<strong> </strong></p><p><strong>The symptoms: </strong>The woman went to the hospital after having three years of chronic, dull pain in her lower abdomen, as well as a growing sense of heaviness in her abdomen that had worsened in recent months. </p><p>When doctors reviewed her medical history, they learned that, three years earlier, she had experienced a number of symptoms that seemed to indicate a pregnancy. She recalled her abdomen growing over time and feeling "fetal movements," her doctors noted in a <a href="https://www.dovepress.com/lithopedion-following-presumed-primary-abdominal-pregnancy-in-a-42-yea-peer-reviewed-fulltext-article-IMCRJ" target="_blank"><u>report of the case</u></a>. Then, the movements stopped, the abdominal growth halted, and the enlargement gradually subsided. She had not sought medical care during or after this apparent pregnancy.</p><p><strong>What happened next: </strong>When doctors physically examined the woman's abdomen, they found a hard, irregular mass that extended to her belly button and barely moved when they touched it. Blood tests showed mild anemia, meaning she had fewer healthy red blood cells than normal. Her white blood cell count and kidney and liver tests were normal, and a pregnancy test was negative.<strong> </strong></p><p>An ultrasound revealed a calcified mass and an empty uterus. Calcification is a buildup of calcium that hardens tissue into a solid mass.</p><p>To get a better look at the mass, which occupied the woman's lower abdomen and pelvis, the doctors ordered an advanced CT scan to create a 3D model. The imaging revealed that the mass contained clearly identifiable fetal skeletal structures, including a skull, a spinal column, ribs, and arm and leg bones. The mass measured roughly 7 by 5 inches (18 by 13 centimeters). </p><p><strong>The diagnosis:</strong> Doctors concluded that the woman had a lithopedion, or "stone baby." The term comes from the Greek words "lithos," meaning stone, and "paidion," meaning child.</p><p>In a typical pregnancy, an egg is fertilized in a fallopian tube — the structure between the ovaries and the womb — and then travels into the uterus, where it implants in the uterine lining. By contrast, <a href="https://www.sciencedirect.com/science/article/pii/S1930043323000523?via%3Dihub" target="_blank"><u>lithopedions most often start</u></a> as abdominal pregnancies,‬ a type of <a href="https://www.acog.org/advocacy/facts-are-important/understanding-ectopic-pregnancy" target="_blank"><u>ectopic pregnancy</u></a> in which the embryo instead implants on the lining of the abdominal cavity. </p><p>There, the embryo shares the space with organs like the stomach, kidneys and appendix. These misplaced pregnancies are <a href="https://www.livescience.com/health/fertility-pregnancy-birth/unprecedented-woman-delivers-full-term-abdominal-pregnancy-while-also-having-22-pound-cyst-removed"><u>almost never</u></a> viable and are highly life-threatening for the mother. Because the placenta attaches directly to delicate abdominal organs and blood vessels, these carry a severe risk of catastrophic internal bleeding. </p><p>If the fetus dies at a developmental stage when it is too large for the mother's body to naturally break down and absorb, her immune system can sometimes treat the retained tissue as a foreign object. To protect the mother from inflammatory complications and infection, the body progressively deposits calcium over the fetal remains, creating a protective casing. In this case, the calcified fetus likely accounted for the woman's chronic abdominal pain and increasing sense of heaviness, her doctors concluded. </p><p><strong>The treatment:</strong> The doctors performed abdominal surgery to completely remove the calcified fetal mass from the woman's pelvis. </p><p>The day after surgery, she developed a mild fever and nausea, but both resolved with treatment. She remained stable and improved during her hospital stay before being discharged in good condition.</p><p>Follow-up visits over the next six months showed she had healed well, with a complete resolution of her abdominal pain. </p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/diagnostic-dilemma-a-fighter-pilot-had-unexplained-headaches-for-over-a-year-the-cause-was-hiding-in-plain-sight">A fighter pilot had unexplained headaches for over a year. The cause was hiding in plain sight.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur">Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li></ul></p></div></div><p><strong>What makes this case unique:</strong> Only about <a href="https://onlinelibrary.wiley.com/doi/10.1002/bdr2.2410" target="_blank"><u>340 cases of lithopedion</u></a> have been documented in the medical literature over the past 400 years, with the <a href="https://journals.sagepub.com/doi/10.1177/014107689608900105" target="_blank"><u>earliest documented in 1582</u></a>.</p><p>This woman's case stands out because she was 42 years old, while many recent cases have been diagnosed in postmenopausal women. (Women typically experience menopause around 51 to 52 years old.) In these cases, the initial ectopic pregnancy occurred during the woman's childbearing years, but she unknowingly carried the calcified remains for decades before developing symptoms. For example, a 74-year old woman from India <a href="https://www.livescience.com/47513-baby-skeleton-removed.html"><u>carried her "stone baby" for more than three decades</u></a>. By contrast, the woman's recent case was caught after only three years.</p><p>The case also highlights the challenges of maternal healthcare in resource-limited settings such as Somaliland, where a lack of access to routine prenatal care and early pregnancy scans can lead to delayed diagnoses. That said, the successful use of advanced 3D imaging and complete surgical recovery demonstrate that excellent outcomes are possible even in these constrained environments, the doctors noted.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Hepatitis B could surge, infecting millions more in childhood, under proposed CDC guidance ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A proposed change to decades-old guidance on hepatitis B vaccination would lead to a dramatic increase in chronic hepatitis B virus (HBV) infections among young people, a new modeling study predicts.</p><p>Previously, the Centers for Disease Control and Prevention (CDC) recommended that all newborns be vaccinated against HBV within hours of birth ‪—‬ a strategy known as "universal birth-dose vaccination." But in December 2025, the <a href="https://www.hhs.gov/press-room/acip-recommends-individual-based-decision-making-hepatitis-b-vaccine-birth-dose-infants-born-women-test-negative-virus.html" target="_blank"><u>Advisory Committee on Immunization Practices (ACIP) advised</u></a> ending this recommendation, and the <a href="https://www.hhs.gov/press-room/cdc-adopts-individual-based-decision-making-for-hepatitis-b-immunization-for-infants-born-to-women-who-test-negative-for-the-hepatitis-b-virus.html" target="_blank"><u>CDC accepted that advice</u></a>. </p><p>The new guidance would recommend birth doses only to babies whose mothers tested positive for HBV or whose HBV status was unknown. The guidance suggests that mothers who test negative should instead ask their doctors about whether their child needs a birth dose — an approach the CDC calls "shared clinical decision-making." The new recommendation states that babies who forgo the birth dose should be at least 2 months old before starting the HBV vaccine series.</p><p><a href="https://www.livescience.com/health/viruses-infections-disease/cdc-panel-stuffed-with-vaccine-skeptics-votes-to-end-recommendation-for-universal-newborn-hepatitis-b-vaccination"><u>Health experts widely criticized</u></a> the proposed change when it was announced, and for the moment, its implementation has been <a href="https://www.aasld.org/aasld-responds-federal-court-ruling-preserving-hepatitis-vaccine" target="_blank"><u>put on pause by legal action</u></a>. The modeling study, published Oct. 19 in the journal <a href="https://www.acpjournals.org/doi/10.7326/ANNALS-26-02135" target="_blank"><u>Annals of Internal Medicine</u></a>, predicts what would happen if it came to pass.</p><p>"Overall, this modeling study has many strengths and I think presents an accurate projection of how the vaccine recommendations may impact future chronic HBV in the U.S.," <a href="https://keck.usc.edu/faculty-search/norah-terrault/" target="_blank"><u>Dr. Norah Terrault</u></a>, a transplant hepatologist at the University of Southern California Keck School of Medicine who wasn't involved in the study, told Live Science in an email.</p><p>When caught in infancy or early childhood, <a href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-b" target="_blank"><u>over 90% of HBV infections</u></a> become chronic. About <a href="https://www.cdc.gov/hepatitis-b/hcp/clinical-overview/index.html" target="_blank"><u>15% to 25% of people</u></a> with chronic HBV go on to develop liver scarring (cirrhosis), a form of liver cancer called hepatocellular carcinoma, or another chronic liver disease. So, an uptick in chronic HBV infections would translate to an uptick in these harmful liver conditions.</p><h2 id="increases-in-infection">Increases in infection</h2><p>"Not every pregnant person is tested for hepatitis B," said study co-author <a href="https://www.massgeneralbrigham.org/en/doctors/m/amir-mohareb-3005068" target="_blank"><u>Dr. Amir Mohareb</u></a>, an infectious-diseases physician-investigator at Massachusetts General Hospital and Harvard Medical School. For those who are tested, there's a chance their results are inaccurate or that they're not provided the right care after testing positive. "Something can be missed at any step in the care process, so the vaccine dose at birth provides protection," he said.</p><p>Mohareb and his colleagues built a simulation model using published data, including the current prevalence of HBV and the screening rate among pregnant people. The team also factored in the HBV test's sensitivity, the share of children who are fully vaccinated by age 2, and the risk of developing chronic HBV infection in different age groups. They made estimates of how often children are exposed to the virus through contact with infected household or community members.</p><p>HBV is "very, very transmissible," Mohareb said. It can spread from mother to child at birth or through <a href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-b" target="_blank"><u>exposure to tiny amounts of bodily fluids</u></a>, like blood from a scratch, after birth. So, even if a baby does not get HBV from their mother, if they are unvaccinated, they can still <a href="https://www.cidrap.umn.edu/hepatitis/tens-thousands-us-newborns-could-be-exposed-hepatitis-b-home-study-suggests" target="_blank"><u>get from another family member</u></a> or from other children.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="7CGofvHJUZ6j5YLF9Syith" name="GettyImages-1402266696-hepb" alt="A series of pink spiky balls against a purple background" src="https://cdn.mos.cms.futurecdn.net/7CGofvHJUZ6j5YLF9Syith-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/7CGofvHJUZ6j5YLF9Syith-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Infants and young children have a greater risk of their HBV infections becoming chronic than people infected in adulthood. </span><span class="credit" itemprop="copyrightHolder">(Image credit: THOM LEACH / SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>With this data, the researchers tested what would happen if vaccination were postponed to 2 months of age for babies whose mothers tested negative. Among babies born in 2026, 19% more would have chronic HBV infections by age 20, compared with universal birth-dose vaccination, they found.</p><p>In this scenario, the babies would still start the HBV vaccine series, albeit two months later than usual. However, the <a href="https://www.hhs.gov/sites/default/files/decision-memo-adopting-revised-childhood-adolescent-immunization-schedule.pdf" target="_blank"><u>CDC's proposed recommendation</u></a> offers more wiggle room; it says that parents should consult with their children's doctors to "decide when or if their child will begin the hepatitis B vaccine series" at all.  </p><p>The researchers ran a stimulation to compare these two scenarios: one where kids get their first shot two months late and one intended to capture this looser "shared clinical decision-making" scenario.</p><p>"Other vaccines whose recommendations employ similar language had uptake as low as 25%," Mohareb noted. This aspect of their modeling has some uncertainty, he emphasized, since it's unknown exactly how the public will respond to such loosening of the guidance.</p><p>The researchers assumed that about 87% of kids would complete the vaccine series by age 2 under the deferred strategy, while only 50% would under the shared decision-making strategy. That 50% coverage, in turn, would increase chronic HBV infections acquired by age 20 by 83%, and about 50% and 70% of those born under that guidance would be susceptible to HBV infection at age 20. </p><p>That's about 1.8 million people in this age group per year, compared with fewer than 250,000 under universal birth-dose vaccination. "This represents a population that is at risk for acquiring HBV via sex, drug use etc — behaviors more prevalent among young adults," Terrault said.</p><h2 id="a-quot-missed-opportunity-to-protect-against-infection-quot">A "missed opportunity to protect against infection"</h2><p>To test the robustness of the findings, Mohareb's team varied the most uncertain inputs across wide ranges and ran the model 1,000 times. In every simulation, the birth-dose strategy led to fewer chronic infections than either alternative.</p><p>These conclusions seem "robust" because "they are the same conclusions no matter how we change the numbers of the model," Mohereb noted. Though of course "the specific magnitude of change depends on how many people defer vaccination," he said. </p><p>The new study does not specifically show how many additional cases of liver disease or cancer would result from the uptick in HBV infections. But Terrault said that the risks of liver failure, cirrhosis and liver cancer "would be anticipated to increase due to the missed opportunity to protect against infection."</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/can-viruses-cause-cancer">Can viruses cause cancer?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/us-government-overhauls-the-childhood-vaccine-schedule-in-unprecedented-move">US government overhauls the childhood vaccine schedule in unprecedented move</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/new-blood-test-aims-to-spot-liver-scarring-before-it-paves-the-way-to-cancer">New blood test aims to spot liver scarring before it paves the way to cancer</a></li></ul></p></div></div><p>Mohareb stressed that he is in no way opposed to the principle of shared decision-making between doctors and patients. "They should always make the decision together," he said. "But we rely on our public health agencies not to tell us that we should be making decisions with the patient, but rather to tell us what policy would make us healthier as a country."</p><p>Childhood HBV infections in the U.S. dropped from more than 25,000 cases a year in 1985 to fewer than 100 reported cases in 2024. This steep decline is credited to HBV screening during pregnancy, antibody treatment for babies born to HBV-positive mothers and universal birth-dose vaccination.</p><p>"Certainly without following a universal dose vaccination recommendation there would be a lot more hep B infections early in life," <a href="https://www.globalhep.org/dr-brian-mcmahon" target="_blank"><u>Dr. Brian McMahon</u></a>, a hepatologist and the director of the Liver Disease and Hepatitis Program at the Alaska Native Medical Center, told Live Science in an email.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/viruses-infections-disease/hepatitis-b-could-surge-infecting-millions-more-in-childhood-under-proposed-cdc-guidance</link>
                                                                            <description>
                            <![CDATA[ A proposed shift in recommendations for hepatitis B vaccination in the U.S. could leave millions of young adults unprotected, a new modeling study suggests. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">GczhR4qDPU6xZHwcgGr3o5</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/nc9Ts8LhHGrwmRYXgt5oPR-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 27 Oct 2026 17:05:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Clarissa Brincat ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/F4o2eTArX4YyraLCgVNxYk-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/nc9Ts8LhHGrwmRYXgt5oPR-1920-80.jpg">
                                                            <media:credit><![CDATA[ojos de hojalata via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Historically, the CDC has recommended that all newborns get the first shot in the hepatitis B vaccine series shortly after birth.]]></media:description>                                                            <media:text><![CDATA[A close up of a gloved latex hand wiping someone&#039;s bandaged arm.]]></media:text>
                                <media:title type="plain"><![CDATA[A close up of a gloved latex hand wiping someone&#039;s bandaged arm.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/nc9Ts8LhHGrwmRYXgt5oPR-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A proposed change to decades-old guidance on hepatitis B vaccination would lead to a dramatic increase in chronic hepatitis B virus (HBV) infections among young people, a new modeling study predicts.</p><p>Previously, the Centers for Disease Control and Prevention (CDC) recommended that all newborns be vaccinated against HBV within hours of birth ‪—‬ a strategy known as "universal birth-dose vaccination." But in December 2025, the <a href="https://www.hhs.gov/press-room/acip-recommends-individual-based-decision-making-hepatitis-b-vaccine-birth-dose-infants-born-women-test-negative-virus.html" target="_blank"><u>Advisory Committee on Immunization Practices (ACIP) advised</u></a> ending this recommendation, and the <a href="https://www.hhs.gov/press-room/cdc-adopts-individual-based-decision-making-for-hepatitis-b-immunization-for-infants-born-to-women-who-test-negative-for-the-hepatitis-b-virus.html" target="_blank"><u>CDC accepted that advice</u></a>. </p><p>The new guidance would recommend birth doses only to babies whose mothers tested positive for HBV or whose HBV status was unknown. The guidance suggests that mothers who test negative should instead ask their doctors about whether their child needs a birth dose — an approach the CDC calls "shared clinical decision-making." The new recommendation states that babies who forgo the birth dose should be at least 2 months old before starting the HBV vaccine series.</p><p><a href="https://www.livescience.com/health/viruses-infections-disease/cdc-panel-stuffed-with-vaccine-skeptics-votes-to-end-recommendation-for-universal-newborn-hepatitis-b-vaccination"><u>Health experts widely criticized</u></a> the proposed change when it was announced, and for the moment, its implementation has been <a href="https://www.aasld.org/aasld-responds-federal-court-ruling-preserving-hepatitis-vaccine" target="_blank"><u>put on pause by legal action</u></a>. The modeling study, published Oct. 19 in the journal <a href="https://www.acpjournals.org/doi/10.7326/ANNALS-26-02135" target="_blank"><u>Annals of Internal Medicine</u></a>, predicts what would happen if it came to pass.</p><p>"Overall, this modeling study has many strengths and I think presents an accurate projection of how the vaccine recommendations may impact future chronic HBV in the U.S.," <a href="https://keck.usc.edu/faculty-search/norah-terrault/" target="_blank"><u>Dr. Norah Terrault</u></a>, a transplant hepatologist at the University of Southern California Keck School of Medicine who wasn't involved in the study, told Live Science in an email.</p><p>When caught in infancy or early childhood, <a href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-b" target="_blank"><u>over 90% of HBV infections</u></a> become chronic. About <a href="https://www.cdc.gov/hepatitis-b/hcp/clinical-overview/index.html" target="_blank"><u>15% to 25% of people</u></a> with chronic HBV go on to develop liver scarring (cirrhosis), a form of liver cancer called hepatocellular carcinoma, or another chronic liver disease. So, an uptick in chronic HBV infections would translate to an uptick in these harmful liver conditions.</p><h2 id="increases-in-infection">Increases in infection</h2><p>"Not every pregnant person is tested for hepatitis B," said study co-author <a href="https://www.massgeneralbrigham.org/en/doctors/m/amir-mohareb-3005068" target="_blank"><u>Dr. Amir Mohareb</u></a>, an infectious-diseases physician-investigator at Massachusetts General Hospital and Harvard Medical School. For those who are tested, there's a chance their results are inaccurate or that they're not provided the right care after testing positive. "Something can be missed at any step in the care process, so the vaccine dose at birth provides protection," he said.</p><p>Mohareb and his colleagues built a simulation model using published data, including the current prevalence of HBV and the screening rate among pregnant people. The team also factored in the HBV test's sensitivity, the share of children who are fully vaccinated by age 2, and the risk of developing chronic HBV infection in different age groups. They made estimates of how often children are exposed to the virus through contact with infected household or community members.</p><p>HBV is "very, very transmissible," Mohareb said. It can spread from mother to child at birth or through <a href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-b" target="_blank"><u>exposure to tiny amounts of bodily fluids</u></a>, like blood from a scratch, after birth. So, even if a baby does not get HBV from their mother, if they are unvaccinated, they can still <a href="https://www.cidrap.umn.edu/hepatitis/tens-thousands-us-newborns-could-be-exposed-hepatitis-b-home-study-suggests" target="_blank"><u>get from another family member</u></a> or from other children.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="7CGofvHJUZ6j5YLF9Syith" name="GettyImages-1402266696-hepb" alt="A series of pink spiky balls against a purple background" src="https://cdn.mos.cms.futurecdn.net/7CGofvHJUZ6j5YLF9Syith-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/7CGofvHJUZ6j5YLF9Syith-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Infants and young children have a greater risk of their HBV infections becoming chronic than people infected in adulthood. </span><span class="credit" itemprop="copyrightHolder">(Image credit: THOM LEACH / SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>With this data, the researchers tested what would happen if vaccination were postponed to 2 months of age for babies whose mothers tested negative. Among babies born in 2026, 19% more would have chronic HBV infections by age 20, compared with universal birth-dose vaccination, they found.</p><p>In this scenario, the babies would still start the HBV vaccine series, albeit two months later than usual. However, the <a href="https://www.hhs.gov/sites/default/files/decision-memo-adopting-revised-childhood-adolescent-immunization-schedule.pdf" target="_blank"><u>CDC's proposed recommendation</u></a> offers more wiggle room; it says that parents should consult with their children's doctors to "decide when or if their child will begin the hepatitis B vaccine series" at all.  </p><p>The researchers ran a stimulation to compare these two scenarios: one where kids get their first shot two months late and one intended to capture this looser "shared clinical decision-making" scenario.</p><p>"Other vaccines whose recommendations employ similar language had uptake as low as 25%," Mohareb noted. This aspect of their modeling has some uncertainty, he emphasized, since it's unknown exactly how the public will respond to such loosening of the guidance.</p><p>The researchers assumed that about 87% of kids would complete the vaccine series by age 2 under the deferred strategy, while only 50% would under the shared decision-making strategy. That 50% coverage, in turn, would increase chronic HBV infections acquired by age 20 by 83%, and about 50% and 70% of those born under that guidance would be susceptible to HBV infection at age 20. </p><p>That's about 1.8 million people in this age group per year, compared with fewer than 250,000 under universal birth-dose vaccination. "This represents a population that is at risk for acquiring HBV via sex, drug use etc — behaviors more prevalent among young adults," Terrault said.</p><h2 id="a-quot-missed-opportunity-to-protect-against-infection-quot">A "missed opportunity to protect against infection"</h2><p>To test the robustness of the findings, Mohareb's team varied the most uncertain inputs across wide ranges and ran the model 1,000 times. In every simulation, the birth-dose strategy led to fewer chronic infections than either alternative.</p><p>These conclusions seem "robust" because "they are the same conclusions no matter how we change the numbers of the model," Mohereb noted. Though of course "the specific magnitude of change depends on how many people defer vaccination," he said. </p><p>The new study does not specifically show how many additional cases of liver disease or cancer would result from the uptick in HBV infections. But Terrault said that the risks of liver failure, cirrhosis and liver cancer "would be anticipated to increase due to the missed opportunity to protect against infection."</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/can-viruses-cause-cancer">Can viruses cause cancer?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/us-government-overhauls-the-childhood-vaccine-schedule-in-unprecedented-move">US government overhauls the childhood vaccine schedule in unprecedented move</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/new-blood-test-aims-to-spot-liver-scarring-before-it-paves-the-way-to-cancer">New blood test aims to spot liver scarring before it paves the way to cancer</a></li></ul></p></div></div><p>Mohareb stressed that he is in no way opposed to the principle of shared decision-making between doctors and patients. "They should always make the decision together," he said. "But we rely on our public health agencies not to tell us that we should be making decisions with the patient, but rather to tell us what policy would make us healthier as a country."</p><p>Childhood HBV infections in the U.S. dropped from more than 25,000 cases a year in 1985 to fewer than 100 reported cases in 2024. This steep decline is credited to HBV screening during pregnancy, antibody treatment for babies born to HBV-positive mothers and universal birth-dose vaccination.</p><p>"Certainly without following a universal dose vaccination recommendation there would be a lot more hep B infections early in life," <a href="https://www.globalhep.org/dr-brian-mcmahon" target="_blank"><u>Dr. Brian McMahon</u></a>, a hepatologist and the director of the Liver Disease and Hepatitis Program at the Alaska Native Medical Center, told Live Science in an email.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Scientists invent implant that can transform sugar in the blood to treat type 2 diabetes ]]></title>
                                                                                                <dc:content><![CDATA[ <p>An experimental medical implant that removes excess sugar from the blood has shown promise in treating diabetes and obesity in tests with lab mice. </p><p>Coupled with a continuous glucose monitor, which tracks blood sugar levels in real time, the tiny device is designed to adjust blood sugar levels according to a patient's needs. It does so using a chemical reaction powered by electricity. In the mouse experiments, it prevented sudden insulin spikes and promoted fat loss. </p><p>The implant, described Oct. 22 in the journal<a href="https://www.science.org/doi/10.1126/science.ady8560" target="_blank"> <u>Science</u></a>, could offer a completely new way to treat diabetes and obesity, study co-author<a href="https://bsse.ethz.ch/people/detail-person.martin-fussenegger.html" target="_blank"> <u>Martin Fussenegger</u></a>, a professor of biotechnology and bioengineering at ETH Zurich, told Live Science in an email. His team is now working toward testing the device in additional lab animals, and eventually, humans.</p><p><a href="https://www.who.int/news-room/fact-sheets/detail/diabetes" target="_blank"><u>About 790 million people</u></a> have type 2 diabetes globally, and <a href="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" target="_blank"><u>over 1 billion</u></a> have obesity. People with obesity often have <a href="https://my.clevelandclinic.org/health/diseases/22206-insulin-resistance" target="_blank"><u>insulin resistance</u></a>, in which cells don't respond to insulin well and can't take in the sugar they need from the blood. At first, the body makes more insulin to compensate, but eventually, it can't keep up; this sets the stage for prediabetes and type 2 diabetes. About <a href="https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/" target="_blank"><u>90% of people</u></a> with type 2 diabetes also have obesity or are overweight.</p><p>At the same time, chemical reactions in the liver convert the extra glucose in the blood into fat stores, contributing to further weight gain.</p><p>Current treatments for these conditions focus on either lifestyle changes, such as diet and exercise, or long-term medications such as <a href="https://www.livescience.com/health/medicine-drugs/the-popular-diabetes-drug-metformin-has-been-used-for-decades-and-scientists-just-figured-out-its-main-mechanism"><u>metformin</u></a>, which lowers blood sugar, and GLP-1s, which reduce appetite to promote weight loss. But Fussenegger and colleagues wondered if they could target the glucose directly.</p><p>They designed an inch-long reactor that converts glucose into a harmless byproduct, called gluconate, through a controlled chemical reaction triggered by tiny amounts of electricity. This transformation takes place at an electrode coated with gold and platinum nanoparticles embedded within a graphite felt. </p><p>Crucially, the reaction occurs only when the device receives sufficient electricity, so the glucose removal can be switched on and off by controlling how much power is supplied to the implant. </p><p>The device is wireless and is both powered and controlled from an ordinary smartphone. The phone emits low-level radio frequency energy, which the implant's electronics then convert to a stable DC current to activate the reaction. Combined with a glucose monitor, the device detects high blood sugar and then sends feedback to the smartphone, which then adjusts the amount of power transferred to the implant.</p><p>"In principle, this enables the device to remove more glucose when [blood sugar] levels are elevated and reduce its activity when glucose returns towards the desired range," Fussenegger said. "The objective is to create an autonomous system that continuously adapts to the patient's metabolic needs."</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="nW5c9vPEMVPiBM6ZqQFM6Y" name="GettyImages-1969670962-diabetes" alt="A woman scans a circular device on her arm with her phone" src="https://cdn.mos.cms.futurecdn.net/nW5c9vPEMVPiBM6ZqQFM6Y-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/nW5c9vPEMVPiBM6ZqQFM6Y-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">In the mouse study, the implant was combined with a continuous glucose monitor, which provided updates on blood sugar levels to a phone that controlled the device. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Halfpoint Images via Getty Images)</span></figcaption></figure><p>The team tested this self-regulating medical device in mice with both diabetes and obesity. Over six weeks, the mice fitted with the implant had much more stable blood sugar levels than the untreated mice did. They also lost an average of 10% of their body weight. </p><p>Because the mice's glucose was consistently maintained within normal levels, the body's metabolic chemistry shifted toward fat burning, while the on-off regulation of the glucose-removal reaction prevented the mice's sugar levels from falling below safe limits.</p><p>It's an exciting proof of concept, Fussenegger thinks. However, "one important challenge is demonstrating that the device can convert sufficient quantities of glucose in a human while maintaining long-term safety and catalytic efficiency," he said. In other words, they still need to show that the chemical reaction works at the larger scale required to treat a human patient.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/has-americas-obesity-rate-plateaued">Has America's obesity rate plateaued?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/obesity-is-linked-to-1-in-10-deaths-from-infection-worldwide-and-scientists-are-still-learning-why">Obesity is linked to 1 in 10 deaths from infection worldwide</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/ozempic-style-drugs-treat-type-1-diabetes-not-only-type-2-study-finds">Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds</a></li></ul></p></div></div><p>In a separate test, the team introduced the device to a large beaker filled with a sugary solution, to see if it could cope with larger volumes of glucose. The amount, about 1.3 gallons (5 liters), was similar to a <a href="https://www.livescience.com/32213-how-much-blood-is-in-the-human-body.html"><u>person's total blood volume</u></a>. The device still effectively controlled sugar levels in this larger system. </p><p>The test is not a substitute for research in larger animals and human patients, though, Fussenegger said. Those studies are the team's next priority. </p><p>Importantly, "our device is not intended to replace healthy nutrition, physical activity, or preventative medicine" for the treatment of diabetes and obesity, Fussenegger said. </p><p>"Obesity and type 2 diabetes are complex conditions involving much more than elevated glucose levels," he added. "We see it as a potentially powerful addition to the therapeutic toolbox, one that could eventually be combined with established treatments and lifestyle interventions."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/scientists-invent-implant-that-can-transform-sugar-in-the-blood-to-treat-type-2-diabetes</link>
                                                                            <description>
                            <![CDATA[ An experimental medical device uses a tiny amount of electricity to spark a chemical reaction and remove extra sugar from the bloodstream. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">YWyFKWUj4LLje7anG2sSjU</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/z7RbGrozJShNsL3c3WgKYn-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 27 Oct 2026 15:30:00 +0000</pubDate>                                                                                                                                <updated>Tue, 27 Oct 2026 18:58:13 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Victoria Atkinson ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/myPb7j2m9WcKXy9W9CXaxZ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/z7RbGrozJShNsL3c3WgKYn-1920-80.jpg">
                                                            <media:credit><![CDATA[nopparit via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[An experimental medical device uses a chemical reaction to convert sugar in the blood into a harmless byproduct.]]></media:description>                                                            <media:text><![CDATA[An illustration of a blood vessel showing its contents including red donut-shaped blood cells and white sugar cubes.]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a blood vessel showing its contents including red donut-shaped blood cells and white sugar cubes.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/z7RbGrozJShNsL3c3WgKYn-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>An experimental medical implant that removes excess sugar from the blood has shown promise in treating diabetes and obesity in tests with lab mice. </p><p>Coupled with a continuous glucose monitor, which tracks blood sugar levels in real time, the tiny device is designed to adjust blood sugar levels according to a patient's needs. It does so using a chemical reaction powered by electricity. In the mouse experiments, it prevented sudden insulin spikes and promoted fat loss. </p><p>The implant, described Oct. 22 in the journal<a href="https://www.science.org/doi/10.1126/science.ady8560" target="_blank"> <u>Science</u></a>, could offer a completely new way to treat diabetes and obesity, study co-author<a href="https://bsse.ethz.ch/people/detail-person.martin-fussenegger.html" target="_blank"> <u>Martin Fussenegger</u></a>, a professor of biotechnology and bioengineering at ETH Zurich, told Live Science in an email. His team is now working toward testing the device in additional lab animals, and eventually, humans.</p><p><a href="https://www.who.int/news-room/fact-sheets/detail/diabetes" target="_blank"><u>About 790 million people</u></a> have type 2 diabetes globally, and <a href="https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight" target="_blank"><u>over 1 billion</u></a> have obesity. People with obesity often have <a href="https://my.clevelandclinic.org/health/diseases/22206-insulin-resistance" target="_blank"><u>insulin resistance</u></a>, in which cells don't respond to insulin well and can't take in the sugar they need from the blood. At first, the body makes more insulin to compensate, but eventually, it can't keep up; this sets the stage for prediabetes and type 2 diabetes. About <a href="https://asmbs.org/resources/type-2-diabetes-and-metabolic-surgery-fact-sheet/" target="_blank"><u>90% of people</u></a> with type 2 diabetes also have obesity or are overweight.</p><p>At the same time, chemical reactions in the liver convert the extra glucose in the blood into fat stores, contributing to further weight gain.</p><p>Current treatments for these conditions focus on either lifestyle changes, such as diet and exercise, or long-term medications such as <a href="https://www.livescience.com/health/medicine-drugs/the-popular-diabetes-drug-metformin-has-been-used-for-decades-and-scientists-just-figured-out-its-main-mechanism"><u>metformin</u></a>, which lowers blood sugar, and GLP-1s, which reduce appetite to promote weight loss. But Fussenegger and colleagues wondered if they could target the glucose directly.</p><p>They designed an inch-long reactor that converts glucose into a harmless byproduct, called gluconate, through a controlled chemical reaction triggered by tiny amounts of electricity. This transformation takes place at an electrode coated with gold and platinum nanoparticles embedded within a graphite felt. </p><p>Crucially, the reaction occurs only when the device receives sufficient electricity, so the glucose removal can be switched on and off by controlling how much power is supplied to the implant. </p><p>The device is wireless and is both powered and controlled from an ordinary smartphone. The phone emits low-level radio frequency energy, which the implant's electronics then convert to a stable DC current to activate the reaction. Combined with a glucose monitor, the device detects high blood sugar and then sends feedback to the smartphone, which then adjusts the amount of power transferred to the implant.</p><p>"In principle, this enables the device to remove more glucose when [blood sugar] levels are elevated and reduce its activity when glucose returns towards the desired range," Fussenegger said. "The objective is to create an autonomous system that continuously adapts to the patient's metabolic needs."</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="nW5c9vPEMVPiBM6ZqQFM6Y" name="GettyImages-1969670962-diabetes" alt="A woman scans a circular device on her arm with her phone" src="https://cdn.mos.cms.futurecdn.net/nW5c9vPEMVPiBM6ZqQFM6Y-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/nW5c9vPEMVPiBM6ZqQFM6Y-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">In the mouse study, the implant was combined with a continuous glucose monitor, which provided updates on blood sugar levels to a phone that controlled the device. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Halfpoint Images via Getty Images)</span></figcaption></figure><p>The team tested this self-regulating medical device in mice with both diabetes and obesity. Over six weeks, the mice fitted with the implant had much more stable blood sugar levels than the untreated mice did. They also lost an average of 10% of their body weight. </p><p>Because the mice's glucose was consistently maintained within normal levels, the body's metabolic chemistry shifted toward fat burning, while the on-off regulation of the glucose-removal reaction prevented the mice's sugar levels from falling below safe limits.</p><p>It's an exciting proof of concept, Fussenegger thinks. However, "one important challenge is demonstrating that the device can convert sufficient quantities of glucose in a human while maintaining long-term safety and catalytic efficiency," he said. In other words, they still need to show that the chemical reaction works at the larger scale required to treat a human patient.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/has-americas-obesity-rate-plateaued">Has America's obesity rate plateaued?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/obesity-is-linked-to-1-in-10-deaths-from-infection-worldwide-and-scientists-are-still-learning-why">Obesity is linked to 1 in 10 deaths from infection worldwide</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/ozempic-style-drugs-treat-type-1-diabetes-not-only-type-2-study-finds">Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds</a></li></ul></p></div></div><p>In a separate test, the team introduced the device to a large beaker filled with a sugary solution, to see if it could cope with larger volumes of glucose. The amount, about 1.3 gallons (5 liters), was similar to a <a href="https://www.livescience.com/32213-how-much-blood-is-in-the-human-body.html"><u>person's total blood volume</u></a>. The device still effectively controlled sugar levels in this larger system. </p><p>The test is not a substitute for research in larger animals and human patients, though, Fussenegger said. Those studies are the team's next priority. </p><p>Importantly, "our device is not intended to replace healthy nutrition, physical activity, or preventative medicine" for the treatment of diabetes and obesity, Fussenegger said. </p><p>"Obesity and type 2 diabetes are complex conditions involving much more than elevated glucose levels," he added. "We see it as a potentially powerful addition to the therapeutic toolbox, one that could eventually be combined with established treatments and lifestyle interventions."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Colorectal cancer cases in kids have risen sixfold over past 2 decades ‪—‬ researchers are racing to understand why ]]></title>
                                                                                                <dc:content><![CDATA[ <p>More children, teens and very young adults are being diagnosed with colorectal cancer in the United States, and new research suggests they often experience aggressive forms of the disease. </p><p>While diagnosis rates are rising, the disease is still rare among young people. Colorectal cancer, which affects the lower intestines and rectum, is largely a disease of age: 55% of all colorectal cancers are diagnosed in people over 65, and only 16% occur in people ages 49 or younger, according to a 2026 study published in the <a href="https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70067" target="_blank"><u>flagship journal of the American Cancer Society</u></a>. Only a few hundred cases per year are diagnosed in people under age 21 in the U.S. </p><p>Nevertheless, the numbers of cases in the very young are rising, even as colorectal cancer rates decline or hold steady in older individuals. This increase coincides with an <a href="https://www.livescience.com/health/cancer/more-young-people-are-getting-colorectal-cancer-heres-what-scientists-think-might-be-happening"><u>overall rise in colon and rectal cancer rates in people under 50</u></a>. </p><p>The reasons for this schism aren't entirely understood. People over 50 receive routine colonoscopies in which precancerous polyps are removed, and that likely accounts for much of the decline in colorectal cancer diagnoses in older adults. But researchers suspect that environmental factors, such as ultraprocessed foods and sedentary lifestyles, might be behind the growing rates in young people.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="gFByBc9oNH8TPPMaV9PfiD" name="GutBacteria_Getty_1386022789.jpg" alt="close up of cells lining the human gut, showing multicolored bacterial cells floating just above the gut cells" src="https://cdn.mos.cms.futurecdn.net/gFByBc9oNH8TPPMaV9PfiD-1920-80.jpg" mos="" align="middle" fullscreen="" width="1920" height="1080" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Scientists are looking to the gut microbiome for clues about why colorectal cancer is on the rise in young people. </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>"Most of the research has really focused on the gut microbiome," the community of bacteria and other microbes that live in the gut, said <a href="https://som.cuanschutz.edu/Profiles/Faculty/Profile/4227" target="_blank"><u>Dr. Christopher Lieu</u></a>, a professor of medical oncology at the University of Colorado Anschutz and a medical adviser to the nonprofit <a href="https://colorectalcancer.org/" target="_blank"><u>Colorectal Cancer Alliance</u></a>. </p><p>Microbiome disruptions <a href="https://www.nature.com/articles/s41522-025-00883-8" target="_blank"><u>may spur inflammation</u></a>, which, in turn, may trigger DNA mutations that cause cancer. But these mechanisms are complicated, Lieu told Live Science, and there likely isn't one simple reason young people's microbiomes may be getting disturbed. </p><p>"It's going to be extraordinarily more complex than that," he said. </p><h2 id="aggressive-disease-in-young-people">Aggressive disease in young people</h2><p>What researchers are starting to learn is that colorectal cancer in people in their early 20s or younger tends to be a more aggressive disease than that often seen in older people. </p><p>"We do feel like it is a bit of a distinct disease than what we're seeing in older adults," said <a href="https://www.nationwidechildrens.org/research/areas-of-research/center-for-child-health-outcomes-research/center-for-surgical-outcomes-research/lab-staff" target="_blank"><u>Dr. Erica Arnold</u></a>, a pediatric surgery research fellow at Nationwide Children's Hospital in Columbus, Ohio. In October, Arnold presented new research on colorectal cancer in people ages 21 or younger <a href="https://aapexperience26.eventscribe.net/fsPopup.asp?PosterID=834321&amp;mode=posterInfo" target="_blank"><u>at the annual meeting of the American Academy of Pediatrics</u></a>.</p><p>Arnold and her colleagues analyzed the cases of 84 patients diagnosed between 2012 and 2023. They found that the median age of diagnosis was 16 years old and the median duration of symptoms before diagnosis was only 12 weeks long.</p><p>Only about 20% of the patients had a close relative with colorectal cancer, suggesting that for many of these young people, the disease did not necessarily emerge due to hereditary factors.</p><div><blockquote><p>If you want my honest opinion, it does suggest that these cancers are developing differently.</p><p> Dr. Christopher Lieu, a professor of medical oncology at the University of Colorado Anschutz</p></blockquote></div><p>Eighty percent of the study participants were diagnosed with Stage III or Stage IV disease, meaning the cancer had already spread locally and to lymph nodes or to other, distant organs when the patients were diagnosed. For comparison, in colorectal cancer patients of all ages, 60% are diagnosed in Stage III or IV, according to the <a href="https://www.cdc.gov/united-states-cancer-statistics/publications/colorectal-cancer-stat-bite.html" target="_blank"><u>Centers for Disease Control and Prevention</u></a> (CDC). </p><p>In addition, Arnold said, one-third of the patients in their study had cellular markers of particularly aggressive cancer. </p><p>"Some of that might be related to delays in diagnosis," Lieu said, "but if you want my honest opinion, it does suggest that these cancers are developing differently."</p><p>The study's data was not nationally representative, but <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13271338/" target="_blank"><u>a recent analysis of CDC data</u></a> has also found that colorectal cancer rates in youth are on the rise. In 1999, the diagnosis rate in kids ages 10 to 14 was 1 in a million. By 2020, it had risen to 6 in a million. For teens between 15 and 19, the rate of diagnosis went from 3 in a million to 13 in a million in that same time frame.</p><h2 id="unclear-causes">Unclear causes</h2><p>There is no definitive reason for this rise, Lieu said. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8777015/" target="_blank"><u>Research on the microbiome</u></a> has suggested that processed food, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10953323/" target="_blank"><u>antibiotic exposure in childhood</u></a>, stress, reduced exercise and other lifestyle factors may contribute to this increased risk of colorectal cancer. </p><p>Some microbes may play a particularly strong role, at least in some cases of colorectal cancer. For instance, a specific variant of the common gut bacterium <em>Escherichia coli</em> is <a href="https://www.nature.com/articles/s41467-023-43329-5" target="_blank"><u>strongly associated with colorectal cancer</u></a>; the variant carries a genetic segment and produces compounds that are toxic to genes. But this variant alone cannot explain all colorectal cancer cases in young people. Nor is it clear why the gut microbiome might be undergoing a shift in the first place. </p><p>"It may be a combination of food, antibiotic use and environmental exposures," Lieu suggested. </p><p>Regardless of the exact causes behind the cases, Arnold's new research pointed to the symptoms that deserve closer scrutiny in young people. Among the 84 patients in the study, 75% reported experiencing back and abdominal pain before their diagnosis, 45% had changes in their bowel movements, 43% experienced unexplained weight loss and 38% had rectal bleeding. </p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/rising-temperatures-could-boost-pregnancy-risks-worldwide-heres-how">Rising temperatures could boost pregnancy risks worldwide — here's how</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/testosterone-for-menopause-the-treatment-is-rising-in-popularity-but-does-it-work">Testosterone for menopause: The treatment is rising in popularity, but does it work?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/mpox-has-not-disappeared-why-the-infectious-disease-is-still-spreading-in-the-us-and-may-be-here-to-stay">'Mpox has not disappeared': Why the infectious disease is still spreading in the US and may be here to stay</a></li></ul></p></div></div><p>These are classic colorectal cancer symptoms, Arnold said, but they might be overlooked in this young age group because these same symptoms can have more common causes. </p><p>Parents should know that in most cases, stomach pain and gastrointestinal disruptions in kids are not caused by colorectal cancer, Lieu said, calling the cancer an "extraordinarily rare event." Nevertheless, pain or gastrointestinal upset that doesn't ease or that worsens over time needs a checkup, and symptoms like weight loss and blood in the stool are very unusual in kids and deserve extra attention. </p><p>"It's just important to investigate it to make sure we're catching colorectal cancer earlier rather than later in these patients," Arnold said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/cancer/colorectal-cancer-cases-in-kids-have-risen-sixfold-over-past-2-decades-researchers-are-racing-to-understand-why</link>
                                                                            <description>
                            <![CDATA[ While rare, colorectal cancer is becoming more common in kids, teens and young adults, and the disease appears particularly aggressive in this age group. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">mW6ggYqt3ipLuEsRRdc8Fg</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/BKENYesL3Tzq4CT6ARD5KV-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 26 Oct 2026 12:00:00 +0000</pubDate>                                                                                                                                <updated>Mon, 26 Oct 2026 12:09:16 +0000</updated>
                                                                                                                                            <category><![CDATA[Cancer]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                    <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                                                                                    <dc:creator><![CDATA[ Stephanie Pappas ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/syig84DuW9p8R73hBYHxPc-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/BKENYesL3Tzq4CT6ARD5KV-1920-80.jpg">
                                                            <media:credit><![CDATA[Marco VDM via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[In recent decades, colorectal cancer rates have risen among young people in the U.S., although in absolute terms, the disease remains rare in this age group.]]></media:description>                                                            <media:text><![CDATA[close up on a child in a hospital bed holding a stuffed toy and their mother&#039;s hand]]></media:text>
                                <media:title type="plain"><![CDATA[close up on a child in a hospital bed holding a stuffed toy and their mother&#039;s hand]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/BKENYesL3Tzq4CT6ARD5KV-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>More children, teens and very young adults are being diagnosed with colorectal cancer in the United States, and new research suggests they often experience aggressive forms of the disease. </p><p>While diagnosis rates are rising, the disease is still rare among young people. Colorectal cancer, which affects the lower intestines and rectum, is largely a disease of age: 55% of all colorectal cancers are diagnosed in people over 65, and only 16% occur in people ages 49 or younger, according to a 2026 study published in the <a href="https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70067" target="_blank"><u>flagship journal of the American Cancer Society</u></a>. Only a few hundred cases per year are diagnosed in people under age 21 in the U.S. </p><p>Nevertheless, the numbers of cases in the very young are rising, even as colorectal cancer rates decline or hold steady in older individuals. This increase coincides with an <a href="https://www.livescience.com/health/cancer/more-young-people-are-getting-colorectal-cancer-heres-what-scientists-think-might-be-happening"><u>overall rise in colon and rectal cancer rates in people under 50</u></a>. </p><p>The reasons for this schism aren't entirely understood. People over 50 receive routine colonoscopies in which precancerous polyps are removed, and that likely accounts for much of the decline in colorectal cancer diagnoses in older adults. But researchers suspect that environmental factors, such as ultraprocessed foods and sedentary lifestyles, might be behind the growing rates in young people.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="gFByBc9oNH8TPPMaV9PfiD" name="GutBacteria_Getty_1386022789.jpg" alt="close up of cells lining the human gut, showing multicolored bacterial cells floating just above the gut cells" src="https://cdn.mos.cms.futurecdn.net/gFByBc9oNH8TPPMaV9PfiD-1920-80.jpg" mos="" align="middle" fullscreen="" width="1920" height="1080" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Scientists are looking to the gut microbiome for clues about why colorectal cancer is on the rise in young people. </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>"Most of the research has really focused on the gut microbiome," the community of bacteria and other microbes that live in the gut, said <a href="https://som.cuanschutz.edu/Profiles/Faculty/Profile/4227" target="_blank"><u>Dr. Christopher Lieu</u></a>, a professor of medical oncology at the University of Colorado Anschutz and a medical adviser to the nonprofit <a href="https://colorectalcancer.org/" target="_blank"><u>Colorectal Cancer Alliance</u></a>. </p><p>Microbiome disruptions <a href="https://www.nature.com/articles/s41522-025-00883-8" target="_blank"><u>may spur inflammation</u></a>, which, in turn, may trigger DNA mutations that cause cancer. But these mechanisms are complicated, Lieu told Live Science, and there likely isn't one simple reason young people's microbiomes may be getting disturbed. </p><p>"It's going to be extraordinarily more complex than that," he said. </p><h2 id="aggressive-disease-in-young-people">Aggressive disease in young people</h2><p>What researchers are starting to learn is that colorectal cancer in people in their early 20s or younger tends to be a more aggressive disease than that often seen in older people. </p><p>"We do feel like it is a bit of a distinct disease than what we're seeing in older adults," said <a href="https://www.nationwidechildrens.org/research/areas-of-research/center-for-child-health-outcomes-research/center-for-surgical-outcomes-research/lab-staff" target="_blank"><u>Dr. Erica Arnold</u></a>, a pediatric surgery research fellow at Nationwide Children's Hospital in Columbus, Ohio. In October, Arnold presented new research on colorectal cancer in people ages 21 or younger <a href="https://aapexperience26.eventscribe.net/fsPopup.asp?PosterID=834321&amp;mode=posterInfo" target="_blank"><u>at the annual meeting of the American Academy of Pediatrics</u></a>.</p><p>Arnold and her colleagues analyzed the cases of 84 patients diagnosed between 2012 and 2023. They found that the median age of diagnosis was 16 years old and the median duration of symptoms before diagnosis was only 12 weeks long.</p><p>Only about 20% of the patients had a close relative with colorectal cancer, suggesting that for many of these young people, the disease did not necessarily emerge due to hereditary factors.</p><div><blockquote><p>If you want my honest opinion, it does suggest that these cancers are developing differently.</p><p> Dr. Christopher Lieu, a professor of medical oncology at the University of Colorado Anschutz</p></blockquote></div><p>Eighty percent of the study participants were diagnosed with Stage III or Stage IV disease, meaning the cancer had already spread locally and to lymph nodes or to other, distant organs when the patients were diagnosed. For comparison, in colorectal cancer patients of all ages, 60% are diagnosed in Stage III or IV, according to the <a href="https://www.cdc.gov/united-states-cancer-statistics/publications/colorectal-cancer-stat-bite.html" target="_blank"><u>Centers for Disease Control and Prevention</u></a> (CDC). </p><p>In addition, Arnold said, one-third of the patients in their study had cellular markers of particularly aggressive cancer. </p><p>"Some of that might be related to delays in diagnosis," Lieu said, "but if you want my honest opinion, it does suggest that these cancers are developing differently."</p><p>The study's data was not nationally representative, but <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13271338/" target="_blank"><u>a recent analysis of CDC data</u></a> has also found that colorectal cancer rates in youth are on the rise. In 1999, the diagnosis rate in kids ages 10 to 14 was 1 in a million. By 2020, it had risen to 6 in a million. For teens between 15 and 19, the rate of diagnosis went from 3 in a million to 13 in a million in that same time frame.</p><h2 id="unclear-causes">Unclear causes</h2><p>There is no definitive reason for this rise, Lieu said. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8777015/" target="_blank"><u>Research on the microbiome</u></a> has suggested that processed food, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10953323/" target="_blank"><u>antibiotic exposure in childhood</u></a>, stress, reduced exercise and other lifestyle factors may contribute to this increased risk of colorectal cancer. </p><p>Some microbes may play a particularly strong role, at least in some cases of colorectal cancer. For instance, a specific variant of the common gut bacterium <em>Escherichia coli</em> is <a href="https://www.nature.com/articles/s41467-023-43329-5" target="_blank"><u>strongly associated with colorectal cancer</u></a>; the variant carries a genetic segment and produces compounds that are toxic to genes. But this variant alone cannot explain all colorectal cancer cases in young people. Nor is it clear why the gut microbiome might be undergoing a shift in the first place. </p><p>"It may be a combination of food, antibiotic use and environmental exposures," Lieu suggested. </p><p>Regardless of the exact causes behind the cases, Arnold's new research pointed to the symptoms that deserve closer scrutiny in young people. Among the 84 patients in the study, 75% reported experiencing back and abdominal pain before their diagnosis, 45% had changes in their bowel movements, 43% experienced unexplained weight loss and 38% had rectal bleeding. </p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/rising-temperatures-could-boost-pregnancy-risks-worldwide-heres-how">Rising temperatures could boost pregnancy risks worldwide — here's how</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/reproductive-health/testosterone-for-menopause-the-treatment-is-rising-in-popularity-but-does-it-work">Testosterone for menopause: The treatment is rising in popularity, but does it work?</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/mpox-has-not-disappeared-why-the-infectious-disease-is-still-spreading-in-the-us-and-may-be-here-to-stay">'Mpox has not disappeared': Why the infectious disease is still spreading in the US and may be here to stay</a></li></ul></p></div></div><p>These are classic colorectal cancer symptoms, Arnold said, but they might be overlooked in this young age group because these same symptoms can have more common causes. </p><p>Parents should know that in most cases, stomach pain and gastrointestinal disruptions in kids are not caused by colorectal cancer, Lieu said, calling the cancer an "extraordinarily rare event." Nevertheless, pain or gastrointestinal upset that doesn't ease or that worsens over time needs a checkup, and symptoms like weight loss and blood in the stool are very unusual in kids and deserve extra attention. </p><p>"It's just important to investigate it to make sure we're catching colorectal cancer earlier rather than later in these patients," Arnold said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Christina Applegate misdiagnosis: Why can MS be difficult to diagnose? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Actor Christina Applegate was diagnosed with multiple sclerosis (MS) over five years ago — but this week, she announced that a recent reevaluation found that she doesn't have the condition after all. In the wake of that revelation, she's been left without a diagnosis, and <a href="https://open.spotify.com/episode/0r5F6ocVlYvDI0crfFsn3N?si=024774abb6c24e1f" target="_blank"><u>she said on a podcast</u></a> that she felt she was "back at square one, where I don't know what's going on with me."</p><p>Applegate's case is not totally unique, although MS diagnosis has improved over the years. <a href="https://journals.sagepub.com/doi/10.1177/13524585241274527" target="_blank"><u>Studies offer different estimates</u></a> of how frequently MS is misdiagnosed, with rates ranging from 5% to over 40%, depending on the patient population and clinical setting. There is also some degree of underdiagnosis — cases in which people with MS aren't flagged as having the disease.</p><p>So, how difficult is MS to identify, and what does that mean for patients? Live Science spoke with experts about the current state of MS diagnostics and the improvements that may be coming in the future.</p><p>"It's also really important that doctors and patients be aware that it's not inappropriate to revisit a diagnosis — to make sure it's right," <a href="https://profiles.ucsf.edu/ari.green" target="_blank"><u>Dr. Ari Green</u></a>, chief of the Division of Neuroimmunology and Glial Biology at the University of California, San Francisco, told Live Science.</p><h2 id="the-importance-of-early-diagnosis">The importance of early diagnosis</h2><p>MS is an autoimmune disorder in which the immune system attacks the central nervous system, meaning the brain and spinal cord. These attacks harm neurons directly and also take aim at myelin — a fatty, insulating substance that coats neurons' outgoing wires and helps them send signals efficiently. </p><p>This damage leads to distinctive scarring in nerve tissue and causes a range of symptoms, including vision problems, muscle weakness, tingling sensations, dizziness and bladder control issues. Patients with untreated and advanced MS can lose the ability to walk and stand or, in some cases, develop partial or complete paralysis.</p><div><blockquote><p>You're trying to be as proactive as possible with this.</p><p>Dr. Yohance Allette, a neuroimmunologist and researcher at Penn State Health</p></blockquote></div><p>These severe outcomes are becoming rarer as treatments have improved significantly, Green said. Current treatments keep immune attacks at bay and thus prevent further nerve damage.</p><p>"It's moved from people ending up with severe, profound disability at 10 or 20 years of disease, and now it's at like 30 or 40 years of disease, they have modest disability," Green told Live Science. The disease most often <a href="https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269" target="_blank"><u>emerges between age 20 and 40</u></a>, although it can occur in any age group. Importantly, Green said, "the earlier people initiate treatment who have MS, the better they do over the long term." </p><p>For that reason, it's important to reach an MS diagnosis efficiently, so that patients can start that critical treatment, said <a href="https://www.pennstatehealth.org/doctors/yohance-m-allette-md" target="_blank"><u>Dr. Yohance Allette</u></a>, a neuroimmunologist and researcher at Penn State Health. "You're trying to be as proactive as possible with this."</p><h2 id="quot-a-diagnosis-of-exclusion-quot">"A diagnosis of exclusion"</h2><p>However, there is no single, surefire test that can reliably show that a person has MS. "With MS, it comes down to the keyword 'criteria," Allette said.</p><p>MS experts have compiled a list of criteria, which are updated periodically, that reflect how the features of MS show up in lab tests; brain, optic nerve and spinal cord scans; and patients' symptoms. (Green was among the dozens of experts involved in the latest update, which was <a href="https://www.nationalmssociety.org/understanding-ms/what-is-ms/how-ms-is-diagnosed/2024-mcdonald-diagnostic-criteria" target="_blank"><u>conducted in 2024</u></a> and <a href="https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00270-4/abstract" target="_blank"><u>published in 2025</u></a>.)</p><p>So, what does diagnosis look like for a patient today? The first step is to recognize symptoms that might point to MS. </p><p>Those early symptoms — such as issues with balance, vision or bowel control — vary significantly from person to person and may not immediately raise red flags that the patient has a neurological problem, Green said. The way those symptoms emerge can be a clue, though; typically, MS symptoms worsen over the course of a day or a few days and then dissipate, he noted. </p><p>Once concerning symptoms are flagged, MRIs of the brain and spinal cord are taken. The scans may reveal evidence of myelin damage, and neurologists note the shape, size and location of those lesions. Damage often appears near blood vessels, since that's where immune cells access the brain, Green noted. </p><p>Other conditions — like migraine, uncontrolled diabetes or vascular disease — can also come with some myelin damage, so it's key to look for specific patterns related to MS. Neurologists who specialize in MS are practiced at this task, while doctors in other neurological specialties may not know how to distinguish MS-related myelin damage from that caused by other conditions, Allette and Green both noted.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2560px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="dSbdLR7As7ZadzE8LegjmR" name="GettyImages-2280116706" alt="illustration of a myelin sheath on an axon cracking" src="https://cdn.mos.cms.futurecdn.net/dSbdLR7As7ZadzE8LegjmR-1920-80.jpg" mos="" align="middle" fullscreen="" width="2560" height="1440" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Myelin (yellow) helps neurons send messages efficiently. In MS, the immune system attacks myelin, causing it to break down. </span><span class="credit" itemprop="copyrightHolder">(Image credit: koto_feja via Getty Images)</span></figcaption></figure><p>MRIs of the optic nerves can also show MS-related damage, and these scans are emphasized in the latest diagnostic criteria, Allette noted. Electrophysiologic tests, which assess the function of nerves, are also "super important because they tell you something totally different than just seeing a lesion on MRI," Green said. Further signs of MS can be found via spinal taps, which sample the fluid around the brain and spinal cord that may carry proteins and inflammatory cells related to MS.</p><p>In addition to collecting these clues, doctors must rule out diseases that look similar to MS. These include <a href="https://my.clevelandclinic.org/health/diseases/9858-neuromyelitis-optica-nmo" target="_blank"><u>neuromyelitis optica</u></a> and <a href="https://www.mayoclinic.org/diseases-conditions/mogad/symptoms-causes/syc-20560476" target="_blank"><u>myelin oligodendrocyte glycoprotein antibody-associated disease</u></a> (MOGAD) — two other autoimmune conditions that affect the central nervous system. Both these diseases are associated with distinctive, rogue immune proteins, called autoantibodies, that latch onto various parts of the nervous system; those specific antibodies are not seen in MS.</p><p><a href="https://msfocus.org/Magazine/Magazine-Items/Posted/Diseases-That-Mimic-MS" target="_blank"><u>Other conditions</u></a> — such as the inflammatory disease lupus and neuromuscular disease myasthenia gravis — can sometimes look like MS at first glance, as well. Some of these "MS mimics" can be ruled out with data from spinal taps or antibody tests, while others require a more laborious battery of assessments.</p><p>"Ultimately, it's a diagnosis of exclusion," Allette said. "There are things that you can rule out quickly," while others take time to investigate thoroughly.</p><p>Conditions like MOGAD and <a href="https://my.clevelandclinic.org/health/diseases/neurosarcoidosis" target="_blank"><u>neurosarcoidosis</u></a>, an inflammatory condition sometimes mistaken for MS, can actually be worsened by MS medications, Green noted. So if a patient's MS flare-ups worsen after they start a treatment, that could hint that something else is the culprit, he said. But because there may be long gaps between flare-ups, doctors may need to track a patient for some time before their worsening becomes apparent.</p><h2 id="gaps-to-fill">Gaps to fill?</h2><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2409px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="DDd2u9zFxjhRYKz926J2jf" name="GettyImages-2268720481" alt="a grid containing many slices of a brain mri" src="https://cdn.mos.cms.futurecdn.net/DDd2u9zFxjhRYKz926J2jf-1920-80.jpg" mos="" align="middle" fullscreen="" width="2409" height="1355" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The updated diagnostic criteria for MS include new guidelines for how to examine brain MRIs. These criteria could likely be improved even more in future, Green noted. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Douglas Sacha via Getty Images)</span></figcaption></figure><p>Given all the tools available, a patient can be reasonably confident in their MS diagnosis, Green said. </p><p>"In general, there's a fair amount of diagnostic confidence that comes with MS diagnosis today," he said. However, that confidence is highest when the tools are in the hands of a specialist who is following the most up-to-date criteria, he noted. The test results require interpretation, and that's one place where uncertainty can creep in. </p><p>Regarding Applegate's circumstances, "to speak bluntly, I think the case came as a bit of a shock because we always expect that part of society to have quick access [to high-quality medical care]," Allette said. For some patients, the road to accessing specialty MS care can be long, which can result in missteps, and even misdiagnoses, along the way. Applegate went five years with an incorrect diagnosis, but "would that have been seven or eight years for somebody who doesn't have that access?" Allette speculated.</p><p>Without knowing the details of Applegate's case, Allette and Green said it would be difficult to speculate on what resulted in her misdiagnosis. (Applegate mentioned that her brain scans had been reassessed with a "new technology," but didn't go into specifics.)</p><p>Looking toward the future of MS diagnostics, Green and Allette think emerging proteomic tests hold a lot of promise. Such tests generate a profile of the proteins and smaller fragments, called peptides, in a patient's blood or cerebrospinal fluid. They can be designed to look for proteins involved in driving the underlying immune attacks, as well as signs of nerve damage that MS wrecks, they explained.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/the-right-diagnosis-is-unbelievably-powerful-it-can-take-years-to-diagnose-rare-diseases-and-scientists-are-trying-to-fix-that">'The right diagnosis is unbelievably powerful': It can take years to diagnose rare diseases, and scientists are trying to fix that</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/why-are-dengue-cases-surging-in-florida-this-year-an-unlucky-combination-of-factors-experts-say">Why are dengue cases surging in Florida this year? An 'unlucky' combination of factors, experts say</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/zombified-cells-may-drive-aging-and-scientists-are-devising-new-ways-to-get-rid-of-them">'Zombie cells' may drive aging, and scientists are devising new ways to get rid of them</a></li></ul></p></div></div><p>These in-depth, protein analyses could help paint a more comprehensive picture of MS, which could ultimately help scientists "look at that whole system in concert" to reach a strong diagnosis, Allette said.</p><p>No proteomics-based diagnostic tests for MS have been approved yet, Green clarified. And even with those upcoming advances, Green doubts there will ever be a simple, one-time test that can determine a patient has MS. "I think that's probably unlikely, that it would ever be that straightforward," he said. </p><p>He does think that, in time, scientists could pare down the number of tests required to reach a diagnosis, but he argued that the clinical evaluation conducted by a neurologist will likely remain crucial. "I'm doubtful that there's going to be a test that will fully replace that," he said, "at least in the foreseeable future."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/immune-system/christina-applegate-misdiagnosis-why-can-ms-be-difficult-to-diagnose</link>
                                                                            <description>
                            <![CDATA[ MS advocate Christina Applegate recently announced that her MS diagnosis was incorrect, based on new test results. Why can the disease be difficult to identify? ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">BjrUYzst8DriFwQ3kV2C79</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/mmuBmZWyBMjZM9FJRxVRZA-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 23 Oct 2026 21:25:48 +0000</pubDate>                                                                                                                                <updated>Mon, 26 Oct 2026 14:56:59 +0000</updated>
                                                                                                                                            <category><![CDATA[Immune System]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/mmuBmZWyBMjZM9FJRxVRZA-1920-80.jpg">
                                                            <media:credit><![CDATA[Gilbert Flores / Contributor via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Christina Applegate previously announced that she had relapsing-remitting multiple sclerosis, the most common form of the disease. New test results have called that diagnosis into question, she said recently.]]></media:description>                                                            <media:text><![CDATA[photo of christina applegate on a red carpet wearing a black velvet jacket]]></media:text>
                                <media:title type="plain"><![CDATA[photo of christina applegate on a red carpet wearing a black velvet jacket]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/mmuBmZWyBMjZM9FJRxVRZA-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Actor Christina Applegate was diagnosed with multiple sclerosis (MS) over five years ago — but this week, she announced that a recent reevaluation found that she doesn't have the condition after all. In the wake of that revelation, she's been left without a diagnosis, and <a href="https://open.spotify.com/episode/0r5F6ocVlYvDI0crfFsn3N?si=024774abb6c24e1f" target="_blank"><u>she said on a podcast</u></a> that she felt she was "back at square one, where I don't know what's going on with me."</p><p>Applegate's case is not totally unique, although MS diagnosis has improved over the years. <a href="https://journals.sagepub.com/doi/10.1177/13524585241274527" target="_blank"><u>Studies offer different estimates</u></a> of how frequently MS is misdiagnosed, with rates ranging from 5% to over 40%, depending on the patient population and clinical setting. There is also some degree of underdiagnosis — cases in which people with MS aren't flagged as having the disease.</p><p>So, how difficult is MS to identify, and what does that mean for patients? Live Science spoke with experts about the current state of MS diagnostics and the improvements that may be coming in the future.</p><p>"It's also really important that doctors and patients be aware that it's not inappropriate to revisit a diagnosis — to make sure it's right," <a href="https://profiles.ucsf.edu/ari.green" target="_blank"><u>Dr. Ari Green</u></a>, chief of the Division of Neuroimmunology and Glial Biology at the University of California, San Francisco, told Live Science.</p><h2 id="the-importance-of-early-diagnosis">The importance of early diagnosis</h2><p>MS is an autoimmune disorder in which the immune system attacks the central nervous system, meaning the brain and spinal cord. These attacks harm neurons directly and also take aim at myelin — a fatty, insulating substance that coats neurons' outgoing wires and helps them send signals efficiently. </p><p>This damage leads to distinctive scarring in nerve tissue and causes a range of symptoms, including vision problems, muscle weakness, tingling sensations, dizziness and bladder control issues. Patients with untreated and advanced MS can lose the ability to walk and stand or, in some cases, develop partial or complete paralysis.</p><div><blockquote><p>You're trying to be as proactive as possible with this.</p><p>Dr. Yohance Allette, a neuroimmunologist and researcher at Penn State Health</p></blockquote></div><p>These severe outcomes are becoming rarer as treatments have improved significantly, Green said. Current treatments keep immune attacks at bay and thus prevent further nerve damage.</p><p>"It's moved from people ending up with severe, profound disability at 10 or 20 years of disease, and now it's at like 30 or 40 years of disease, they have modest disability," Green told Live Science. The disease most often <a href="https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269" target="_blank"><u>emerges between age 20 and 40</u></a>, although it can occur in any age group. Importantly, Green said, "the earlier people initiate treatment who have MS, the better they do over the long term." </p><p>For that reason, it's important to reach an MS diagnosis efficiently, so that patients can start that critical treatment, said <a href="https://www.pennstatehealth.org/doctors/yohance-m-allette-md" target="_blank"><u>Dr. Yohance Allette</u></a>, a neuroimmunologist and researcher at Penn State Health. "You're trying to be as proactive as possible with this."</p><h2 id="quot-a-diagnosis-of-exclusion-quot">"A diagnosis of exclusion"</h2><p>However, there is no single, surefire test that can reliably show that a person has MS. "With MS, it comes down to the keyword 'criteria," Allette said.</p><p>MS experts have compiled a list of criteria, which are updated periodically, that reflect how the features of MS show up in lab tests; brain, optic nerve and spinal cord scans; and patients' symptoms. (Green was among the dozens of experts involved in the latest update, which was <a href="https://www.nationalmssociety.org/understanding-ms/what-is-ms/how-ms-is-diagnosed/2024-mcdonald-diagnostic-criteria" target="_blank"><u>conducted in 2024</u></a> and <a href="https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00270-4/abstract" target="_blank"><u>published in 2025</u></a>.)</p><p>So, what does diagnosis look like for a patient today? The first step is to recognize symptoms that might point to MS. </p><p>Those early symptoms — such as issues with balance, vision or bowel control — vary significantly from person to person and may not immediately raise red flags that the patient has a neurological problem, Green said. The way those symptoms emerge can be a clue, though; typically, MS symptoms worsen over the course of a day or a few days and then dissipate, he noted. </p><p>Once concerning symptoms are flagged, MRIs of the brain and spinal cord are taken. The scans may reveal evidence of myelin damage, and neurologists note the shape, size and location of those lesions. Damage often appears near blood vessels, since that's where immune cells access the brain, Green noted. </p><p>Other conditions — like migraine, uncontrolled diabetes or vascular disease — can also come with some myelin damage, so it's key to look for specific patterns related to MS. Neurologists who specialize in MS are practiced at this task, while doctors in other neurological specialties may not know how to distinguish MS-related myelin damage from that caused by other conditions, Allette and Green both noted.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2560px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="dSbdLR7As7ZadzE8LegjmR" name="GettyImages-2280116706" alt="illustration of a myelin sheath on an axon cracking" src="https://cdn.mos.cms.futurecdn.net/dSbdLR7As7ZadzE8LegjmR-1920-80.jpg" mos="" align="middle" fullscreen="" width="2560" height="1440" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Myelin (yellow) helps neurons send messages efficiently. In MS, the immune system attacks myelin, causing it to break down. </span><span class="credit" itemprop="copyrightHolder">(Image credit: koto_feja via Getty Images)</span></figcaption></figure><p>MRIs of the optic nerves can also show MS-related damage, and these scans are emphasized in the latest diagnostic criteria, Allette noted. Electrophysiologic tests, which assess the function of nerves, are also "super important because they tell you something totally different than just seeing a lesion on MRI," Green said. Further signs of MS can be found via spinal taps, which sample the fluid around the brain and spinal cord that may carry proteins and inflammatory cells related to MS.</p><p>In addition to collecting these clues, doctors must rule out diseases that look similar to MS. These include <a href="https://my.clevelandclinic.org/health/diseases/9858-neuromyelitis-optica-nmo" target="_blank"><u>neuromyelitis optica</u></a> and <a href="https://www.mayoclinic.org/diseases-conditions/mogad/symptoms-causes/syc-20560476" target="_blank"><u>myelin oligodendrocyte glycoprotein antibody-associated disease</u></a> (MOGAD) — two other autoimmune conditions that affect the central nervous system. Both these diseases are associated with distinctive, rogue immune proteins, called autoantibodies, that latch onto various parts of the nervous system; those specific antibodies are not seen in MS.</p><p><a href="https://msfocus.org/Magazine/Magazine-Items/Posted/Diseases-That-Mimic-MS" target="_blank"><u>Other conditions</u></a> — such as the inflammatory disease lupus and neuromuscular disease myasthenia gravis — can sometimes look like MS at first glance, as well. Some of these "MS mimics" can be ruled out with data from spinal taps or antibody tests, while others require a more laborious battery of assessments.</p><p>"Ultimately, it's a diagnosis of exclusion," Allette said. "There are things that you can rule out quickly," while others take time to investigate thoroughly.</p><p>Conditions like MOGAD and <a href="https://my.clevelandclinic.org/health/diseases/neurosarcoidosis" target="_blank"><u>neurosarcoidosis</u></a>, an inflammatory condition sometimes mistaken for MS, can actually be worsened by MS medications, Green noted. So if a patient's MS flare-ups worsen after they start a treatment, that could hint that something else is the culprit, he said. But because there may be long gaps between flare-ups, doctors may need to track a patient for some time before their worsening becomes apparent.</p><h2 id="gaps-to-fill">Gaps to fill?</h2><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2409px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="DDd2u9zFxjhRYKz926J2jf" name="GettyImages-2268720481" alt="a grid containing many slices of a brain mri" src="https://cdn.mos.cms.futurecdn.net/DDd2u9zFxjhRYKz926J2jf-1920-80.jpg" mos="" align="middle" fullscreen="" width="2409" height="1355" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The updated diagnostic criteria for MS include new guidelines for how to examine brain MRIs. These criteria could likely be improved even more in future, Green noted. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Douglas Sacha via Getty Images)</span></figcaption></figure><p>Given all the tools available, a patient can be reasonably confident in their MS diagnosis, Green said. </p><p>"In general, there's a fair amount of diagnostic confidence that comes with MS diagnosis today," he said. However, that confidence is highest when the tools are in the hands of a specialist who is following the most up-to-date criteria, he noted. The test results require interpretation, and that's one place where uncertainty can creep in. </p><p>Regarding Applegate's circumstances, "to speak bluntly, I think the case came as a bit of a shock because we always expect that part of society to have quick access [to high-quality medical care]," Allette said. For some patients, the road to accessing specialty MS care can be long, which can result in missteps, and even misdiagnoses, along the way. Applegate went five years with an incorrect diagnosis, but "would that have been seven or eight years for somebody who doesn't have that access?" Allette speculated.</p><p>Without knowing the details of Applegate's case, Allette and Green said it would be difficult to speculate on what resulted in her misdiagnosis. (Applegate mentioned that her brain scans had been reassessed with a "new technology," but didn't go into specifics.)</p><p>Looking toward the future of MS diagnostics, Green and Allette think emerging proteomic tests hold a lot of promise. Such tests generate a profile of the proteins and smaller fragments, called peptides, in a patient's blood or cerebrospinal fluid. They can be designed to look for proteins involved in driving the underlying immune attacks, as well as signs of nerve damage that MS wrecks, they explained.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/the-right-diagnosis-is-unbelievably-powerful-it-can-take-years-to-diagnose-rare-diseases-and-scientists-are-trying-to-fix-that">'The right diagnosis is unbelievably powerful': It can take years to diagnose rare diseases, and scientists are trying to fix that</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/viruses-infections-disease/why-are-dengue-cases-surging-in-florida-this-year-an-unlucky-combination-of-factors-experts-say">Why are dengue cases surging in Florida this year? An 'unlucky' combination of factors, experts say</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/zombified-cells-may-drive-aging-and-scientists-are-devising-new-ways-to-get-rid-of-them">'Zombie cells' may drive aging, and scientists are devising new ways to get rid of them</a></li></ul></p></div></div><p>These in-depth, protein analyses could help paint a more comprehensive picture of MS, which could ultimately help scientists "look at that whole system in concert" to reach a strong diagnosis, Allette said.</p><p>No proteomics-based diagnostic tests for MS have been approved yet, Green clarified. And even with those upcoming advances, Green doubts there will ever be a simple, one-time test that can determine a patient has MS. "I think that's probably unlikely, that it would ever be that straightforward," he said. </p><p>He does think that, in time, scientists could pare down the number of tests required to reach a diagnosis, but he argued that the clinical evaluation conducted by a neurologist will likely remain crucial. "I'm doubtful that there's going to be a test that will fully replace that," he said, "at least in the foreseeable future."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Brain scans reveal 'number line' that's used to mentally compare values ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Picture a number line, with the values running from the smallest to the largest. New research shows that the <a href="https://www.livescience.com/29365-human-brain.html"><u>human brain</u></a> uses a similar system when comparing numbers; in the study, scientists uncovered a "mental map" in which numbers have unique coordinates in the brain, which may help us place them in order of magnitude.</p><p>"Numbers are abstract concepts, but our brains have ways of organizing them that allow us to compare and reason about their values," said study co-authors <a href="https://www.researchgate.net/profile/Daniela-Valerio" target="_blank"><u>Daniela Valério</u></a>, a postdoctoral researcher in the <a href="https://joliot.cea.fr/drf/joliot/en/Pages/research_entities/NeuroSpin/unicog.aspx" target="_blank"><u>INSERM-CEA Cognitive Neuroimaging Unit</u></a> (UNICOG) in France, and <a href="https://www.college-de-france.fr/en/chair/stanislas-dehaene-experimental-cognitive-psychology-statutory-chair/biography" target="_blank"><u>Stanislas Dehaene</u></a><u>,</u> the director of UNICOG. </p><p>"What is fascinating is that the brain can bring together numbers that look very different, such as integers [whole numbers] and fractions, within a common system," they told Live Science in a joint statement.</p><p>That system is a map for both sets of numerical values within the brain, they reported Thursday (Oct. 22) in the journal <a href="https://doi.org/10.1371/journal.pbio.3003820?utm_source=chatgpt.com" target="_blank"><u>PLOS Biology</u></a>.</p><p>To investigate how the brain represents different types of numbers, Valério, Dehaene and their colleagues used a high-resolution functional magnetic resonance imaging (fMRI) scanner, which tracks blood flow through the brain as an indirect measure of activity. They measured brain activity in 20 adults while they worked through a simple task of comparing numbers — a mix of fractions and whole numbers — and determining whether each number was bigger or smaller than the previous one shown.</p><p>The brain scans revealed distinct activity patterns in the anterior inferior parietal cortex — part of the brain that's known to be key for processing numbers. As participants compared numerical values, the brain region lit up in an organized pattern resembling a number line. The whole numbers and fractions were represented along this shared line according to their size, rather than being mapped in separate systems.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="4WoAi3yuoFwtRPEsMwtXiJ" name="16_9 BrainMapNumbers" alt="3D scans of brains with various colors showing different areas lighting up during activity." src="https://cdn.mos.cms.futurecdn.net/4WoAi3yuoFwtRPEsMwtXiJ-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/4WoAi3yuoFwtRPEsMwtXiJ-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">fMRI scans performed during the study revealed similar patterns of brain activity when participants compared integers and fractions. Smaller numbers are represented in reddish hues and larger numbers in bluish hues; these activity patterns represent an average across the study participants. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Valério D, et al., 2026, PLOS Biology, <a href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</a> )</span></figcaption></figure><p>The brain's shared map brings different number formats into a common system based on the quantities they represent, the researchers concluded. </p><p>"For me, it is how the brain gets from a symbol to its meaning," said <a href="https://lifebylogic.com/about/" target="_blank"><u>Abiot Derbie</u></a>, a cognitive neuroscientist and founder of the company LifeByLogic, which makes psychology assessments. </p><p>The fraction "¼" contains the digit "4," but the fraction's value is much closer to zero, he noted. "The activity patterns reflected that numerical relationship, going beyond the digits themselves," Derbie, who was not involved in the research, told Live Science in an email.</p><p>The idea that the brain represents numerical magnitude in the parietal lobe is <a href="https://www.sciencedirect.com/science/article/abs/pii/S1053811909002808?via%3Dihub" target="_blank"><u>not novel</u></a>. However, scientists mostly understood how the brain dealt with whole numbers, while its strategy for fractions was not well understood. The new work builds on that existing research by exploring how both numerical magnitude and number type are processed together. </p><p>"To the best of our knowledge, this is the first study to investigate the geometry of neural representations in a task involving both integers and fractions," the researchers wrote in their report. "In the future, it might be interesting to expand the present work to decimal numbers."</p><p>From previous work, "scientists already knew that fractions and whole numbers engage overlapping parts of the brain's number-processing network," Derbie said. "This study gives us a clearer picture of how their values are organized."</p><p>In the future, the team could examine how this neural representation varies across people of different ages, educational levels and mathematical backgrounds, Derbie suggested. The study also included only native French speakers, so may not reflect differences across language or culture.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/map-of-600-000-brain-cells-rewrites-the-textbook-on-how-the-brain-makes-decisions">Map of 600,000 brain cells rewrites the textbook on how the brain makes decisions</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/super-detailed-map-of-brain-cells-that-keep-us-awake-could-improve-our-understanding-of-consciousness">Super-detailed map of brain cells that keep us awake could improve our understanding of consciousness</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/first-of-its-kind-map-of-the-mouse-nose-reveals-surprises-about-the-sense-of-smell">First-of-its-kind map of the mouse nose reveals surprises about the sense of smell</a></li></ul></p></div></div><p>"I would want to see how this organization develops as people learn," Derbie said. For instance, the team could follow children before and after they learn about fractions, to see whether changes in brain activity accompany better understanding.</p><p>In the current study, the participants found it more difficult to compare fractions than to compare whole numbers, the researchers noted; they were slower and made more errors while working with fractions, which was expected. But the study's results don't offer hints as to why.</p><p>"Our study was not designed to explain why fractions are harder to learn or understand," Valério and Dehaene told Live Science. "What is new in our study is that we show that these different types of numbers are organized within a shared map in the brain."</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/brain-scans-reveal-number-line-thats-used-to-mentally-compare-values</link>
                                                                            <description>
                            <![CDATA[ Although whole numbers and fractions are processed differently in the brain, when you compare their values, a single "mental map" akin to a number line lights up. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">G8S6B5bmvwVckJG7kqfEzU</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/LZmRWHsLdXZ5ara3urSgU-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 22 Oct 2026 18:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Jenna Congdon ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/uvLtUAUqUtznj4MgxjDnji-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/LZmRWHsLdXZ5ara3urSgU-1920-80.jpg">
                                                            <media:credit><![CDATA[ GrafikLab via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A new study uses fMRI scans to show how whole numbers and fractions are represented in the brain as you compare their magnitudes.]]></media:description>                                                            <media:text><![CDATA[A cartoon of a head with numbers coming out of the back.]]></media:text>
                                <media:title type="plain"><![CDATA[A cartoon of a head with numbers coming out of the back.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/LZmRWHsLdXZ5ara3urSgU-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Picture a number line, with the values running from the smallest to the largest. New research shows that the <a href="https://www.livescience.com/29365-human-brain.html"><u>human brain</u></a> uses a similar system when comparing numbers; in the study, scientists uncovered a "mental map" in which numbers have unique coordinates in the brain, which may help us place them in order of magnitude.</p><p>"Numbers are abstract concepts, but our brains have ways of organizing them that allow us to compare and reason about their values," said study co-authors <a href="https://www.researchgate.net/profile/Daniela-Valerio" target="_blank"><u>Daniela Valério</u></a>, a postdoctoral researcher in the <a href="https://joliot.cea.fr/drf/joliot/en/Pages/research_entities/NeuroSpin/unicog.aspx" target="_blank"><u>INSERM-CEA Cognitive Neuroimaging Unit</u></a> (UNICOG) in France, and <a href="https://www.college-de-france.fr/en/chair/stanislas-dehaene-experimental-cognitive-psychology-statutory-chair/biography" target="_blank"><u>Stanislas Dehaene</u></a><u>,</u> the director of UNICOG. </p><p>"What is fascinating is that the brain can bring together numbers that look very different, such as integers [whole numbers] and fractions, within a common system," they told Live Science in a joint statement.</p><p>That system is a map for both sets of numerical values within the brain, they reported Thursday (Oct. 22) in the journal <a href="https://doi.org/10.1371/journal.pbio.3003820?utm_source=chatgpt.com" target="_blank"><u>PLOS Biology</u></a>.</p><p>To investigate how the brain represents different types of numbers, Valério, Dehaene and their colleagues used a high-resolution functional magnetic resonance imaging (fMRI) scanner, which tracks blood flow through the brain as an indirect measure of activity. They measured brain activity in 20 adults while they worked through a simple task of comparing numbers — a mix of fractions and whole numbers — and determining whether each number was bigger or smaller than the previous one shown.</p><p>The brain scans revealed distinct activity patterns in the anterior inferior parietal cortex — part of the brain that's known to be key for processing numbers. As participants compared numerical values, the brain region lit up in an organized pattern resembling a number line. The whole numbers and fractions were represented along this shared line according to their size, rather than being mapped in separate systems.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="4WoAi3yuoFwtRPEsMwtXiJ" name="16_9 BrainMapNumbers" alt="3D scans of brains with various colors showing different areas lighting up during activity." src="https://cdn.mos.cms.futurecdn.net/4WoAi3yuoFwtRPEsMwtXiJ-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/4WoAi3yuoFwtRPEsMwtXiJ-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">fMRI scans performed during the study revealed similar patterns of brain activity when participants compared integers and fractions. Smaller numbers are represented in reddish hues and larger numbers in bluish hues; these activity patterns represent an average across the study participants. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Valério D, et al., 2026, PLOS Biology, <a href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</a> )</span></figcaption></figure><p>The brain's shared map brings different number formats into a common system based on the quantities they represent, the researchers concluded. </p><p>"For me, it is how the brain gets from a symbol to its meaning," said <a href="https://lifebylogic.com/about/" target="_blank"><u>Abiot Derbie</u></a>, a cognitive neuroscientist and founder of the company LifeByLogic, which makes psychology assessments. </p><p>The fraction "¼" contains the digit "4," but the fraction's value is much closer to zero, he noted. "The activity patterns reflected that numerical relationship, going beyond the digits themselves," Derbie, who was not involved in the research, told Live Science in an email.</p><p>The idea that the brain represents numerical magnitude in the parietal lobe is <a href="https://www.sciencedirect.com/science/article/abs/pii/S1053811909002808?via%3Dihub" target="_blank"><u>not novel</u></a>. However, scientists mostly understood how the brain dealt with whole numbers, while its strategy for fractions was not well understood. The new work builds on that existing research by exploring how both numerical magnitude and number type are processed together. </p><p>"To the best of our knowledge, this is the first study to investigate the geometry of neural representations in a task involving both integers and fractions," the researchers wrote in their report. "In the future, it might be interesting to expand the present work to decimal numbers."</p><p>From previous work, "scientists already knew that fractions and whole numbers engage overlapping parts of the brain's number-processing network," Derbie said. "This study gives us a clearer picture of how their values are organized."</p><p>In the future, the team could examine how this neural representation varies across people of different ages, educational levels and mathematical backgrounds, Derbie suggested. The study also included only native French speakers, so may not reflect differences across language or culture.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/map-of-600-000-brain-cells-rewrites-the-textbook-on-how-the-brain-makes-decisions">Map of 600,000 brain cells rewrites the textbook on how the brain makes decisions</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/super-detailed-map-of-brain-cells-that-keep-us-awake-could-improve-our-understanding-of-consciousness">Super-detailed map of brain cells that keep us awake could improve our understanding of consciousness</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/first-of-its-kind-map-of-the-mouse-nose-reveals-surprises-about-the-sense-of-smell">First-of-its-kind map of the mouse nose reveals surprises about the sense of smell</a></li></ul></p></div></div><p>"I would want to see how this organization develops as people learn," Derbie said. For instance, the team could follow children before and after they learn about fractions, to see whether changes in brain activity accompany better understanding.</p><p>In the current study, the participants found it more difficult to compare fractions than to compare whole numbers, the researchers noted; they were slower and made more errors while working with fractions, which was expected. But the study's results don't offer hints as to why.</p><p>"Our study was not designed to explain why fractions are harder to learn or understand," Valério and Dehaene told Live Science. "What is new in our study is that we show that these different types of numbers are organized within a shared map in the brain."</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A fighter pilot had unexplained headaches for over a year. The cause was hiding in plain sight. ]]></title>
                                                                                                <dc:content><![CDATA[ <p><strong>The patient: </strong>A 29-year-old man in India</p><p><strong>The symptoms: </strong>The man, a fighter pilot in the Indian Air Force, went to a civilian neurologist after having persistent headaches for 18 months. The headaches would occur approximately two to three times per month, starting in the late afternoon and lasting up to three days. Sleep did not improve his symptoms. </p><p>The pain was typically greater on the right side of his head, but he would often feel pain on the left side as well. The pilot also reported that just before a headache, he would experience a "sense of lousiness," his doctors wrote in a <a href="https://indjaerospacemed.com/a-strange-case-of-headache-in-a-fighter-aircrew-a-case-study/" target="_blank"><u>report of the case</u></a>. </p><p>Sometimes, the pain was so intense that the man was unable to take part in scheduled flights. If he flew anyway during an episode, his headache would be even worse the next day.</p><p><strong>What happened next:</strong> According to the man, his finances and personal relationships were not a source of stress. (Stress, in general, is a <a href="https://www.mayoclinic.org/diseases-conditions/tension-headache/symptoms-causes/syc-20353977" target="_blank"><u>very common headache trigger</u></a>.) </p><p>When asked about his medical history, the pilot recalled no recent ailments or conditions that could cause recurring headaches, such as inflammation and congestion of the sinuses (sinusitis). He had no family history of chronic headaches or migraine, a neurological disease that frequently causes moderate to severe headache, <a href="http://americanmigrainefoundation.org/migraine-signs-symptoms/" target="_blank"><u>among other symptoms</u></a>. Nor did he experience nausea, vomiting or visual anomalies called "auras," which often accompany or precede migraines. </p><p>Nevertheless, the civilian doctor determined that migraines were the culprit. He prescribed divalproex ‪—‬ an oral medication used for migraine prevention — and told the patient that he would likely need this medication for years. Concerned about taking the drug over a long period, the pilot decided to consult an authorized specialist at a military medical facility for further evaluation. </p><p><strong>The diagnosis: </strong>The military doctors reviewed the pilot's case and examined him. All of his test results were in the normal range, and a CT scan showed no brain abnormalities. They ordered a nasal endoscopy — an exam that uses a camera to examine the nasal cavity and sinuses — and found that the patient had a deviated septum. However, the deviation was so minor that they ruled it out as a possible cause of his pain. </p><p>Finally, the doctors agreed with the initial diagnosis: The pilot was experiencing migraines. The causes of migraine are not fully understood, although <a href="https://link.springer.com/article/10.1007/s11916-024-01228-4" target="_blank"><u>genetics and environmental factors</u></a> may contribute to both the duration and intensity of migraine pain in a given individual. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="FknoHrC2vfKVk5YYiayjJf" name="GettyImages-1220895806-fighter jet" alt="Three gray fighter jets float amidst clouds in the sky." src="https://cdn.mos.cms.futurecdn.net/FknoHrC2vfKVk5YYiayjJf-1920-80.jpg" mos="" align="middle" fullscreen="" width="2000" height="1126" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Indian Air Force (IAF) fighter jets photographed in 2019. The patient's headaches were sometimes so bad that they stopped him from conducting scheduled flights. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Abhishek Singh via Getty Images)</span></figcaption></figure><p><strong>The treatment:</strong> The pilot was given the migraine medicine sumatriptan, to be taken at the first sign of pain, and aspirin, to be taken during headaches. He was allowed to continue flying under restricted conditions, and he had to report to a military neurologist for monthly reviews over the next three months.</p><p>Four months later, he was headache-free and had stopped taking medication, according to the report. However, his superior officers needed a detailed medical review before they could restore his unrestricted flight status, as severe migraines can disqualify pilots from flying.</p><p>Over three days, doctors conducted in-depth interviews with the pilot, focusing on the first appearance of his symptoms and the circumstances leading up to his headaches. They were puzzled by certain details: His lack of nausea, vomiting and auras, and the fact that he got no relief through sleep. These facts raised questions about the migraine diagnosis.</p><p>During the interviews, the pilot recalled that his headaches began around the time that he started using a new type of helmet with a tighter fit. The headaches corresponded with days in which he flew multiple flights and became worse the longer he wore the helmet. Then, around the time he started taking the prescribed medication, he coincidentally received a new allotment of personal flying clothing — including a helmet that was the correct size — for a new plane assignment. His headaches suddenly stopped. </p><p>"At that point the officer did not connect the cessation of headaches with the use of the new helmet," the doctors reported. "Reviewing the case in its entirety, the diagnosis of migraine or vascular headache was found to be incorrect; instead the individual was suffering from external compression headache due to an ill fitting helmet." </p><p><a href="https://link.springer.com/article/10.1007/s11916-010-0122-x" target="_blank"><u>Compression headaches</u></a> are caused by tight external pressure on the scalp and forehead, and they typically resolve when the pressure eases.</p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur">Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-womans-5-year-struggle-with-balance-and-walking-was-caused-by-a-one-in-a-million-disorder">Woman's 5-year struggle with balance and walking was caused by a 'one-in-a-million' disorder</a></li></ul></p></div></div><p>Doctors instructed the pilot to keep a headache diary and scheduled follow-up visits to confirm their findings. Five months later, his headaches had not returned, as he'd continued using the better-fitting helmet.</p><p><strong>What makes the case unique: </strong>When the military doctors scoured peer-reviewed studies, they found no reports of similar instances of compression headache "in any of the Air Forces of the world," they wrote in the report. </p><p>This case, they added, emphasizes the medical significance of making sure that pilots' flight uniforms — especially their helmets — fit properly.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/diagnostic-dilemma-a-fighter-pilot-had-unexplained-headaches-for-over-a-year-the-cause-was-hiding-in-plain-sight</link>
                                                                            <description>
                            <![CDATA[ A fighter pilot suddenly began experiencing intense headaches, and doctors' initial diagnoses of the problem were wrong. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">QW85krSzazxQnreBXJq6Ye</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/oNHYXTiuyqrJEUeLWcdR6C-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 21 Oct 2026 10:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 21 Oct 2026 15:28:07 +0000</updated>
                                                                                                                                            <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Mindy Weisberger ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/AhFB8tWuFKe7LsbCTX5BUE-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ &lt;p&gt;Mindy Weisberger is a science journalist and author of the book &quot;Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control,&quot; published by Hopkins Press. She formerly edited for Scholastic and reported for Live Science as a channel editor and senior writer. She has reported on general science, covering climate change, paleontology, biology and space. Mindy studied film at Columbia University; prior to Live Science she produced, wrote and directed media for the American Museum of Natural History in New York City. Her videos about dinosaurs, astrophysics, biodiversity and evolution appear in museums and science centers worldwide, earning awards such as the CINE Golden Eagle and the Communicator Award of Excellence. Her writing has also appeared in Scientific American, The Washington Post, How It Works Magazine and CNN.&lt;/p&gt; ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/oNHYXTiuyqrJEUeLWcdR6C-1920-80.jpg">
                                                            <media:credit><![CDATA[iStock / Getty Images Plus via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The patient described in the case below was a fighter pilot for the Indian Air Force. (This is a stock image.)]]></media:description>                                                            <media:text><![CDATA[a photo of a fighter pilot in the cockpit of a small plane]]></media:text>
                                <media:title type="plain"><![CDATA[a photo of a fighter pilot in the cockpit of a small plane]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/oNHYXTiuyqrJEUeLWcdR6C-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><strong>The patient: </strong>A 29-year-old man in India</p><p><strong>The symptoms: </strong>The man, a fighter pilot in the Indian Air Force, went to a civilian neurologist after having persistent headaches for 18 months. The headaches would occur approximately two to three times per month, starting in the late afternoon and lasting up to three days. Sleep did not improve his symptoms. </p><p>The pain was typically greater on the right side of his head, but he would often feel pain on the left side as well. The pilot also reported that just before a headache, he would experience a "sense of lousiness," his doctors wrote in a <a href="https://indjaerospacemed.com/a-strange-case-of-headache-in-a-fighter-aircrew-a-case-study/" target="_blank"><u>report of the case</u></a>. </p><p>Sometimes, the pain was so intense that the man was unable to take part in scheduled flights. If he flew anyway during an episode, his headache would be even worse the next day.</p><p><strong>What happened next:</strong> According to the man, his finances and personal relationships were not a source of stress. (Stress, in general, is a <a href="https://www.mayoclinic.org/diseases-conditions/tension-headache/symptoms-causes/syc-20353977" target="_blank"><u>very common headache trigger</u></a>.) </p><p>When asked about his medical history, the pilot recalled no recent ailments or conditions that could cause recurring headaches, such as inflammation and congestion of the sinuses (sinusitis). He had no family history of chronic headaches or migraine, a neurological disease that frequently causes moderate to severe headache, <a href="http://americanmigrainefoundation.org/migraine-signs-symptoms/" target="_blank"><u>among other symptoms</u></a>. Nor did he experience nausea, vomiting or visual anomalies called "auras," which often accompany or precede migraines. </p><p>Nevertheless, the civilian doctor determined that migraines were the culprit. He prescribed divalproex ‪—‬ an oral medication used for migraine prevention — and told the patient that he would likely need this medication for years. Concerned about taking the drug over a long period, the pilot decided to consult an authorized specialist at a military medical facility for further evaluation. </p><p><strong>The diagnosis: </strong>The military doctors reviewed the pilot's case and examined him. All of his test results were in the normal range, and a CT scan showed no brain abnormalities. They ordered a nasal endoscopy — an exam that uses a camera to examine the nasal cavity and sinuses — and found that the patient had a deviated septum. However, the deviation was so minor that they ruled it out as a possible cause of his pain. </p><p>Finally, the doctors agreed with the initial diagnosis: The pilot was experiencing migraines. The causes of migraine are not fully understood, although <a href="https://link.springer.com/article/10.1007/s11916-024-01228-4" target="_blank"><u>genetics and environmental factors</u></a> may contribute to both the duration and intensity of migraine pain in a given individual. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="FknoHrC2vfKVk5YYiayjJf" name="GettyImages-1220895806-fighter jet" alt="Three gray fighter jets float amidst clouds in the sky." src="https://cdn.mos.cms.futurecdn.net/FknoHrC2vfKVk5YYiayjJf-1920-80.jpg" mos="" align="middle" fullscreen="" width="2000" height="1126" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Indian Air Force (IAF) fighter jets photographed in 2019. The patient's headaches were sometimes so bad that they stopped him from conducting scheduled flights. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Abhishek Singh via Getty Images)</span></figcaption></figure><p><strong>The treatment:</strong> The pilot was given the migraine medicine sumatriptan, to be taken at the first sign of pain, and aspirin, to be taken during headaches. He was allowed to continue flying under restricted conditions, and he had to report to a military neurologist for monthly reviews over the next three months.</p><p>Four months later, he was headache-free and had stopped taking medication, according to the report. However, his superior officers needed a detailed medical review before they could restore his unrestricted flight status, as severe migraines can disqualify pilots from flying.</p><p>Over three days, doctors conducted in-depth interviews with the pilot, focusing on the first appearance of his symptoms and the circumstances leading up to his headaches. They were puzzled by certain details: His lack of nausea, vomiting and auras, and the fact that he got no relief through sleep. These facts raised questions about the migraine diagnosis.</p><p>During the interviews, the pilot recalled that his headaches began around the time that he started using a new type of helmet with a tighter fit. The headaches corresponded with days in which he flew multiple flights and became worse the longer he wore the helmet. Then, around the time he started taking the prescribed medication, he coincidentally received a new allotment of personal flying clothing — including a helmet that was the correct size — for a new plane assignment. His headaches suddenly stopped. </p><p>"At that point the officer did not connect the cessation of headaches with the use of the new helmet," the doctors reported. "Reviewing the case in its entirety, the diagnosis of migraine or vascular headache was found to be incorrect; instead the individual was suffering from external compression headache due to an ill fitting helmet." </p><p><a href="https://link.springer.com/article/10.1007/s11916-010-0122-x" target="_blank"><u>Compression headaches</u></a> are caused by tight external pressure on the scalp and forehead, and they typically resolve when the pressure eases.</p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur">Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-womans-5-year-struggle-with-balance-and-walking-was-caused-by-a-one-in-a-million-disorder">Woman's 5-year struggle with balance and walking was caused by a 'one-in-a-million' disorder</a></li></ul></p></div></div><p>Doctors instructed the pilot to keep a headache diary and scheduled follow-up visits to confirm their findings. Five months later, his headaches had not returned, as he'd continued using the better-fitting helmet.</p><p><strong>What makes the case unique: </strong>When the military doctors scoured peer-reviewed studies, they found no reports of similar instances of compression headache "in any of the Air Forces of the world," they wrote in the report. </p><p>This case, they added, emphasizes the medical significance of making sure that pilots' flight uniforms — especially their helmets — fit properly.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Could 'body clocks' play a role in depression? Study proposes a new 'circadian' subtype ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Some people with depression sleep far more than average, wake up exhausted, habitually stay up late, and experience mood shifts with the seasons. A new study suggests that these symptoms may cluster in a distinct subtype of depression that's tied to the body's internal clock.</p><p><a href="https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30139-1/abstract" target="_blank"><u>While research has long linked</u></a> a scrambled <a href="https://www.livescience.com/what-is-a-circadian-rhythm"><u>circadian rhythm</u></a> to a risk of mood disorders, neuroscientists are now proposing that these disruptions define a specific form of depression that they call "circadian depression." <a href="https://pubmed.ncbi.nlm.nih.gov/33689801/" target="_blank"><u>First conceptualized in 2021</u></a>, the body-clock subtype may affect about 1 in 4 people with severe, recurrent or persistent depression, the researchers estimate. </p><p>In their new study, published Wednesday (Oct. 21) in <a href="http://dx.doi.org/10.1192/bjp.2026.10798" target="_blank"><u>The British Journal of Psychiatry</u></a>, the team identified the subtype in about 2,600 people out of over 11,000 evaluated.</p><p>"Circadian depression is a biologically informed subtype," said study co-author <a href="https://profiles.sydney.edu.au/emiliana.tonini" target="_blank"><u>Emiliana Tonini</u></a>, a neuroscientist at the University of Sydney. "Unlike subtypes defined mainly by symptoms, the core feature here is a disturbed circadian system, which common antidepressants may not fully address," Tonini told Live Science in an email.</p><p>The researchers think treatments that target the sleep-wake system, such as the sleep hormone <a href="https://www.livescience.com/health/medicine-drugs/its-being-promoted-like-theres-absolutely-no-risk-why-some-experts-say-melatonin-should-be-considered-a-drug-rather-than-a-supplement"><u>melatonin</u></a> or <a href="https://www.livescience.com/52842-bright-light-eases-depression-symptoms.html"><u>bright light therapy</u></a>, might be beneficial for people with this subtype. However, because the subtype is still a proposal and not formally established yet, other experts say that further research is needed before the findings can inform clinical practice.</p><h2 id="more-than-just-bad-sleep">More than just bad sleep</h2><p>Tonini and her team analyzed data from 11,380 adults ages 18 to 90 who took part in the <a href="https://www.qimrb.edu.au/studies/australian-genetics-of-depression-study" target="_blank"><u>Australian Genetics of Depression Study (AGDS)</u></a>, a nationwide study exploring how genes and life experiences influence depression and responses to treatment. They classified participants under the "circadian" umbrella if they had at least three of six features: seasonal mood swings, late sleep schedules, <a href="https://www.livescience.com/health/what-is-jetlag-and-how-can-you-avoid-it"><u>social jet lag</u></a> (a mismatch between sleep routine during workdays and free days), <a href="https://www.livescience.com/health/heart-circulation/night-owls-may-have-worse-heart-health-but-why"><u>night-owl habits</u></a>, excessive sleep (<a href="https://www.livescience.com/hypersomnia-symptoms-causes-treatments"><u>hypersomnia</u></a>), and fatigue upon waking.</p><p>A total of 2,604 people fit the proposed subtype. Compared with others in the AGDS cohort, this group was younger and developed depression earlier in life — around 19, compared with about 23 for the rest of the cohort. </p><p>The group also skewed female, and individuals reported greater psychological distress, frequent suicidal thoughts and more physical complaints than people who didn't fit the proposed subtype. Some experienced weight gain during depressive episodes and symptoms resembling<a href="https://my.clevelandclinic.org/health/diseases/21774-hypomania" target="_blank"> <u>hypomania</u></a>, a revved-up state of elevated mood and energy that's milder than full-blown mania.</p><p>However, having this constellation of symptoms doesn't mean someone's biological clock is disrupted, said <a href="https://www.psychiatry.pitt.edu/about-us/our-people/brant-p-hasler-phd" target="_blank"><u>Brant Hasler</u></a>, a psychologist and sleep researcher at the University of Pittsburgh who was not involved in the study. The researchers relied on the participants' self-reports of their sleep patterns; that data correlates only modestly with direct measures of circadian timing, such as measurements of melatonin in saliva, he said in an email.</p><p>"One can identify as an evening-type, and report later sleep timing, and still have physiological circadian timing that is not particularly delayed," he said.</p><p>So, in addition to checking symptoms, the team hunted for genetic clues underlying the proposed subtype. They analyzed DNA from participants' saliva samples and calculated "polygenic risk scores," which add up the influence of thousands of different genetic variants to estimate how likely someone is to develop a given condition. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="GTLqiD2GLtgqF5vPWfZyCK" name="GettyImages-1607063777 (1)-hypothalamus" alt="A close up of an illustration of a transparent brain with the hypothalamus in red." src="https://cdn.mos.cms.futurecdn.net/GTLqiD2GLtgqF5vPWfZyCK-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/GTLqiD2GLtgqF5vPWfZyCK-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The body's sleep-wake cycle is largely controlled by a hub of cells within the hypothalamus (red). </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>"Mental health conditions are shaped by hundreds or thousands of variants that each add a small amount of risk, so everyone carries a unique 'portfolio' of risk," Tonini explained.</p><p>People in the circadian group had a higher genetic risk for depression, anxiety, attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder, the analysis suggested. They also had a greater genetic risk of higher body weight, <a href="https://www.livescience.com/34757-insulin-resistance-develop-diabetes-heart-disease.html"><u>insulin resistance</u></a>, <a href="https://www.livescience.com/52344-inflammation.html"><u>inflammation</u></a>, <a href="https://www.livescience.com/34756-sleep-disorder-insomnia.html"><u>insomnia</u></a> and late-night sleep habits, compared with the other study participants. </p><p>This suggests "circadian depression is more than just 'depression with bad sleep,'" Tonini said. "It involves a mix of metabolic, inflammatory, circadian, and mood-related processes."</p><h2 id="could-this-change-depression-treatment">Could this change depression treatment?</h2><p>The researchers looked at the participants' past experiences with antidepressants, finding that the circadian group reported less benefit from common medications, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Common examples include the SSRI Lexapro and the SNRI Cymbalta. </p><p>The circadian group also experienced more side effects from these treatments, such as drowsiness, nausea, anxiety and weight gain.</p><p>"If circadian disruption is a core biological mechanism in these individuals, treatments that fail to address those abnormalities may naturally be less effective," said <a href="https://school.wakehealth.edu/faculty/b/ruth-benca" target="_blank"><u>Dr. Ruth Benca</u></a>, a psychiatrist and sleep researcher at Wake Forest University School of Medicine who was not involved in the study. However, Benca cautioned that body-clock disruption may not be the only reason standard drugs fall short for these patients. </p><p>"People with more pronounced circadian disturbances often have more severe illness and other psychiatric conditions, which can contribute to treatment resistance," Benca told Live Science in an email.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/6-distinct-forms-of-depression-identified-by-ai-in-brain-study">6 distinct forms of depression identified by AI in brain study</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/it-could-revolutionize-completely-the-way-we-treat-depression-researchers-are-exploring-promising-immune-therapy-for-treating-psychiatric-symptoms">'It could revolutionize, completely, the way we treat depression': Researchers are exploring promising immune therapy for treating psychiatric symptoms</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/sleep/scientists-have-just-defined-five-sleep-profiles-and-some-could-help-spot-mental-illness">Scientists have just defined five sleep profiles — and some could help spot mental illness</a></li></ul></p></div></div><p>Even so, tracking sleep, measurements of circadian rhythm, and seasonal shifts in mood could help clinicians identify at-risk patients earlier and select more effective treatments sooner in the course of illness, Benca suggested. "Potential approaches include behavioral routines, structured sleep schedules, or <a href="https://pubmed.ncbi.nlm.nih.gov/34225975/" target="_blank"><u>chronotherapy</u></a>," in which the timing of medication or light exposure is strategically coordinated with internal body rhythms, she added.</p><p>Clinical trials are still needed to draw firm conclusions about potential treatments, Tonini noted. The findings also must be validated in broader populations, since the study drew on a single Australian cohort and its genetic analysis included only people of European ancestry. </p><p>For now, "the study is an important step toward a more personalized treatment approach," she said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/sleep/could-body-clocks-play-a-role-in-depression-study-proposes-a-new-circadian-subtype</link>
                                                                            <description>
                            <![CDATA[ Researchers propose a new subtype of depression linked to body-clock patterns. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">niMgsh26hTHUMdCLoZHaYn</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/bxjnrVZim5Nqyqgm8VWX2Q-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 20 Oct 2026 23:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Sleep]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Isha Ishtiaq ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/wXThBYHTfbXiYY2GhijqFf-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/bxjnrVZim5Nqyqgm8VWX2Q-1920-80.jpg">
                                                            <media:credit><![CDATA[ ljubaphoto via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Scientists in Australia have proposed that there&amp;#39;s a specific form of depression that heavily involves circadian disruptions.]]></media:description>                                                            <media:text><![CDATA[A woman wearing blue pajamas puts her hand to her forehead while laying in bed]]></media:text>
                                <media:title type="plain"><![CDATA[A woman wearing blue pajamas puts her hand to her forehead while laying in bed]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/bxjnrVZim5Nqyqgm8VWX2Q-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Some people with depression sleep far more than average, wake up exhausted, habitually stay up late, and experience mood shifts with the seasons. A new study suggests that these symptoms may cluster in a distinct subtype of depression that's tied to the body's internal clock.</p><p><a href="https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30139-1/abstract" target="_blank"><u>While research has long linked</u></a> a scrambled <a href="https://www.livescience.com/what-is-a-circadian-rhythm"><u>circadian rhythm</u></a> to a risk of mood disorders, neuroscientists are now proposing that these disruptions define a specific form of depression that they call "circadian depression." <a href="https://pubmed.ncbi.nlm.nih.gov/33689801/" target="_blank"><u>First conceptualized in 2021</u></a>, the body-clock subtype may affect about 1 in 4 people with severe, recurrent or persistent depression, the researchers estimate. </p><p>In their new study, published Wednesday (Oct. 21) in <a href="http://dx.doi.org/10.1192/bjp.2026.10798" target="_blank"><u>The British Journal of Psychiatry</u></a>, the team identified the subtype in about 2,600 people out of over 11,000 evaluated.</p><p>"Circadian depression is a biologically informed subtype," said study co-author <a href="https://profiles.sydney.edu.au/emiliana.tonini" target="_blank"><u>Emiliana Tonini</u></a>, a neuroscientist at the University of Sydney. "Unlike subtypes defined mainly by symptoms, the core feature here is a disturbed circadian system, which common antidepressants may not fully address," Tonini told Live Science in an email.</p><p>The researchers think treatments that target the sleep-wake system, such as the sleep hormone <a href="https://www.livescience.com/health/medicine-drugs/its-being-promoted-like-theres-absolutely-no-risk-why-some-experts-say-melatonin-should-be-considered-a-drug-rather-than-a-supplement"><u>melatonin</u></a> or <a href="https://www.livescience.com/52842-bright-light-eases-depression-symptoms.html"><u>bright light therapy</u></a>, might be beneficial for people with this subtype. However, because the subtype is still a proposal and not formally established yet, other experts say that further research is needed before the findings can inform clinical practice.</p><h2 id="more-than-just-bad-sleep">More than just bad sleep</h2><p>Tonini and her team analyzed data from 11,380 adults ages 18 to 90 who took part in the <a href="https://www.qimrb.edu.au/studies/australian-genetics-of-depression-study" target="_blank"><u>Australian Genetics of Depression Study (AGDS)</u></a>, a nationwide study exploring how genes and life experiences influence depression and responses to treatment. They classified participants under the "circadian" umbrella if they had at least three of six features: seasonal mood swings, late sleep schedules, <a href="https://www.livescience.com/health/what-is-jetlag-and-how-can-you-avoid-it"><u>social jet lag</u></a> (a mismatch between sleep routine during workdays and free days), <a href="https://www.livescience.com/health/heart-circulation/night-owls-may-have-worse-heart-health-but-why"><u>night-owl habits</u></a>, excessive sleep (<a href="https://www.livescience.com/hypersomnia-symptoms-causes-treatments"><u>hypersomnia</u></a>), and fatigue upon waking.</p><p>A total of 2,604 people fit the proposed subtype. Compared with others in the AGDS cohort, this group was younger and developed depression earlier in life — around 19, compared with about 23 for the rest of the cohort. </p><p>The group also skewed female, and individuals reported greater psychological distress, frequent suicidal thoughts and more physical complaints than people who didn't fit the proposed subtype. Some experienced weight gain during depressive episodes and symptoms resembling<a href="https://my.clevelandclinic.org/health/diseases/21774-hypomania" target="_blank"> <u>hypomania</u></a>, a revved-up state of elevated mood and energy that's milder than full-blown mania.</p><p>However, having this constellation of symptoms doesn't mean someone's biological clock is disrupted, said <a href="https://www.psychiatry.pitt.edu/about-us/our-people/brant-p-hasler-phd" target="_blank"><u>Brant Hasler</u></a>, a psychologist and sleep researcher at the University of Pittsburgh who was not involved in the study. The researchers relied on the participants' self-reports of their sleep patterns; that data correlates only modestly with direct measures of circadian timing, such as measurements of melatonin in saliva, he said in an email.</p><p>"One can identify as an evening-type, and report later sleep timing, and still have physiological circadian timing that is not particularly delayed," he said.</p><p>So, in addition to checking symptoms, the team hunted for genetic clues underlying the proposed subtype. They analyzed DNA from participants' saliva samples and calculated "polygenic risk scores," which add up the influence of thousands of different genetic variants to estimate how likely someone is to develop a given condition. </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="GTLqiD2GLtgqF5vPWfZyCK" name="GettyImages-1607063777 (1)-hypothalamus" alt="A close up of an illustration of a transparent brain with the hypothalamus in red." src="https://cdn.mos.cms.futurecdn.net/GTLqiD2GLtgqF5vPWfZyCK-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/GTLqiD2GLtgqF5vPWfZyCK-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The body's sleep-wake cycle is largely controlled by a hub of cells within the hypothalamus (red). </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>"Mental health conditions are shaped by hundreds or thousands of variants that each add a small amount of risk, so everyone carries a unique 'portfolio' of risk," Tonini explained.</p><p>People in the circadian group had a higher genetic risk for depression, anxiety, attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder, the analysis suggested. They also had a greater genetic risk of higher body weight, <a href="https://www.livescience.com/34757-insulin-resistance-develop-diabetes-heart-disease.html"><u>insulin resistance</u></a>, <a href="https://www.livescience.com/52344-inflammation.html"><u>inflammation</u></a>, <a href="https://www.livescience.com/34756-sleep-disorder-insomnia.html"><u>insomnia</u></a> and late-night sleep habits, compared with the other study participants. </p><p>This suggests "circadian depression is more than just 'depression with bad sleep,'" Tonini said. "It involves a mix of metabolic, inflammatory, circadian, and mood-related processes."</p><h2 id="could-this-change-depression-treatment">Could this change depression treatment?</h2><p>The researchers looked at the participants' past experiences with antidepressants, finding that the circadian group reported less benefit from common medications, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Common examples include the SSRI Lexapro and the SNRI Cymbalta. </p><p>The circadian group also experienced more side effects from these treatments, such as drowsiness, nausea, anxiety and weight gain.</p><p>"If circadian disruption is a core biological mechanism in these individuals, treatments that fail to address those abnormalities may naturally be less effective," said <a href="https://school.wakehealth.edu/faculty/b/ruth-benca" target="_blank"><u>Dr. Ruth Benca</u></a>, a psychiatrist and sleep researcher at Wake Forest University School of Medicine who was not involved in the study. However, Benca cautioned that body-clock disruption may not be the only reason standard drugs fall short for these patients. </p><p>"People with more pronounced circadian disturbances often have more severe illness and other psychiatric conditions, which can contribute to treatment resistance," Benca told Live Science in an email.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/6-distinct-forms-of-depression-identified-by-ai-in-brain-study">6 distinct forms of depression identified by AI in brain study</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/it-could-revolutionize-completely-the-way-we-treat-depression-researchers-are-exploring-promising-immune-therapy-for-treating-psychiatric-symptoms">'It could revolutionize, completely, the way we treat depression': Researchers are exploring promising immune therapy for treating psychiatric symptoms</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/sleep/scientists-have-just-defined-five-sleep-profiles-and-some-could-help-spot-mental-illness">Scientists have just defined five sleep profiles — and some could help spot mental illness</a></li></ul></p></div></div><p>Even so, tracking sleep, measurements of circadian rhythm, and seasonal shifts in mood could help clinicians identify at-risk patients earlier and select more effective treatments sooner in the course of illness, Benca suggested. "Potential approaches include behavioral routines, structured sleep schedules, or <a href="https://pubmed.ncbi.nlm.nih.gov/34225975/" target="_blank"><u>chronotherapy</u></a>," in which the timing of medication or light exposure is strategically coordinated with internal body rhythms, she added.</p><p>Clinical trials are still needed to draw firm conclusions about potential treatments, Tonini noted. The findings also must be validated in broader populations, since the study drew on a single Australian cohort and its genetic analysis included only people of European ancestry. </p><p>For now, "the study is an important step toward a more personalized treatment approach," she said.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Ultrasound waves that jiggle deep brain structures may relieve delusions in schizophrenia, small trial hints ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Stimulating the brain with ultrasound could help counter the delusions people experience in schizophrenia, a small trial finds.</p><p>The trial involved transcranial ultrasound stimulation, in which a device placed on a patient's head delivers ultrasound waves through the skull and into the brain. Its goal is to change the activity in a targeted brain region. </p><p><a href="https://www.mayoclinic.org/diseases-conditions/schizophrenia/symptoms-causes/syc-20354443" target="_blank"><u>Delusions</u></a> are false beliefs that are very difficult to shake; for example, a person might believe they are being stalked when they aren't or think that a major disaster is about to occur without any evidence to suggest so. In the trial, researchers found that a 10-minute session of the ultrasound treatment reduced the severity of delusions for at least a week in patients with schizophrenia or a related disorder. </p><p>This targeted ultrasound treatment delivered directly to the brain could avoid some of the full-body effects of antipsychotic medications, such as <a href="https://doi.org/10.1016/j.jad.2026.122587" target="_blank"><u>weight gain and high blood pressure</u></a>. That said, the new results, published Tuesday (Oct. 20) in the journal <a href="https://doi.org/10.1038/s44384-026-00076-3" target="_blank"><u>npj Acoustics</u></a>, are a first step and will need further verification in larger trials.</p><p>"It's too early to know for certain what the therapeutic benefits will be, but it's very exciting," study co-author <a href="https://nyulangone.org/doctors/1881672590/donald-c-goff" target="_blank"><u>Dr. Donald Goff</u></a>, a professor of psychiatry at the New York University Grossman School of Medicine, told Live Science.</p><h2 id="targeting-deep-brain-structures">Targeting deep brain structures</h2><p>The pilot study included 10 patients with either schizophrenia or schizoaffective disorder. In both conditions, patients experience psychotic symptoms, including delusions and hallucinations. Schizoaffective disorder also includes mood symptoms, such as mania. </p><p>The researchers interviewed each participant to characterize the content of their delusions, and also documented their cognitive state and experiences with auditory hallucinations — perceptions of sounds that aren't actually occurring. The participants then received both an ultrasound treatment and a placebo treatment, spaced one week apart.</p><p>Other noninvasive therapies — such as transcranial magnetic stimulation, which uses magnetic fields — can also stimulate the brain. But the ultrasound technique differs from these therapies because ultrasound waves can penetrate deeper into the brain with greater specificity, study co-author <a href="https://med.nyu.edu/faculty/shy-shoham" target="_blank"><u>Shy Shoham</u></a>, a neural engineer at NYU Grossman, told Live Science. He compared the way a transducer directs ultrasound waves toward a given brain region with the way a lens focuses light.</p><p>In this case, the researchers focused this lens on a brain network called the <a href="https://doi.org/10.1038/s41386-018-0059-z" target="_blank"><u>cortico-striatal-pallido-thalamic circuit</u></a>, which includes structures underneath the brain's outer cortex. The relationship between this circuit and schizophrenia symptoms is still somewhat unclear, partly because its deeper components are hard to study in adequate resolution with MRI, said co-author <a href="https://nyulangone.org/doctors/1710411897/wei-qi" target="_blank"><u>Dr. Wei Qi</u></a>, a clinical assistant professor of psychiatry at NYU Grossman. However, some past studies have suggested that this network plays a part in schizophrenia.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="FmDCehLMrX6fqWh4Bbkztg" name="GettyImages-1607064463-brain" alt="A cartoon of a transparent brain with an inner region glowing red." src="https://cdn.mos.cms.futurecdn.net/FmDCehLMrX6fqWh4Bbkztg-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/FmDCehLMrX6fqWh4Bbkztg-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The ultrasound treatment targeted a brain structure called the globus pallidus internus (orange). </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>Much of what scientists know about the network comes from research in movement disorders, such as <a href="https://www.livescience.com/65123-parkinsons-disease.html"><u>Parkinson's disease</u></a>, in which there is an imbalance between excitation and inhibition in the neurons that control movement. A similar dynamic could help to explain symptoms of schizophrenia, the scientists think. </p><p>"Our hypothesis is that, in schizophrenia, there is an imbalance between excitation and inhibition regarding what in the environment is actually important," Qi told Live Science. "The failure to inhibit irrelevant signals could be the basis of psychosis."</p><h2 id="quot-quite-optimistic-quot">"Quite optimistic"</h2><p>The researchers surveyed the study participants after each treatment, asking about the degree of belief each person had in their delusions and the amount of stress they caused. Compared with the placebo treatment, the ultrasound stimulation was associated with less-severe delusions over the following week. There was no significant change in patients' auditory hallucinations or overall cognition, though. </p><p>The ultrasound therapy came with mild side effects, such as fatigue and headache. Some patients had transient increases in delusions, which Qi attributed to normal fluctuations in symptoms that are expected in schizophrenia. These outcomes were just as common after the placebo treatment, so they may not be related to the ultrasound specifically.</p><p>The stimulation was aimed specifically at the right side of a brain structure called the globus pallidus internus (GPI). <a href="https://doi.org/10.1016/j.schres.2023.09.018" target="_blank"><u>In a previous study</u></a>, the authors found that greater connectivity between this region and another structure — the dorsal anterior cingulate gyrus — was linked to more-severe psychotic symptoms in schizophrenia. So, they made the GPI their target.</p><p>To date, "there haven't been many successful therapeutic attempts at targeting some of these deeper structures," said <a href="https://www.psychiatry.pitt.edu/about-us/our-people/deepak-k-sarpal-md" target="_blank"><u>Dr. Deepak Sarpal</u></a>, an associate professor of psychiatry at the University of Pittsburgh School of Medicine who was not involved with the study. Ultrasound waves reach brain regions under the cortex in a less-invasive manner than <a href="https://doi.org/10.1016/j.biopsych.2021.03.007" target="_blank"><u>deep brain stimulation</u></a>, in which a surgeon implants an electrode in a patient's brain, Sarpal noted.</p><p>The researchers are not the only group using transcranial ultrasound to influence the cortico-striatal-pallido-thalamic circuit. Earlier this year, another group <a href="https://doi.org/10.1016/j.brs.2026.103084" target="_blank"><u>stimulated portions of the striatum</u></a>, which is located directly under the cortex, in patients with schizophrenia. They evaluated hallucinations rather than delusions, finding that the treatment reduced symptoms for at least a week after the procedure.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/5-genetic-signatures-underpin-a-range-of-psychiatric-conditions">5 genetic 'signatures' underpin a range of psychiatric conditions</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/ai-pinpoints-where-psychosis-originates-in-the-brain">AI pinpoints where psychosis originates in the brain</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/strikingly-simple-dial-in-the-brain-may-help-it-distinguish-imagination-from-reality">Strikingly simple 'dial' in the brain may help it distinguish imagination from reality</a></li></ul></p></div></div><p>In this line of research, the targeted nature of transcranial ultrasound presents advantages as a research tool as well as a treatment approach. </p><p>"If we find that a specific circuit or a node in a circuit seems to be closely linked to symptoms we're trying to treat, then it will be a matter of understanding what pattern of stimulation may allow us to correct that," Goff said. Qi, Goff and colleagues now plan to continue testing their technique on more patients and to experiment with different doses of ultrasound. </p><p>"A lot more work needs to be done," Goff said, "but we're really quite optimistic about its promise."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/ultrasound-waves-that-jiggle-deep-brain-structures-may-relieve-delusions-in-schizophrenia-small-trial-hints</link>
                                                                            <description>
                            <![CDATA[ In a new pilot study, 10 minutes of transcranial ultrasound stimulation reduced patients' delusion severity, scientists report. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">cDKLnX9hGr3XiqbaApY6rf</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/PdKSnTq9KAnGCraXZ7kGaP-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 20 Oct 2026 14:10:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Lauren Schneider ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/5pJMPoJukHhyjB7CuxEXh4-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/PdKSnTq9KAnGCraXZ7kGaP-1920-80.jpg">
                                                            <media:credit><![CDATA[J Studios via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A small trial tested an ultrasound-based treatment for schizophrenia.]]></media:description>                                                            <media:text><![CDATA[A cartoon of a brain behind a vertical partition]]></media:text>
                                <media:title type="plain"><![CDATA[A cartoon of a brain behind a vertical partition]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/PdKSnTq9KAnGCraXZ7kGaP-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Stimulating the brain with ultrasound could help counter the delusions people experience in schizophrenia, a small trial finds.</p><p>The trial involved transcranial ultrasound stimulation, in which a device placed on a patient's head delivers ultrasound waves through the skull and into the brain. Its goal is to change the activity in a targeted brain region. </p><p><a href="https://www.mayoclinic.org/diseases-conditions/schizophrenia/symptoms-causes/syc-20354443" target="_blank"><u>Delusions</u></a> are false beliefs that are very difficult to shake; for example, a person might believe they are being stalked when they aren't or think that a major disaster is about to occur without any evidence to suggest so. In the trial, researchers found that a 10-minute session of the ultrasound treatment reduced the severity of delusions for at least a week in patients with schizophrenia or a related disorder. </p><p>This targeted ultrasound treatment delivered directly to the brain could avoid some of the full-body effects of antipsychotic medications, such as <a href="https://doi.org/10.1016/j.jad.2026.122587" target="_blank"><u>weight gain and high blood pressure</u></a>. That said, the new results, published Tuesday (Oct. 20) in the journal <a href="https://doi.org/10.1038/s44384-026-00076-3" target="_blank"><u>npj Acoustics</u></a>, are a first step and will need further verification in larger trials.</p><p>"It's too early to know for certain what the therapeutic benefits will be, but it's very exciting," study co-author <a href="https://nyulangone.org/doctors/1881672590/donald-c-goff" target="_blank"><u>Dr. Donald Goff</u></a>, a professor of psychiatry at the New York University Grossman School of Medicine, told Live Science.</p><h2 id="targeting-deep-brain-structures">Targeting deep brain structures</h2><p>The pilot study included 10 patients with either schizophrenia or schizoaffective disorder. In both conditions, patients experience psychotic symptoms, including delusions and hallucinations. Schizoaffective disorder also includes mood symptoms, such as mania. </p><p>The researchers interviewed each participant to characterize the content of their delusions, and also documented their cognitive state and experiences with auditory hallucinations — perceptions of sounds that aren't actually occurring. The participants then received both an ultrasound treatment and a placebo treatment, spaced one week apart.</p><p>Other noninvasive therapies — such as transcranial magnetic stimulation, which uses magnetic fields — can also stimulate the brain. But the ultrasound technique differs from these therapies because ultrasound waves can penetrate deeper into the brain with greater specificity, study co-author <a href="https://med.nyu.edu/faculty/shy-shoham" target="_blank"><u>Shy Shoham</u></a>, a neural engineer at NYU Grossman, told Live Science. He compared the way a transducer directs ultrasound waves toward a given brain region with the way a lens focuses light.</p><p>In this case, the researchers focused this lens on a brain network called the <a href="https://doi.org/10.1038/s41386-018-0059-z" target="_blank"><u>cortico-striatal-pallido-thalamic circuit</u></a>, which includes structures underneath the brain's outer cortex. The relationship between this circuit and schizophrenia symptoms is still somewhat unclear, partly because its deeper components are hard to study in adequate resolution with MRI, said co-author <a href="https://nyulangone.org/doctors/1710411897/wei-qi" target="_blank"><u>Dr. Wei Qi</u></a>, a clinical assistant professor of psychiatry at NYU Grossman. However, some past studies have suggested that this network plays a part in schizophrenia.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="FmDCehLMrX6fqWh4Bbkztg" name="GettyImages-1607064463-brain" alt="A cartoon of a transparent brain with an inner region glowing red." src="https://cdn.mos.cms.futurecdn.net/FmDCehLMrX6fqWh4Bbkztg-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/FmDCehLMrX6fqWh4Bbkztg-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The ultrasound treatment targeted a brain structure called the globus pallidus internus (orange). </span><span class="credit" itemprop="copyrightHolder">(Image credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>Much of what scientists know about the network comes from research in movement disorders, such as <a href="https://www.livescience.com/65123-parkinsons-disease.html"><u>Parkinson's disease</u></a>, in which there is an imbalance between excitation and inhibition in the neurons that control movement. A similar dynamic could help to explain symptoms of schizophrenia, the scientists think. </p><p>"Our hypothesis is that, in schizophrenia, there is an imbalance between excitation and inhibition regarding what in the environment is actually important," Qi told Live Science. "The failure to inhibit irrelevant signals could be the basis of psychosis."</p><h2 id="quot-quite-optimistic-quot">"Quite optimistic"</h2><p>The researchers surveyed the study participants after each treatment, asking about the degree of belief each person had in their delusions and the amount of stress they caused. Compared with the placebo treatment, the ultrasound stimulation was associated with less-severe delusions over the following week. There was no significant change in patients' auditory hallucinations or overall cognition, though. </p><p>The ultrasound therapy came with mild side effects, such as fatigue and headache. Some patients had transient increases in delusions, which Qi attributed to normal fluctuations in symptoms that are expected in schizophrenia. These outcomes were just as common after the placebo treatment, so they may not be related to the ultrasound specifically.</p><p>The stimulation was aimed specifically at the right side of a brain structure called the globus pallidus internus (GPI). <a href="https://doi.org/10.1016/j.schres.2023.09.018" target="_blank"><u>In a previous study</u></a>, the authors found that greater connectivity between this region and another structure — the dorsal anterior cingulate gyrus — was linked to more-severe psychotic symptoms in schizophrenia. So, they made the GPI their target.</p><p>To date, "there haven't been many successful therapeutic attempts at targeting some of these deeper structures," said <a href="https://www.psychiatry.pitt.edu/about-us/our-people/deepak-k-sarpal-md" target="_blank"><u>Dr. Deepak Sarpal</u></a>, an associate professor of psychiatry at the University of Pittsburgh School of Medicine who was not involved with the study. Ultrasound waves reach brain regions under the cortex in a less-invasive manner than <a href="https://doi.org/10.1016/j.biopsych.2021.03.007" target="_blank"><u>deep brain stimulation</u></a>, in which a surgeon implants an electrode in a patient's brain, Sarpal noted.</p><p>The researchers are not the only group using transcranial ultrasound to influence the cortico-striatal-pallido-thalamic circuit. Earlier this year, another group <a href="https://doi.org/10.1016/j.brs.2026.103084" target="_blank"><u>stimulated portions of the striatum</u></a>, which is located directly under the cortex, in patients with schizophrenia. They evaluated hallucinations rather than delusions, finding that the treatment reduced symptoms for at least a week after the procedure.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/5-genetic-signatures-underpin-a-range-of-psychiatric-conditions">5 genetic 'signatures' underpin a range of psychiatric conditions</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/mind/ai-pinpoints-where-psychosis-originates-in-the-brain">AI pinpoints where psychosis originates in the brain</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/strikingly-simple-dial-in-the-brain-may-help-it-distinguish-imagination-from-reality">Strikingly simple 'dial' in the brain may help it distinguish imagination from reality</a></li></ul></p></div></div><p>In this line of research, the targeted nature of transcranial ultrasound presents advantages as a research tool as well as a treatment approach. </p><p>"If we find that a specific circuit or a node in a circuit seems to be closely linked to symptoms we're trying to treat, then it will be a matter of understanding what pattern of stimulation may allow us to correct that," Goff said. Qi, Goff and colleagues now plan to continue testing their technique on more patients and to experiment with different doses of ultrasound. </p><p>"A lot more work needs to be done," Goff said, "but we're really quite optimistic about its promise."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ A gene variant triples the risk of getting Alzheimer's disease — fat buildup in brain cells may be to blame, study finds ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A gene variant called APOE4 dramatically increases the risk of late-onset Alzheimer's disease, the most common form of dementia. Now, emerging research is revealing APOE4's true role in the condition, and a new study pinpoints a possible way to treat it.</p><p>Historically, scientists studying <a href="https://www.livescience.com/65748-alzheimers-disease.html"><u>Alzheimer's disease</u></a> have focused on two proteins that accumulate in patients' brains: amyloid-beta and tau. However, there's a "third thing that people didn't pay attention to, until recently," said study co-author <a href="https://tsailaboratory.mit.edu/li-huei-tsai/" target="_blank"><u>Li-Huei Tsai</u></a>, a neuroscientist at MIT. That third thing is the accumulation of droplets of fat, or lipids, in the brain, she told Live Science.</p><p>The APOE gene makes proteins responsible for transporting fat around cells throughout the body and brain. A version of the gene called APOE4, which increases the risk of late-onset Alzheimer's three- to 12-fold, makes proteins that are less efficient at this function, Tsai said. But how APOE4 affects different brain cells was not clearly understood.</p><p>Tsai's team has been working to close that gap for about a decade. </p><p>"APOE4 can influence many different cell types," she emphasized. "It's not just one cell type."</p><h2 id="zeroing-in-on-the-clues">Zeroing in on the clues</h2><p>In past laboratory research, Tsai's team found that <a href="https://www.science.org/doi/10.1126/scitranslmed.aaz4564" target="_blank"><u>APOE4 causes a buildup</u></a> of cholesterol in astrocytes, star-shaped brain cells that support the function of neurons. Genetic analyses suggested that the gene variant may mess with how these cells process fat.</p><p>Another study zoomed in on oligodendrocytes, cells that help insulate neurons' outgoing wires with a fatty material called myelin. This material helps neurons send messages more efficiently. <a href="https://www.nature.com/articles/s41586-022-05439-w" target="_blank"><u>APOE4 caused the oligodendrocytes</u></a> to accumulate cholesterol. So, in lab mice, the team used a drug to help the cells get rid of that extra cholesterol, and it improved the cells' ability to make myelin and the mice's performance on cognitive tests.</p><p>In their latest research, published Thursday (Oct. 15) in the journal <a href="https://www.sciencedirect.com/science/article/abs/pii/S1934590926003541?via%3Dihub" target="_blank"><u>Cell Stem Cell</u></a>, Tsai's team dug into the question of why APOE4 causes fat to accumulate in the first place.</p><p>They used stem cells to grow APOE4-carrying oligodendrocytes and then turned specific genes on or off, to see if they increased or decreased the formation of fat droplets. This screening pointed to a major group of genes involved in cell-to-cell communication, called the Wnt signaling pathway. This included a key gene called DKK1, which acts as a brake on this signaling system.</p><p>Disabling DKK1 — essentially lifting the brake — reduced the concentration of fat droplets in the cells, the team found. </p><p>In brain tissue samples from <a href="https://www.cell.com/cell/fulltext/S0092-8674(23)00974-1" target="_blank"><u>organ donors with APOE4</u></a>, the team also found signs of low Wnt signaling. This finding "establishes a very strong link" between the signaling pathway and formation of fat droplets, said <a href="https://www.dundee.ac.uk/people/rosie-jackson" target="_blank"><u>Rosie Jackson</u></a>, a cell biologist at the University of Dundee who was not involved in this study.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="BpFg6z4Pzwsv4mk3v8fzt6" name="GettyImages-2280116697-alzheimers" alt="A close up on an axon with myelin shown in orange" src="https://cdn.mos.cms.futurecdn.net/BpFg6z4Pzwsv4mk3v8fzt6-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/BpFg6z4Pzwsv4mk3v8fzt6-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Myelin (orange) is a fatty material that coats the outgoing wires of many neurons, helping the cells send signals more efficiently.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: koto_feja via Getty Images)</span></figcaption></figure><h2 id="apoe4-39-s-effects-across-the-brain">APOE4's effects across the brain </h2><p>The researchers then investigated exactly how Wnt signaling was disrupted in oligodendrocytes. </p><p>APOE4 seemed to decrease the cells' supply of a protein that helps relay Wnt signals. That helpful protein was being broken down by an enzyme whose levels had been boosted by the APOE4. In mice, the team used a drug to block that extra enzyme, and the treatment ultimately restored normal Wnt signaling, reduced fat buildup, and helped the cells make myelin properly.</p><p>This could change how scientists think about treating Alzheimer's disease, Jackson said. It "opens up a new wave of potential therapeutics" that could target the accumulated fats, rather than going after only amyloid-beta and tau, she said.</p><p>"I think that this is becoming a really common idea in the field — that we're going to need multiple medications that target slightly different elements," she told Live Science. "And targeting lipids will be a really important part of that."</p><p>That said, the findings have not been confirmed in humans yet.</p><p>"It's very encouraging that facilitating lipid clearance and lipid movement is a potential therapeutic avenue," said study co-author <a href="https://profiles.icahn.mssm.edu/joel-blanchard" target="_blank"><u>Joel Blanchard</u></a>, a neuroscientist at the Icahn School of Medicine at Mount Sinai. The question is how we can do that in a safe and effective manner in humans, he said.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/alzheimers-dementia/single-protein-could-dramatically-alter-trajectory-of-alzheimers-disease">Single protein could dramatically alter trajectory of Alzheimer's disease</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/alzheimers-dementia/alzheimers-comes-in-at-least-5-distinct-forms-study-reveals">Alzheimer's comes in at least 5 distinct forms, study reveals</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/alzheimers-dementia/a-gene-carried-by-99-percent-of-humanity-strongly-determines-the-risk-of-alzheimers-could-gene-therapy-correct-it">A gene carried by 99% of humanity raises Alzheimer's risk dramatically. Could gene therapy correct it?</a></li></ul></p></div></div><p>Blanchard has led other research that underscores APOE4's effects beyond fats and myelin. The gene variant may <a href="https://www.cell.com/cell/fulltext/S0092-8674(26)01069-X" target="_blank"><u>affect cells that support blood vessels</u></a> in the brain by driving scarring and contributing to amyloid-beta buildup. It may also <a href="https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(26)00302-4" target="_blank"><u>mess with the "trash collectors" inside astrocytes</u></a>, again leading to a buildup of harmful proteins.</p><p>While cells with other versions of the APOE gene can put a lot of energy toward breaking down the proteins, APOE4-carrying cells put all their energy toward fat storage, Blanchard said. </p><p>But more research is needed to understand how to fix the problem, he said. Hopefully, targeting fat storage "could rescue not just one thing but multiple things that go wrong in the course of Alzheimer's disease," he told Live Science.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/alzheimers-dementia/a-gene-variant-triples-the-risk-of-getting-alzheimers-disease-fat-buildup-in-brain-cells-may-be-to-blame-study-finds</link>
                                                                            <description>
                            <![CDATA[ A gene variant called APOE4 is the biggest genetic risk factor for Alzheimer's disease. Scientists are finally figuring out how it works. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">5KFAP4FTfByq3PC5gpJZGd</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/dh7FSyMfdiecrqF2QtmuiU-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 19 Oct 2026 19:35:00 +0000</pubDate>                                                                                                                                <updated>Tue, 20 Oct 2026 14:40:16 +0000</updated>
                                                                                                                                            <category><![CDATA[Alzheimers & Dementia]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                    <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                                                                                    <dc:creator><![CDATA[ Zunnash Khan ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/wrV7sdVdmyubSn8MbHtvvc-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/dh7FSyMfdiecrqF2QtmuiU-1920-80.jpg">
                                                            <media:credit><![CDATA[Westend61 via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A gene variant called APOE4 is known to raise the risk of Alzheimer&amp;#39;s disease, but scientists are only now figuring out why.]]></media:description>                                                            <media:text><![CDATA[A brain scan superimposed on a colorful visual analysis of DNA]]></media:text>
                                <media:title type="plain"><![CDATA[A brain scan superimposed on a colorful visual analysis of DNA]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/dh7FSyMfdiecrqF2QtmuiU-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A gene variant called APOE4 dramatically increases the risk of late-onset Alzheimer's disease, the most common form of dementia. Now, emerging research is revealing APOE4's true role in the condition, and a new study pinpoints a possible way to treat it.</p><p>Historically, scientists studying <a href="https://www.livescience.com/65748-alzheimers-disease.html"><u>Alzheimer's disease</u></a> have focused on two proteins that accumulate in patients' brains: amyloid-beta and tau. However, there's a "third thing that people didn't pay attention to, until recently," said study co-author <a href="https://tsailaboratory.mit.edu/li-huei-tsai/" target="_blank"><u>Li-Huei Tsai</u></a>, a neuroscientist at MIT. That third thing is the accumulation of droplets of fat, or lipids, in the brain, she told Live Science.</p><p>The APOE gene makes proteins responsible for transporting fat around cells throughout the body and brain. A version of the gene called APOE4, which increases the risk of late-onset Alzheimer's three- to 12-fold, makes proteins that are less efficient at this function, Tsai said. But how APOE4 affects different brain cells was not clearly understood.</p><p>Tsai's team has been working to close that gap for about a decade. </p><p>"APOE4 can influence many different cell types," she emphasized. "It's not just one cell type."</p><h2 id="zeroing-in-on-the-clues">Zeroing in on the clues</h2><p>In past laboratory research, Tsai's team found that <a href="https://www.science.org/doi/10.1126/scitranslmed.aaz4564" target="_blank"><u>APOE4 causes a buildup</u></a> of cholesterol in astrocytes, star-shaped brain cells that support the function of neurons. Genetic analyses suggested that the gene variant may mess with how these cells process fat.</p><p>Another study zoomed in on oligodendrocytes, cells that help insulate neurons' outgoing wires with a fatty material called myelin. This material helps neurons send messages more efficiently. <a href="https://www.nature.com/articles/s41586-022-05439-w" target="_blank"><u>APOE4 caused the oligodendrocytes</u></a> to accumulate cholesterol. So, in lab mice, the team used a drug to help the cells get rid of that extra cholesterol, and it improved the cells' ability to make myelin and the mice's performance on cognitive tests.</p><p>In their latest research, published Thursday (Oct. 15) in the journal <a href="https://www.sciencedirect.com/science/article/abs/pii/S1934590926003541?via%3Dihub" target="_blank"><u>Cell Stem Cell</u></a>, Tsai's team dug into the question of why APOE4 causes fat to accumulate in the first place.</p><p>They used stem cells to grow APOE4-carrying oligodendrocytes and then turned specific genes on or off, to see if they increased or decreased the formation of fat droplets. This screening pointed to a major group of genes involved in cell-to-cell communication, called the Wnt signaling pathway. This included a key gene called DKK1, which acts as a brake on this signaling system.</p><p>Disabling DKK1 — essentially lifting the brake — reduced the concentration of fat droplets in the cells, the team found. </p><p>In brain tissue samples from <a href="https://www.cell.com/cell/fulltext/S0092-8674(23)00974-1" target="_blank"><u>organ donors with APOE4</u></a>, the team also found signs of low Wnt signaling. This finding "establishes a very strong link" between the signaling pathway and formation of fat droplets, said <a href="https://www.dundee.ac.uk/people/rosie-jackson" target="_blank"><u>Rosie Jackson</u></a>, a cell biologist at the University of Dundee who was not involved in this study.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="BpFg6z4Pzwsv4mk3v8fzt6" name="GettyImages-2280116697-alzheimers" alt="A close up on an axon with myelin shown in orange" src="https://cdn.mos.cms.futurecdn.net/BpFg6z4Pzwsv4mk3v8fzt6-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/BpFg6z4Pzwsv4mk3v8fzt6-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Myelin (orange) is a fatty material that coats the outgoing wires of many neurons, helping the cells send signals more efficiently.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: koto_feja via Getty Images)</span></figcaption></figure><h2 id="apoe4-39-s-effects-across-the-brain">APOE4's effects across the brain </h2><p>The researchers then investigated exactly how Wnt signaling was disrupted in oligodendrocytes. </p><p>APOE4 seemed to decrease the cells' supply of a protein that helps relay Wnt signals. That helpful protein was being broken down by an enzyme whose levels had been boosted by the APOE4. In mice, the team used a drug to block that extra enzyme, and the treatment ultimately restored normal Wnt signaling, reduced fat buildup, and helped the cells make myelin properly.</p><p>This could change how scientists think about treating Alzheimer's disease, Jackson said. It "opens up a new wave of potential therapeutics" that could target the accumulated fats, rather than going after only amyloid-beta and tau, she said.</p><p>"I think that this is becoming a really common idea in the field — that we're going to need multiple medications that target slightly different elements," she told Live Science. "And targeting lipids will be a really important part of that."</p><p>That said, the findings have not been confirmed in humans yet.</p><p>"It's very encouraging that facilitating lipid clearance and lipid movement is a potential therapeutic avenue," said study co-author <a href="https://profiles.icahn.mssm.edu/joel-blanchard" target="_blank"><u>Joel Blanchard</u></a>, a neuroscientist at the Icahn School of Medicine at Mount Sinai. The question is how we can do that in a safe and effective manner in humans, he said.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/alzheimers-dementia/single-protein-could-dramatically-alter-trajectory-of-alzheimers-disease">Single protein could dramatically alter trajectory of Alzheimer's disease</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/alzheimers-dementia/alzheimers-comes-in-at-least-5-distinct-forms-study-reveals">Alzheimer's comes in at least 5 distinct forms, study reveals</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/alzheimers-dementia/a-gene-carried-by-99-percent-of-humanity-strongly-determines-the-risk-of-alzheimers-could-gene-therapy-correct-it">A gene carried by 99% of humanity raises Alzheimer's risk dramatically. Could gene therapy correct it?</a></li></ul></p></div></div><p>Blanchard has led other research that underscores APOE4's effects beyond fats and myelin. The gene variant may <a href="https://www.cell.com/cell/fulltext/S0092-8674(26)01069-X" target="_blank"><u>affect cells that support blood vessels</u></a> in the brain by driving scarring and contributing to amyloid-beta buildup. It may also <a href="https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(26)00302-4" target="_blank"><u>mess with the "trash collectors" inside astrocytes</u></a>, again leading to a buildup of harmful proteins.</p><p>While cells with other versions of the APOE gene can put a lot of energy toward breaking down the proteins, APOE4-carrying cells put all their energy toward fat storage, Blanchard said. </p><p>But more research is needed to understand how to fix the problem, he said. Hopefully, targeting fat storage "could rescue not just one thing but multiple things that go wrong in the course of Alzheimer's disease," he told Live Science.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Rising temperatures could boost pregnancy risks worldwide — here's how ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Rising temperatures around the globe are contributing to a range of health risks, from <a href="https://www.livescience.com/planet-earth/climate-change/infectious-diseases-will-seed-new-ground-as-the-planet-warms-heres-where-theyll-spread"><u>infectious disease</u></a> to <a href="https://www.livescience.com/planet-earth/climate-change/the-apple-you-eat-isnt-the-apple-your-granddaughter-will-eat-whats-on-the-menu-in-a-warming-world"><u>food insecurity</u></a> and <a href="https://www.livescience.com/planet-earth/climate-change/wildfire-smoke-is-the-fastest-growing-environmental-threat-in-the-us-how-a-warming-world-will-poison-the-air-we-breathe"><u>wildfire smoke</u></a>. Extreme heat is another major public health concern, as climate change drives up both average temperatures and the frequency of extremely hot days. This August was the <a href="https://climate.copernicus.eu/climate-bulletin" target="_blank"><u>world's hottest on record</u></a>, and it drove upticks in <a href="https://www.kxan.com/news/local/austin/2026-sees-more-emergency-room-visits-from-heat-related-illness-than-in-2025/" target="_blank"><u>heat-related emergency visits</u></a> and <a href="https://marylandmatters.org/2026/08/07/health-officials-report-record-breaking-50-heat-related-deaths-this-summer/" target="_blank"><u>deaths</u></a> in various U.S. states.</p><p>Hotter weather is expected to pose <a href="https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(26)00025-3/fulltext" target="_blank"><u>dangerous health risks</u></a> for millions, and pregnant people are especially vulnerable to its impacts, experts caution.</p><p>"Pregnant people are physiologically more vulnerable to heat," <a href="https://personale.unipr.it/en/ugovdocenti/person/216239" target="_blank"><u>Dr. Susanna Esposito</u></a>, a pediatrician at the University of Parma in Italy, told Live Science. "Climate adaptation should treat pregnant people as a priority population."</p><p>Extreme heat is linked to adverse birth outcomes that can be fatal for both mothers and newborns. Heat can also hinder fetuses' development, contributing to long-term health and cognitive effects.</p><p>Scientists and public health experts are working to identify the thresholds between safe and dangerous heat for maternal and prenatal health. As the planet warms, how will that affect the risks associated with pregnancy? And how can those risks be countered?</p><h2 id="low-birth-weight">Low birth weight</h2><p>When the body tries to cool down, blood moves to the extremities to dissipate heat through the skin's surface. Some studies suggest that, in a pregnant person, this <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11354433/" target="_blank"><u>may reduce blood flow</u></a> to the placenta, which in turn reduces the organ's supply of oxygen and nutrients. This is thought to contribute to low birth weight, which is associated with a heightened <a href="https://www.sciencedirect.com/science/article/abs/pii/S0266613816301061" target="_blank"><u>risk of illness and death</u></a> shortly after birth, as well as <a href="https://psycnet.apa.org/doiLanding?doi=10.1037%2Fbul0000091" target="_blank"><u>cognitive and mental-health challenges</u></a> later in life.</p><p>Heat stress may also spike the body's levels of cortisol beyond what they should be in a healthy pregnancy, <a href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1149284/ful" target="_blank"><u>studies in lab animals suggest</u></a>. This may expose developing fetuses to more cortisol than usual, affecting some aspects of development and functions of the placenta. This mechanism is not fully understood in humans yet, though.</p><p>That said, several studies in humans support the notion of a link between heat exposure and low birth weight. Mothers who were <a href="https://www.sciencedirect.com/science/article/pii/S0160412024003167?via%3Dihub" target="_blank"><u>pregnant during a 2003 heat wave in France</u></a> were more than twice as likely to have a baby of low birth weight than mothers whose pregnancies did not coincide with the extreme heat. The trend was especially strong when the heat wave hit during a person's first trimester. </p><p>In a <a href="https://www.mdpi.com/2076-3298/12/4/118" target="_blank"><u>study conducted in Arizona</u></a>, hotter temperatures during the third trimester were also associated with lower birth weight, said study co-author <a href="https://search.asu.edu/profile/2181912" target="_blank"><u>Kristin Mickelson</u></a>, a social-health psychologist who studies public health at the Arizona State University.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="mYgcP3mEqGrRA73Yv2Gqde" name="GettyImages-532031183-pregnancy" alt="A woman wearing a hospital gown holds her pregnant stomach." src="https://cdn.mos.cms.futurecdn.net/mYgcP3mEqGrRA73Yv2Gqde-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/mYgcP3mEqGrRA73Yv2Gqde-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Exposure to extreme heat has been linked to a higher chance of babies being born at a low weight. The reasons why are still being studied, however. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Jose Luis Pelaez Inc via Getty Images)</span></figcaption></figure><h2 id="preterm-and-early-birth">Preterm and early birth</h2><p>Preterm delivery — before 37 weeks of gestation — is one of the most concerning health outcomes that's been linked to heat, Esposito told Live Science. The risk of neurological and developmental disabilities is <a href="https://www.nejm.org/doi/abs/10.1056/NEJMra2303347" target="_blank"><u>higher in preterm babies</u></a> than in full-term babies.</p><p>"If you're born preterm, you have a heightened risk of all sorts of adversities throughout infancy, but then also extending into childhood and even longer term," said <a href="https://portal.research.lu.se/en/persons/clara-sofia-heil/" target="_blank"><u>Clara Heil</u></a>, health researcher at Lund University in Sweden.</p><p>Severe heat may make preterm birth more likely. <a href="https://www.bmj.com/content/371/bmj.m3811.short" target="_blank"><u>A review of 70 studies</u></a> suggests that the chance of preterm birth is 16% higher when a multiday heat wave hits during the final weeks of pregnancy. Regarding average temperatures across an entire pregnancy, each additional 1.8 degrees Fahrenheit (1 degree Celsius) boosts the risk of preterm birth by 5%, the same review found. </p><p>High temperatures have also been tied to early births, which occur after 37 weeks of pregnancy but before 39 completed weeks. Early birth is associated with <a href="https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000003076~acog-committee-opinion-no-765-avoidance-of-nonmedically" target="_blank"><u>an increased risk of hospitalizations</u></a> through childhood and slower neurologic development.</p><p>A study <a href="https://www.nature.com/articles/s41558-019-0632-4" target="_blank"><u>analyzing 56 million U.S. births</u></a> across two decades suggested there was about 1 more early birth per 100,000 pregnancies on days with a maximum temperature above 90 F (32.2 C), compared to 60 to 70 F (15 to 21 C). Deliveries on hot days were typically about six days earlier than anticipated, but some were up to two weeks early.</p><p>With average temperatures continuing to rise, early and premature births could become more common. The United Nations predicts that the world is <a href="https://www.unep.org/news-and-stories/press-release/unep-world-set-cross-15degc-global-warming-can-still-limit-adapt-and" target="_blank"><u>set to cross the 1.5 C (2.7 F) threshold</u></a> of warming compared with pre-industrial levels, likely within the next five years, and we may even surpass the 2 C (3.6 F) threshold in that timeframe. </p><p>"We can probably expect to see these temperatures, or worse, in the upcoming years," <a href="https://www.tilburguniversity.edu/staff/l-burgosochoa" target="_blank"><u>Lizbeth Burgos Ochoa</u></a>, statistician at Tilburg University in the Netherlands, told Live Science.</p><h2 id="preeclampsia-heart-defects-and-other-risks">Preeclampsia, heart defects and other risks</h2><p>Maternal heat exposure has also been associated with an increased risk of preeclampsia, a pregnancy complication related to blood pressure that <a href="https://onlinelibrary.wiley.com/doi/10.1111/nure.12055" target="_blank"><u>can be fatal</u></a>. In <a href="https://onlinelibrary.wiley.com/doi/10.1111/ppe.12196" target="_blank"><u>a 2011 study</u></a> conducted in France, hotter temperatures during the first trimester were associated with a slightly increased risk of severe preeclampsia, although more research is needed to understand why. </p><p>Heat exposure has also been linked to other conditions of pregnancy, including gestational diabetes and hypertension, as well as increased <a href="https://www.mdpi.com/2077-0383/14/4/1123" target="_blank"><u>emergency hospital admissions during pregnancy, overall</u></a>.</p><p>Additional studies have highlighted potential risks for developing fetuses and newborns. For example, <a href="https://pubs.acs.org/evhpaz/article/125/1/8/5241929/Risk-of-Congenital-Heart-Defects-after-Ambient" target="_blank"><u>following a heat wave in Canada</u></a>, the risk of a baby being born with critical heart defects was <a href="https://pubs.acs.org/evhpaz/article/125/1/8/5241929/Risk-of-Congenital-Heart-Defects-after-Ambient" target="_blank"><u>6% higher</u></a>, one study found. Babies with the highest risk had been exposed to temperatures of 86 F (30 C) or higher for at least 15 days during the first trimester of pregnancy. </p><p>Extreme heat waves may also raise the chance of stillbirth, according to <a href="https://link.springer.com/article/10.1186/s12940-022-00870-y" target="_blank"><u>a study conducted across six U.S. states</u></a>. Four consecutive unusually hot days — exceeding the 97.5th percentile of temperature for a given county — in the last week of pregnancy was linked to a 3% increase in the risk of stillbirth.</p><p>These studies are observational, so they show links between heat and pregnancy outcomes but cannot directly show that the heat spurred the increased risks. They also don't take into account study participants' home environments or strategies for cooling off, so they don't provide a full picture of how much heat they were exposed to.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="WoQ98BDEFdupQgEkTRXHpX" name="GettyImages-1642387751-infant" alt="A blue gloved hand measures an infant's foot." src="https://cdn.mos.cms.futurecdn.net/WoQ98BDEFdupQgEkTRXHpX-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/WoQ98BDEFdupQgEkTRXHpX-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Studies suggest that both maternal, prenatal and newborn health can be negatively impacted by exposure to extreme heat during pregnancy.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Abraham Gonzalez Fernandez viaGetty Images)</span></figcaption></figure><h2 id="caring-for-pregnant-people-and-the-next-generation">Caring for pregnant people and the next generation</h2><p>Researchers are still working to understand what temperatures pregnant people should be most concerned about.</p><p>"It would be [helpful] to understand what level of heat becomes dangerous to women," Heil said. "Is there a threshold where it becomes difficult for the body to dissipate heat? And especially for the pregnant body, which is different from the non-pregnant body, to cope with that heat?"</p><p>Heil and her research team synthesized over 100 studies on <a href="https://www.nature.com/articles/s41467-026-76822-8" target="_blank"><u>heat and poor birth outcomes</u></a>, such as stillbirth, preterm birth, <a href="https://www.mayoclinic.org/diseases-conditions/placental-abruption/symptoms-causes/syc-20376458" target="_blank"><u>placental abruption</u></a> and preeclampsia. The studies varied considerably in that they covered different timeframes, focusing on just one trimester or all three, for instance. But in general, their results converged on a pattern: The risk of poor outcomes rose as temperatures hit about 87 F (30.5 C). At 102 F (39 C), the combined risk of poor outcomes rose by 20%.</p><p>This summer, <a href="https://www.ncei.noaa.gov/news/national-climate-202608" target="_blank"><u>daytime maximum temperatures</u></a> in the continental U.S. averaged a record-breaking 88.6 F (31.4 C). The number of days per year over 105 F (35 C) <a href="https://www.livescience.com/health/climate-change-will-triple-the-number-of-days-over-105-f-in-the-us-the-health-impacts-will-be-dire"><u>is expected to triple</u></a> in the U.S. by midcentury.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/climate-change-will-harm-our-health-heres-what-could-protect-us">Climate change will harm our health. Here's what could protect us.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/they-didnt-question-it-why-doctors-prescribe-too-many-antibiotics">'They didn't question it': Why doctors prescribe too many antibiotics</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/fossil-fuels/the-world-is-being-held-hostage-by-its-reliance-on-oil-how-can-we-break-free-from-the-fossil-fuel">The world is being held hostage by its reliance on oil. How can we break free from the fossil fuel?</a></li></ul></p></div></div><p>Heat's detrimental effects on birth outcomes are even <a href="https://www.sciencedirect.com/science/article/pii/S0033350625002653?" target="_blank"><u>more extreme</u></a> for those with disadvantaged socioeconomic conditions,  Burgos Ochoa noted. People with lower incomes are less likely to have air conditioning, and neighborhoods with a lower median income tend to have less green space, <a href="https://www.nature.com/articles/s42949-025-00198-9" target="_blank"><u>which contributes to trapped heat</u></a> in their immediate surroundings. <a href="https://www.livescience.com/planet-earth/plants/extreme-heat-waves-are-making-our-cities-buckle-investing-in-urban-nature-is-no-longer-optional-opinion"><u>Expanding green spaces</u></a> and adding bodies of water can help cool down neighborhoods and mitigate heat impacts on health, she said.</p><p>Heil's research team has developed a phone app for pregnant people and those who have recently given birth that forecasts the risk of heat stress and suggests actions to take to mitigate those risks, such as hydrating or changing clothing. Heil is hopeful that the app and similar early-warning systems can make a difference.</p><p>"Maternal health should be at the top [of our concerns], because it is about the next generation," Mickelson said. "If we don't take care of the mothers that are giving birth to the next generation, that's going to have long-term consequences down the road."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/reproductive-health/rising-temperatures-could-boost-pregnancy-risks-worldwide-heres-how</link>
                                                                            <description>
                            <![CDATA[ As climate change fuels extreme temperatures and makes severely hot days more frequent, doctors are concerned about the health impacts on pregnant people. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">J6JVegfPPRUrJxkKbGQjjd</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/g9ULntRpuH29675zcK2hGo-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Mon, 19 Oct 2026 09:00:00 +0000</pubDate>                                                                                                                                <updated>Tue, 20 Oct 2026 15:10:56 +0000</updated>
                                                                                                                                            <category><![CDATA[Reproductive Health]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Olivia Ferrari ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/ecYWkHFMRNLe2QDbiAP44J-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/g9ULntRpuH29675zcK2hGo-1920-80.jpg">
                                                            <media:credit><![CDATA[isayildiz via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[As climate change makes extreme heat more frequent, how will that impact maternal health?]]></media:description>                                                            <media:text><![CDATA[A pregnant woman wearing a white t-shirt fans herself while laying in front of a large fan.]]></media:text>
                                <media:title type="plain"><![CDATA[A pregnant woman wearing a white t-shirt fans herself while laying in front of a large fan.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/g9ULntRpuH29675zcK2hGo-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Rising temperatures around the globe are contributing to a range of health risks, from <a href="https://www.livescience.com/planet-earth/climate-change/infectious-diseases-will-seed-new-ground-as-the-planet-warms-heres-where-theyll-spread"><u>infectious disease</u></a> to <a href="https://www.livescience.com/planet-earth/climate-change/the-apple-you-eat-isnt-the-apple-your-granddaughter-will-eat-whats-on-the-menu-in-a-warming-world"><u>food insecurity</u></a> and <a href="https://www.livescience.com/planet-earth/climate-change/wildfire-smoke-is-the-fastest-growing-environmental-threat-in-the-us-how-a-warming-world-will-poison-the-air-we-breathe"><u>wildfire smoke</u></a>. Extreme heat is another major public health concern, as climate change drives up both average temperatures and the frequency of extremely hot days. This August was the <a href="https://climate.copernicus.eu/climate-bulletin" target="_blank"><u>world's hottest on record</u></a>, and it drove upticks in <a href="https://www.kxan.com/news/local/austin/2026-sees-more-emergency-room-visits-from-heat-related-illness-than-in-2025/" target="_blank"><u>heat-related emergency visits</u></a> and <a href="https://marylandmatters.org/2026/08/07/health-officials-report-record-breaking-50-heat-related-deaths-this-summer/" target="_blank"><u>deaths</u></a> in various U.S. states.</p><p>Hotter weather is expected to pose <a href="https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(26)00025-3/fulltext" target="_blank"><u>dangerous health risks</u></a> for millions, and pregnant people are especially vulnerable to its impacts, experts caution.</p><p>"Pregnant people are physiologically more vulnerable to heat," <a href="https://personale.unipr.it/en/ugovdocenti/person/216239" target="_blank"><u>Dr. Susanna Esposito</u></a>, a pediatrician at the University of Parma in Italy, told Live Science. "Climate adaptation should treat pregnant people as a priority population."</p><p>Extreme heat is linked to adverse birth outcomes that can be fatal for both mothers and newborns. Heat can also hinder fetuses' development, contributing to long-term health and cognitive effects.</p><p>Scientists and public health experts are working to identify the thresholds between safe and dangerous heat for maternal and prenatal health. As the planet warms, how will that affect the risks associated with pregnancy? And how can those risks be countered?</p><h2 id="low-birth-weight">Low birth weight</h2><p>When the body tries to cool down, blood moves to the extremities to dissipate heat through the skin's surface. Some studies suggest that, in a pregnant person, this <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11354433/" target="_blank"><u>may reduce blood flow</u></a> to the placenta, which in turn reduces the organ's supply of oxygen and nutrients. This is thought to contribute to low birth weight, which is associated with a heightened <a href="https://www.sciencedirect.com/science/article/abs/pii/S0266613816301061" target="_blank"><u>risk of illness and death</u></a> shortly after birth, as well as <a href="https://psycnet.apa.org/doiLanding?doi=10.1037%2Fbul0000091" target="_blank"><u>cognitive and mental-health challenges</u></a> later in life.</p><p>Heat stress may also spike the body's levels of cortisol beyond what they should be in a healthy pregnancy, <a href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1149284/ful" target="_blank"><u>studies in lab animals suggest</u></a>. This may expose developing fetuses to more cortisol than usual, affecting some aspects of development and functions of the placenta. This mechanism is not fully understood in humans yet, though.</p><p>That said, several studies in humans support the notion of a link between heat exposure and low birth weight. Mothers who were <a href="https://www.sciencedirect.com/science/article/pii/S0160412024003167?via%3Dihub" target="_blank"><u>pregnant during a 2003 heat wave in France</u></a> were more than twice as likely to have a baby of low birth weight than mothers whose pregnancies did not coincide with the extreme heat. The trend was especially strong when the heat wave hit during a person's first trimester. </p><p>In a <a href="https://www.mdpi.com/2076-3298/12/4/118" target="_blank"><u>study conducted in Arizona</u></a>, hotter temperatures during the third trimester were also associated with lower birth weight, said study co-author <a href="https://search.asu.edu/profile/2181912" target="_blank"><u>Kristin Mickelson</u></a>, a social-health psychologist who studies public health at the Arizona State University.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="mYgcP3mEqGrRA73Yv2Gqde" name="GettyImages-532031183-pregnancy" alt="A woman wearing a hospital gown holds her pregnant stomach." src="https://cdn.mos.cms.futurecdn.net/mYgcP3mEqGrRA73Yv2Gqde-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/mYgcP3mEqGrRA73Yv2Gqde-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Exposure to extreme heat has been linked to a higher chance of babies being born at a low weight. The reasons why are still being studied, however. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Jose Luis Pelaez Inc via Getty Images)</span></figcaption></figure><h2 id="preterm-and-early-birth">Preterm and early birth</h2><p>Preterm delivery — before 37 weeks of gestation — is one of the most concerning health outcomes that's been linked to heat, Esposito told Live Science. The risk of neurological and developmental disabilities is <a href="https://www.nejm.org/doi/abs/10.1056/NEJMra2303347" target="_blank"><u>higher in preterm babies</u></a> than in full-term babies.</p><p>"If you're born preterm, you have a heightened risk of all sorts of adversities throughout infancy, but then also extending into childhood and even longer term," said <a href="https://portal.research.lu.se/en/persons/clara-sofia-heil/" target="_blank"><u>Clara Heil</u></a>, health researcher at Lund University in Sweden.</p><p>Severe heat may make preterm birth more likely. <a href="https://www.bmj.com/content/371/bmj.m3811.short" target="_blank"><u>A review of 70 studies</u></a> suggests that the chance of preterm birth is 16% higher when a multiday heat wave hits during the final weeks of pregnancy. Regarding average temperatures across an entire pregnancy, each additional 1.8 degrees Fahrenheit (1 degree Celsius) boosts the risk of preterm birth by 5%, the same review found. </p><p>High temperatures have also been tied to early births, which occur after 37 weeks of pregnancy but before 39 completed weeks. Early birth is associated with <a href="https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000003076~acog-committee-opinion-no-765-avoidance-of-nonmedically" target="_blank"><u>an increased risk of hospitalizations</u></a> through childhood and slower neurologic development.</p><p>A study <a href="https://www.nature.com/articles/s41558-019-0632-4" target="_blank"><u>analyzing 56 million U.S. births</u></a> across two decades suggested there was about 1 more early birth per 100,000 pregnancies on days with a maximum temperature above 90 F (32.2 C), compared to 60 to 70 F (15 to 21 C). Deliveries on hot days were typically about six days earlier than anticipated, but some were up to two weeks early.</p><p>With average temperatures continuing to rise, early and premature births could become more common. The United Nations predicts that the world is <a href="https://www.unep.org/news-and-stories/press-release/unep-world-set-cross-15degc-global-warming-can-still-limit-adapt-and" target="_blank"><u>set to cross the 1.5 C (2.7 F) threshold</u></a> of warming compared with pre-industrial levels, likely within the next five years, and we may even surpass the 2 C (3.6 F) threshold in that timeframe. </p><p>"We can probably expect to see these temperatures, or worse, in the upcoming years," <a href="https://www.tilburguniversity.edu/staff/l-burgosochoa" target="_blank"><u>Lizbeth Burgos Ochoa</u></a>, statistician at Tilburg University in the Netherlands, told Live Science.</p><h2 id="preeclampsia-heart-defects-and-other-risks">Preeclampsia, heart defects and other risks</h2><p>Maternal heat exposure has also been associated with an increased risk of preeclampsia, a pregnancy complication related to blood pressure that <a href="https://onlinelibrary.wiley.com/doi/10.1111/nure.12055" target="_blank"><u>can be fatal</u></a>. In <a href="https://onlinelibrary.wiley.com/doi/10.1111/ppe.12196" target="_blank"><u>a 2011 study</u></a> conducted in France, hotter temperatures during the first trimester were associated with a slightly increased risk of severe preeclampsia, although more research is needed to understand why. </p><p>Heat exposure has also been linked to other conditions of pregnancy, including gestational diabetes and hypertension, as well as increased <a href="https://www.mdpi.com/2077-0383/14/4/1123" target="_blank"><u>emergency hospital admissions during pregnancy, overall</u></a>.</p><p>Additional studies have highlighted potential risks for developing fetuses and newborns. For example, <a href="https://pubs.acs.org/evhpaz/article/125/1/8/5241929/Risk-of-Congenital-Heart-Defects-after-Ambient" target="_blank"><u>following a heat wave in Canada</u></a>, the risk of a baby being born with critical heart defects was <a href="https://pubs.acs.org/evhpaz/article/125/1/8/5241929/Risk-of-Congenital-Heart-Defects-after-Ambient" target="_blank"><u>6% higher</u></a>, one study found. Babies with the highest risk had been exposed to temperatures of 86 F (30 C) or higher for at least 15 days during the first trimester of pregnancy. </p><p>Extreme heat waves may also raise the chance of stillbirth, according to <a href="https://link.springer.com/article/10.1186/s12940-022-00870-y" target="_blank"><u>a study conducted across six U.S. states</u></a>. Four consecutive unusually hot days — exceeding the 97.5th percentile of temperature for a given county — in the last week of pregnancy was linked to a 3% increase in the risk of stillbirth.</p><p>These studies are observational, so they show links between heat and pregnancy outcomes but cannot directly show that the heat spurred the increased risks. They also don't take into account study participants' home environments or strategies for cooling off, so they don't provide a full picture of how much heat they were exposed to.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.30%;"><img id="WoQ98BDEFdupQgEkTRXHpX" name="GettyImages-1642387751-infant" alt="A blue gloved hand measures an infant's foot." src="https://cdn.mos.cms.futurecdn.net/WoQ98BDEFdupQgEkTRXHpX-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1126" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/WoQ98BDEFdupQgEkTRXHpX-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Studies suggest that both maternal, prenatal and newborn health can be negatively impacted by exposure to extreme heat during pregnancy.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Abraham Gonzalez Fernandez viaGetty Images)</span></figcaption></figure><h2 id="caring-for-pregnant-people-and-the-next-generation">Caring for pregnant people and the next generation</h2><p>Researchers are still working to understand what temperatures pregnant people should be most concerned about.</p><p>"It would be [helpful] to understand what level of heat becomes dangerous to women," Heil said. "Is there a threshold where it becomes difficult for the body to dissipate heat? And especially for the pregnant body, which is different from the non-pregnant body, to cope with that heat?"</p><p>Heil and her research team synthesized over 100 studies on <a href="https://www.nature.com/articles/s41467-026-76822-8" target="_blank"><u>heat and poor birth outcomes</u></a>, such as stillbirth, preterm birth, <a href="https://www.mayoclinic.org/diseases-conditions/placental-abruption/symptoms-causes/syc-20376458" target="_blank"><u>placental abruption</u></a> and preeclampsia. The studies varied considerably in that they covered different timeframes, focusing on just one trimester or all three, for instance. But in general, their results converged on a pattern: The risk of poor outcomes rose as temperatures hit about 87 F (30.5 C). At 102 F (39 C), the combined risk of poor outcomes rose by 20%.</p><p>This summer, <a href="https://www.ncei.noaa.gov/news/national-climate-202608" target="_blank"><u>daytime maximum temperatures</u></a> in the continental U.S. averaged a record-breaking 88.6 F (31.4 C). The number of days per year over 105 F (35 C) <a href="https://www.livescience.com/health/climate-change-will-triple-the-number-of-days-over-105-f-in-the-us-the-health-impacts-will-be-dire"><u>is expected to triple</u></a> in the U.S. by midcentury.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/climate-change-will-harm-our-health-heres-what-could-protect-us">Climate change will harm our health. Here's what could protect us.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/they-didnt-question-it-why-doctors-prescribe-too-many-antibiotics">'They didn't question it': Why doctors prescribe too many antibiotics</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/fossil-fuels/the-world-is-being-held-hostage-by-its-reliance-on-oil-how-can-we-break-free-from-the-fossil-fuel">The world is being held hostage by its reliance on oil. How can we break free from the fossil fuel?</a></li></ul></p></div></div><p>Heat's detrimental effects on birth outcomes are even <a href="https://www.sciencedirect.com/science/article/pii/S0033350625002653?" target="_blank"><u>more extreme</u></a> for those with disadvantaged socioeconomic conditions,  Burgos Ochoa noted. People with lower incomes are less likely to have air conditioning, and neighborhoods with a lower median income tend to have less green space, <a href="https://www.nature.com/articles/s42949-025-00198-9" target="_blank"><u>which contributes to trapped heat</u></a> in their immediate surroundings. <a href="https://www.livescience.com/planet-earth/plants/extreme-heat-waves-are-making-our-cities-buckle-investing-in-urban-nature-is-no-longer-optional-opinion"><u>Expanding green spaces</u></a> and adding bodies of water can help cool down neighborhoods and mitigate heat impacts on health, she said.</p><p>Heil's research team has developed a phone app for pregnant people and those who have recently given birth that forecasts the risk of heat stress and suggests actions to take to mitigate those risks, such as hydrating or changing clothing. Heil is hopeful that the app and similar early-warning systems can make a difference.</p><p>"Maternal health should be at the top [of our concerns], because it is about the next generation," Mickelson said. "If we don't take care of the mothers that are giving birth to the next generation, that's going to have long-term consequences down the road."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'A uniquely direct route that might cause damage': Scientists uncover link between air pollution and eye diseases like glaucoma ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Aging is one of the biggest risk factors for developing glaucoma or cataracts — but as scientists look more closely at what happens to the eyes over a lifetime, they are finding that people's exposure to air pollution also plays a role in whether they develop these eye conditions.</p><p>Glaucoma, which affects about <a href="https://glaucoma.org/articles/glaucoma-worldwide-a-growing-concern" target="_blank"><u>80 million people worldwide</u></a>, is a group of diseases that damage the optic nerve, which carries visual information from the eye to the brain. It can lead to permanent vision loss, usually affecting peripheral vision at first and later central vision. Cataracts are even more common, affecting more than <a href="https://www.who.int/news/item/11-02-2026-one-in-two-people-facing-cataract-blindness-need-access-to-life-changing-surgery" target="_blank"><u>94 million people globally</u></a>; the condition occurs when the eye's lens becomes cloudy, causing blurred vision and, eventually, blindness. </p><p>Aging raises the risk of both diseases, as do certain medical conditions, such as diabetes. But now, a review of 41 studies suggests that people who are exposed to higher levels of air pollution may also face a greater risk of these diseases. The research, <a href="https://www.escrs.org/channels/news/people-exposed-to-more-polluted-air-face-higher-risk-of-glaucoma-and-cataract" target="_blank"><u>presented in September</u></a> at the 44th Congress of the European Society of Cataract and Refractive Surgeons in London, brought together evidence from dozens of studies collectively involving millions of people across East Asia and the U.K. </p><p>The studies were observational, meaning they can only draw a link between air pollution and the eye conditions, rather than prove that air pollution causes the diseases. But still, "this reframes glaucoma and cataract as conditions shaped by where you live and breathe, not just how long you've lived," said study co-author <a href="https://www.researchgate.net/scientific-contributions/Ahmed-N-Alnabihi-2246754137" target="_blank"><u>Dr. Ahmed Alnabihi</u></a>, an ophthalmologist at King Khaled Eye Specialist Hospital and Research Center in Saudi Arabia, who presented the findings. These environmental exposures may compound age-related decline in the eye as they do in cardiovascular disease, he said.</p><h2 id="pm2-5-shows-the-clearest-links">PM2.5 shows the clearest links</h2><p>The researchers examined exposure to several pollutants, including different sizes of particulate matter (PM), such as fine PM2.5 and larger PM10. They also looked at nitrogen dioxide, sulfur dioxide, ozone and carbon monoxide.</p><p>Most studies included in the review estimated people's long-term exposure based on the pollution levels around their homes and in their communities. They used a range of methods, including government monitoring systems, satellite data and computer models designed to estimate pollution levels. A few studies examined short-term exposure and its relation to more sudden eye issues, such as <a href="https://my.clevelandclinic.org/health/diseases/angle-closure-glaucoma" target="_blank"><u>acute angle-closure glaucoma</u></a>, a medical emergency that can quickly cause vision loss.</p><p>Using this wealth of data, the team compared pollution exposure with rates of glaucoma, cataracts and <a href="https://www.aao.org/eye-health/diseases/amd-macular-degeneration" target="_blank"><u>age-related macular degeneration</u></a> (AMD), another common eye condition that impairs vision. PM2.5 — tiny particles that measure 2.5 micrometers or smaller — showed the clearest associations with glaucoma and cataract risk.</p><p>People with the highest exposure to PM2.5 had 70% higher odds of glaucoma, compared to those with the least exposure. Plus, an increase in PM2.5 exposure equivalent to the difference between the 25th and 75th percentiles of exposure within each study was associated with 8% higher odds of glaucoma and a 4% higher hazard of cataracts.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="rtG7rJTFtuGYrWmFvYaXme" name="IMG_8748" alt="A ditch burns with white smoke filling the air." src="https://cdn.mos.cms.futurecdn.net/rtG7rJTFtuGYrWmFvYaXme-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/rtG7rJTFtuGYrWmFvYaXme-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Smoke from burning agricultural residue contains fine particulate matter. In a review of 41 studies, higher PM2.5 exposure showed a strong association with glaucoma and cataract. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Sanket Jain)</span></figcaption></figure><p>The evidence was less consistent for air pollution and age-related macular degeneration, which damages the central part of the <a href="https://www.livescience.com/health/anatomy/what-are-eyes-made-of"><u>retina</u></a> that's responsible for sharp, detailed vision. And unlike the clear connection seen with PM2.5, other pollutants showed less consistent links to eye disease. For instance, nitrogen dioxide was not significantly tied to AMD, ozone was not tied to cataracts, and neither pollutant was linked to glaucoma. Sulfur dioxide and PM10 showed no significant associations with any of the three conditions.</p><p>The association between PM2.5 and glaucoma was relatively consistent across the reviewed studies, said <a href="https://www.researchgate.net/profile/Nidhi-Singh-13" target="_blank"><u>Nidhi Singh</u></a>, an environmental epidemiologist at the IUF-Leibniz Research Institute for Environmental Medicine in Germany, who was not involved in the study. The findings for PM2.5 and cataracts were moderately consistent, albeit more variable than the glaucoma data; still, she said that the analysis seems to support a link.</p><p>Singh did caution that the underlying evidence is observational. "Therefore, the results demonstrate an association, not by themselves a causal effect of PM2.5 on glaucoma or cataract," she told Live Science.</p><h2 id="what-explains-the-increased-risk">What explains the increased risk?</h2><p>The exact biological mechanisms behind these links remain unclear, but Alnabihi noted that fine particulate matter is small enough to be absorbed into the body. This can trigger <a href="https://www.livescience.com/what-is-oxidative-stress"><u>oxidative stress</u></a>, in which harmful molecules overwhelm natural defenses and cause damage. It also drives chronic, low-grade <a href="https://www.livescience.com/health/immune-system/inflammation-is-a-mismatch-between-our-evolutionary-history-and-modern-environment-says-immunologist-ruslan-medzhitov"><u>inflammation</u></a>, in which the immune system stays mildly activated for long periods, he explained. </p><p>In the eye's lens, these processes can "damage the crystallin proteins that keep it transparent, causing them to misfold and cloud, which is what a cataract is," Alnabihi said. </p><p>In the optic nerve, the same processes are thought to damage retinal ganglion cells, a special type of neuron that relays information from the retina to the brain. This can contribute to glaucoma independent of internal eye pressure, he said, which is another big risk factor. </p><p>"Unlike the lungs or gut, its [the eye's] surface is in direct, continuous contact with outdoor air, giving pollutants a uniquely direct route that might cause damage," he added.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/wildfire-smoke-is-the-fastest-growing-environmental-threat-in-the-us-how-a-warming-world-will-poison-the-air-we-breathe">'Wildfire smoke is the fastest-growing environmental threat in the US': How a warming world will poison the air we breathe</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/chinas-huge-push-to-reduce-air-pollution-had-an-unexpected-consequence-in-the-arctic">China's huge push to reduce air pollution had an unexpected consequence in the Arctic</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/pollution-may-fuel-depression-anxiety-and-other-mental-health-problems-emerging-research-suggests">Pollution may fuel depression, anxiety and other mental health problems, emerging research suggests</a></li></ul></p></div></div><p>Other studies have found clues that support the link between PM2.5 and eye damage. Mice that were exposed to ambient PM2.5 for nine months <a href="https://www.sciencedirect.com/science/article/pii/S0147651321010757" target="_blank"><u>developed elevated pressure inside their eyes</u></a>, a glaucoma risk factor. The researchers observed both oxidative stress and nitrative stress — a similar phenomenon — in the tissues that drain fluid from the eye, which may help to explain the rise in pressure.</p><p>Studies of humans and human cells have uncovered similar patterns. In data from more than 480,000 people in the UK Biobank, a large repository of health information, those exposed to higher PM2.5 were more likely to <a href="https://iovs.arvojournals.org/article.aspx?articleid=2802136" target="_blank"><u>develop glaucoma over time</u></a>. In another study, scientists exposed lab-grown human retinal tissue made from stem cells to PM2.5. The particles <a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.607341/full" target="_blank"><u>disrupted retinal cell development</u></a>, including that of retinal ganglion cells, while increasing cell death. </p><p>These studies offer pieces of a possible mechanism, but for now, how those pieces fit together in people remains unclear.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/a-uniquely-direct-route-that-might-cause-damage-scientists-uncover-link-between-air-pollution-and-eye-diseases-like-glaucoma</link>
                                                                            <description>
                            <![CDATA[ A review of 41 studies found that higher exposure to air pollution was linked to greater odds of glaucoma and cataracts, with PM2.5 pollution showing the clearest association. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">5AqfrXSDRdC53Y9N6pdR44</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/A3tSwokK22Cij8dttWgjGC-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sun, 18 Oct 2026 15:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Sanket Jain ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/urS28UaqMFwwS3PGWh6jJQ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/A3tSwokK22Cij8dttWgjGC-1920-80.jpg">
                                                            <media:credit><![CDATA[ Bloomberg via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Exposure to air pollution, especially particulate matter, has been linked to various eye diseases in a new analysis.]]></media:description>                                                            <media:text><![CDATA[A man wears glasses and a white face mask. Smog is visible in the background.]]></media:text>
                                <media:title type="plain"><![CDATA[A man wears glasses and a white face mask. Smog is visible in the background.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/A3tSwokK22Cij8dttWgjGC-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Aging is one of the biggest risk factors for developing glaucoma or cataracts — but as scientists look more closely at what happens to the eyes over a lifetime, they are finding that people's exposure to air pollution also plays a role in whether they develop these eye conditions.</p><p>Glaucoma, which affects about <a href="https://glaucoma.org/articles/glaucoma-worldwide-a-growing-concern" target="_blank"><u>80 million people worldwide</u></a>, is a group of diseases that damage the optic nerve, which carries visual information from the eye to the brain. It can lead to permanent vision loss, usually affecting peripheral vision at first and later central vision. Cataracts are even more common, affecting more than <a href="https://www.who.int/news/item/11-02-2026-one-in-two-people-facing-cataract-blindness-need-access-to-life-changing-surgery" target="_blank"><u>94 million people globally</u></a>; the condition occurs when the eye's lens becomes cloudy, causing blurred vision and, eventually, blindness. </p><p>Aging raises the risk of both diseases, as do certain medical conditions, such as diabetes. But now, a review of 41 studies suggests that people who are exposed to higher levels of air pollution may also face a greater risk of these diseases. The research, <a href="https://www.escrs.org/channels/news/people-exposed-to-more-polluted-air-face-higher-risk-of-glaucoma-and-cataract" target="_blank"><u>presented in September</u></a> at the 44th Congress of the European Society of Cataract and Refractive Surgeons in London, brought together evidence from dozens of studies collectively involving millions of people across East Asia and the U.K. </p><p>The studies were observational, meaning they can only draw a link between air pollution and the eye conditions, rather than prove that air pollution causes the diseases. But still, "this reframes glaucoma and cataract as conditions shaped by where you live and breathe, not just how long you've lived," said study co-author <a href="https://www.researchgate.net/scientific-contributions/Ahmed-N-Alnabihi-2246754137" target="_blank"><u>Dr. Ahmed Alnabihi</u></a>, an ophthalmologist at King Khaled Eye Specialist Hospital and Research Center in Saudi Arabia, who presented the findings. These environmental exposures may compound age-related decline in the eye as they do in cardiovascular disease, he said.</p><h2 id="pm2-5-shows-the-clearest-links">PM2.5 shows the clearest links</h2><p>The researchers examined exposure to several pollutants, including different sizes of particulate matter (PM), such as fine PM2.5 and larger PM10. They also looked at nitrogen dioxide, sulfur dioxide, ozone and carbon monoxide.</p><p>Most studies included in the review estimated people's long-term exposure based on the pollution levels around their homes and in their communities. They used a range of methods, including government monitoring systems, satellite data and computer models designed to estimate pollution levels. A few studies examined short-term exposure and its relation to more sudden eye issues, such as <a href="https://my.clevelandclinic.org/health/diseases/angle-closure-glaucoma" target="_blank"><u>acute angle-closure glaucoma</u></a>, a medical emergency that can quickly cause vision loss.</p><p>Using this wealth of data, the team compared pollution exposure with rates of glaucoma, cataracts and <a href="https://www.aao.org/eye-health/diseases/amd-macular-degeneration" target="_blank"><u>age-related macular degeneration</u></a> (AMD), another common eye condition that impairs vision. PM2.5 — tiny particles that measure 2.5 micrometers or smaller — showed the clearest associations with glaucoma and cataract risk.</p><p>People with the highest exposure to PM2.5 had 70% higher odds of glaucoma, compared to those with the least exposure. Plus, an increase in PM2.5 exposure equivalent to the difference between the 25th and 75th percentiles of exposure within each study was associated with 8% higher odds of glaucoma and a 4% higher hazard of cataracts.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="rtG7rJTFtuGYrWmFvYaXme" name="IMG_8748" alt="A ditch burns with white smoke filling the air." src="https://cdn.mos.cms.futurecdn.net/rtG7rJTFtuGYrWmFvYaXme-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/rtG7rJTFtuGYrWmFvYaXme-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Smoke from burning agricultural residue contains fine particulate matter. In a review of 41 studies, higher PM2.5 exposure showed a strong association with glaucoma and cataract. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Sanket Jain)</span></figcaption></figure><p>The evidence was less consistent for air pollution and age-related macular degeneration, which damages the central part of the <a href="https://www.livescience.com/health/anatomy/what-are-eyes-made-of"><u>retina</u></a> that's responsible for sharp, detailed vision. And unlike the clear connection seen with PM2.5, other pollutants showed less consistent links to eye disease. For instance, nitrogen dioxide was not significantly tied to AMD, ozone was not tied to cataracts, and neither pollutant was linked to glaucoma. Sulfur dioxide and PM10 showed no significant associations with any of the three conditions.</p><p>The association between PM2.5 and glaucoma was relatively consistent across the reviewed studies, said <a href="https://www.researchgate.net/profile/Nidhi-Singh-13" target="_blank"><u>Nidhi Singh</u></a>, an environmental epidemiologist at the IUF-Leibniz Research Institute for Environmental Medicine in Germany, who was not involved in the study. The findings for PM2.5 and cataracts were moderately consistent, albeit more variable than the glaucoma data; still, she said that the analysis seems to support a link.</p><p>Singh did caution that the underlying evidence is observational. "Therefore, the results demonstrate an association, not by themselves a causal effect of PM2.5 on glaucoma or cataract," she told Live Science.</p><h2 id="what-explains-the-increased-risk">What explains the increased risk?</h2><p>The exact biological mechanisms behind these links remain unclear, but Alnabihi noted that fine particulate matter is small enough to be absorbed into the body. This can trigger <a href="https://www.livescience.com/what-is-oxidative-stress"><u>oxidative stress</u></a>, in which harmful molecules overwhelm natural defenses and cause damage. It also drives chronic, low-grade <a href="https://www.livescience.com/health/immune-system/inflammation-is-a-mismatch-between-our-evolutionary-history-and-modern-environment-says-immunologist-ruslan-medzhitov"><u>inflammation</u></a>, in which the immune system stays mildly activated for long periods, he explained. </p><p>In the eye's lens, these processes can "damage the crystallin proteins that keep it transparent, causing them to misfold and cloud, which is what a cataract is," Alnabihi said. </p><p>In the optic nerve, the same processes are thought to damage retinal ganglion cells, a special type of neuron that relays information from the retina to the brain. This can contribute to glaucoma independent of internal eye pressure, he said, which is another big risk factor. </p><p>"Unlike the lungs or gut, its [the eye's] surface is in direct, continuous contact with outdoor air, giving pollutants a uniquely direct route that might cause damage," he added.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/wildfire-smoke-is-the-fastest-growing-environmental-threat-in-the-us-how-a-warming-world-will-poison-the-air-we-breathe">'Wildfire smoke is the fastest-growing environmental threat in the US': How a warming world will poison the air we breathe</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/chinas-huge-push-to-reduce-air-pollution-had-an-unexpected-consequence-in-the-arctic">China's huge push to reduce air pollution had an unexpected consequence in the Arctic</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/planet-earth/climate-change/pollution-may-fuel-depression-anxiety-and-other-mental-health-problems-emerging-research-suggests">Pollution may fuel depression, anxiety and other mental health problems, emerging research suggests</a></li></ul></p></div></div><p>Other studies have found clues that support the link between PM2.5 and eye damage. Mice that were exposed to ambient PM2.5 for nine months <a href="https://www.sciencedirect.com/science/article/pii/S0147651321010757" target="_blank"><u>developed elevated pressure inside their eyes</u></a>, a glaucoma risk factor. The researchers observed both oxidative stress and nitrative stress — a similar phenomenon — in the tissues that drain fluid from the eye, which may help to explain the rise in pressure.</p><p>Studies of humans and human cells have uncovered similar patterns. In data from more than 480,000 people in the UK Biobank, a large repository of health information, those exposed to higher PM2.5 were more likely to <a href="https://iovs.arvojournals.org/article.aspx?articleid=2802136" target="_blank"><u>develop glaucoma over time</u></a>. In another study, scientists exposed lab-grown human retinal tissue made from stem cells to PM2.5. The particles <a href="https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.607341/full" target="_blank"><u>disrupted retinal cell development</u></a>, including that of retinal ganglion cells, while increasing cell death. </p><p>These studies offer pieces of a possible mechanism, but for now, how those pieces fit together in people remains unclear.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Is the brain actually 2 nervous systems smooshed together? A new study claims it is. ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Recent research challenges a long-standing idea about how the brain develops: Rather than arising from a single source, the brain may emerge from two distinct populations of cells, the study finds.</p><p>"The brain appears as one organ," said study co-author <a href="https://profiles.stanford.edu/kyle-loh" target="_blank"><u>Kyle Loh</u></a>, an associate professor of developmental biology at Stanford University. "However, we discovered that the front part of the brain and the back part of the brain come from different sources, which are pushed together to create the appearance of a single organ," Loh told Live Science in an email.</p><p>The findings, published in September in the journal <a href="https://www.nature.com/articles/s41593-026-02433-7" target="_blank"><u>Nature Neuroscience</u></a>, not only challenge <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2989000/" target="_blank"><u>established models of how the brain forms</u></a> but may also explain why researchers have struggled to grow certain types of brain cells in the laboratory. The scientists say the work could offer new ways to investigate diseases that affect the brainstem, the "stalk" that connects the brain to the spinal cord.</p><h2 id="two-developmental-journeys">Two developmental journeys</h2><p>The human brain is divided into <a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/anatomy-of-the-brain" target="_blank"><u>three main regions</u></a> — called the forebrain, midbrain and hindbrain — that perform different but interconnected functions.</p><p>The <a href="https://qbi.uq.edu.au/brain/brain-anatomy/forebrain" target="_blank"><u>forebrain</u></a>, which includes the cerebral hemispheres, is involved in higher-level cognitive processes, such as language, planning and abstract thinking. The midbrain, the uppermost part of the brainstem, connects the forebrain and the hindbrain and acts as a key relay center for sensory information and movement control. The <a href="https://qbi.uq.edu.au/brain/brain-anatomy/hindbrain" target="_blank"><u>hindbrain</u></a> — which includes the bottom of the brainstem, along with other structures — also helps to coordinate movement, as well as regulate essential functions such as breathing, <a href="https://www.livescience.com/health/sleep/sleep-facts-about-how-and-why-we-sleep"><u>sleep</u></a> and heart rate.</p><p>Historically, the hindbrain has been difficult to study. One reason is that scientists have faced persistent challenges in generating functional hindbrain neurons in laboratory conditions. </p><p>To help understand why, Loh and his team looked at the early stages of embryonic development in lab mice. They focused on <a href="http://embryology.med.unsw.edu.au/embryology/index.php/Gastrulation" target="_blank"><u>gastrulation</u></a>, the point when cells begin to organize into structures that will later form different organs. The researchers identified two distinct populations of immature cells that would go on to give rise to nervous system tissue, including the brain. </p><p>One cell population expressed a gene called <a href="https://pubmed.ncbi.nlm.nih.gov/23523800/" target="_blank"><u>Otx2</u></a>, which helps to direct the early development of the forebrain and midbrain. The second group of cells expressed the gene <a href="https://learn.mapmygenome.ai/gbx2" target="_blank"><u>Gbx2</u></a>, which is involved in the development of the midbrain and hindbrain.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:840px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="QBNodFYwxqQZ5xzFkiDkHX" name="Gbx2 CreER lineage trace E95 for media" alt="A blue and red swirl of embryo showing two different cell types." src="https://cdn.mos.cms.futurecdn.net/QBNodFYwxqQZ5xzFkiDkHX-1920-80.png" mos="" align="middle" fullscreen="" width="840" height="840" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">This photograph shows a 9.5-day-old mouse embryo and depicts the two separate developmental origins of the brain. The forebrain and part of the midbrain (blue) express the Otx2 gene, while the hindbrain and the rest of the midbrain (red) express Gbx2. The red cell population also extends into the spinal cord.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Stanford Medicine)</span></figcaption></figure><p>The functions of these genes were already known, but their distinct expression in these two groups of cells was revealed by the new research. The cell populations remained distinct as they developed into full-fledged nervous tissue, rather than overlapping.</p><p>The team also examined <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chromatin" target="_blank"><u>chromatin</u></a>, the molecular structure that packages DNA tightly inside the nucleus and helps regulate which genes a cell can use. The two cell populations show different chromatin configurations, the team found, which further supports the idea that they follow separate developmental pathways. </p><p>That may help to explain why scientists' attempts to grow hindbrain neurons have been largely unsuccessful. </p><p>"Previous attempts to make hindbrain neurons likely tried to coax forebrain and midbrain progenitors into hindbrain cells, which our study shows is not possible," study co-author <a href="https://loh.stanford.edu/members" target="_blank"><u>Rayyan Jokhai</u></a>, a graduate student in Loh's lab, <a href="https://med.stanford.edu/news/all-news/2026/09/two-separate-brains.html" target="_blank"><u>said in a statement</u></a>. </p><h2 id="why-it-matters">Why it matters</h2><p>Using the information uncovered in their experiments, the researchers successfully guided human <a href="https://www.livescience.com/65269-stem-cells.html"><u>stem cells</u></a> to transform into functional hindbrain motor neurons, which are involved in controlling movement. Specifically, these cells produced proteins characteristic of the hard-to-grow hindbrain regions that help control muscles of the face and those involved in swallowing.</p><p>In several neurological diseases, including <a href="https://www.livescience.com/health/medicine-drugs/deadly-motor-neuron-disease-treated-in-the-womb-in-world-1st"><u>spinal muscular atrophy</u></a> and <a href="https://www.livescience.com/health/genetics/some-people-recover-from-als-now-we-might-know-why"><u>amyotrophic lateral sclerosis</u></a>, motor neurons deteriorate and affected patients can lose their ability to swallow, speak and breathe independently. </p><p>"We cannot sample living motor neurons from a patient's hindbrain to watch how these diseases attack these neurons," Loh said. "Growing these hindbrain motor neurons in a dish gives us a way to investigate these diseases." Looking forward, the team aims to use their findings to study these diseases and pinpoint new treatments.</p><p>The new findings could also reveal something fundamental about the evolution of vertebrate animals.</p><p>The study authors investigated whether the two developmental pathways were unique to humans or reflected a much older evolutionary arrangement. They turned to previously published data on other species — including macaques (<em>Macaca</em>), zebrafish (<em>Danio rerio</em>) and chickens (<em>Gallus gallus domesticus</em>) — and again found two distinct cell populations expressing the two key genes.</p><p>And even in acorn worms — a marine invertebrate whose evolution diverged from vertebrates about 550 million years ago — they again found these two distinct groups of cells.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/in-secrets-of-the-brain-jim-al-khalili-explores-600-million-years-of-brain-evolution-to-understand-what-makes-us-human">In 'Secrets of the Brain,' Jim Al-Khalili explores 600 million years of brain evolution to understand what makes us human</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/chemistry/brains-dont-always-rot-scientists-may-finally-know-how-human-brains-have-evaded-decay-for-thousands-of-years">Brains don't always rot: Scientists may finally know how human brains have evaded decay for thousands of years</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/human-evolution/if-humans-are-getting-smarter-why-are-our-brains-shrinking">If humans are getting smarter, why are our brains shrinking?</a></li></ul></p></div></div><p>"The Stanford discovery establishes that the deep ancestry of the vertebrate brain is fundamentally modular," said <a href="https://scholar.google.com/citations?user=s8jNe_4AAAAJ&amp;hl=en" target="_blank"><u>Anna Di Cosmo</u></a>, a professor of biology at the University of Naples Federico II in Italy who wasn't involved with the study. "The developmental separation between the anterior lineage (forebrain/midbrain) and the posterior lineage (hindbrain) is traceably ancient," Cosmo told Live Science in an email. </p><p>Loh's team speculates that these developmental trajectories seen in the womb may suggest that the two cell populations once belonged to two separate nervous systems. "Later in evolution, these two nervous systems may have been pushed together to give rise to the appearance of one integrated brain," Loh said.</p><p>However, the study doesn't reveal exactly when the two pathways arose or establish how they integrated. "It is important to emphasize that this is only an idea, and it might change as scientists learn more," Loh said.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/is-the-brain-actually-2-nervous-systems-smooshed-together-a-new-study-claims-it-is</link>
                                                                            <description>
                            <![CDATA[ A recent study may reshape our understanding of brain evolution and open new avenues for studying neurological diseases. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">vNGem6pPNQWSmRgt4MbaHh</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/h8YzrR6tXJcJUvvt4TrKQD-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Sat, 17 Oct 2026 11:00:00 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kenna Hughes-Castleberry ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mgEvZdqXoF3NyR25Gj96va-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/h8YzrR6tXJcJUvvt4TrKQD-1920-80.jpg">
                                                            <media:credit><![CDATA[nopparit via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[New research suggests that different portions of the human brain evolved from different sources.]]></media:description>                                                            <media:text><![CDATA[An illustration of a translucent person with various parts of their brain glowing in orange.]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a translucent person with various parts of their brain glowing in orange.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/h8YzrR6tXJcJUvvt4TrKQD-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Recent research challenges a long-standing idea about how the brain develops: Rather than arising from a single source, the brain may emerge from two distinct populations of cells, the study finds.</p><p>"The brain appears as one organ," said study co-author <a href="https://profiles.stanford.edu/kyle-loh" target="_blank"><u>Kyle Loh</u></a>, an associate professor of developmental biology at Stanford University. "However, we discovered that the front part of the brain and the back part of the brain come from different sources, which are pushed together to create the appearance of a single organ," Loh told Live Science in an email.</p><p>The findings, published in September in the journal <a href="https://www.nature.com/articles/s41593-026-02433-7" target="_blank"><u>Nature Neuroscience</u></a>, not only challenge <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2989000/" target="_blank"><u>established models of how the brain forms</u></a> but may also explain why researchers have struggled to grow certain types of brain cells in the laboratory. The scientists say the work could offer new ways to investigate diseases that affect the brainstem, the "stalk" that connects the brain to the spinal cord.</p><h2 id="two-developmental-journeys">Two developmental journeys</h2><p>The human brain is divided into <a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/anatomy-of-the-brain" target="_blank"><u>three main regions</u></a> — called the forebrain, midbrain and hindbrain — that perform different but interconnected functions.</p><p>The <a href="https://qbi.uq.edu.au/brain/brain-anatomy/forebrain" target="_blank"><u>forebrain</u></a>, which includes the cerebral hemispheres, is involved in higher-level cognitive processes, such as language, planning and abstract thinking. The midbrain, the uppermost part of the brainstem, connects the forebrain and the hindbrain and acts as a key relay center for sensory information and movement control. The <a href="https://qbi.uq.edu.au/brain/brain-anatomy/hindbrain" target="_blank"><u>hindbrain</u></a> — which includes the bottom of the brainstem, along with other structures — also helps to coordinate movement, as well as regulate essential functions such as breathing, <a href="https://www.livescience.com/health/sleep/sleep-facts-about-how-and-why-we-sleep"><u>sleep</u></a> and heart rate.</p><p>Historically, the hindbrain has been difficult to study. One reason is that scientists have faced persistent challenges in generating functional hindbrain neurons in laboratory conditions. </p><p>To help understand why, Loh and his team looked at the early stages of embryonic development in lab mice. They focused on <a href="http://embryology.med.unsw.edu.au/embryology/index.php/Gastrulation" target="_blank"><u>gastrulation</u></a>, the point when cells begin to organize into structures that will later form different organs. The researchers identified two distinct populations of immature cells that would go on to give rise to nervous system tissue, including the brain. </p><p>One cell population expressed a gene called <a href="https://pubmed.ncbi.nlm.nih.gov/23523800/" target="_blank"><u>Otx2</u></a>, which helps to direct the early development of the forebrain and midbrain. The second group of cells expressed the gene <a href="https://learn.mapmygenome.ai/gbx2" target="_blank"><u>Gbx2</u></a>, which is involved in the development of the midbrain and hindbrain.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:840px;"><p class="vanilla-image-block" style="padding-top:100.00%;"><img id="QBNodFYwxqQZ5xzFkiDkHX" name="Gbx2 CreER lineage trace E95 for media" alt="A blue and red swirl of embryo showing two different cell types." src="https://cdn.mos.cms.futurecdn.net/QBNodFYwxqQZ5xzFkiDkHX-1920-80.png" mos="" align="middle" fullscreen="" width="840" height="840" attribution="" endorsement="" class="inline" /></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">This photograph shows a 9.5-day-old mouse embryo and depicts the two separate developmental origins of the brain. The forebrain and part of the midbrain (blue) express the Otx2 gene, while the hindbrain and the rest of the midbrain (red) express Gbx2. The red cell population also extends into the spinal cord.  </span><span class="credit" itemprop="copyrightHolder">(Image credit: Stanford Medicine)</span></figcaption></figure><p>The functions of these genes were already known, but their distinct expression in these two groups of cells was revealed by the new research. The cell populations remained distinct as they developed into full-fledged nervous tissue, rather than overlapping.</p><p>The team also examined <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chromatin" target="_blank"><u>chromatin</u></a>, the molecular structure that packages DNA tightly inside the nucleus and helps regulate which genes a cell can use. The two cell populations show different chromatin configurations, the team found, which further supports the idea that they follow separate developmental pathways. </p><p>That may help to explain why scientists' attempts to grow hindbrain neurons have been largely unsuccessful. </p><p>"Previous attempts to make hindbrain neurons likely tried to coax forebrain and midbrain progenitors into hindbrain cells, which our study shows is not possible," study co-author <a href="https://loh.stanford.edu/members" target="_blank"><u>Rayyan Jokhai</u></a>, a graduate student in Loh's lab, <a href="https://med.stanford.edu/news/all-news/2026/09/two-separate-brains.html" target="_blank"><u>said in a statement</u></a>. </p><h2 id="why-it-matters">Why it matters</h2><p>Using the information uncovered in their experiments, the researchers successfully guided human <a href="https://www.livescience.com/65269-stem-cells.html"><u>stem cells</u></a> to transform into functional hindbrain motor neurons, which are involved in controlling movement. Specifically, these cells produced proteins characteristic of the hard-to-grow hindbrain regions that help control muscles of the face and those involved in swallowing.</p><p>In several neurological diseases, including <a href="https://www.livescience.com/health/medicine-drugs/deadly-motor-neuron-disease-treated-in-the-womb-in-world-1st"><u>spinal muscular atrophy</u></a> and <a href="https://www.livescience.com/health/genetics/some-people-recover-from-als-now-we-might-know-why"><u>amyotrophic lateral sclerosis</u></a>, motor neurons deteriorate and affected patients can lose their ability to swallow, speak and breathe independently. </p><p>"We cannot sample living motor neurons from a patient's hindbrain to watch how these diseases attack these neurons," Loh said. "Growing these hindbrain motor neurons in a dish gives us a way to investigate these diseases." Looking forward, the team aims to use their findings to study these diseases and pinpoint new treatments.</p><p>The new findings could also reveal something fundamental about the evolution of vertebrate animals.</p><p>The study authors investigated whether the two developmental pathways were unique to humans or reflected a much older evolutionary arrangement. They turned to previously published data on other species — including macaques (<em>Macaca</em>), zebrafish (<em>Danio rerio</em>) and chickens (<em>Gallus gallus domesticus</em>) — and again found two distinct cell populations expressing the two key genes.</p><p>And even in acorn worms — a marine invertebrate whose evolution diverged from vertebrates about 550 million years ago — they again found these two distinct groups of cells.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/in-secrets-of-the-brain-jim-al-khalili-explores-600-million-years-of-brain-evolution-to-understand-what-makes-us-human">In 'Secrets of the Brain,' Jim Al-Khalili explores 600 million years of brain evolution to understand what makes us human</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/chemistry/brains-dont-always-rot-scientists-may-finally-know-how-human-brains-have-evaded-decay-for-thousands-of-years">Brains don't always rot: Scientists may finally know how human brains have evaded decay for thousands of years</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/archaeology/human-evolution/if-humans-are-getting-smarter-why-are-our-brains-shrinking">If humans are getting smarter, why are our brains shrinking?</a></li></ul></p></div></div><p>"The Stanford discovery establishes that the deep ancestry of the vertebrate brain is fundamentally modular," said <a href="https://scholar.google.com/citations?user=s8jNe_4AAAAJ&amp;hl=en" target="_blank"><u>Anna Di Cosmo</u></a>, a professor of biology at the University of Naples Federico II in Italy who wasn't involved with the study. "The developmental separation between the anterior lineage (forebrain/midbrain) and the posterior lineage (hindbrain) is traceably ancient," Cosmo told Live Science in an email. </p><p>Loh's team speculates that these developmental trajectories seen in the womb may suggest that the two cell populations once belonged to two separate nervous systems. "Later in evolution, these two nervous systems may have been pushed together to give rise to the appearance of one integrated brain," Loh said.</p><p>However, the study doesn't reveal exactly when the two pathways arose or establish how they integrated. "It is important to emphasize that this is only an idea, and it might change as scientists learn more," Loh said.</p><p><strong>See how much you know about the most complex organ in the human body with our </strong><a href="https://www.livescience.com/health/neuroscience/brain-quiz-test-your-knowledge-of-the-most-complex-organ-in-the-body"><u><strong>brain quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-XpYMle"></div>                            </div>                            <script src="https://kwizly.com/embed/XpYMle.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Testosterone for menopause: The treatment is rising in popularity, but does it work? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>If you're approaching menopause, you are likely being bombarded by online ads for treatments promising relief for everything from hot flashes to brain fog. Some of these therapies have been approved by the Food and Drug Administration (FDA) and have strong evidence to support them — but one hormone-based treatment that's gaining in popularity has much less science to back its use for menopause.</p><p>More doctors are writing their menopausal patients prescriptions for testosterone therapy. A<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13309321/" target="_blank"> <u>2026 study conducted in the U.S.</u></a> recorded over 90,000 off-label prescriptions for testosterone to women in 2025, mainly among women ages 45 to 64 and those with diagnoses of menopause. This marked a 58.7% increase from 2024. </p><p>These prescriptions are "off-label" because the FDA has not yet approved testosterone as a treatment for menopause, perimenopause (the transition into menopause) or postmenopause (the time period afterward).  </p><p>So, does scientific evidence support the use of testosterone to alleviate menopause symptoms? Or is it too soon to say? </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="ceJKHEs7QJjGtvx2jtphAN" name="GettyImages-143490378-testosterone gel" alt="A close up of a blue box's label that reads "AndroGel"" src="https://cdn.mos.cms.futurecdn.net/ceJKHEs7QJjGtvx2jtphAN-1920-80.gif" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ceJKHEs7QJjGtvx2jtphAN-1920-80.gif' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">While testosterone treatment for menopause has gained popularity, there's limited evidence to back up its use, experts say. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Bloomberg via Getty Images)</span></figcaption></figure><h2 id="no-direct-link-to-menopause-symptoms">No direct link to menopause symptoms</h2><p>Although often called a "male" hormone, testosterone is also produced by females, albeit at lower levels than in males, on average.</p><p>There's a common misconception that females experience "androgen deficiency" — a marked decline in testosterone and related hormones — leading up to menopause, said <a href="https://research.monash.edu/en/persons/susan-davis/" target="_blank"><u>Susan Davis</u></a>, a professor of endocrinology and the head of the Women's Health Research Program at Monash University in Australia. This is not the case.</p><p>Rather, in females, testosterone levels tend to <a href="https://www.jeanhailes.org.au/health-topics/sex-and-sexual-health/testosterone-therapy/" target="_blank"><u>drop slowly</u></a> between ages 20 and 60, and there's a slight rebound from age 60 onward. Menopause, which generally occurs around age 51 to 52, is <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12552971/" target="_blank"><u>not linked to a marked decline in testosterone</u></a>. Estrogen and progesterone fluctuate during perimenopause and then decline sharply, and these changes clearly contribute to the telltale symptoms of perimenopause and menopause.</p><p>Placebo-controlled trials have not been able to show that testosterone treatment helps to alleviate brain fog or improve well-being, mood, bone density or muscle function in menopausal patients, said Davis, who has <a href="https://pubmed.ncbi.nlm.nih.gov/18987368/" target="_blank"><u>conducted a number of these trials herself</u></a>. </p><p>"Telling women that fatigue, low mood, brain fog are symptoms of androgen deficiency is completely untrue," she emphasized. </p><p>On Sept. 17, the FDA <a href="https://www.fda.gov/consumers/womens-health-events/fda-public-meeting-testosterone-use-menopausal-women-09172026" target="_blank"><u>held a public workshop</u></a> to evaluate the evidence for testosterone therapy for menopause, concluding that more evidence is needed to fully assess the use of the hormone as a menopause treatment.</p><h2 id="testosterone-for-low-sex-drive">Testosterone for low sex drive?</h2><p>There is some evidence to suggest that testosterone might help to treat a condition called <a href="https://www.plannedparenthood.org/learn/sex-pleasure-and-sexual-dysfunction/sexual-dysfunction/hypoactive-sexual-desire-disorder-hsdd" target="_blank"><u>hypoactive sexual desire disorder</u></a> (HSDD) in postmenopausal women. HSDD describes when a person has little to no sex drive and it causes them distress. Men and women of many ages experience it, so the condition is not unique to menopause. But it can sometimes develop in perimenopausal and postmenopausal women.</p><p>A <a href="https://www.monash.edu/medicine/sphpm/womenshealth/research/findings/safety-and-efficacy-of-testosterone-for-women" target="_blank"><u>review of 36 randomized trials</u></a> involving 8,480 participants found that testosterone treatment delivered with skin patches was associated with 0.85 additional satisfying sexual events per month in postmenopausal women, compared to a placebo. This observed effect is not huge, <a href="https://medschool.cuanschutz.edu/ob-gyn/divisions/division-of-reproductive-sciences/our-faculty/nanette-santoro-md" target="_blank"><u>Dr. Nanette Santoro</u></a>, a professor of obstetrics and gynecology at the University of Colorado School of Medicine, told Live Science in an email. </p><div><blockquote><p>Of all the studies done to date, if there was a screaming benefit, you think you would have seen it.</p><p>Susan Davis, head of the Women's Health Research Program at Monash University</p></blockquote></div><p>Lately, anecdotal accounts of postmenopausal women having "fantastic sexual awakenings" after taking testosterone have been floating around, Santoro said. But these anecdotes haven't been backed by hard data yet. "Patients are being bombarded with a tsunami of information providing them with the most sky-high expectations imaginable," she said. </p><p>Notably, testosterone is not FDA approved as a treatment for HSDD in menopause yet. A drug called flibanserin, which affects serotonin in the brain, is approved to treat HSDD for <a href="https://www.webmd.com/drugs/updates/addyi-low-sexual-desire-postmenopause" target="_blank"><u>pre- and postmenopausal women under age 65</u></a>.</p><h2 id="placebo-effects-muddy-the-data">Placebo effects muddy the data</h2><p>The <a href="https://www.livescience.com/32941-is-the-placebo-effect-real.html"><u>placebo effect</u></a> — when patients perceive an improvement in their health or well-being despite receiving a treatment with no active ingredient — can also complicate testosterone trials.</p><p>Davis said that in her patient groups, it's common for about 1 in 3 trial participants to report an improvement of their symptoms even though they are taking a placebo. <a href="https://academic.oup.com/jsm/article-abstract/6/1/175/6832512?redirectedFrom=fulltext" target="_blank"><u>Other trials have reported</u></a> similar findings in their placebo groups, with about 30% to 40% experiencing some improvement in sexual desire and satisfaction, for example.</p><p>"I wouldn't say that there is definitely not a benefit," Davis said. "It's just that a benefit has not been shown."</p><p>One study trying to address this gap is the U.K. National Institute for Health and Care Research's <a href="https://fundingawards.nihr.ac.uk/award/NIHR159538" target="_blank"><u>ESTEEM trial</u></a>. This large-scale, gold-standard trial aims to recruit hundreds of menopausal women and test whether using testosterone cream can reliably improve their quality of life. The cream will deliver testosterone through the skin and be applied to the lower abdomen and thighs. (Doctors often advise women to apply the creams in this way because those body parts are easy to hide if the treatment causes localized hair growth that the patients would prefer to conceal.)</p><p>The trial runners will track participants' symptoms linked to menopause, looking at sleep quality, memory performance, feelings of anxiousness, migraines, body mass, and overall well-being. The results of that trial are currently expected by 2028.</p><p>In the meantime, though, there isn't strong evidence that testosterone directly improves symptoms of menopause beyond HSDD. "Of all the studies done to date, if there was a screaming benefit, you think you would have seen it," Davis said.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="KsPANypL2gVudBvm6gKJ8e" name="GettyImages-1148109989-testosterone" alt="A blue and purple molecule with a few ends colored red." src="https://cdn.mos.cms.futurecdn.net/KsPANypL2gVudBvm6gKJ8e-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/KsPANypL2gVudBvm6gKJ8e-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Females' testosterone levels generally decline throughout adulthood, with a slight increase after age 60. However, there isn't a sharp dip in testosterone around the time of menopause. </span><span class="credit" itemprop="copyrightHolder">(Image credit: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><h2 id="could-taking-testosterone-for-menopause-be-harmful">Could taking testosterone for menopause be harmful? </h2><p>Testosterone treatments available in most countries are not necessarily dosed for use in female patients. Only four countries — <a href="https://www.safetyandquality.gov.au/medicine-finder/androfeme-1" target="_blank"><u>Australia</u></a>, <a href="https://pharmacorp.co.za/products/schedule-2-5/testafeme/" target="_blank"><u>South Africa</u></a>, <a href="https://www.androfeme.nz/" target="_blank"><u>New Zealand</u></a> and the <a href="https://mhraproducts4853.blob.core.windows.net/docs/6f5c86bfb5b17ab2f9f219e3ff8d0188a500e085" target="_blank"><u>United Kingdom</u></a> — have authorized a testosterone cream that's specifically formulated and dosed for women. These products differ from testosterone therapies for men in that they contain lower doses of the hormone. They are available to postmenopausal women with HSDD, specifically. </p><p>In other countries, such as the U.S., doctors are left trying to adapt medication dosed for males for their female patients, which can lead to a wide variation in dosing. And the effects of these different dosing regimens are <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6821450/" target="_blank"><u>poorly understood</u></a> for female patients. "It is not necessarily unsafe to use male preparations for women, it's just that much, much less must be used," Santoro said. </p><p>Excessive doses raise concern about unwanted masculinizing effects, such as clitoral enlargement, voice deepening, hair thinning, baldness, and rapid growth of facial and body hair, Santoro said. (These masculinizing effects might be sought after in the context of <a href="https://transcare.ucsf.edu/article/information-testosterone-hormone-therapy" target="_blank"><u>gender-affirming care for transgender men</u></a> and transmasculine people, but would often be undesirable for cisgender women.)</p><p>Additionally, the potential impacts of extra testosterone on cardiovascular health and breast cancer risk are poorly understood, Santoro noted. At lower doses, testosterone can cause mild acne, oily skin, and some increase in facial and body hair growth in postmenopausal women, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6821450/" target="_blank"><u>trials have found</u></a>; if these symptoms remain mild, they are generally considered acceptable.</p><p>Testosterone is being used off-label in the U.S., which means the "safety, efficacy and appropriate dosing for that use have not been evaluated and approved by the FDA," a spokesperson for the agency told Live Science in an email. The dosages and formulations approved for males "may differ substantially from what might be appropriate for women, whose testosterone levels and metabolic profiles are clinically distinct," the spokesperson said.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/could-psilocybin-treat-brain-injuries-neuroscientist-explains-how-psychedelics-could-fill-a-gap-in-head-trauma-care">Could psilocybin treat brain injuries? Neuroscientist explains how psychedelics could fill a gap in head trauma care</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/adversity-shaped-our-evolution-as-a-species-people-raised-in-it-may-have-underrecognized-strengths-because-of-it">Adversity shaped our evolution as a species. People raised in it may have underrecognized strengths because of it.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/the-right-diagnosis-is-unbelievably-powerful-it-can-take-years-to-diagnose-rare-diseases-and-scientists-are-trying-to-fix-that">'The right diagnosis is unbelievably powerful': It can take years to diagnose rare diseases, and scientists are trying to fix that</a></li></ul></p></div></div><p>Anecdotally, Santoro encountered one female patient who had received very high levels of testosterone through an implant placed under the skin, which had been prescribed to her by a different doctor. She started losing her hair and seeing sizable growth in her clitoris, while her breasts started "shrinking away." </p><p>"Women are being prescribed some very big doses in North America, and no one studied the safety of these," Santoro said. </p><p>At the end of the day, Davis argues that women deserve to be given accurate information, given that navigating menopause can already feel like "swimming through wet cement." Good menopause care not only involves discussing potential pharmacological treatments, but also evaluating a patient's lifestyle, such as diet and exercise, and discussing societal pressures that often affect menopausal people. For instance, they may face pressure to maintain an active sex life and younger-looking physique.</p><p>When it comes to hyped therapies like testosterone, she said, "just be cautious about people who tell you they've got the answer that no one else has got."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/reproductive-health/testosterone-for-menopause-the-treatment-is-rising-in-popularity-but-does-it-work</link>
                                                                            <description>
                            <![CDATA[ Women are using testosterone in the hope that it will treat their menopause symptoms, but little evidence supports the approach, experts say. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">VoKSZrbicUDNBwJUU8ufvG</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/xa4ve82Soj26TvvcxGdnJZ-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 15 Oct 2026 09:00:00 +0000</pubDate>                                                                                                                                <updated>Thu, 15 Oct 2026 11:44:09 +0000</updated>
                                                                                                                                            <category><![CDATA[Reproductive Health]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Marianne Guenot ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/StCsomdk7AdY2q5dEqLFAV-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>true</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/xa4ve82Soj26TvvcxGdnJZ-1920-80.jpg">
                                                            <media:credit><![CDATA[Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[More doctors are prescribing their menopausal patients testosterone treatment, but what does the science actually say about the hormone therapy?]]></media:description>                                                            <media:text><![CDATA[Woman clasping her head in her hands]]></media:text>
                                <media:title type="plain"><![CDATA[Woman clasping her head in her hands]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/xa4ve82Soj26TvvcxGdnJZ-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>If you're approaching menopause, you are likely being bombarded by online ads for treatments promising relief for everything from hot flashes to brain fog. Some of these therapies have been approved by the Food and Drug Administration (FDA) and have strong evidence to support them — but one hormone-based treatment that's gaining in popularity has much less science to back its use for menopause.</p><p>More doctors are writing their menopausal patients prescriptions for testosterone therapy. A<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13309321/" target="_blank"> <u>2026 study conducted in the U.S.</u></a> recorded over 90,000 off-label prescriptions for testosterone to women in 2025, mainly among women ages 45 to 64 and those with diagnoses of menopause. This marked a 58.7% increase from 2024. </p><p>These prescriptions are "off-label" because the FDA has not yet approved testosterone as a treatment for menopause, perimenopause (the transition into menopause) or postmenopause (the time period afterward).  </p><p>So, does scientific evidence support the use of testosterone to alleviate menopause symptoms? Or is it too soon to say? </p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="ceJKHEs7QJjGtvx2jtphAN" name="GettyImages-143490378-testosterone gel" alt="A close up of a blue box's label that reads "AndroGel"" src="https://cdn.mos.cms.futurecdn.net/ceJKHEs7QJjGtvx2jtphAN-1920-80.gif" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/ceJKHEs7QJjGtvx2jtphAN-1920-80.gif' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">While testosterone treatment for menopause has gained popularity, there's limited evidence to back up its use, experts say. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Bloomberg via Getty Images)</span></figcaption></figure><h2 id="no-direct-link-to-menopause-symptoms">No direct link to menopause symptoms</h2><p>Although often called a "male" hormone, testosterone is also produced by females, albeit at lower levels than in males, on average.</p><p>There's a common misconception that females experience "androgen deficiency" — a marked decline in testosterone and related hormones — leading up to menopause, said <a href="https://research.monash.edu/en/persons/susan-davis/" target="_blank"><u>Susan Davis</u></a>, a professor of endocrinology and the head of the Women's Health Research Program at Monash University in Australia. This is not the case.</p><p>Rather, in females, testosterone levels tend to <a href="https://www.jeanhailes.org.au/health-topics/sex-and-sexual-health/testosterone-therapy/" target="_blank"><u>drop slowly</u></a> between ages 20 and 60, and there's a slight rebound from age 60 onward. Menopause, which generally occurs around age 51 to 52, is <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12552971/" target="_blank"><u>not linked to a marked decline in testosterone</u></a>. Estrogen and progesterone fluctuate during perimenopause and then decline sharply, and these changes clearly contribute to the telltale symptoms of perimenopause and menopause.</p><p>Placebo-controlled trials have not been able to show that testosterone treatment helps to alleviate brain fog or improve well-being, mood, bone density or muscle function in menopausal patients, said Davis, who has <a href="https://pubmed.ncbi.nlm.nih.gov/18987368/" target="_blank"><u>conducted a number of these trials herself</u></a>. </p><p>"Telling women that fatigue, low mood, brain fog are symptoms of androgen deficiency is completely untrue," she emphasized. </p><p>On Sept. 17, the FDA <a href="https://www.fda.gov/consumers/womens-health-events/fda-public-meeting-testosterone-use-menopausal-women-09172026" target="_blank"><u>held a public workshop</u></a> to evaluate the evidence for testosterone therapy for menopause, concluding that more evidence is needed to fully assess the use of the hormone as a menopause treatment.</p><h2 id="testosterone-for-low-sex-drive">Testosterone for low sex drive?</h2><p>There is some evidence to suggest that testosterone might help to treat a condition called <a href="https://www.plannedparenthood.org/learn/sex-pleasure-and-sexual-dysfunction/sexual-dysfunction/hypoactive-sexual-desire-disorder-hsdd" target="_blank"><u>hypoactive sexual desire disorder</u></a> (HSDD) in postmenopausal women. HSDD describes when a person has little to no sex drive and it causes them distress. Men and women of many ages experience it, so the condition is not unique to menopause. But it can sometimes develop in perimenopausal and postmenopausal women.</p><p>A <a href="https://www.monash.edu/medicine/sphpm/womenshealth/research/findings/safety-and-efficacy-of-testosterone-for-women" target="_blank"><u>review of 36 randomized trials</u></a> involving 8,480 participants found that testosterone treatment delivered with skin patches was associated with 0.85 additional satisfying sexual events per month in postmenopausal women, compared to a placebo. This observed effect is not huge, <a href="https://medschool.cuanschutz.edu/ob-gyn/divisions/division-of-reproductive-sciences/our-faculty/nanette-santoro-md" target="_blank"><u>Dr. Nanette Santoro</u></a>, a professor of obstetrics and gynecology at the University of Colorado School of Medicine, told Live Science in an email. </p><div><blockquote><p>Of all the studies done to date, if there was a screaming benefit, you think you would have seen it.</p><p>Susan Davis, head of the Women's Health Research Program at Monash University</p></blockquote></div><p>Lately, anecdotal accounts of postmenopausal women having "fantastic sexual awakenings" after taking testosterone have been floating around, Santoro said. But these anecdotes haven't been backed by hard data yet. "Patients are being bombarded with a tsunami of information providing them with the most sky-high expectations imaginable," she said. </p><p>Notably, testosterone is not FDA approved as a treatment for HSDD in menopause yet. A drug called flibanserin, which affects serotonin in the brain, is approved to treat HSDD for <a href="https://www.webmd.com/drugs/updates/addyi-low-sexual-desire-postmenopause" target="_blank"><u>pre- and postmenopausal women under age 65</u></a>.</p><h2 id="placebo-effects-muddy-the-data">Placebo effects muddy the data</h2><p>The <a href="https://www.livescience.com/32941-is-the-placebo-effect-real.html"><u>placebo effect</u></a> — when patients perceive an improvement in their health or well-being despite receiving a treatment with no active ingredient — can also complicate testosterone trials.</p><p>Davis said that in her patient groups, it's common for about 1 in 3 trial participants to report an improvement of their symptoms even though they are taking a placebo. <a href="https://academic.oup.com/jsm/article-abstract/6/1/175/6832512?redirectedFrom=fulltext" target="_blank"><u>Other trials have reported</u></a> similar findings in their placebo groups, with about 30% to 40% experiencing some improvement in sexual desire and satisfaction, for example.</p><p>"I wouldn't say that there is definitely not a benefit," Davis said. "It's just that a benefit has not been shown."</p><p>One study trying to address this gap is the U.K. National Institute for Health and Care Research's <a href="https://fundingawards.nihr.ac.uk/award/NIHR159538" target="_blank"><u>ESTEEM trial</u></a>. This large-scale, gold-standard trial aims to recruit hundreds of menopausal women and test whether using testosterone cream can reliably improve their quality of life. The cream will deliver testosterone through the skin and be applied to the lower abdomen and thighs. (Doctors often advise women to apply the creams in this way because those body parts are easy to hide if the treatment causes localized hair growth that the patients would prefer to conceal.)</p><p>The trial runners will track participants' symptoms linked to menopause, looking at sleep quality, memory performance, feelings of anxiousness, migraines, body mass, and overall well-being. The results of that trial are currently expected by 2028.</p><p>In the meantime, though, there isn't strong evidence that testosterone directly improves symptoms of menopause beyond HSDD. "Of all the studies done to date, if there was a screaming benefit, you think you would have seen it," Davis said.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="KsPANypL2gVudBvm6gKJ8e" name="GettyImages-1148109989-testosterone" alt="A blue and purple molecule with a few ends colored red." src="https://cdn.mos.cms.futurecdn.net/KsPANypL2gVudBvm6gKJ8e-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/KsPANypL2gVudBvm6gKJ8e-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Females' testosterone levels generally decline throughout adulthood, with a slight increase after age 60. However, there isn't a sharp dip in testosterone around the time of menopause. </span><span class="credit" itemprop="copyrightHolder">(Image credit: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><h2 id="could-taking-testosterone-for-menopause-be-harmful">Could taking testosterone for menopause be harmful? </h2><p>Testosterone treatments available in most countries are not necessarily dosed for use in female patients. Only four countries — <a href="https://www.safetyandquality.gov.au/medicine-finder/androfeme-1" target="_blank"><u>Australia</u></a>, <a href="https://pharmacorp.co.za/products/schedule-2-5/testafeme/" target="_blank"><u>South Africa</u></a>, <a href="https://www.androfeme.nz/" target="_blank"><u>New Zealand</u></a> and the <a href="https://mhraproducts4853.blob.core.windows.net/docs/6f5c86bfb5b17ab2f9f219e3ff8d0188a500e085" target="_blank"><u>United Kingdom</u></a> — have authorized a testosterone cream that's specifically formulated and dosed for women. These products differ from testosterone therapies for men in that they contain lower doses of the hormone. They are available to postmenopausal women with HSDD, specifically. </p><p>In other countries, such as the U.S., doctors are left trying to adapt medication dosed for males for their female patients, which can lead to a wide variation in dosing. And the effects of these different dosing regimens are <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6821450/" target="_blank"><u>poorly understood</u></a> for female patients. "It is not necessarily unsafe to use male preparations for women, it's just that much, much less must be used," Santoro said. </p><p>Excessive doses raise concern about unwanted masculinizing effects, such as clitoral enlargement, voice deepening, hair thinning, baldness, and rapid growth of facial and body hair, Santoro said. (These masculinizing effects might be sought after in the context of <a href="https://transcare.ucsf.edu/article/information-testosterone-hormone-therapy" target="_blank"><u>gender-affirming care for transgender men</u></a> and transmasculine people, but would often be undesirable for cisgender women.)</p><p>Additionally, the potential impacts of extra testosterone on cardiovascular health and breast cancer risk are poorly understood, Santoro noted. At lower doses, testosterone can cause mild acne, oily skin, and some increase in facial and body hair growth in postmenopausal women, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6821450/" target="_blank"><u>trials have found</u></a>; if these symptoms remain mild, they are generally considered acceptable.</p><p>Testosterone is being used off-label in the U.S., which means the "safety, efficacy and appropriate dosing for that use have not been evaluated and approved by the FDA," a spokesperson for the agency told Live Science in an email. The dosages and formulations approved for males "may differ substantially from what might be appropriate for women, whose testosterone levels and metabolic profiles are clinically distinct," the spokesperson said.</p><div  class="fancy-box"><div class="fancy_box-title">Exclusive to Live Science Pro</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/could-psilocybin-treat-brain-injuries-neuroscientist-explains-how-psychedelics-could-fill-a-gap-in-head-trauma-care">Could psilocybin treat brain injuries? Neuroscientist explains how psychedelics could fill a gap in head trauma care</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/human-behavior/adversity-shaped-our-evolution-as-a-species-people-raised-in-it-may-have-underrecognized-strengths-because-of-it">Adversity shaped our evolution as a species. People raised in it may have underrecognized strengths because of it.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/the-right-diagnosis-is-unbelievably-powerful-it-can-take-years-to-diagnose-rare-diseases-and-scientists-are-trying-to-fix-that">'The right diagnosis is unbelievably powerful': It can take years to diagnose rare diseases, and scientists are trying to fix that</a></li></ul></p></div></div><p>Anecdotally, Santoro encountered one female patient who had received very high levels of testosterone through an implant placed under the skin, which had been prescribed to her by a different doctor. She started losing her hair and seeing sizable growth in her clitoris, while her breasts started "shrinking away." </p><p>"Women are being prescribed some very big doses in North America, and no one studied the safety of these," Santoro said. </p><p>At the end of the day, Davis argues that women deserve to be given accurate information, given that navigating menopause can already feel like "swimming through wet cement." Good menopause care not only involves discussing potential pharmacological treatments, but also evaluating a patient's lifestyle, such as diet and exercise, and discussing societal pressures that often affect menopausal people. For instance, they may face pressure to maintain an active sex life and younger-looking physique.</p><p>When it comes to hyped therapies like testosterone, she said, "just be cautious about people who tell you they've got the answer that no one else has got."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><em><strong>Help us improve Live Science Pro: </strong></em><em>We're always trying to make our content better. </em><a href="https://docs.google.com/forms/d/e/1FAIpQLSdDw0lKmNB5K8lPZ6c0ZcehXoymQKSePP3YViEqSw7P0P2O5g/viewform" target="_blank"><u><em>Leave us feedback about Pro here</em></u></a><em>.</em></p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Chronic back pain may activate an unexpected brain network, study finds ]]></title>
                                                                                                <dc:content><![CDATA[ <p>For people with chronic back pain, everyday movements like bending down to tie their shoes or picking up a grocery bag can trigger painful flare-ups. Now, scientists have made a surprising discovery: These episodes may activate a brain network that's associated with our sense of self.</p><p>In a new study, the researchers found that movement-induced chronic back pain was tied to increased activity in the brain's <a href="https://www.annualreviews.org/content/journals/10.1146/annurev-neuro-071013-014030" target="_blank"><u>default mode network</u></a>, a group of connected brain regions that lights up during self-reflection and mind wandering. This finding was unexpected because the network typically becomes less active during acute pain, such as transient pain triggered from touching a hot stove or banging your knee on a table.</p><p>The new study, published Oct. 5 in the <a href="https://doi.org/10.1016/j.bja.2026.08.010" target="_blank"><u>British Journal of Anaesthesia</u></a>, suggests that chronic-pain flare-ups may involve brain processes beyond those responsible for detecting painful sensations.</p><h2 id="how-the-brain-responds-to-chronic-pain">How the brain responds to chronic pain</h2><p><a href="https://www.who.int/news-room/fact-sheets/detail/low-back-pain" target="_blank"><u>Chronic lower back pain</u></a>, defined as lasting at least three months, is a leading cause of disability worldwide. It's thought that when chronic pain first begins, a network of regions in the brain called the "<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10672144/" target="_blank"><u>pain neuromatrix</u></a>" becomes sensitized so that the pain persists even after the painful stimulus is gone. Although scientists know that chronic pain is associated with <a href="https://www.mdpi.com/1422-0067/20/13/3130" target="_blank"><u>changes in brain activity</u></a>, they don't fully understand what happens when movements trigger sudden increases in that ongoing pain.</p><p>To investigate, researchers recruited 114 adults with chronic lower back pain and used functional magnetic resonance imaging (fMRI) to examine their brain activity. fMRI measures changes in blood flow, which acts as an indirect measure of brain activity. </p><p>After an initial scan, a researcher helped lift each participant's leg until their back pain increased, held it in position for 10 seconds, and then lowered it. The researchers scanned the participants' brains immediately after this pain-inducing leg movement  and compared the results with scans collected beforehand. On average, the test increased the participants' reported pain intensity by 23%.</p><p>As expected, during the leg movement, the researchers observed increased blood flow in brain regions involved in processing pain and movement. But they also detected increased activity in key regions of the default mode network, which typically becomes more active when a person is thinking about themselves or their autobiographical memories or just letting their mind wander.</p><div><blockquote><p>We expected it to be deactivated to the point that we had to triple-check our work to make sure that the results were legit.</p><p>Fadel Zeidan, neuroscientist at UC San Diego</p></blockquote></div><p>Acute pain lowers activity in the default mode network, <a href="https://www.annualreviews.org/content/journals/10.1146/annurev-neuro-071013-014030" target="_blank"><u>studies show</u></a>, presumably because it induces an awareness of something separate from yourself.</p><p>"When we saw just the first round of analysis, we're like, 'Did we do it right?'" study co-author <a href="https://profiles.ucsd.edu/morgan.gianola" target="_blank"><u>Morgan Gianola</u></a>, a postdoctoral scholar at the University of California, San Diego, told Live Science. </p><p>"We did not expect [the default mode network] to be involved at all," said study co-author <a href="https://www.zeidanlab.com/" target="_blank"><u>Fadel Zeidan</u></a>, a neuroscientist at UC San Diego, told Live Science. "We expected it to be deactivated to the point that we had to triple-check our work to make sure that the results were legit."</p><p>The researchers also exposed participants' calves to painful heat ‪—‬ a common method of <a href="https://journals.lww.com/pain/fulltext/10.1016/j.pain.2009.11.008~exploring-the-brain-in-pain-activations-deactivations-and" target="_blank"><u>studying brain activity during acute pain</u></a>. Unlike the movement-induced back pain, the heat was associated with reduced activity in part of the default mode network, suggesting a different mechanism was at play.</p><h2 id="when-pain-becomes-part-of-our-internal-experience">When pain becomes part of our internal experience</h2><p>Participants who reported more severe chronic back pain had stronger connectivity between the default mode network and brain regions that process sensations from the back. This suggests that chronic pain may become intertwined with how people perceive themselves and their bodies, the study authors concluded.</p><p>"This pain flare has almost become a part of who they are from an egocentric perspective," Zeidan said.</p><p><a href="https://medschool.duke.edu/profile/katherine-martucci" target="_blank"><u>Katherine Martucci</u></a>, a neuroscientist at Duke University who wasn't involved in the study, praised the experimental design, noting that researchers typically avoid movement during brain scans because it can interfere with the clarity of the scan. This study "nicely gets around" that problem by taking scans before and after the painful motion, Martucci told Live Science in an email.</p><p>However, she noted that the observed brain activity could also reflect lingering pain or anxiety following the painful leg raise. In addition, the study couldn't determine whether the altered brain activity observed contributes to chronic pain or develops in response to it.</p><p>Nonetheless, Zeidan and colleagues think the findings could eventually inform future treatments for chronic pain. The therapies might address how people relate to their pain, rather than solely targeting the painful sensations themselves. Zeidan, who coincidentally developed chronic back pain while conducting the study, believes that people's past experiences and memories with chronic pain have influenced their brain processes to a point where the pain itself becomes part of who they are.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/pain-lasts-longer-in-women-and-immune-cells-may-the-culprit">Pain lasts longer in women, and immune cells may be the culprit</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/brain-signals-underlying-chronic-pain-could-be-short-circuited-study-suggests">Brain signals underlying chronic pain could be 'short-circuited,' study suggests</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/mental-effort-physical-pain-trade-off.html">People sometimes prefer burning hot pain to thinking too hard</a></li></ul></p></div></div><p>Zeidan's team is now investigating whether existing approaches, such as <a href="https://link.springer.com/article/10.1007/s44202-025-00525-2" target="_blank"><u>mindfulness meditation</u></a> or <a href="https://link.springer.com/article/10.1007/s40122-018-0099-4" target="_blank"><u>cognitive behavioral therapy</u></a>, can influence the default mode network and help relieve chronic pain. (Cognitive behavior therapy for chronic pain, or CBT-CP, is already a <a href="https://pain.ucsf.edu/nonpharmacological-pain-management/cognitive-behavioral-therapy-cbt" target="_blank"><u>well-established treatment option</u></a>.)</p><p>Martucci cautioned that it's too early to draw conclusions about how these results might be applied in clinical practice. But she said the current findings provide important evidence of how the brain responds to chronic pain flare-ups.</p><p>"They do provide solid data on how people with chronic low back pain show important changes in their brain responses after a condition provoking their pain," she said. "The brain imaging data validate their [the participants'] experience of pain in an important and very visible way."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/neuroscience/chronic-back-pain-may-activate-an-unexpected-brain-network-study-finds</link>
                                                                            <description>
                            <![CDATA[ Movement-induced flares in chronic back pain activate brain regions involved in self-reflection, suggesting chronic pain may be processed differently than acute pain. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">zPRBusBiPZUCxK6PgoNTVj</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/bEUAXNaWDdkpcKGUxCfcpT-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 14 Oct 2026 20:35:40 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Neuroscience]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Jennifer Zieba ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mDePcdwvrQtQojqXJtfezd-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/bEUAXNaWDdkpcKGUxCfcpT-1920-80.jpg">
                                                            <media:credit><![CDATA[Curly_photo via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[A new study finds a surprising connection between chronic back pain and the brain&amp;#39;s default mode network.]]></media:description>                                                            <media:text><![CDATA[A silhouette of a person holding their side with a red light where their hand is touching their lower side.]]></media:text>
                                <media:title type="plain"><![CDATA[A silhouette of a person holding their side with a red light where their hand is touching their lower side.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/bEUAXNaWDdkpcKGUxCfcpT-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>For people with chronic back pain, everyday movements like bending down to tie their shoes or picking up a grocery bag can trigger painful flare-ups. Now, scientists have made a surprising discovery: These episodes may activate a brain network that's associated with our sense of self.</p><p>In a new study, the researchers found that movement-induced chronic back pain was tied to increased activity in the brain's <a href="https://www.annualreviews.org/content/journals/10.1146/annurev-neuro-071013-014030" target="_blank"><u>default mode network</u></a>, a group of connected brain regions that lights up during self-reflection and mind wandering. This finding was unexpected because the network typically becomes less active during acute pain, such as transient pain triggered from touching a hot stove or banging your knee on a table.</p><p>The new study, published Oct. 5 in the <a href="https://doi.org/10.1016/j.bja.2026.08.010" target="_blank"><u>British Journal of Anaesthesia</u></a>, suggests that chronic-pain flare-ups may involve brain processes beyond those responsible for detecting painful sensations.</p><h2 id="how-the-brain-responds-to-chronic-pain">How the brain responds to chronic pain</h2><p><a href="https://www.who.int/news-room/fact-sheets/detail/low-back-pain" target="_blank"><u>Chronic lower back pain</u></a>, defined as lasting at least three months, is a leading cause of disability worldwide. It's thought that when chronic pain first begins, a network of regions in the brain called the "<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10672144/" target="_blank"><u>pain neuromatrix</u></a>" becomes sensitized so that the pain persists even after the painful stimulus is gone. Although scientists know that chronic pain is associated with <a href="https://www.mdpi.com/1422-0067/20/13/3130" target="_blank"><u>changes in brain activity</u></a>, they don't fully understand what happens when movements trigger sudden increases in that ongoing pain.</p><p>To investigate, researchers recruited 114 adults with chronic lower back pain and used functional magnetic resonance imaging (fMRI) to examine their brain activity. fMRI measures changes in blood flow, which acts as an indirect measure of brain activity. </p><p>After an initial scan, a researcher helped lift each participant's leg until their back pain increased, held it in position for 10 seconds, and then lowered it. The researchers scanned the participants' brains immediately after this pain-inducing leg movement  and compared the results with scans collected beforehand. On average, the test increased the participants' reported pain intensity by 23%.</p><p>As expected, during the leg movement, the researchers observed increased blood flow in brain regions involved in processing pain and movement. But they also detected increased activity in key regions of the default mode network, which typically becomes more active when a person is thinking about themselves or their autobiographical memories or just letting their mind wander.</p><div><blockquote><p>We expected it to be deactivated to the point that we had to triple-check our work to make sure that the results were legit.</p><p>Fadel Zeidan, neuroscientist at UC San Diego</p></blockquote></div><p>Acute pain lowers activity in the default mode network, <a href="https://www.annualreviews.org/content/journals/10.1146/annurev-neuro-071013-014030" target="_blank"><u>studies show</u></a>, presumably because it induces an awareness of something separate from yourself.</p><p>"When we saw just the first round of analysis, we're like, 'Did we do it right?'" study co-author <a href="https://profiles.ucsd.edu/morgan.gianola" target="_blank"><u>Morgan Gianola</u></a>, a postdoctoral scholar at the University of California, San Diego, told Live Science. </p><p>"We did not expect [the default mode network] to be involved at all," said study co-author <a href="https://www.zeidanlab.com/" target="_blank"><u>Fadel Zeidan</u></a>, a neuroscientist at UC San Diego, told Live Science. "We expected it to be deactivated to the point that we had to triple-check our work to make sure that the results were legit."</p><p>The researchers also exposed participants' calves to painful heat ‪—‬ a common method of <a href="https://journals.lww.com/pain/fulltext/10.1016/j.pain.2009.11.008~exploring-the-brain-in-pain-activations-deactivations-and" target="_blank"><u>studying brain activity during acute pain</u></a>. Unlike the movement-induced back pain, the heat was associated with reduced activity in part of the default mode network, suggesting a different mechanism was at play.</p><h2 id="when-pain-becomes-part-of-our-internal-experience">When pain becomes part of our internal experience</h2><p>Participants who reported more severe chronic back pain had stronger connectivity between the default mode network and brain regions that process sensations from the back. This suggests that chronic pain may become intertwined with how people perceive themselves and their bodies, the study authors concluded.</p><p>"This pain flare has almost become a part of who they are from an egocentric perspective," Zeidan said.</p><p><a href="https://medschool.duke.edu/profile/katherine-martucci" target="_blank"><u>Katherine Martucci</u></a>, a neuroscientist at Duke University who wasn't involved in the study, praised the experimental design, noting that researchers typically avoid movement during brain scans because it can interfere with the clarity of the scan. This study "nicely gets around" that problem by taking scans before and after the painful motion, Martucci told Live Science in an email.</p><p>However, she noted that the observed brain activity could also reflect lingering pain or anxiety following the painful leg raise. In addition, the study couldn't determine whether the altered brain activity observed contributes to chronic pain or develops in response to it.</p><p>Nonetheless, Zeidan and colleagues think the findings could eventually inform future treatments for chronic pain. The therapies might address how people relate to their pain, rather than solely targeting the painful sensations themselves. Zeidan, who coincidentally developed chronic back pain while conducting the study, believes that people's past experiences and memories with chronic pain have influenced their brain processes to a point where the pain itself becomes part of who they are.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/pain-lasts-longer-in-women-and-immune-cells-may-the-culprit">Pain lasts longer in women, and immune cells may be the culprit</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/brain-signals-underlying-chronic-pain-could-be-short-circuited-study-suggests">Brain signals underlying chronic pain could be 'short-circuited,' study suggests</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/mental-effort-physical-pain-trade-off.html">People sometimes prefer burning hot pain to thinking too hard</a></li></ul></p></div></div><p>Zeidan's team is now investigating whether existing approaches, such as <a href="https://link.springer.com/article/10.1007/s44202-025-00525-2" target="_blank"><u>mindfulness meditation</u></a> or <a href="https://link.springer.com/article/10.1007/s40122-018-0099-4" target="_blank"><u>cognitive behavioral therapy</u></a>, can influence the default mode network and help relieve chronic pain. (Cognitive behavior therapy for chronic pain, or CBT-CP, is already a <a href="https://pain.ucsf.edu/nonpharmacological-pain-management/cognitive-behavioral-therapy-cbt" target="_blank"><u>well-established treatment option</u></a>.)</p><p>Martucci cautioned that it's too early to draw conclusions about how these results might be applied in clinical practice. But she said the current findings provide important evidence of how the brain responds to chronic pain flare-ups.</p><p>"They do provide solid data on how people with chronic low back pain show important changes in their brain responses after a condition provoking their pain," she said. "The brain imaging data validate their [the participants'] experience of pain in an important and very visible way."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Tapeworm drug could help treat endometriosis, mouse study hints ]]></title>
                                                                                                <dc:content><![CDATA[ <p>A modified tapeworm medication could be a promising new treatment for endometriosis, an early study in mice hints. </p><p>In <a href="https://www.livescience.com/health/reproductive-health/endometriosis-messes-with-the-immune-system-and-causes-ripple-effects-across-the-body"><u>endometriosis</u></a>, tissue similar to the lining of the uterus grows outside the organ, and these patches of tissue, called "lesions," trigger painful inflammation and heavy menstrual bleeding. In the new study, scientists fitted an anti-worm drug with nanotech armor, and it directly targeted these painful lesions in laboratory mice. </p><p>The treatment reduced inflammation and slowed or prevented further spread of the lesions, researchers reported in August in the journal<a href="https://advanced.onlinelibrary.wiley.com/doi/10.1002/adhm.71661" target="_blank"> <u>Advanced Healthcare Materials</u></a>. The team is already working on bringing the new drug to clinical trials and hopes this will bring fresh attention to an understudied disease with limited treatment options.</p><h2 id="rogue-immune-cells-are-a-promising-drug-target">Rogue immune cells are a promising drug target</h2><p>Endometriosis is a chronic, hormone-driven condition that affects roughly <a href="https://www.nejm.org/doi/10.1056/NEJMra1810764" target="_blank"><u>10% of reproductive-age females</u></a> ‪—‬ an estimated 190 million individuals worldwide. "The main symptoms are chronic pelvic pain and infertility," said<a href="https://www.research.ed.ac.uk/en/persons/ioannis-simitsidellis/publications/" target="_blank"> <u>Ioannis Simitsidellis</u></a>, a postdoctoral researcher at the University of Edinburgh's Centres for Reproductive Health and Inflammation Research, who wasn't involved in the study.</p><p>There is currently no cure, so existing treatments aim to alleviate the symptoms. Hormonal medications can stall the menstrual cycle to limit the growth and inflammation of the lesions, while surgery can physically remove lesions. However, the former can come with side effects, such as nausea and mood swings, and lesions often regrow after surgery. So additional options are needed.</p><p><a href="https://www.nature.com/articles/s42003-022-04211-0" target="_blank"><u>In previous research with mice</u></a>, study co-author<a href="https://vetmed.wsu.edu/our-team/wsu-profile/k.hayashi/" target="_blank"> <u>Kanako Hayashi</u></a>, a professor in the Washington State University School of Molecular Biosciences, identified a group of rogue immune cells specific to endometrial lesion tissue. These cells turbocharged the painful inflammatory reactions and drove the growth of more of this problematic tissue.</p><p>The cells also happen to have a unique chemical label, called a folate receptor, which makes them an excellent potential drug target. But why start from scratch when there's an existing medication that might do the trick?</p><p>Enter niclosamide, a drug approved by the Food and Drug Administration to treat tapeworm infections. In recent years, clinicians have been exploring whether this medicine could also prove effective for other conditions, ranging from cancer to Parkinson's disease. </p><div><blockquote><p>The drug is attached in such a way that when it is in systemic circulation, nothing happens until it goes inside the diseased cells.</p><p>Anjali Sharma, nanomedicine specialist at the University of Michigan</p></blockquote></div><p>"We have reported that niclosamide inhibits endometriosis progression, suppressing the inflammatory mechanisms and cytokine secretions," said Hayashi,<a href="https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202002541RRR" target="_blank"> <u>referencing more of the group's past work</u></a> in mice. However, several issues made the drug impractical: It doesn't dissolve well in water, last long in the body, or target the cells where it's needed most.</p><p>So the researchers teamed up with<a href="https://pharmacy.umich.edu/people/sharma-anjali/" target="_blank"> <u>Anjali Sharma</u></a>, a nanomedicine specialist at the University of Michigan, to tweak the drug's structure. Using click chemistry — a simple reaction that bolts together two chemical building blocks — Sharma attached the niclosamide unit to a large, tree-like molecule called a dendrimer. This helped the drug dissolve better in blood. </p><p>She then added a folate group, which ensured that the modified medication would only target the rogue immune cells with the complementary receptor. </p><p>"The drug is attached in such a way that when it is in systemic circulation, nothing happens until it goes inside the diseased cells," Sharma said. Once there, it is slowly released inside the cell over a period of two weeks. "Basically, the dendrimer is like the Uber, the folate is like the GPS, and the drug is like the passenger," she explained.</p><h2 id="the-next-steps">The next steps</h2><p>With these practical issues resolved, the team tested the modified drug in a mouse model, which mimics the lesions seen in endometriosis in humans. Scans of the mice showed that the treatment directly zeroed in on the affected endometrial tissue and didn't accumulate in other organs, like the liver. </p><p>Treating mice with a single injection dramatically reduced their pain symptoms, compared with untreated mice. It also slowed ‪—‬ or, in some cases, entirely halted ‪—‬ the growth of new lesions.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/fertility-pregnancy-birth/endometriosis-may-quadruple-risk-of-ovarian-cancer-study-finds">Endometriosis may quadruple risk of ovarian cancer, study finds</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/fertility-pregnancy-birth/migraine-molecules-may-drive-endometriosis-pain-existing-drugs-might-help">Migraine molecules may drive endometriosis pain. Existing drugs might help.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/endometriosis-and-gut-disorders-have-a-genetic-link">Endometriosis and gut disorders have a genetic link</a></li></ul></p></div></div><p>Because mice don't naturally menstruate or develop endometriosis, there is still significant work to do before these findings can be replicated in humans. But for now, the study is a promising stepping stone for future research, Simitsidellis said. </p><p>"There's a lot of potential in repurposing of drugs that have been tested in clinical trials to see if they would be effective in endometriosis ‪—‬ for example, targeting inflammation or immune cell dysfunction," he told Live Science. "The next steps would be to replicate on larger sample sizes and, if that's promising, do a phase one clinical trial in humans." That initial trial would test the treatment's safety in patients, while later trials would look at its effectiveness for endometriosis. </p><p>Even at this early stage, though, patients are clamoring to get involved in the upcoming research. Hayashi and Sharma have received hundreds of emails asking to join a future trial. </p><p>"They are really suffering," Hayashi said. "Endometriosis is an understudied, underacknowledged, underfunded disease, but hopefully we can make this a solution in the near future."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/reproductive-health/tapeworm-drug-could-help-treat-endometriosis-mouse-study-hints</link>
                                                                            <description>
                            <![CDATA[ A recent study in mice hints that a modified tapeworm medicine might help relieve painful lesions seen in endometriosis. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">7Kk5xjd7EureUfSZicNt9J</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/mjMHs9nr3Esa8zRzgmYFsd-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 14 Oct 2026 19:34:46 +0000</pubDate>                                                                                                                                                                                                                                <category><![CDATA[Reproductive Health]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Victoria Atkinson ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/myPb7j2m9WcKXy9W9CXaxZ-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/mjMHs9nr3Esa8zRzgmYFsd-1920-80.jpg">
                                                            <media:credit><![CDATA[Grace Cary via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[In endometriosis, painful lesions grow outside the uterus and cause inflammation.]]></media:description>                                                            <media:text><![CDATA[A woman wearing black and a brown sweater clutches her abdomen]]></media:text>
                                <media:title type="plain"><![CDATA[A woman wearing black and a brown sweater clutches her abdomen]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/mjMHs9nr3Esa8zRzgmYFsd-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>A modified tapeworm medication could be a promising new treatment for endometriosis, an early study in mice hints. </p><p>In <a href="https://www.livescience.com/health/reproductive-health/endometriosis-messes-with-the-immune-system-and-causes-ripple-effects-across-the-body"><u>endometriosis</u></a>, tissue similar to the lining of the uterus grows outside the organ, and these patches of tissue, called "lesions," trigger painful inflammation and heavy menstrual bleeding. In the new study, scientists fitted an anti-worm drug with nanotech armor, and it directly targeted these painful lesions in laboratory mice. </p><p>The treatment reduced inflammation and slowed or prevented further spread of the lesions, researchers reported in August in the journal<a href="https://advanced.onlinelibrary.wiley.com/doi/10.1002/adhm.71661" target="_blank"> <u>Advanced Healthcare Materials</u></a>. The team is already working on bringing the new drug to clinical trials and hopes this will bring fresh attention to an understudied disease with limited treatment options.</p><h2 id="rogue-immune-cells-are-a-promising-drug-target">Rogue immune cells are a promising drug target</h2><p>Endometriosis is a chronic, hormone-driven condition that affects roughly <a href="https://www.nejm.org/doi/10.1056/NEJMra1810764" target="_blank"><u>10% of reproductive-age females</u></a> ‪—‬ an estimated 190 million individuals worldwide. "The main symptoms are chronic pelvic pain and infertility," said<a href="https://www.research.ed.ac.uk/en/persons/ioannis-simitsidellis/publications/" target="_blank"> <u>Ioannis Simitsidellis</u></a>, a postdoctoral researcher at the University of Edinburgh's Centres for Reproductive Health and Inflammation Research, who wasn't involved in the study.</p><p>There is currently no cure, so existing treatments aim to alleviate the symptoms. Hormonal medications can stall the menstrual cycle to limit the growth and inflammation of the lesions, while surgery can physically remove lesions. However, the former can come with side effects, such as nausea and mood swings, and lesions often regrow after surgery. So additional options are needed.</p><p><a href="https://www.nature.com/articles/s42003-022-04211-0" target="_blank"><u>In previous research with mice</u></a>, study co-author<a href="https://vetmed.wsu.edu/our-team/wsu-profile/k.hayashi/" target="_blank"> <u>Kanako Hayashi</u></a>, a professor in the Washington State University School of Molecular Biosciences, identified a group of rogue immune cells specific to endometrial lesion tissue. These cells turbocharged the painful inflammatory reactions and drove the growth of more of this problematic tissue.</p><p>The cells also happen to have a unique chemical label, called a folate receptor, which makes them an excellent potential drug target. But why start from scratch when there's an existing medication that might do the trick?</p><p>Enter niclosamide, a drug approved by the Food and Drug Administration to treat tapeworm infections. In recent years, clinicians have been exploring whether this medicine could also prove effective for other conditions, ranging from cancer to Parkinson's disease. </p><div><blockquote><p>The drug is attached in such a way that when it is in systemic circulation, nothing happens until it goes inside the diseased cells.</p><p>Anjali Sharma, nanomedicine specialist at the University of Michigan</p></blockquote></div><p>"We have reported that niclosamide inhibits endometriosis progression, suppressing the inflammatory mechanisms and cytokine secretions," said Hayashi,<a href="https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202002541RRR" target="_blank"> <u>referencing more of the group's past work</u></a> in mice. However, several issues made the drug impractical: It doesn't dissolve well in water, last long in the body, or target the cells where it's needed most.</p><p>So the researchers teamed up with<a href="https://pharmacy.umich.edu/people/sharma-anjali/" target="_blank"> <u>Anjali Sharma</u></a>, a nanomedicine specialist at the University of Michigan, to tweak the drug's structure. Using click chemistry — a simple reaction that bolts together two chemical building blocks — Sharma attached the niclosamide unit to a large, tree-like molecule called a dendrimer. This helped the drug dissolve better in blood. </p><p>She then added a folate group, which ensured that the modified medication would only target the rogue immune cells with the complementary receptor. </p><p>"The drug is attached in such a way that when it is in systemic circulation, nothing happens until it goes inside the diseased cells," Sharma said. Once there, it is slowly released inside the cell over a period of two weeks. "Basically, the dendrimer is like the Uber, the folate is like the GPS, and the drug is like the passenger," she explained.</p><h2 id="the-next-steps">The next steps</h2><p>With these practical issues resolved, the team tested the modified drug in a mouse model, which mimics the lesions seen in endometriosis in humans. Scans of the mice showed that the treatment directly zeroed in on the affected endometrial tissue and didn't accumulate in other organs, like the liver. </p><p>Treating mice with a single injection dramatically reduced their pain symptoms, compared with untreated mice. It also slowed ‪—‬ or, in some cases, entirely halted ‪—‬ the growth of new lesions.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/fertility-pregnancy-birth/endometriosis-may-quadruple-risk-of-ovarian-cancer-study-finds">Endometriosis may quadruple risk of ovarian cancer, study finds</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/fertility-pregnancy-birth/migraine-molecules-may-drive-endometriosis-pain-existing-drugs-might-help">Migraine molecules may drive endometriosis pain. Existing drugs might help.</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/endometriosis-and-gut-disorders-have-a-genetic-link">Endometriosis and gut disorders have a genetic link</a></li></ul></p></div></div><p>Because mice don't naturally menstruate or develop endometriosis, there is still significant work to do before these findings can be replicated in humans. But for now, the study is a promising stepping stone for future research, Simitsidellis said. </p><p>"There's a lot of potential in repurposing of drugs that have been tested in clinical trials to see if they would be effective in endometriosis ‪—‬ for example, targeting inflammation or immune cell dysfunction," he told Live Science. "The next steps would be to replicate on larger sample sizes and, if that's promising, do a phase one clinical trial in humans." That initial trial would test the treatment's safety in patients, while later trials would look at its effectiveness for endometriosis. </p><p>Even at this early stage, though, patients are clamoring to get involved in the upcoming research. Hayashi and Sharma have received hundreds of emails asking to join a future trial. </p><p>"They are really suffering," Hayashi said. "Endometriosis is an understudied, underacknowledged, underfunded disease, but hopefully we can make this a solution in the near future."</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Teenager's rare autoimmune disorder caused her to hallucinate a flying green dinosaur ]]></title>
                                                                                                <dc:content><![CDATA[ <p><strong>The patient: </strong>A 16-year-old girl in California</p><p><strong>The symptoms: </strong>The teenager was referred to an emergency department because she was having hallucinations, including seeing a flying green dinosaur and hearing voices telling her to hurt others. She also had a sense that she was being followed.</p><p>In the emergency room, she was trembling and sweating and had a racing pulse and shallow, fast breathing. She did not have a fever, although she did have one at the hospital that had referred her.</p><p>During her conversations with ER clinicians, the teen reacted to the vision of the dinosaur as though the creature were present in the room. She reported that she had experienced these hallucinations since seventh grade,‬ so for about four years.</p><p>While her parents countered that she hadn’t exhibited psychotic symptoms until 48 hours before they arrived in the ER, they noted that her interest in school and extracurriculars had waned over the past month.</p><p><strong>What happened next: </strong>Because of the patient's abnormal vital signs, the ER doctors suspected that her hallucinations might be secondary to some physical ailment, such as trauma to the brain, they wrote in a <a href="https://doi.org/10.5811/cpcem.48533" target="_blank"><u>case report</u></a>. However, a CT scan showed no signs of swelling or hemorrhage in her head. The doctors attempted a lumbar puncture (also called a spinal tap) but failed to collect any cerebrospinal fluid that they could test for irregularities.</p><p>The doctors judged the girl to be too medically unstable to be referred to the hospital's psychiatric ward, so she was admitted to the general pediatric department. Pediatric neurologists suggested an electroencephalogram (EEG), a test that measures electric signaling in the brain, but this revealed no further clues.</p><p>On her second day in the hospital, the girl entered a complete <a href="https://doi.org/10.1016/S2215-0366(18)30474-7" target="_blank"><u>catatonic state</u></a>. Her specific symptoms were not described in the report, but in general, catatonia disrupts how a person processes and reacts to the world around them. Catatonic patients often stop moving and speaking. Doctors treated the patient with <a href="https://www.ncbi.nlm.nih.gov/books/NBK532890/" target="_blank"><u>lorazepam</u></a>, which slows down nervous-system signaling, and her catatonia subsided in days.</p><p>Meanwhile, interventional radiologists performed a successful second lumbar puncture, but the girl's cerebrospinal fluid appeared normal in the initial panels they ran.</p><p>After the patient had spent eight days in the hospital, psychiatrists recommended that the girl be transferred to their ward. However, this was not possible because she developed problems with feeding herself. Her continued psychotic symptoms were treated with the antipsychotic drug olanzapine.</p><p><strong>The diagnosis:</strong> While initial tests of the girl's cerebrospinal fluid did not show signs of <a href="https://my.clevelandclinic.org/health/diseases/14600-meningitis" target="_blank"><u>meningitis</u></a> or other abnormalities, a later test came back positive for autoantibodies — immune proteins that target healthy tissues instead of foreign invaders. These antibodies targeted <a href="https://doi.org/10.1101/cshperspect.a018309" target="_blank"><u>neuronal intermediate filament</u></a> (NIF), a protein that helps give nerve cells structural support.</p><p>Based on this finding, the patient was diagnosed with <a href="https://doi.org/10.1038/s41572-025-00650-1" target="_blank"><u>autoimmune encephalitis</u></a>, a condition in which the body produces antibodies that attack nervous tissue, leading to harmful inflammation that can cause psychiatric symptoms.</p><p>Autoimmune encephalitis is often <a href="https://autoimmune-encephalitis.org/2023/11/28/connection-cancer-autoimmune-encephalitis/" target="_blank"><u>triggered by a tumor</u></a>; proteins produced by the growth can resemble proteins within nervous tissue, and the immune system develops a harmful response against the latter while attempting to fight the tumor. The doctors performed MRIs and a PET scan to look for tumors, but they did not find any.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1751px;"><p class="vanilla-image-block" style="padding-top:61.68%;"><img id="4pjUby5wCXoizooZXEhWA8" name="shutterstock_677357518.jpg" alt="Illustration of Y shaped antibody proteins" src="https://cdn.mos.cms.futurecdn.net/4pjUby5wCXoizooZXEhWA8-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1751" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/4pjUby5wCXoizooZXEhWA8-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The girl was diagnosed with autoimmune encephalitis, a condition in which antibodies attacked her own nervous tissue. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Shutterstock)</span></figcaption></figure><p><strong>The treatment: </strong>The girl received intravenous infusions of a steroid to reduce inflammation, as well as <a href="https://doi.org/10.1002/acn3.51540" target="_blank"><u>immunoglobulin</u></a> — antibodies from healthy donors that are often used to calm autoimmune reactions. She also got an infusion of<strong> </strong><a href="https://doi.org/10.1016/j.heliyon.2025.e41747" target="_blank"><u>rituximab</u></a>, a drug that kills B lymphocytes, a type of white blood cell that makes antibodies like the ones attacking the girl's neurons.</p><p>In addition to these infusions, the girl underwent five sessions of <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plasmapheresis" target="_blank"><u>plasmapheresis</u></a> over the next month. In that procedure, blood is drawn from the body, a machine separates plasma (the liquid portion of blood) from blood cells, and the extracted plasma is substituted with a replacement fluid before that blood is returned to the patient. This treatment can help rid the body of autoantibodies.</p><p>The girl was discharged after having spent almost two months in the hospital. She was treated with ongoing prescriptions of olanzapine and lorazepam, as well as prednisone and monthly immunoglobulin treatments. As her symptoms improved over the following year, she stopped taking the psychiatric drugs but continued her immunotherapy.</p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-womans-5-year-struggle-with-balance-and-walking-was-caused-by-a-one-in-a-million-disorder">Woman's 5-year struggle with balance and walking was caused by a 'one-in-a-million' disorder</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-a-mans-sudden-fainting-episodes-landed-him-in-the-hospital-and-a-hair-dye-was-to-blame">A man's sudden fainting episodes landed him in the hospital — and a hair dye was to blame</a></li></ul></p></div></div><p><strong>What makes the case unique: </strong>Autoimmune encephalitis is rare. One study conducted in the U.K. suggests it affects <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3810913/" target="_blank"><u>only 5 to 8 out of every 100,000 people</u></a>. Additionally, most data about the condition in pediatric patients comes from cases caused by autoantibodies that target NMDA receptors, which detect a key chemical messenger in the brain, rather than NIF.</p><p>The case report did not name a specific trigger for the girl's condition, but the authors noted that anti-NIF autoimmune encephalitis has been <a href="https://doi.org/10.1002/acn3.51284" target="_blank"><u>documented in adults</u></a> following infections, including certain tick-borne bacterial infections, HIV and <a href="https://doi.org/10.1212/01.wnl.0000903252.71277.22" target="_blank"><u>COVID-19</u></a>. Cases associated with these infections are rarer than those linked to tumors.</p><p>The doctors did not attribute the teen's case to a specific infection, but her family did report that she'd had a cough three weeks before going to the emergency room. The family had visited the Philippines, and the girl and multiple relatives came down with the same illness.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/immune-system/diagnostic-dilemma-teenagers-rare-autoimmune-disorder-caused-her-to-hallucinate-a-flying-green-dinosaur</link>
                                                                            <description>
                            <![CDATA[ Doctors ran many tests to uncover the cause of a teen girl's auditory and visual hallucinations. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">hSo3kf4isLWTT9nqn4EBz7</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/JJKXYKcSLjZPyqFfUhGxvX-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Wed, 14 Oct 2026 10:00:00 +0000</pubDate>                                                                                                                                <updated>Wed, 14 Oct 2026 19:05:25 +0000</updated>
                                                                                                                                            <category><![CDATA[Immune System]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Lauren Schneider ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/5pJMPoJukHhyjB7CuxEXh4-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/JJKXYKcSLjZPyqFfUhGxvX-1920-80.jpg">
                                                            <media:credit><![CDATA[Yuriy Priymak/Stocktrek Images via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[The girl described one of her hallucinations as a &amp;quot;flying green dinosaur,&amp;quot; although the case report did not describe the hallucination in detail. ]]></media:description>                                                            <media:text><![CDATA[An illustration of a green flying dinosaur with feathered wings in a forest. ]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of a green flying dinosaur with feathered wings in a forest. ]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/JJKXYKcSLjZPyqFfUhGxvX-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p><strong>The patient: </strong>A 16-year-old girl in California</p><p><strong>The symptoms: </strong>The teenager was referred to an emergency department because she was having hallucinations, including seeing a flying green dinosaur and hearing voices telling her to hurt others. She also had a sense that she was being followed.</p><p>In the emergency room, she was trembling and sweating and had a racing pulse and shallow, fast breathing. She did not have a fever, although she did have one at the hospital that had referred her.</p><p>During her conversations with ER clinicians, the teen reacted to the vision of the dinosaur as though the creature were present in the room. She reported that she had experienced these hallucinations since seventh grade,‬ so for about four years.</p><p>While her parents countered that she hadn’t exhibited psychotic symptoms until 48 hours before they arrived in the ER, they noted that her interest in school and extracurriculars had waned over the past month.</p><p><strong>What happened next: </strong>Because of the patient's abnormal vital signs, the ER doctors suspected that her hallucinations might be secondary to some physical ailment, such as trauma to the brain, they wrote in a <a href="https://doi.org/10.5811/cpcem.48533" target="_blank"><u>case report</u></a>. However, a CT scan showed no signs of swelling or hemorrhage in her head. The doctors attempted a lumbar puncture (also called a spinal tap) but failed to collect any cerebrospinal fluid that they could test for irregularities.</p><p>The doctors judged the girl to be too medically unstable to be referred to the hospital's psychiatric ward, so she was admitted to the general pediatric department. Pediatric neurologists suggested an electroencephalogram (EEG), a test that measures electric signaling in the brain, but this revealed no further clues.</p><p>On her second day in the hospital, the girl entered a complete <a href="https://doi.org/10.1016/S2215-0366(18)30474-7" target="_blank"><u>catatonic state</u></a>. Her specific symptoms were not described in the report, but in general, catatonia disrupts how a person processes and reacts to the world around them. Catatonic patients often stop moving and speaking. Doctors treated the patient with <a href="https://www.ncbi.nlm.nih.gov/books/NBK532890/" target="_blank"><u>lorazepam</u></a>, which slows down nervous-system signaling, and her catatonia subsided in days.</p><p>Meanwhile, interventional radiologists performed a successful second lumbar puncture, but the girl's cerebrospinal fluid appeared normal in the initial panels they ran.</p><p>After the patient had spent eight days in the hospital, psychiatrists recommended that the girl be transferred to their ward. However, this was not possible because she developed problems with feeding herself. Her continued psychotic symptoms were treated with the antipsychotic drug olanzapine.</p><p><strong>The diagnosis:</strong> While initial tests of the girl's cerebrospinal fluid did not show signs of <a href="https://my.clevelandclinic.org/health/diseases/14600-meningitis" target="_blank"><u>meningitis</u></a> or other abnormalities, a later test came back positive for autoantibodies — immune proteins that target healthy tissues instead of foreign invaders. These antibodies targeted <a href="https://doi.org/10.1101/cshperspect.a018309" target="_blank"><u>neuronal intermediate filament</u></a> (NIF), a protein that helps give nerve cells structural support.</p><p>Based on this finding, the patient was diagnosed with <a href="https://doi.org/10.1038/s41572-025-00650-1" target="_blank"><u>autoimmune encephalitis</u></a>, a condition in which the body produces antibodies that attack nervous tissue, leading to harmful inflammation that can cause psychiatric symptoms.</p><p>Autoimmune encephalitis is often <a href="https://autoimmune-encephalitis.org/2023/11/28/connection-cancer-autoimmune-encephalitis/" target="_blank"><u>triggered by a tumor</u></a>; proteins produced by the growth can resemble proteins within nervous tissue, and the immune system develops a harmful response against the latter while attempting to fight the tumor. The doctors performed MRIs and a PET scan to look for tumors, but they did not find any.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1751px;"><p class="vanilla-image-block" style="padding-top:61.68%;"><img id="4pjUby5wCXoizooZXEhWA8" name="shutterstock_677357518.jpg" alt="Illustration of Y shaped antibody proteins" src="https://cdn.mos.cms.futurecdn.net/4pjUby5wCXoizooZXEhWA8-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1751" height="1080" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/4pjUby5wCXoizooZXEhWA8-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The girl was diagnosed with autoimmune encephalitis, a condition in which antibodies attacked her own nervous tissue. </span><span class="credit" itemprop="copyrightHolder">(Image credit: Shutterstock)</span></figcaption></figure><p><strong>The treatment: </strong>The girl received intravenous infusions of a steroid to reduce inflammation, as well as <a href="https://doi.org/10.1002/acn3.51540" target="_blank"><u>immunoglobulin</u></a> — antibodies from healthy donors that are often used to calm autoimmune reactions. She also got an infusion of<strong> </strong><a href="https://doi.org/10.1016/j.heliyon.2025.e41747" target="_blank"><u>rituximab</u></a>, a drug that kills B lymphocytes, a type of white blood cell that makes antibodies like the ones attacking the girl's neurons.</p><p>In addition to these infusions, the girl underwent five sessions of <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plasmapheresis" target="_blank"><u>plasmapheresis</u></a> over the next month. In that procedure, blood is drawn from the body, a machine separates plasma (the liquid portion of blood) from blood cells, and the extracted plasma is substituted with a replacement fluid before that blood is returned to the patient. This treatment can help rid the body of autoantibodies.</p><p>The girl was discharged after having spent almost two months in the hospital. She was treated with ongoing prescriptions of olanzapine and lorazepam, as well as prednisone and monthly immunoglobulin treatments. As her symptoms improved over the following year, she stopped taking the psychiatric drugs but continued her immunotherapy.</p><div  class="fancy-box"><div class="fancy_box-title">Other dilemmas</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/diagnostic-dilemma-woman-saw-dead-people-and-fired-a-gun-at-them-after-taking-too-many-aspirin">Woman 'saw dead people' and fired a gun at them after taking too many aspirin</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-womans-5-year-struggle-with-balance-and-walking-was-caused-by-a-one-in-a-million-disorder">Woman's 5-year struggle with balance and walking was caused by a 'one-in-a-million' disorder</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/diagnostic-dilemma-a-mans-sudden-fainting-episodes-landed-him-in-the-hospital-and-a-hair-dye-was-to-blame">A man's sudden fainting episodes landed him in the hospital — and a hair dye was to blame</a></li></ul></p></div></div><p><strong>What makes the case unique: </strong>Autoimmune encephalitis is rare. One study conducted in the U.K. suggests it affects <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3810913/" target="_blank"><u>only 5 to 8 out of every 100,000 people</u></a>. Additionally, most data about the condition in pediatric patients comes from cases caused by autoantibodies that target NMDA receptors, which detect a key chemical messenger in the brain, rather than NIF.</p><p>The case report did not name a specific trigger for the girl's condition, but the authors noted that anti-NIF autoimmune encephalitis has been <a href="https://doi.org/10.1002/acn3.51284" target="_blank"><u>documented in adults</u></a> following infections, including certain tick-borne bacterial infections, HIV and <a href="https://doi.org/10.1212/01.wnl.0000903252.71277.22" target="_blank"><u>COVID-19</u></a>. Cases associated with these infections are rarer than those linked to tumors.</p><p>The doctors did not attribute the teen's case to a specific infection, but her family did report that she'd had a cough three weeks before going to the emergency room. The family had visited the Philippines, and the girl and multiple relatives came down with the same illness.</p><p><em>For more intriguing medical cases, check out our </em><a href="https://www.livescience.com/tag/diagnostic-dilemma"><u><em>Diagnostic Dilemma archives</em></u></a><em>.</em></p><p>This article is for informational purposes only and is not meant to offer medical advice.</p><p><strong>Can you guess the diagnosis in these strange medical cases? Find out with our </strong><a href="https://www.livescience.com/health/diagnostic-dilemma-quiz-can-you-guess-the-diagnosis-in-these-strange-medical-cases"><u><strong>diagnostic dilemma quiz!</strong></u></a></p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-eMGxrO"></div>                            </div>                            <script src="https://kwizly.com/embed/eMGxrO.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'I won't trust AI': Readers share mixed reaction to AI tools that calculate people's biological ages ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Scientists are harnessing the power of <a href="https://www.livescience.com/technology/artificial-intelligence"><u>artificial intelligence</u></a> (AI) to <a href="https://www.livescience.com/health/ageing/aging-clocks-tell-you-how-much-older-you-are-than-your-chronological-age-how-do-they-work"><u>measure people's biological ages</u></a>. </p><p>Unlike chronological age, or the number of years a person has been living, <a href="https://www.livescience.com/health/cancer/rise-in-cancer-in-younger-adults-may-be-explained-by-faster-biological-aging-early-study-hints"><u>biological age</u></a> should reflect how well a person's bodily systems are working. Someone with a higher biological age has a higher risk for age-related diseases, such as <a href="https://www.livescience.com/health/viruses-infections-disease/cancer"><u>cancer</u></a> or <a href="https://www.livescience.com/health/alzheimers-dementia/dementia-facts-about-alzheimers-and-other-forms-of-dementia"><u>dementia</u></a>, than a person with a younger biological age. While some <a href="https://www.livescience.com/health/ageing/aging-clocks-tell-you-how-much-older-you-are-than-your-chronological-age-how-do-they-work"><u>AI clocks look at epigenetic markers</u></a>, others focus on other features, like the <a href="https://www.livescience.com/health/aging/your-voice-may-reveal-how-fast-youre-aging-new-ai-speech-clock-suggests"><u>pitch and pace</u></a> of people's voices, to calculate a biological age. </p><p>We <a href="https://www.livescience.com/health/aging/would-you-trust-ai-to-calculate-your-true-biological-age-poll"><u>recently asked</u></a> our readers if they would trust such AI tools to measure their biological age. Over 170 people responded, with 44% of voters choosing "Yes, I would take the results with a grain of salt, but it can still provide some helpful insights." The next-largest group, including 23% of voters, also chose a positive answer, clicking the "Yes, I think it would provide useful health information."</p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xrgy0e"></div>                            </div>                            <script src="https://kwizly.com/embed/Xrgy0e.js" async=""></script><p>But readers' comments seemed to reflect the opposite trend, with one commenter writing, "NO!!! Unplug it !!! Heed the warnings!" Another reader posted a similar sentiment, saying: "A.I. is dangerous! It's often going beyond its programming and doing things it's not supposed to do! Trusting it with my life is something I will never do!" </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/can-ai-detect-cognitive-decline-better-than-a-doctor-new-study-reveals-surprising-accuracy">Can AI detect cognitive decline better than a doctor? New study reveals surprising accuracy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/doctors-say-ai-model-can-predict-biological-age-from-a-selfie-and-want-to-use-it-to-guide-cancer-treatment">Doctors say AI model can predict 'biological age' from a selfie — and want to use it to guide cancer treatment</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/theres-a-sense-that-these-algorithms-are-objective-and-they-get-to-know-you-how-social-media-warps-our-understanding-of-healthcare">'There's a sense that these algorithms are objective and they get to know you': How social media warps our understanding of healthcare</a></li></ul></p></div></div><p>Other commenters highlighted the need for more research to be conducted before using they'd use the tools, with one reader writing, "I might wait at least a few years before trying this, because the genetic research the AI is basing its results on is likely to expand quickly, so results are likely to be more accurate &amp; meaningful." </p><p>Another reader commented on the idea of accuracy and truth when using these tools, saying, "I won't trust AI. Al on one hand gives amazing possibilities, but on another hand with AI we would never know what the real truth is." </p><p>What do you think? Let us know in the comments! </p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/aging/i-wont-trust-ai-readers-share-mixed-reaction-to-ai-tools-that-calculate-peoples-biological-ages</link>
                                                                            <description>
                            <![CDATA[ Scientists have developed AI tools to measure a person's true "biological age." Live Science asked readers whether they would be comfortable using these tools. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">Kf8c8abtcp7QtDFkDoVzx6</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/MYcWzJneZZTnZwKpt3p7ae-1920-80.gif" type="image/gif" length="0"></enclosure>
                                                                        <pubDate>Tue, 13 Oct 2026 20:40:36 +0000</pubDate>                                                                                                                                <updated>Wed, 14 Oct 2026 10:29:48 +0000</updated>
                                                                                                                                            <category><![CDATA[Aging]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kenna Hughes-Castleberry ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mgEvZdqXoF3NyR25Gj96va-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/gif" url="https://cdn.mos.cms.futurecdn.net/MYcWzJneZZTnZwKpt3p7ae-1920-80.gif">
                                                            <media:credit><![CDATA[janiecbros via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Live Science asked its readers whether they would trust AI to calculate their biological age.]]></media:description>                                                            <media:text><![CDATA[A GIF showing the letters &quot;AI&quot; in front of a series of clocks]]></media:text>
                                <media:title type="plain"><![CDATA[A GIF showing the letters &quot;AI&quot; in front of a series of clocks]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/MYcWzJneZZTnZwKpt3p7ae-1920-80.gif" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Scientists are harnessing the power of <a href="https://www.livescience.com/technology/artificial-intelligence"><u>artificial intelligence</u></a> (AI) to <a href="https://www.livescience.com/health/ageing/aging-clocks-tell-you-how-much-older-you-are-than-your-chronological-age-how-do-they-work"><u>measure people's biological ages</u></a>. </p><p>Unlike chronological age, or the number of years a person has been living, <a href="https://www.livescience.com/health/cancer/rise-in-cancer-in-younger-adults-may-be-explained-by-faster-biological-aging-early-study-hints"><u>biological age</u></a> should reflect how well a person's bodily systems are working. Someone with a higher biological age has a higher risk for age-related diseases, such as <a href="https://www.livescience.com/health/viruses-infections-disease/cancer"><u>cancer</u></a> or <a href="https://www.livescience.com/health/alzheimers-dementia/dementia-facts-about-alzheimers-and-other-forms-of-dementia"><u>dementia</u></a>, than a person with a younger biological age. While some <a href="https://www.livescience.com/health/ageing/aging-clocks-tell-you-how-much-older-you-are-than-your-chronological-age-how-do-they-work"><u>AI clocks look at epigenetic markers</u></a>, others focus on other features, like the <a href="https://www.livescience.com/health/aging/your-voice-may-reveal-how-fast-youre-aging-new-ai-speech-clock-suggests"><u>pitch and pace</u></a> of people's voices, to calculate a biological age. </p><p>We <a href="https://www.livescience.com/health/aging/would-you-trust-ai-to-calculate-your-true-biological-age-poll"><u>recently asked</u></a> our readers if they would trust such AI tools to measure their biological age. Over 170 people responded, with 44% of voters choosing "Yes, I would take the results with a grain of salt, but it can still provide some helpful insights." The next-largest group, including 23% of voters, also chose a positive answer, clicking the "Yes, I think it would provide useful health information."</p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xrgy0e"></div>                            </div>                            <script src="https://kwizly.com/embed/Xrgy0e.js" async=""></script><p>But readers' comments seemed to reflect the opposite trend, with one commenter writing, "NO!!! Unplug it !!! Heed the warnings!" Another reader posted a similar sentiment, saying: "A.I. is dangerous! It's often going beyond its programming and doing things it's not supposed to do! Trusting it with my life is something I will never do!" </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/can-ai-detect-cognitive-decline-better-than-a-doctor-new-study-reveals-surprising-accuracy">Can AI detect cognitive decline better than a doctor? New study reveals surprising accuracy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/doctors-say-ai-model-can-predict-biological-age-from-a-selfie-and-want-to-use-it-to-guide-cancer-treatment">Doctors say AI model can predict 'biological age' from a selfie — and want to use it to guide cancer treatment</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/theres-a-sense-that-these-algorithms-are-objective-and-they-get-to-know-you-how-social-media-warps-our-understanding-of-healthcare">'There's a sense that these algorithms are objective and they get to know you': How social media warps our understanding of healthcare</a></li></ul></p></div></div><p>Other commenters highlighted the need for more research to be conducted before using they'd use the tools, with one reader writing, "I might wait at least a few years before trying this, because the genetic research the AI is basing its results on is likely to expand quickly, so results are likely to be more accurate &amp; meaningful." </p><p>Another reader commented on the idea of accuracy and truth when using these tools, saying, "I won't trust AI. Al on one hand gives amazing possibilities, but on another hand with AI we would never know what the real truth is." </p><p>What do you think? Let us know in the comments! </p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Flu season is kicking off early — are you getting a vaccine? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Flu season in the U.S. typically starts around late October or early November and peaks between December and February. But new data reveals that the <a href="https://www.livescience.com/health/flu/october-is-the-ideal-time-to-get-vaccinated-flu-season-is-kicking-off-early-experts-say"><u>current flu season is starting slightly earlier than normal</u></a>. </p><p><a href="https://www.cdc.gov/fluview/surveillance/2026-week-38.html" target="_blank"><u>According to the Centers for Disease Control and Prevention (CDC)</u></a>, around 3.4% of respiratory samples tested for flu came back positive for the week of Sept. 26. That's around seven times the rate compared with the <a href="https://www.cdc.gov/fluview/surveillance/2025-week-39.html" target="_blank"><u>same week in 2025</u></a>. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/universal-cancer-vaccine-heading-to-human-trials-could-be-useful-for-all-forms-of-cancer">'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/trumps-childhood-vaccine-order-will-threaten-childrens-safety-even-if-it-doesnt-directly-change-policy">Trump's childhood vaccine order will threaten children's safety, even if it doesn't directly change policy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/universal-nasal-spray-vaccine-protects-against-viruses-bacteria-and-allergens-in-mice">'Universal' nasal-spray vaccine protects against viruses, bacteria and allergens in mice</a></li></ul></p></div></div><p>The positive tests are coming mainly from Western states, including California, Washington and Arizona. Regardless of where you're located in the U.S., though, most people are recommended to get their annual flu shot in September or October, and the same goes for this flu season.</p><p>The annual flu shot is the <a href="https://www.livescience.com/why-you-should-get-flu-shot"><u>best way to prevent hospitalization and death</u></a> from seasonal influenza. Nearly everyone ages 6 months and older is recommended to get a flu vaccine, and older adults have several special options, including a high-dose shot, a vaccine containing an extra immune-stimulating ingredient called an adjuvant, and a <a href="https://www.livescience.com/health/medicine-drugs/fda-approves-first-mrna-vaccine-for-seasonal-flu"><u>brand-new mRNA vaccine</u></a>.</p><p>Given that flu season is off to an earlier start this year, our latest poll asks whether you plan to get vaccinated or have gotten vaccinated already. Tell us your thoughts in the comments below. </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-ON9ynW"></div>                            </div>                            <script src="https://kwizly.com/embed/ON9ynW.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/flu/flu-season-is-kicking-off-early-are-you-getting-a-vaccine</link>
                                                                            <description>
                            <![CDATA[ New data reveals that flu season is off to an early start in several Western states. Live Science wants to know if you have already gotten the flu vaccine or plan to do so this year. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">74myrQPngvY9ECXw5Xx2PK</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/ZaD6PymBBzYaaZPqMBMugW-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Tue, 13 Oct 2026 16:39:44 +0000</pubDate>                                                                                                                                <updated>Tue, 13 Oct 2026 19:06:01 +0000</updated>
                                                                                                                                            <category><![CDATA[Flu]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                    <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                                                                                    <dc:creator><![CDATA[ Kenna Hughes-Castleberry ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mgEvZdqXoF3NyR25Gj96va-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/ZaD6PymBBzYaaZPqMBMugW-1920-80.jpg">
                                                            <media:credit><![CDATA[FatCamera via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Experts recommend getting a flu vaccine in October, and they&amp;#39;ve noted that flu season is off to an early start in some parts of the U.S.]]></media:description>                                                            <media:text><![CDATA[An older woman gets a circular band aid put on her by a woman with dark hair wearing a white lab coat.]]></media:text>
                                <media:title type="plain"><![CDATA[An older woman gets a circular band aid put on her by a woman with dark hair wearing a white lab coat.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/ZaD6PymBBzYaaZPqMBMugW-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Flu season in the U.S. typically starts around late October or early November and peaks between December and February. But new data reveals that the <a href="https://www.livescience.com/health/flu/october-is-the-ideal-time-to-get-vaccinated-flu-season-is-kicking-off-early-experts-say"><u>current flu season is starting slightly earlier than normal</u></a>. </p><p><a href="https://www.cdc.gov/fluview/surveillance/2026-week-38.html" target="_blank"><u>According to the Centers for Disease Control and Prevention (CDC)</u></a>, around 3.4% of respiratory samples tested for flu came back positive for the week of Sept. 26. That's around seven times the rate compared with the <a href="https://www.cdc.gov/fluview/surveillance/2025-week-39.html" target="_blank"><u>same week in 2025</u></a>. </p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/cancer/universal-cancer-vaccine-heading-to-human-trials-could-be-useful-for-all-forms-of-cancer">'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/trumps-childhood-vaccine-order-will-threaten-childrens-safety-even-if-it-doesnt-directly-change-policy">Trump's childhood vaccine order will threaten children's safety, even if it doesn't directly change policy</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/universal-nasal-spray-vaccine-protects-against-viruses-bacteria-and-allergens-in-mice">'Universal' nasal-spray vaccine protects against viruses, bacteria and allergens in mice</a></li></ul></p></div></div><p>The positive tests are coming mainly from Western states, including California, Washington and Arizona. Regardless of where you're located in the U.S., though, most people are recommended to get their annual flu shot in September or October, and the same goes for this flu season.</p><p>The annual flu shot is the <a href="https://www.livescience.com/why-you-should-get-flu-shot"><u>best way to prevent hospitalization and death</u></a> from seasonal influenza. Nearly everyone ages 6 months and older is recommended to get a flu vaccine, and older adults have several special options, including a high-dose shot, a vaccine containing an extra immune-stimulating ingredient called an adjuvant, and a <a href="https://www.livescience.com/health/medicine-drugs/fda-approves-first-mrna-vaccine-for-seasonal-flu"><u>brand-new mRNA vaccine</u></a>.</p><p>Given that flu season is off to an earlier start this year, our latest poll asks whether you plan to get vaccinated or have gotten vaccinated already. Tell us your thoughts in the comments below. </p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-ON9ynW"></div>                            </div>                            <script src="https://kwizly.com/embed/ON9ynW.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ 'October is the ideal time to get vaccinated': Flu season is kicking off early, experts say ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Flu season is off to an early start in some parts of the U.S., data shows. </p><p>In a typical year, U.S. flu activity starts building in late fall — typically in October or November — and peaks between December and February. This year, flu activity is currently low but rising nationwide: During the week ending Sept. 26, 3.4% of respiratory samples tested by clinical labs were positive for flu, according to <a href="https://www.cdc.gov/fluview/surveillance/2026-week-38.html" target="_blank"><u>Centers for Disease Control and Prevention (CDC) data</u></a>. </p><p>That's about seven times the rate that was seen at the same point last year. About <a href="https://www.cdc.gov/fluview/surveillance/2025-week-39.html" target="_blank"><u>0.5% of samples</u></a> tested positive during the week ending Sept. 27, 2025.</p><p>"This particular year, it appears to be starting early — like right now," <a href="https://www.vumc.org/health-policy/person/william-schaffner-md" target="_blank"><u>Dr. William Schaffner</u></a>, a professor of preventive medicine and infectious diseases at Vanderbilt Health in Tennessee, told Live Science. Patients at clinics in his area are already testing positive for flu, he said.</p><p>The early uptick in flu is mostly unfolding in Western states, including Washington, California and Arizona<em>. </em>In Washington, for example, the share of emergency department visits diagnosed as flu climbed from 0.25% in the week ending Aug. 29 to 1.34% in the week ending Oct. 3, according to <a href="https://data.cdc.gov/Public-Health-Surveillance/NSSP-Emergency-Department-Visit-Trajectories-by-St/rdmq-nq56/explore/query/SELECT%0A%20%20%60week_end%60%2C%0A%20%20%60geography%60%2C%0A%20%20%60county%60%2C%0A%20%20%60percent_visits_combined%60%2C%0A%20%20%60percent_visits_covid%60%2C%0A%20%20%60percent_visits_influenza%60%2C%0A%20%20%60percent_visits_rsv%60%2C%0A%20%20%60percent_visits_smoothed%60%2C%0A%20%20%60percent_visits_smoothed_covid%60%2C%0A%20%20%60percent_visits_smoothed_1%60%2C%0A%20%20%60percent_visits_smoothed_rsv%60%2C%0A%20%20%60ed_trends_covid%60%2C%0A%20%20%60ed_trends_influenza%60%2C%0A%20%20%60ed_trends_rsv%60%2C%0A%20%20%60hsa%60%2C%0A%20%20%60hsa_counties%60%2C%0A%20%20%60hsa_nci_id%60%2C%0A%20%20%60fips%60%2C%0A%20%20%60trend_source%60%2C%0A%20%20%60buildnumber%60%0AORDER%20BY%20%60week_end%60%20DESC%20NULL%20LAST%2C%20%60geography%60%20DESC%20NULL%20LAST/page/aggregate" target="_blank"><u>CDC emergency department data</u></a>. That's a more than fivefold increase over six weeks.</p><p>Where the flu took off first isn't a warning sign in itself, Schaffner noted. </p><p>"There's nothing unusual about flu starting in the West Coast and moving east," he said. Recent seasons have more often begun in the Southeast or Midwest, he noted, but "it can start almost anywhere."</p><h2 id="leading-with-h1n1">Leading with H1N1</h2><p>Nowadays, seasonal flu is caused by three subtypes of flu viruses: two subtypes of influenza A, called H1N1 and H3N2, and the Victoria lineage of influenza B. (A second subtype of influenza B used to circulate but is <a href="https://www.livescience.com/health/flu/a-branch-of-the-flu-family-tree-has-died-and-wont-be-included-in-future-us-vaccines"><u>now thought to be extinct</u></a>.) </p><p>Last season, a fast-spreading version of H3N2 known as <a href="https://www.cdc.gov/cfa-qualitative-assessments/php/data-research/season-outlook25-26-dec-update.html" target="_blank"><u>subclade K dominated</u></a>. The CDC classified the 2025-2026 season as highly severe for children, as at least <a href="https://www.cdc.gov/fluview/surveillance/2026-week-38.html" target="_blank"><u>195 children died</u></a> of flu-related causes.</p><p>Schaffner likens influenza A and B to siblings. "They're very related, but they each have their own individual characteristics," he said. Influenza A strains usually cause the biggest outbreaks early in the season, while influenza B strains "kind of smolder along" and account for most cases toward the end, he noted.</p><p>This year, H1N1 has taken the initial lead. Of the influenza A samples that public health labs subtyped during the week ending Sept. 26, 96% were identified as H1N1, according to CDC data. That doesn't mean H1N1 will continue to dominate throughout the season; it just gives a snapshot of what's happening now.</p><p>The dominant strain matters because flu is "a moving target," said <a href="https://www.chop.edu/doctors/offit-paul-a" target="_blank"><u>Dr. Paul Offit</u></a>, director of the Vaccine Education Center at Children's Hospital of Philadelphia. The virus constantly mutates — especially hemagglutinin, the protein on the virus's surface that it uses to latch onto human cells. Hemagglutinin is the main target of flu vaccines.</p><p>An early start to the season doesn't guarantee it'll be a severe one, either. In its <a href="https://www.cdc.gov/cfa-qualitative-assessments/php/data-research/season-outlook26-27.html" target="_blank"><u>2026-2027 season outlook</u></a>, the CDC projected that this season will likely be moderate, although it has only low-to-moderate confidence in that forecast.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.67%;"><img id="FmLCcY3SkUwdJt2JuLcRbm" name="rsv-vaccine-GettyImages-1935660240.jpg" alt="a woman receives a vaccine" src="https://cdn.mos.cms.futurecdn.net/FmLCcY3SkUwdJt2JuLcRbm-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1088" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/FmLCcY3SkUwdJt2JuLcRbm-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Everyone ages 6 months and older is recommended to get a flu shot, and older adults have several options, including high-dose, adjuvanted and mRNA vaccines. </span><span class="credit" itemprop="copyrightHolder">(Image credit: andreswd via Getty Images)</span></figcaption></figure><h2 id="when-to-get-vaccinated">When to get vaccinated</h2><p>Everyone 6 months and older is <a href="https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html" target="_blank"><u>recommended to get an annual flu vaccine</u></a>. </p><p>Influenza is especially dangerous for children under 5, adults 65 and older, people with chronic health conditions and pregnant people, as these groups are more prone to severe infections. <a href="https://www.livescience.com/health/flu/how-do-people-die-of-the-flu"><u>Serious cases of flu</u></a> can lead to complications such as pneumonia, sepsis, and brain or heart inflammation, and in some cases, they can be deadly. <a href="https://www.cdc.gov/flu-burden/php/php/data-vis/2025-2026.html" target="_blank"><u>Tens of thousands of people die</u></a> of flu each season in the U.S.</p><p>For flu vaccination, timing matters. The CDC generally doesn't recommend vaccination in July or August for most adults, because the shot's protection can wane over the course of a season. But with flu arriving early, "October is the ideal time to get vaccinated, and even more so right now," Schaffner said. </p><p>When circulating strains' features differ from those captured in the vaccine, "that usually predicts a more difficult season," Offit said. That said, it's too early to know if this year's flu shots are a good match for the circulating flu viruses.</p><p>Protection begins building right after you get the shot, but it takes up to about two weeks to reach full strength.</p><p>How much protection a flu vaccine offers <a href="https://www.livescience.com/why-does-the-flu-shot-have-low-effectiveness"><u>varies by season</u></a>, depending partly on how well its formulation matches the strains that circulate. Offit said that protection against symptomatic illness varies by age group and that the vaccines are "a little more effective" at preventing more severe illness. In terms of flu cases that prompt people to seek medical care, the shot has been 29% to 56% effective over the past decade, <a href="https://www.cdc.gov/flu-vaccines-work/php/effectiveness-studies/past-seasons-estimates.html" target="_blank"><u>the CDC estimates</u></a>.</p><p>While the vaccines are less reliable at preventing mild cases of flu, Schaffner said, they work best at "keeping you out of the hospital, keeping you out of the intensive care unit, and keeping you out of the cemetery."</p><p>The CDC's<a href="https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html" target="_blank"> <u>2026-2027 guidance</u></a> keeps its recommendation of an annual flu vaccine for everyone 6 months and older, with high-dose and adjuvanted shots preferred for adults 65 and older. (Adjuvanted shots contain an extra ingredient to help rev up the immune system.)</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/how-to-get-better-faster-when-you-have-the-flu-according-to-science">How to get better faster when you have the flu, according to science</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/fdas-approval-of-new-mrna-vaccine-does-not-necessarily-signal-the-governments-embrace-of-the-technology-experts-say">FDA's approval of new mRNA vaccine does not necessarily signal the government's embrace of the technology, experts say</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/how-long-is-the-flu-contagioushttps://www.livescience.com/health/flu/how-long-is-the-flu-contagious">How long is the flu contagious?</a></li></ul></p></div></div><p>There's also a new option: In August, the Food and Drug Administration approved mFlusiva, <a href="https://www.livescience.com/health/medicine-drugs/fda-approves-first-mrna-vaccine-for-seasonal-flu"><u>the first mRNA flu vaccine</u></a>, for adults 50 and older. (You can find out where mFlusiva shots are available near you using <a href="https://products.modernatx.com/finder?placeId=AQAEAJUA4HuW7wcXQlcyrnZdlQihywt6MCu4hyxs56ooyuFRKKGdBkwNcVg600K_JFP6g01PPXhbLtHOOkZFCcTD4um04zOumjGRYiHgdU23kH_3QNoN3veitaBUbLddf1kOnrLtHv2fELxzLXywPT3mCQS33mbRPNYFRLHElW6Ke7xdz-M51eDRkKezTqLDFm5UF4m4t9qG4eHhaD5Q4KCC4opljvOebnLeYjtpad0vN7lelWs4FSLUWg&amp;vaccines=mflusiva" target="_blank"><u>Moderna's vaccine finder</u></a>.) With the mRNA shot, "you're less likely to get symptomatic disease," Offit told Live Science.</p><p>Traditional flu shots contain purified pieces of the virus itself, Schaffner explained. With mRNA, the vaccine contains a "blueprint" of those proteins — essentially a set of genetic instructions that the body's cells then use. In mFlusiva's case, those instructions code for hemagglutinin (the protein on the virus's surface that it uses to latch onto human cells) from each of three flu subtypes, Offit said. The mRNA then breaks down in the body, Offit noted. It "cannot influence human genetic material," Schaffner emphasized.</p><p>Whether this early start gives way to a heavy flu season should become clearer in the coming weeks, as the CDC's weekly surveillance reports will show whether cases keep climbing beyond the West.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/flu/october-is-the-ideal-time-to-get-vaccinated-flu-season-is-kicking-off-early-experts-say</link>
                                                                            <description>
                            <![CDATA[ Flu tests are coming back positive at higher rates than is typical for early fall in several Western states, data suggests. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">4M7RAwowRm8JAjr6LH5NqN</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/5ZjJxZtDDaMuw9bcDa5EjC-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 09 Oct 2026 19:10:00 +0000</pubDate>                                                                                                                                <updated>Fri, 09 Oct 2026 20:11:18 +0000</updated>
                                                                                                                                            <category><![CDATA[Flu]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                    <category><![CDATA[Viruses, Infections & Disease]]></category>
                                                                                                <author><![CDATA[ olivia.maule@futurenet.com (Olivia Maule) ]]></author>                    <dc:creator><![CDATA[ Olivia Maule ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/mpNwB8YVJPXWns7gXUQJGG-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/5ZjJxZtDDaMuw9bcDa5EjC-1920-80.jpg">
                                                            <media:credit><![CDATA[KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Flu cases are rising unusually early in several Western states this fall.]]></media:description>                                                            <media:text><![CDATA[An illustration of spheres with spikes on the end.]]></media:text>
                                <media:title type="plain"><![CDATA[An illustration of spheres with spikes on the end.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/5ZjJxZtDDaMuw9bcDa5EjC-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Flu season is off to an early start in some parts of the U.S., data shows. </p><p>In a typical year, U.S. flu activity starts building in late fall — typically in October or November — and peaks between December and February. This year, flu activity is currently low but rising nationwide: During the week ending Sept. 26, 3.4% of respiratory samples tested by clinical labs were positive for flu, according to <a href="https://www.cdc.gov/fluview/surveillance/2026-week-38.html" target="_blank"><u>Centers for Disease Control and Prevention (CDC) data</u></a>. </p><p>That's about seven times the rate that was seen at the same point last year. About <a href="https://www.cdc.gov/fluview/surveillance/2025-week-39.html" target="_blank"><u>0.5% of samples</u></a> tested positive during the week ending Sept. 27, 2025.</p><p>"This particular year, it appears to be starting early — like right now," <a href="https://www.vumc.org/health-policy/person/william-schaffner-md" target="_blank"><u>Dr. William Schaffner</u></a>, a professor of preventive medicine and infectious diseases at Vanderbilt Health in Tennessee, told Live Science. Patients at clinics in his area are already testing positive for flu, he said.</p><p>The early uptick in flu is mostly unfolding in Western states, including Washington, California and Arizona<em>. </em>In Washington, for example, the share of emergency department visits diagnosed as flu climbed from 0.25% in the week ending Aug. 29 to 1.34% in the week ending Oct. 3, according to <a href="https://data.cdc.gov/Public-Health-Surveillance/NSSP-Emergency-Department-Visit-Trajectories-by-St/rdmq-nq56/explore/query/SELECT%0A%20%20%60week_end%60%2C%0A%20%20%60geography%60%2C%0A%20%20%60county%60%2C%0A%20%20%60percent_visits_combined%60%2C%0A%20%20%60percent_visits_covid%60%2C%0A%20%20%60percent_visits_influenza%60%2C%0A%20%20%60percent_visits_rsv%60%2C%0A%20%20%60percent_visits_smoothed%60%2C%0A%20%20%60percent_visits_smoothed_covid%60%2C%0A%20%20%60percent_visits_smoothed_1%60%2C%0A%20%20%60percent_visits_smoothed_rsv%60%2C%0A%20%20%60ed_trends_covid%60%2C%0A%20%20%60ed_trends_influenza%60%2C%0A%20%20%60ed_trends_rsv%60%2C%0A%20%20%60hsa%60%2C%0A%20%20%60hsa_counties%60%2C%0A%20%20%60hsa_nci_id%60%2C%0A%20%20%60fips%60%2C%0A%20%20%60trend_source%60%2C%0A%20%20%60buildnumber%60%0AORDER%20BY%20%60week_end%60%20DESC%20NULL%20LAST%2C%20%60geography%60%20DESC%20NULL%20LAST/page/aggregate" target="_blank"><u>CDC emergency department data</u></a>. That's a more than fivefold increase over six weeks.</p><p>Where the flu took off first isn't a warning sign in itself, Schaffner noted. </p><p>"There's nothing unusual about flu starting in the West Coast and moving east," he said. Recent seasons have more often begun in the Southeast or Midwest, he noted, but "it can start almost anywhere."</p><h2 id="leading-with-h1n1">Leading with H1N1</h2><p>Nowadays, seasonal flu is caused by three subtypes of flu viruses: two subtypes of influenza A, called H1N1 and H3N2, and the Victoria lineage of influenza B. (A second subtype of influenza B used to circulate but is <a href="https://www.livescience.com/health/flu/a-branch-of-the-flu-family-tree-has-died-and-wont-be-included-in-future-us-vaccines"><u>now thought to be extinct</u></a>.) </p><p>Last season, a fast-spreading version of H3N2 known as <a href="https://www.cdc.gov/cfa-qualitative-assessments/php/data-research/season-outlook25-26-dec-update.html" target="_blank"><u>subclade K dominated</u></a>. The CDC classified the 2025-2026 season as highly severe for children, as at least <a href="https://www.cdc.gov/fluview/surveillance/2026-week-38.html" target="_blank"><u>195 children died</u></a> of flu-related causes.</p><p>Schaffner likens influenza A and B to siblings. "They're very related, but they each have their own individual characteristics," he said. Influenza A strains usually cause the biggest outbreaks early in the season, while influenza B strains "kind of smolder along" and account for most cases toward the end, he noted.</p><p>This year, H1N1 has taken the initial lead. Of the influenza A samples that public health labs subtyped during the week ending Sept. 26, 96% were identified as H1N1, according to CDC data. That doesn't mean H1N1 will continue to dominate throughout the season; it just gives a snapshot of what's happening now.</p><p>The dominant strain matters because flu is "a moving target," said <a href="https://www.chop.edu/doctors/offit-paul-a" target="_blank"><u>Dr. Paul Offit</u></a>, director of the Vaccine Education Center at Children's Hospital of Philadelphia. The virus constantly mutates — especially hemagglutinin, the protein on the virus's surface that it uses to latch onto human cells. Hemagglutinin is the main target of flu vaccines.</p><p>An early start to the season doesn't guarantee it'll be a severe one, either. In its <a href="https://www.cdc.gov/cfa-qualitative-assessments/php/data-research/season-outlook26-27.html" target="_blank"><u>2026-2027 season outlook</u></a>, the CDC projected that this season will likely be moderate, although it has only low-to-moderate confidence in that forecast.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:1920px;"><p class="vanilla-image-block" style="padding-top:56.67%;"><img id="FmLCcY3SkUwdJt2JuLcRbm" name="rsv-vaccine-GettyImages-1935660240.jpg" alt="a woman receives a vaccine" src="https://cdn.mos.cms.futurecdn.net/FmLCcY3SkUwdJt2JuLcRbm-1920-80.jpg" mos="" align="middle" fullscreen="1" width="1920" height="1088" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/FmLCcY3SkUwdJt2JuLcRbm-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">Everyone ages 6 months and older is recommended to get a flu shot, and older adults have several options, including high-dose, adjuvanted and mRNA vaccines. </span><span class="credit" itemprop="copyrightHolder">(Image credit: andreswd via Getty Images)</span></figcaption></figure><h2 id="when-to-get-vaccinated">When to get vaccinated</h2><p>Everyone 6 months and older is <a href="https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html" target="_blank"><u>recommended to get an annual flu vaccine</u></a>. </p><p>Influenza is especially dangerous for children under 5, adults 65 and older, people with chronic health conditions and pregnant people, as these groups are more prone to severe infections. <a href="https://www.livescience.com/health/flu/how-do-people-die-of-the-flu"><u>Serious cases of flu</u></a> can lead to complications such as pneumonia, sepsis, and brain or heart inflammation, and in some cases, they can be deadly. <a href="https://www.cdc.gov/flu-burden/php/php/data-vis/2025-2026.html" target="_blank"><u>Tens of thousands of people die</u></a> of flu each season in the U.S.</p><p>For flu vaccination, timing matters. The CDC generally doesn't recommend vaccination in July or August for most adults, because the shot's protection can wane over the course of a season. But with flu arriving early, "October is the ideal time to get vaccinated, and even more so right now," Schaffner said. </p><p>When circulating strains' features differ from those captured in the vaccine, "that usually predicts a more difficult season," Offit said. That said, it's too early to know if this year's flu shots are a good match for the circulating flu viruses.</p><p>Protection begins building right after you get the shot, but it takes up to about two weeks to reach full strength.</p><p>How much protection a flu vaccine offers <a href="https://www.livescience.com/why-does-the-flu-shot-have-low-effectiveness"><u>varies by season</u></a>, depending partly on how well its formulation matches the strains that circulate. Offit said that protection against symptomatic illness varies by age group and that the vaccines are "a little more effective" at preventing more severe illness. In terms of flu cases that prompt people to seek medical care, the shot has been 29% to 56% effective over the past decade, <a href="https://www.cdc.gov/flu-vaccines-work/php/effectiveness-studies/past-seasons-estimates.html" target="_blank"><u>the CDC estimates</u></a>.</p><p>While the vaccines are less reliable at preventing mild cases of flu, Schaffner said, they work best at "keeping you out of the hospital, keeping you out of the intensive care unit, and keeping you out of the cemetery."</p><p>The CDC's<a href="https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html" target="_blank"> <u>2026-2027 guidance</u></a> keeps its recommendation of an annual flu vaccine for everyone 6 months and older, with high-dose and adjuvanted shots preferred for adults 65 and older. (Adjuvanted shots contain an extra ingredient to help rev up the immune system.)</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/how-to-get-better-faster-when-you-have-the-flu-according-to-science">How to get better faster when you have the flu, according to science</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/medicine-drugs/fdas-approval-of-new-mrna-vaccine-does-not-necessarily-signal-the-governments-embrace-of-the-technology-experts-say">FDA's approval of new mRNA vaccine does not necessarily signal the government's embrace of the technology, experts say</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/flu/how-long-is-the-flu-contagioushttps://www.livescience.com/health/flu/how-long-is-the-flu-contagious">How long is the flu contagious?</a></li></ul></p></div></div><p>There's also a new option: In August, the Food and Drug Administration approved mFlusiva, <a href="https://www.livescience.com/health/medicine-drugs/fda-approves-first-mrna-vaccine-for-seasonal-flu"><u>the first mRNA flu vaccine</u></a>, for adults 50 and older. (You can find out where mFlusiva shots are available near you using <a href="https://products.modernatx.com/finder?placeId=AQAEAJUA4HuW7wcXQlcyrnZdlQihywt6MCu4hyxs56ooyuFRKKGdBkwNcVg600K_JFP6g01PPXhbLtHOOkZFCcTD4um04zOumjGRYiHgdU23kH_3QNoN3veitaBUbLddf1kOnrLtHv2fELxzLXywPT3mCQS33mbRPNYFRLHElW6Ke7xdz-M51eDRkKezTqLDFm5UF4m4t9qG4eHhaD5Q4KCC4opljvOebnLeYjtpad0vN7lelWs4FSLUWg&amp;vaccines=mflusiva" target="_blank"><u>Moderna's vaccine finder</u></a>.) With the mRNA shot, "you're less likely to get symptomatic disease," Offit told Live Science.</p><p>Traditional flu shots contain purified pieces of the virus itself, Schaffner explained. With mRNA, the vaccine contains a "blueprint" of those proteins — essentially a set of genetic instructions that the body's cells then use. In mFlusiva's case, those instructions code for hemagglutinin (the protein on the virus's surface that it uses to latch onto human cells) from each of three flu subtypes, Offit said. The mRNA then breaks down in the body, Offit noted. It "cannot influence human genetic material," Schaffner emphasized.</p><p>Whether this early start gives way to a heavy flu season should become clearer in the coming weeks, as the CDC's weekly surveillance reports will show whether cases keep climbing beyond the West.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Scientists have identified a 'protein signature' in blood that could predict healthy aging ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Two people born on the exact same day can age in totally different ways ‪—‬ one in relative health and the other with chronic disease. Now, scientists have found a key difference in the immune systems of people who are more prone to age-related conditions, and it could help explain why some people remain healthier longer. </p><p>In young people, the immune system contains many naive <a href="https://my.clevelandclinic.org/health/body/24630-t-cells" target="_blank"><u>T cells</u></a>, a type of white blood cell. Over time, exposure to pathogens and vaccinations transforms some of these T cells into <a href="https://en.wikipedia.org/wiki/Memory_T_cell" target="_blank"><u>memory cells</u></a>, which can respond quickly to defend the body against germs. </p><p>These memory cells make different types of characteristic proteins, called granzymes, which kill infected cells. They come in different "flavors," including granzyme K and granzyme B.</p><p>In a new study, published Friday (Oct. 9) in the journal <a href="https://dx.doi.org/10.1016/j.immuni.2026.09.012" target="_blank"><u>Immunity</u></a>, scientists found that individuals with more memory cells that make granzyme K than cells that make granzyme B tend to have healthier aging.</p><p>In the future, the balance of cells making granzyme K and granzyme B in a person's blood could be used as a test to determine "whether you're on the right trajectory of aging or not," study co-author <a href="https://pathology.wustl.edu/people/maxim-n-artyomov-phd/" target="_blank"><u>Maxim Artyomov</u></a>, an immunologist at Washington University in St. Louis, told Live Science.</p><h2 id="hunting-for-a-signature-of-healthy-aging">Hunting for a signature of healthy aging</h2><p>In <a href="https://www.cell.com/immunity/fulltext/S1074-7613(20)30492-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1074761320304921%3Fshowall%3Dtrue" target="_blank"><u>earlier research</u></a>, the same team found that, in old lab mice, granzyme K-making cells accumulated in several tissues and were linked to inflammation. They also observed the same increase in granzyme K cells in blood samples from older adults. </p><p>In the new study, they uncovered another piece of the puzzle: a dynamic with granzyme B-producing cells.</p><p>They began by analyzing immune cells sampled from over 2,600 people ages 18 to 97, looking at the balance of granzyme K- and granzyme B-making cells. They found that people with a lower ratio of granzyme K to granzyme B cell populations were more likely to have autoimmune diseases or other chronic immune conditions. </p><p>In a second analysis, they looked at both immune cells and blood-borne proteins sampled from 329 people, using the data to pinpoint a "protein signature" linked to an abundance of granzyme B-making cells.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="pwoZnNChrJaCfHy4ix9VUT" name="GettyImages-2216286015-immune cells" alt="An illustration of a spiky purple sphere in the midst of blood cells" src="https://cdn.mos.cms.futurecdn.net/pwoZnNChrJaCfHy4ix9VUT-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/pwoZnNChrJaCfHy4ix9VUT-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The balance of cells that make different granzymes may be important to how the immune system functions with age. </span><span class="credit" itemprop="copyrightHolder">(Image credit: RUSLANAS BARANAUSKAS/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>They went on to hunt for this protein signature in around 48,000 participants who'd provided data to the UK Biobank, a large database of health data from U.K.-based adults. People who were predicted to have higher levels of granzyme B-making cells based on their blood proteins had worse health outcomes in the following 17 years, with a higher risk of death and of conditions like diabetes, high blood pressure, and liver and kidney disease.</p><p>The findings might point to an aspect of immune aging that wasn't previously understood. </p><p>"I think that's really exciting," <a href="https://alleninstitute.org/person/claire-gustafson" target="_blank"><u>Claire Gustafson</u></a>, an immunologist at the Allen Institute, said of the results. "It highlights there's potentially some novel biology that we haven't really observed before," Gustafson, who was not involved in the research, told Live Science. </p><p>However, while there's a strong association between the balance of these cell populations and disease risks, Artyomov emphasized that the study does not prove that this ratio directly causes the poor health outcomes. Further studies would be needed to understand why having more granzyme B cells is linked with poorer health. </p><p>"This observation might be just a consequence, not a cause of the disease," Artyomov noted. </p><p>It's also important to note that granzyme K-making cells in mice are not the same as granzyme K-making cells in humans. In mice, they represent a more mature, specialized stage of immune cell development, whereas in humans, granzyme B cells better fit that description, he told Live Science.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/regular-exercise-reshapes-the-immune-system-at-a-cellular-level-study-suggests">Regular exercise reshapes the immune system at a cellular level, study suggests</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/zombified-cells-may-drive-aging-and-scientists-are-devising-new-ways-to-get-rid-of-them">'Zombie cells' may drive aging, and scientists are devising new ways to get rid of them</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/aging-and-inflammation-may-not-go-hand-in-hand-study-suggests">Aging and inflammation may not go hand in hand, study suggests</a></li></ul></p></div></div><p>That points to a key way that immunity in mice and humans is different, which was "underappreciated" before, Gustafson said. So when we're comparing these cells in mice and humans, "we're not looking at apples to apples," she said. Scientists now specifically "need to look more into humans, as it's not reflected in animal models."</p><p>In people, immune cells' features can also vary across diverse human populations, Gustafson added. We need more data across different populations to get a "true understanding of universal immune health," she said. The K-to-B ratio may be a "novel" clue that can help scientists understand healthy aging, but more data is needed to unpack why and how that ratio is linked to healthy or unhealthy aging.</p><p>"This is kind of like the first step to be able to get there," she told Live Science.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/aging/scientists-have-identified-a-protein-signature-in-blood-that-could-predict-healthy-aging</link>
                                                                            <description>
                            <![CDATA[ Having a certain ratio of proteins produced by immune cells in your blood is linked to a higher risk of age-related diseases, scientists report. ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">q4naD7u9AWLcrQQcjcikQ6</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/9u8bk373eLYmtBFf9hAhAM-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Fri, 09 Oct 2026 15:00:00 +0000</pubDate>                                                                                                                                <updated>Fri, 09 Oct 2026 20:15:19 +0000</updated>
                                                                                                                                            <category><![CDATA[Aging]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Zunnash Khan ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/wrV7sdVdmyubSn8MbHtvvc-320-70.jpg ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/9u8bk373eLYmtBFf9hAhAM-1920-80.jpg">
                                                            <media:credit><![CDATA[TEK IMAGE/SCIENCE PHOTO LIBRARY via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Scientists have uncovered subtle differences in immune cells that may help determine if someone ages healthily or is prone to disease.]]></media:description>                                                            <media:text><![CDATA[A blue gloved hand holds a blood-filled vial.]]></media:text>
                                <media:title type="plain"><![CDATA[A blue gloved hand holds a blood-filled vial.]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/9u8bk373eLYmtBFf9hAhAM-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Two people born on the exact same day can age in totally different ways ‪—‬ one in relative health and the other with chronic disease. Now, scientists have found a key difference in the immune systems of people who are more prone to age-related conditions, and it could help explain why some people remain healthier longer. </p><p>In young people, the immune system contains many naive <a href="https://my.clevelandclinic.org/health/body/24630-t-cells" target="_blank"><u>T cells</u></a>, a type of white blood cell. Over time, exposure to pathogens and vaccinations transforms some of these T cells into <a href="https://en.wikipedia.org/wiki/Memory_T_cell" target="_blank"><u>memory cells</u></a>, which can respond quickly to defend the body against germs. </p><p>These memory cells make different types of characteristic proteins, called granzymes, which kill infected cells. They come in different "flavors," including granzyme K and granzyme B.</p><p>In a new study, published Friday (Oct. 9) in the journal <a href="https://dx.doi.org/10.1016/j.immuni.2026.09.012" target="_blank"><u>Immunity</u></a>, scientists found that individuals with more memory cells that make granzyme K than cells that make granzyme B tend to have healthier aging.</p><p>In the future, the balance of cells making granzyme K and granzyme B in a person's blood could be used as a test to determine "whether you're on the right trajectory of aging or not," study co-author <a href="https://pathology.wustl.edu/people/maxim-n-artyomov-phd/" target="_blank"><u>Maxim Artyomov</u></a>, an immunologist at Washington University in St. Louis, told Live Science.</p><h2 id="hunting-for-a-signature-of-healthy-aging">Hunting for a signature of healthy aging</h2><p>In <a href="https://www.cell.com/immunity/fulltext/S1074-7613(20)30492-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1074761320304921%3Fshowall%3Dtrue" target="_blank"><u>earlier research</u></a>, the same team found that, in old lab mice, granzyme K-making cells accumulated in several tissues and were linked to inflammation. They also observed the same increase in granzyme K cells in blood samples from older adults. </p><p>In the new study, they uncovered another piece of the puzzle: a dynamic with granzyme B-producing cells.</p><p>They began by analyzing immune cells sampled from over 2,600 people ages 18 to 97, looking at the balance of granzyme K- and granzyme B-making cells. They found that people with a lower ratio of granzyme K to granzyme B cell populations were more likely to have autoimmune diseases or other chronic immune conditions. </p><p>In a second analysis, they looked at both immune cells and blood-borne proteins sampled from 329 people, using the data to pinpoint a "protein signature" linked to an abundance of granzyme B-making cells.</p><figure class="van-image-figure  inline-layout" data-bordeaux-image-check="" ><div class='image-full-width-wrapper'><div class='image-widthsetter' style="max-width:2000px;"><p class="vanilla-image-block" style="padding-top:56.25%;"><img id="pwoZnNChrJaCfHy4ix9VUT" name="GettyImages-2216286015-immune cells" alt="An illustration of a spiky purple sphere in the midst of blood cells" src="https://cdn.mos.cms.futurecdn.net/pwoZnNChrJaCfHy4ix9VUT-1920-80.jpg" mos="" align="middle" fullscreen="1" width="2000" height="1125" attribution="" endorsement="" class="inline expandable" /><a href='https://cdn.mos.cms.futurecdn.net/pwoZnNChrJaCfHy4ix9VUT-1920-80.jpg' target='_blank' class='expand-button icon-expand-image icon' ></a></p></div></div><figcaption itemprop="caption description" class=" inline-layout"><span class="caption-text">The balance of cells that make different granzymes may be important to how the immune system functions with age. </span><span class="credit" itemprop="copyrightHolder">(Image credit: RUSLANAS BARANAUSKAS/SCIENCE PHOTO LIBRARY via Getty Images)</span></figcaption></figure><p>They went on to hunt for this protein signature in around 48,000 participants who'd provided data to the UK Biobank, a large database of health data from U.K.-based adults. People who were predicted to have higher levels of granzyme B-making cells based on their blood proteins had worse health outcomes in the following 17 years, with a higher risk of death and of conditions like diabetes, high blood pressure, and liver and kidney disease.</p><p>The findings might point to an aspect of immune aging that wasn't previously understood. </p><p>"I think that's really exciting," <a href="https://alleninstitute.org/person/claire-gustafson" target="_blank"><u>Claire Gustafson</u></a>, an immunologist at the Allen Institute, said of the results. "It highlights there's potentially some novel biology that we haven't really observed before," Gustafson, who was not involved in the research, told Live Science. </p><p>However, while there's a strong association between the balance of these cell populations and disease risks, Artyomov emphasized that the study does not prove that this ratio directly causes the poor health outcomes. Further studies would be needed to understand why having more granzyme B cells is linked with poorer health. </p><p>"This observation might be just a consequence, not a cause of the disease," Artyomov noted. </p><p>It's also important to note that granzyme K-making cells in mice are not the same as granzyme K-making cells in humans. In mice, they represent a more mature, specialized stage of immune cell development, whereas in humans, granzyme B cells better fit that description, he told Live Science.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/immune-system/regular-exercise-reshapes-the-immune-system-at-a-cellular-level-study-suggests">Regular exercise reshapes the immune system at a cellular level, study suggests</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/zombified-cells-may-drive-aging-and-scientists-are-devising-new-ways-to-get-rid-of-them">'Zombie cells' may drive aging, and scientists are devising new ways to get rid of them</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/aging-and-inflammation-may-not-go-hand-in-hand-study-suggests">Aging and inflammation may not go hand in hand, study suggests</a></li></ul></p></div></div><p>That points to a key way that immunity in mice and humans is different, which was "underappreciated" before, Gustafson said. So when we're comparing these cells in mice and humans, "we're not looking at apples to apples," she said. Scientists now specifically "need to look more into humans, as it's not reflected in animal models."</p><p>In people, immune cells' features can also vary across diverse human populations, Gustafson added. We need more data across different populations to get a "true understanding of universal immune health," she said. The K-to-B ratio may be a "novel" clue that can help scientists understand healthy aging, but more data is needed to unpack why and how that ratio is linked to healthy or unhealthy aging.</p><p>"This is kind of like the first step to be able to get there," she told Live Science.</p><p>This article is for informational purposes only and is not meant to offer medical advice.</p>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
                                <item>
                                                            <title><![CDATA[ Would you trust AI to calculate your true 'biological age'? ]]></title>
                                                                                                <dc:content><![CDATA[ <p>Scientists have recently harnessed <a href="https://www.livescience.com/technology/artificial-intelligence"><u>artificial intelligence</u></a> (AI) to build "aging clocks" that aim to estimate a person's true biological age. </p><p>While a person's chronological age reflects the number of years they've been alive, their biological age is intended to capture how well their bodily systems are functioning. The idea is that people with older biological ages have a higher risk of age-related diseases ‪—‬ such as <a href="https://www.livescience.com/health/viruses-infections-disease/cancer"><u>cancer</u></a>, <a href="https://www.livescience.com/34733-heart-disease-high-cholesterol-heart-surgery.html"><u>heart disease</u></a> or <a href="https://www.livescience.com/health/alzheimers-dementia/dementia-facts-about-alzheimers-and-other-forms-of-dementia"><u>dementia</u></a> ‪—‬ while younger biological ages come with less risk. Some aging clocks even aim to <a href="https://www.livescience.com/health/ageing/new-biological-aging-test-predicts-your-odds-of-dying-within-the-next-12-months"><u>predict people's impending risk of death</u></a>.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/sped-up-biological-aging-linked-to-worse-memory">Sped-up 'biological aging' linked to worse memory</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/aging-doesnt-look-the-same-for-everyone-at-the-molecular-level-its-individualized-and-context-dependent">Aging doesn't look the same for everyone at the molecular level — it's 'individualized and context-dependent'</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/we-can-identify-these-really-early-before-the-clinical-diagnosis-epigenetics-may-help-explain-why-native-hawaiians-are-aging-faster">'We can identify these really early, before the clinical diagnosis': Epigenetic markers may help explain why Native Hawaiians are aging faster</a></li></ul></p></div></div><p><a href="https://www.livescience.com/health/ageing/aging-clocks-tell-you-how-much-older-you-are-than-your-chronological-age-how-do-they-work"><u>Many aging clocks look at epigenetic markers</u></a>, meaning chemical tags that bind DNA and change how genes activate, while others measure features <a href="https://www.livescience.com/health/aging/your-voice-may-reveal-how-fast-youre-aging-new-ai-speech-clock-suggests"><u>such as the pace and pitch of people's voices</u></a>. But some scientists say we don't know how to use these aging clocks yet, arguing that the tools are <a href="https://www.livescience.com/health/aging/tests-that-measure-biological-age-arent-helpful-for-tracking-your-health-scientists-say"><u>useful for studying aging at a population level</u></a> but not for guiding individual health decisions. </p><p>Others posit that the data the clocks are based on is too noisy, and thus, there's potential for drawing faulty conclusions about what they're measuring. They say, for example, that we don't know if the clocks are <a href="https://www.livescience.com/health/ageing/biological-aging-may-not-be-driven-by-what-we-thought"><u>measuring the downstream effects of aging or its underlying causes</u></a>. And in any case, we don't currently have any treatments to "wind back" the clocks.</p><p>What do you think? Would you use these AI tools to measure your biological age? Let us know in the poll below, and explain your reasoning and additional thoughts about the technology in the comments.</p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xrgy0e"></div>                            </div>                            <script src="https://kwizly.com/embed/Xrgy0e.js" async=""></script> ]]></dc:content>
                                                                                                                                            <link>https://www.livescience.com/health/aging/would-you-trust-ai-to-calculate-your-true-biological-age-poll</link>
                                                                            <description>
                            <![CDATA[ Scientists have developed various AI tools to measure people's biological ages. Would you use one? ]]>
                                                                                                            </description>
                                                                                                                                <guid isPermaLink="false">JJQAbq6iEJinsFgLzBpQYj</guid>
                                                                                                <enclosure url="https://cdn.mos.cms.futurecdn.net/QT2Jq7HvXFkFB9qowu6jMP-1920-80.jpg" type="image/jpeg" length="0"></enclosure>
                                                                        <pubDate>Thu, 08 Oct 2026 16:09:52 +0000</pubDate>                                                                                                                                <updated>Thu, 08 Oct 2026 19:03:43 +0000</updated>
                                                                                                                                            <category><![CDATA[Aging]]></category>
                                                    <category><![CDATA[Health]]></category>
                                                                                                                    <dc:creator><![CDATA[ Nicoletta Lanese ]]></dc:creator>                                                                                    <dc:source><![CDATA[ https://cdn.mos.cms.futurecdn.net/aMtC8hYQZowYSCj5DjpmTE-320-70.png ]]></dc:source>
                                                                <dc:description><![CDATA[ null ]]></dc:description>
                                                                                                                                <cf:isSponsored>false</cf:isSponsored>
                <cf:hasAffiliateLinks>false</cf:hasAffiliateLinks>
                <cf:isPaid>false</cf:isPaid>
                                                                                                                                                                                    <media:content type="image/jpeg" url="https://cdn.mos.cms.futurecdn.net/QT2Jq7HvXFkFB9qowu6jMP-1920-80.jpg">
                                                            <media:credit><![CDATA[Sadik Demiroz via Getty Images]]></media:credit>
                                                                                                                                                                        <media:description><![CDATA[Aging clocks are intended to reflect how well you&amp;#39;re aging, so to speak. Would you use the technology?]]></media:description>                                                            <media:text><![CDATA[A white analog clock with a series of binary numbers in the background]]></media:text>
                                <media:title type="plain"><![CDATA[A white analog clock with a series of binary numbers in the background]]></media:title>
                                                    </media:content>
                                                    <media:thumbnail url="https://cdn.mos.cms.futurecdn.net/QT2Jq7HvXFkFB9qowu6jMP-1920-80.jpg" />
                                                                                                                                                                    <content:encoded >
                            <![CDATA[
                            <article>
                                <p>Scientists have recently harnessed <a href="https://www.livescience.com/technology/artificial-intelligence"><u>artificial intelligence</u></a> (AI) to build "aging clocks" that aim to estimate a person's true biological age. </p><p>While a person's chronological age reflects the number of years they've been alive, their biological age is intended to capture how well their bodily systems are functioning. The idea is that people with older biological ages have a higher risk of age-related diseases ‪—‬ such as <a href="https://www.livescience.com/health/viruses-infections-disease/cancer"><u>cancer</u></a>, <a href="https://www.livescience.com/34733-heart-disease-high-cholesterol-heart-surgery.html"><u>heart disease</u></a> or <a href="https://www.livescience.com/health/alzheimers-dementia/dementia-facts-about-alzheimers-and-other-forms-of-dementia"><u>dementia</u></a> ‪—‬ while younger biological ages come with less risk. Some aging clocks even aim to <a href="https://www.livescience.com/health/ageing/new-biological-aging-test-predicts-your-odds-of-dying-within-the-next-12-months"><u>predict people's impending risk of death</u></a>.</p><div  class="fancy-box"><div class="fancy_box-title">Related stories</div><div class="fancy_box_body"><p class="fancy-box__body-text"><ul><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/ageing/sped-up-biological-aging-linked-to-worse-memory">Sped-up 'biological aging' linked to worse memory</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/aging/aging-doesnt-look-the-same-for-everyone-at-the-molecular-level-its-individualized-and-context-dependent">Aging doesn't look the same for everyone at the molecular level — it's 'individualized and context-dependent'</a></li><li><a data-analytics-id="inline-link" href="https://www.livescience.com/health/genetics/we-can-identify-these-really-early-before-the-clinical-diagnosis-epigenetics-may-help-explain-why-native-hawaiians-are-aging-faster">'We can identify these really early, before the clinical diagnosis': Epigenetic markers may help explain why Native Hawaiians are aging faster</a></li></ul></p></div></div><p><a href="https://www.livescience.com/health/ageing/aging-clocks-tell-you-how-much-older-you-are-than-your-chronological-age-how-do-they-work"><u>Many aging clocks look at epigenetic markers</u></a>, meaning chemical tags that bind DNA and change how genes activate, while others measure features <a href="https://www.livescience.com/health/aging/your-voice-may-reveal-how-fast-youre-aging-new-ai-speech-clock-suggests"><u>such as the pace and pitch of people's voices</u></a>. But some scientists say we don't know how to use these aging clocks yet, arguing that the tools are <a href="https://www.livescience.com/health/aging/tests-that-measure-biological-age-arent-helpful-for-tracking-your-health-scientists-say"><u>useful for studying aging at a population level</u></a> but not for guiding individual health decisions. </p><p>Others posit that the data the clocks are based on is too noisy, and thus, there's potential for drawing faulty conclusions about what they're measuring. They say, for example, that we don't know if the clocks are <a href="https://www.livescience.com/health/ageing/biological-aging-may-not-be-driven-by-what-we-thought"><u>measuring the downstream effects of aging or its underlying causes</u></a>. And in any case, we don't currently have any treatments to "wind back" the clocks.</p><p>What do you think? Would you use these AI tools to measure your biological age? Let us know in the poll below, and explain your reasoning and additional thoughts about the technology in the comments.</p><div style="min-height: 250px;">                                <div class="kwizly-quiz kwizly-Xrgy0e"></div>                            </div>                            <script src="https://kwizly.com/embed/Xrgy0e.js" async=""></script>
                                                            </article>
                            ]]>
                        </content:encoded>
                                                </item>
            </channel>
</rss>